
<html lang="en"     class="pb-page"  data-request-id="6bd18a75-9392-43e3-9a5d-654b4930a943"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2018.61.issue-8;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.7b01795;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Structure-based Design of Pyridone–Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition" /></meta><meta name="dc.Creator" content="Siegfried H.  Reich" /></meta><meta name="dc.Creator" content="Paul A.  Sprengeler" /></meta><meta name="dc.Creator" content="Gary G.  Chiang" /></meta><meta name="dc.Creator" content="James R.  Appleman" /></meta><meta name="dc.Creator" content="Joan  Chen" /></meta><meta name="dc.Creator" content="Jeff  Clarine" /></meta><meta name="dc.Creator" content="Boreth  Eam" /></meta><meta name="dc.Creator" content="Justin T.  Ernst" /></meta><meta name="dc.Creator" content="Qing  Han" /></meta><meta name="dc.Creator" content="Vikas K.  Goel" /></meta><meta name="dc.Creator" content="Edward Z. R.  Han" /></meta><meta name="dc.Creator" content="Vera  Huang" /></meta><meta name="dc.Creator" content="Ivy N. J.  Hung" /></meta><meta name="dc.Creator" content="Adrianna  Jemison" /></meta><meta name="dc.Creator" content="Katti A.  Jessen" /></meta><meta name="dc.Creator" content="Jolene  Molter" /></meta><meta name="dc.Creator" content="Douglas  Murphy" /></meta><meta name="dc.Creator" content="Melissa  Neal" /></meta><meta name="dc.Creator" content="Gregory S.  Parker" /></meta><meta name="dc.Creator" content="Michael  Shaghafi" /></meta><meta name="dc.Creator" content="Samuel  Sperry" /></meta><meta name="dc.Creator" content="Jocelyn  Staunton" /></meta><meta name="dc.Creator" content="Craig R.  Stumpf" /></meta><meta name="dc.Creator" content="Peggy A.  Thompson" /></meta><meta name="dc.Creator" content="Chinh  Tran" /></meta><meta name="dc.Creator" content="Stephen E.  Webber" /></meta><meta name="dc.Creator" content="Christopher J.  Wegerski" /></meta><meta name="dc.Creator" content="Hong  Zheng" /></meta><meta name="dc.Creator" content="Kevin R.  Webster" /></meta><meta name="dc.Description" content="Dysregulated translation of mRNA plays a major role in tumorigenesis. Mitogen-activated protein kinase interacting kinases (MNK)1/2 are key regulators of mRNA translation integrating signals from o..." /></meta><meta name="Description" content="Dysregulated translation of mRNA plays a major role in tumorigenesis. Mitogen-activated protein kinase interacting kinases (MNK)1/2 are key regulators of mRNA translation integrating signals from o..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 10, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01795" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01795" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01795" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01795" /></link>
        
    
    

<title>Structure-based Design of Pyridone–Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01795" /></meta><meta property="og:title" content="Structure-based Design of Pyridone–Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0020.jpeg" /></meta><meta property="og:description" content="Dysregulated translation of mRNA plays a major role in tumorigenesis. Mitogen-activated protein kinase interacting kinases (MNK)1/2 are key regulators of mRNA translation integrating signals from oncogenic and immune signaling pathways through phosphorylation of eIF4E and other mRNA binding proteins. Modulation of these key effector proteins regulates mRNA, which controls tumor/stromal cell signaling. Compound 23 (eFT508), an exquisitely selective, potent dual MNK1/2 inhibitor, was designed to assess the potential for control of oncogene signaling at the level of mRNA translation. The crystal structure-guided design leverages stereoelectronic interactions unique to MNK culminating in a novel pyridone–aminal structure described for the first time in the kinase literature. Compound 23 has potent in vivo antitumor activity in models of diffuse large cell B-cell lymphoma and solid tumors, suggesting that controlling dysregulated translation has real therapeutic potential. Compound 23 is currently being evaluated in Phase 2 clinical trials in solid tumors and lymphoma. Compound 23 is the first highly selective dual MNK inhibitor targeting dysregulated translation being assessed clinically." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01795"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01795">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01795&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01795&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01795&amp;href=/doi/10.1021/acs.jmedchem.7b01795" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 8</span><span class="cit-fg-pageRange">, 3516-3540</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/8" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01775" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b01804" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structure-based Design of Pyridone–Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Siegfried H. Reich</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Siegfried H. Reich</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">eFFECTOR Therapeutics, 11180 Roselle Street, San Diego, California 92121, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Phone 619-729-9526. E-mail: <a href="/cdn-cgi/l/email-protection#cab9b8afa3a9a28aafacacafa9bea5b8e4a9a5a7"><span class="__cf_email__" data-cfemail="ef9c9d8a868c87af8a89898a8c9b809dc18c8082">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Siegfried+H.++Reich">Siegfried H. Reich</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6840-2618" title="Orcid link">http://orcid.org/0000-0002-6840-2618</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Paul A. Sprengeler</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Paul A. Sprengeler</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">eFFECTOR Therapeutics, 11180 Roselle Street, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Paul+A.++Sprengeler">Paul A. Sprengeler</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gary G. Chiang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gary G. Chiang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">eFFECTOR Therapeutics, 11180 Roselle Street, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gary+G.++Chiang">Gary G. Chiang</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3004-7400" title="Orcid link">http://orcid.org/0000-0003-3004-7400</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">James R. Appleman</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">James R. Appleman</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Primmune Therapeutics, Inc., 3210 Merryfield Row, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=James+R.++Appleman">James R. Appleman</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Joan Chen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Joan Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">eFFECTOR Therapeutics, 11180 Roselle Street, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Joan++Chen">Joan Chen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jeff Clarine</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jeff Clarine</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">eFFECTOR Therapeutics, 11180 Roselle Street, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jeff++Clarine">Jeff Clarine</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Boreth Eam</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Boreth Eam</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">eFFECTOR Therapeutics, 11180 Roselle Street, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Boreth++Eam">Boreth Eam</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Justin T. Ernst</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Justin T. Ernst</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">eFFECTOR Therapeutics, 11180 Roselle Street, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Justin+T.++Ernst">Justin T. Ernst</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Qing Han</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Qing Han</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Structure-Based Design, Inc., 6048 Cornerstone Court West #D, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Qing++Han">Qing Han</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Vikas K. Goel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vikas K. Goel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">eFFECTOR Therapeutics, 11180 Roselle Street, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vikas+K.++Goel">Vikas K. Goel</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Edward Z. R. Han</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Edward Z. R. Han</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Structure-Based Design, Inc., 6048 Cornerstone Court West #D, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Edward+Z.+R.++Han">Edward Z. R. Han</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Vera Huang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vera Huang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Molecular Stethoscope, 10835 Road to the Cure #100, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vera++Huang">Vera Huang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ivy N. J. Hung</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ivy N. J. Hung</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">eFFECTOR Therapeutics, 11180 Roselle Street, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ivy+N.+J.++Hung">Ivy N. J. Hung</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Adrianna Jemison</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Adrianna Jemison</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, University of Pennsylvania, 231 South 34th Street, Philadelphia, Pennsylvania 19104, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Adrianna++Jemison">Adrianna Jemison</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Katti A. Jessen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Katti A. Jessen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncternal Therapeutics, 3525 Del Mar Heights Road #821, San Diego, California 92130, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Katti+A.++Jessen">Katti A. Jessen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jolene Molter</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jolene Molter</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">eFFECTOR Therapeutics, 11180 Roselle Street, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jolene++Molter">Jolene Molter</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Douglas Murphy</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Douglas Murphy</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Molcentrics, Inc., 11835 Carmel Mountain Road #1304-110, San Diego, California 92128, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Douglas++Murphy">Douglas Murphy</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Melissa Neal</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Melissa Neal</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">eFFECTOR Therapeutics, 11180 Roselle Street, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Melissa++Neal">Melissa Neal</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gregory S. Parker</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gregory S. Parker</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">eFFECTOR Therapeutics, 11180 Roselle Street, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gregory+S.++Parker">Gregory S. Parker</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michael Shaghafi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael Shaghafi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Abide Therapeutics, 10835 Road to the Cure, Suite 250, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Shaghafi">Michael Shaghafi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Samuel Sperry</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Samuel Sperry</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">eFFECTOR Therapeutics, 11180 Roselle Street, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Samuel++Sperry">Samuel Sperry</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jocelyn Staunton</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jocelyn Staunton</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">eFFECTOR Therapeutics, 11180 Roselle Street, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jocelyn++Staunton">Jocelyn Staunton</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Craig R. Stumpf</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Craig R. Stumpf</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">eFFECTOR Therapeutics, 11180 Roselle Street, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Craig+R.++Stumpf">Craig R. Stumpf</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Peggy A. Thompson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Peggy A. Thompson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">eFFECTOR Therapeutics, 11180 Roselle Street, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Peggy+A.++Thompson">Peggy A. Thompson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Chinh Tran</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chinh Tran</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">eFFECTOR Therapeutics, 11180 Roselle Street, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chinh++Tran">Chinh Tran</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stephen E. Webber</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stephen E. Webber</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Polaris Pharmaceuticals, 9373 Towne Centre Drive #150, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stephen+E.++Webber">Stephen E. Webber</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christopher J. Wegerski</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christopher J. Wegerski</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">eFFECTOR Therapeutics, 11180 Roselle Street, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+J.++Wegerski">Christopher J. Wegerski</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hong Zheng</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hong Zheng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Structure-Based Design, Inc., 6048 Cornerstone Court West #D, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hong++Zheng">Hong Zheng</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Kevin R. Webster</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kevin R. Webster</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">eFFECTOR Therapeutics, 11180 Roselle Street, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kevin+R.++Webster">Kevin R. Webster</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01795&amp;href=/doi/10.1021%2Facs.jmedchem.7b01795" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 8</span><span class="cit-pageRange">, 3516–3540</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 10, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>5 December 2017</li><li><span class="item_label"><b>Published</b> online</span>10 March 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 April 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01795" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01795</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3516%26pageCount%3D25%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DSiegfried%2BH.%2BReich%252C%2BPaul%2BA.%2BSprengeler%252C%2BGary%2BG.%2BChiang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D8%26contentID%3Dacs.jmedchem.7b01795%26title%3DStructure-based%2BDesign%2Bof%2BPyridone%25E2%2580%2593Aminal%2BeFT508%2BTargeting%2BDysregulated%2BTranslation%2Bby%2BSelective%2BMitogen-activated%2BProtein%2BKinase%2BInteracting%2BKinases%2B1%2Band%2B2%2B%2528MNK1%252F2%2529%2BInhibition%26numPages%3D25%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3540%26publicationDate%3DApril%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01795"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">5085</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">68</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01795" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structure-based Design of Pyridone–Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Siegfried&quot;,&quot;last_name&quot;:&quot;H. Reich&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;A. Sprengeler&quot;},{&quot;first_name&quot;:&quot;Gary&quot;,&quot;last_name&quot;:&quot;G. Chiang&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;R. Appleman&quot;},{&quot;first_name&quot;:&quot;Joan&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Jeff&quot;,&quot;last_name&quot;:&quot;Clarine&quot;},{&quot;first_name&quot;:&quot;Boreth&quot;,&quot;last_name&quot;:&quot;Eam&quot;},{&quot;first_name&quot;:&quot;Justin&quot;,&quot;last_name&quot;:&quot;T. Ernst&quot;},{&quot;first_name&quot;:&quot;Qing&quot;,&quot;last_name&quot;:&quot;Han&quot;},{&quot;first_name&quot;:&quot;Vikas&quot;,&quot;last_name&quot;:&quot;K. Goel&quot;},{&quot;first_name&quot;:&quot;Edward&quot;,&quot;last_name&quot;:&quot;Z. R. Han&quot;},{&quot;first_name&quot;:&quot;Vera&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Ivy&quot;,&quot;last_name&quot;:&quot;N. J. Hung&quot;},{&quot;first_name&quot;:&quot;Adrianna&quot;,&quot;last_name&quot;:&quot;Jemison&quot;},{&quot;first_name&quot;:&quot;Katti&quot;,&quot;last_name&quot;:&quot;A. Jessen&quot;},{&quot;first_name&quot;:&quot;Jolene&quot;,&quot;last_name&quot;:&quot;Molter&quot;},{&quot;first_name&quot;:&quot;Douglas&quot;,&quot;last_name&quot;:&quot;Murphy&quot;},{&quot;first_name&quot;:&quot;Melissa&quot;,&quot;last_name&quot;:&quot;Neal&quot;},{&quot;first_name&quot;:&quot;Gregory&quot;,&quot;last_name&quot;:&quot;S. Parker&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Shaghafi&quot;},{&quot;first_name&quot;:&quot;Samuel&quot;,&quot;last_name&quot;:&quot;Sperry&quot;},{&quot;first_name&quot;:&quot;Jocelyn&quot;,&quot;last_name&quot;:&quot;Staunton&quot;},{&quot;first_name&quot;:&quot;Craig&quot;,&quot;last_name&quot;:&quot;R. Stumpf&quot;},{&quot;first_name&quot;:&quot;Peggy&quot;,&quot;last_name&quot;:&quot;A. Thompson&quot;},{&quot;first_name&quot;:&quot;Chinh&quot;,&quot;last_name&quot;:&quot;Tran&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;E. Webber&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;J. Wegerski&quot;},{&quot;first_name&quot;:&quot;Hong&quot;,&quot;last_name&quot;:&quot;Zheng&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;R. Webster&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;10&quot;,&quot;issue&quot;:&quot;8&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;3516-3540&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01795&quot;},&quot;abstract&quot;:&quot;Dysregulated translation of mRNA plays a major role in tumorigenesis. Mitogen-activated protein kinase interacting kinases (MNK)1/2 are key regulators of mRNA translation integrating signals from oncogenic and immune signaling pathways through phosphorylation of eIF4E and other mRNA binding proteins. Modulation of these key effector proteins regulates mRNA, which controls tumor/stromal cell signaling. Compound 23 (eFT508), an exquisitely selective, potent dual MNK1/2 inhibitor, was designed to assess the potential for control of oncogene signaling at the level of mRNA translation. The crystal structure-guided design leverages stereoelectronic interactions unique to MNK culminating in a novel pyridone–aminal structure described for the first time in the kinase literature. Compound 23 has potent in vivo antitumor activity in models of diffuse large cell B-cell lymphoma and solid tumors, suggesting that controlling dysregulated translation has real therapeutic potential. Compound 23 is currently being evaluated &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01795&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01795" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01795&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01795" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01795&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01795" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01795&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01795&amp;href=/doi/10.1021/acs.jmedchem.7b01795" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01795" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01795" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (14 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01795%26sid%3Dliteratum%253Aachs%26pmid%3D29526098%26genre%3Darticle%26aulast%3DReich%26date%3D2018%26atitle%3DStructure-based%2BDesign%2Bof%2BPyridone%25E2%2580%2593Aminal%2BeFT508%2BTargeting%2BDysregulated%2BTranslation%2Bby%2BSelective%2BMitogen-activated%2BProtein%2BKinase%2BInteracting%2BKinases%2B1%2Band%2B2%2B%2528MNK1%252F2%2529%2BInhibition%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D8%26spage%3D3516%26epage%3D3540%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291297" title="Cell signaling">Cell signaling</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/8" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/jmcmar.2018.61.issue-8/20180426/jmcmar.2018.61.issue-8.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/medium/jm-2017-01795d_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01795&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Dysregulated translation of mRNA plays a major role in tumorigenesis. Mitogen-activated protein kinase interacting kinases (MNK)1/2 are key regulators of mRNA translation integrating signals from oncogenic and immune signaling pathways through phosphorylation of eIF4E and other mRNA binding proteins. Modulation of these key effector proteins regulates mRNA, which controls tumor/stromal cell signaling. Compound <b>23</b> (eFT508), an exquisitely selective, potent dual MNK1/2 inhibitor, was designed to assess the potential for control of oncogene signaling at the level of mRNA translation. The crystal structure-guided design leverages stereoelectronic interactions unique to MNK culminating in a novel pyridone–aminal structure described for the first time in the kinase literature. Compound <b>23</b> has potent <i>in vivo</i> antitumor activity in models of diffuse large cell B-cell lymphoma and solid tumors, suggesting that controlling dysregulated translation has real therapeutic potential. Compound <b>23</b> is currently being evaluated in Phase 2 clinical trials in solid tumors and lymphoma. Compound <b>23</b> is the first highly selective dual MNK inhibitor targeting dysregulated translation being assessed clinically.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20111" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20111" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Translation, the most energy consuming process in the cell, plays a significant role in gene regulation and ultimately the control of protein levels. The precept that there is a direct correspondence between the abundance of mRNA and that of its corresponding protein product is an oversimplification. Translation is a tightly controlled process for a select set of mRNAs, and dysregulation of this process drives aberrant proliferation, angiogenesis, survival, and alterations in immune function, all hallmarks of cancer (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5">(1−5)</a> The key step of cap-dependent translation initiation relies upon the availability and activity of eukaryotic initiation factor eIF4E, which is in turn regulated by the mitogen-activated protein kinase interacting kinases (MNK)1/2.<a onclick="showRef(event, 'ref6 ref7 ref8 ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8 ref9 ref10 ref11">(6−11)</a> The MNKs are activated by upstream Ras/Raf/Erk and MyD88/p38 signaling pathways, resulting in regulation of RNA translation through eIF4E and other key effector proteins such as heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) and protein-associated splicing factor (PSF).<a onclick="showRef(event, 'ref1 ref2 ref4 ref12 ref13 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref4 ref12 ref13 ref14 ref15 ref16">(1,2,4,12−16)</a> Phosphorylation of these mRNA binding proteins selectively regulates the translation and stability of a subset of cellular mRNA that control both tumor and stromal cell signaling. MNK, a Ser/Thr kinase, is the only kinase known to phosphorylate eIF4E at serine 209. This modification has been shown to be essential for eIF4E’s role in tumorigenesis but not for normal development and cell homeostasis. MNK1/2 double knockout studies in mice further demonstrated that these kinases are not required for normal growth and development.<a onclick="showRef(event, 'ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19">(17−19)</a> Thus, the underlying genetics of MNK lead to an expectation that a potent and selective MNK inhibitor would not necessarily have a strong antiproliferative phenotype but would limit cellular processes necessary for oncogene driven signaling and survival, sparing normal tissues and offering the potential for a good therapeutic window. This distinction between transformed versus normal cells makes the MNKs particularly exciting as a therapeutic opportunity. Interestingly, the literature has examples of less selective MNK inhibitors that do have a broad antiproliferative phenotype, which may be a result of off-target effects unrelated to MNK.<a onclick="showRef(event, 'ref20 ref21 ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22 ref23 ref24">(20−24)</a> Other MNK inhibitors have demonstrated improved selectivity.<a onclick="showRef(event, 'ref25 ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27 ref28">(25−28)</a> While the biology of MNK and its effects on tumorigenesis have been the subject of many studies, the breadth of these effects, particularly through pharmacological intervention, has not been demonstrated for a potent, selective dual MNK inhibitor to date. As a consequence, the full potential for control of mRNA translation via MNK in cancer therapy has not been revealed.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/medium/jm-2017-01795d_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0001.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Translation is a tightly controlled process for a select set of mRNAs and dysregulation of this process drives aberrant proliferation, angiogenesis, survival, and alterations in immune function, all hallmarks of cancer. The key step of cap-dependent translation initiation by the eIF4F complex relies upon the availability of eukaryotic initiation factor eIF4E, which is in turn regulated by the mitogen-activated protein kinase interacting kinases MNK1/2. The MNKs are key regulators of mRNA translation integrating signals from oncogenic and immune signaling pathways (Ras, p38, TCR, and TLRs).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01795&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">As a result, we sought to identify a dual MNK1/2 inhibitor with both exceptional kinome selectivity and cellular potency so that the pharmacologic phenotype of MNK1/2 inhibition could be fully explored. We have designed a highly selective and potent MNK1/2 inhibitor, compound <b>23</b> (eFT508), leveraging the unique active site of this kinase in an iterative structure-based approach.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The pyridone-aminal chemotype has not been reported in kinase inhibitors to date.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30,31)</a> Compound <b>23</b> activity in models of diffuse large cell B-cell lymphoma (DLBCL) is associated with potent p-eIF4E knockdown and selective destabilization of pro-inflammatory cytokine mRNA. Pro-inflammatory cytokines, including interleukin-6 (IL-6), interleukin-8 (IL-8), and TNFα, are drivers of many hallmarks of cancer, e.g., tumor cell survival, migration and invasion, angiogenesis, immune evasion, and stress response, while affecting drug resistance.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32,33)</a> Importantly, this p-eIF4E and cytokine knockdown translates into potent <i>in vivo</i> antitumor activity in DLBCL models harboring activating MyD88 mutations, consistent with the MNKs being activated by TLR signaling.<a onclick="showRef(event, 'ref13 ref32'); return false;" href="javascript:void(0);" class="ref ref13 ref32">(13,32)</a> In addition, efficacy has been demonstrated in solid tumor settings, which may reflect the MNKs’ impact on mRNA translation that controls tumor and stromal cell signaling. This breadth of antitumor activity highlights the significant potential for control of dysregulated translation by a small molecule inhibitor.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Compound <b>23</b> is currently in Phase 2 clinical trials for the treatment of both solid and hematologic cancers and has been granted Orphan Drug status by the FDA for the treatment of DLBCL.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03654" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03654" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Molecular Design Strategy Leading to the Pyridone–Aminal Chemotype</h3><div class="NLM_p">A common approach to selective kinase inhibition is to begin with a molecule that contains a potent hinge binding motif and whose shape complements the targeted kinase. Additional groups are then added that are tolerated by the kinase of interest but make negative interactions with the antitargets.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Our approach to MNK inhibitor design focused on incorporating <i>favorable</i> stereoelectronic interactions with the MNK active site residues that differentiate it from other kinases. Stereoelectronic interactions are highly sensitive to distance and orientation, which can improve selectivity.<a onclick="showRef(event, 'ref35 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37">(35−37)</a> These interactions are often less affected by solvation, which can enhance potency and permeability. There are several atypical residues in the ATP binding site of MNK1/2, two of which offered the greatest opportunity for stereoelectronic interactions, the gatekeeper, Phe159, and the pre-DFG residue, Cys225, and these were the focus of our design.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Across the kinome, only Flt3 and 4, cyclin-dependent kinase-like (CDKL)1–5, PRP4 (serine/threonine-protein kinase-PRP4), a dual specificity tyrosine-phosphorylation-regulated kinase family kinase, mitogen-activated protein kinase-7, and MNK have this combination suggesting that interacting with these residues in a ligand efficient manner could facilitate the design of MNK-selective inhibitors (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A). A unique sequence element in the MNK1/2 kinases is a DFD motif in place of the canonical DFG; however, these residues are more distant from the hinge.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> The active sites of MNK1 and MNK2 are nearly identical (90%), so there was an expectation that achieving similar affinity for both isoforms should be feasible.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Dual inhibition was thought to be necessary as the isoforms can compensate for one another in the phosphorylation of eIF4E.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/medium/jm-2017-01795d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0002.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Crystal structures were obtained with MNK2 mutated to the canonical DFG from DFD to facilitate cocrystallization experiments.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> (A) Cocrystal structure showing the MNK2 active site with carboxamide <b>1</b> bound along with its binding data (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CJE">6CJE</a>). The surface representation of the electrostatic potential of Phe159 was calculated by DFT using the B3LYP method employing the 6-31G* basis set with Spartan (Wavefunction). (B) MNK2 crystal structure and binding data of compound <b>2</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CJW">6CJW</a>). (C) Compound <b>3</b> structure and data (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CJH">6CJH</a>). (D) One conformation of the compound <b>4</b> cocrystal structure along with its binding data (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CJ5">6CJ5</a>). (E,F) Two-dimensional structures and data for the compounds for which a cocrystal structure with MNK2 was not obtained, <b>5</b> and <b>6</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01795&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Our early strategy was to identify a chemical starting point with high ligand efficiency. Time spent on identifying the best starting scaffold and then maintaining its attributes can greatly facilitate medicinal chemistry success later; this is the underlying principle of fragment-based drug discovery wherein a priority is placed on ligand efficiency and physicochemical properties at the outset of design. We identified six initial fragments or fragment-like scaffolds (15–20 heavy atoms, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A–F). Compounds <b>1</b>, <b>2</b>, <b>3</b>, and <b>6</b> were in the public domain, and <b>4</b> and <b>5</b> were designed using common kinase inhibitor hinge binding motifs modeled into the MNK2 crystal structure. We utilized a mutated MNK protein for crystallization as it has been shown that mutation of the WT MNK from DFD to the more canonical DFG results in a more readily crystallized protein.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> All had good affinity for MNK as measured by their MNK1 IC<sub>50</sub> and ligand efficiency. We attempted to obtain crystal structures of each compound in complex with mutated MNK2 to understand their potential for making protein interactions and facilitate the design of a cohort of initial follow-on molecules; structures were obtained for four of the six. <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A shows the cocrystal structure of carboxamide <b>1</b> in the MNK2 active site and highlights the electrostatic potential of the gatekeeper residue Phe159 and the cone representing the nucleophilic directionality of the sulfur of the pre-DFG Cys225. The negative potential of the Phe159 face suggested that ligand moieties having positive potential (i.e., the edge of an aromatic ring, a methyl group, a polarizable atom, etc.) would be complementary. This structure indicated potential interactions were possible with both key residues, Phe159 and Cys225, for compound <b>1</b> optimization. It also revealed that the N-9 nitrogen of the imidazole ring was engaged with the hinge through a 3.5 Å hydrogen bond to the Met162 carbonyl oxygen, a weak interaction. The binding mode of compound <b>2</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B) also showed good potential for interactions with Phe159 and Cys225 (compound <b>2</b> shares the imidazo[1,2-<i>b</i>]pyridazine core of BAY1143269).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Compound <b>3</b>, however, did not make intimate interactions with either the gatekeeper or the hinge, and its suitability for engaging Cys225 was deemed low. Compound <b>4</b> crystallized in two conformations (only the pose most representative of the series shown), and similar to <b>3</b>, the ability of compound <b>4</b> to interact with the gatekeeper and Cys225 was considered to be marginal. The crystal structures for <b>5</b> and <b>6</b> could not be determined; nevertheless, a small cohort of compounds was designed using all six fragments as starting points, and the potency trajectory of each scaffold was assessed (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). The carboxamide scaffold <b>1</b> emerged as the preferred structure, having one of the highest ligand efficiencies and good vectors allowing rapid optimization to low nanomolar binding to MNK with less than 20 compounds. The purine was deconstructed to pyrimidine <b>7</b> resulting in a 10-fold loss in potency; however, the molecular weight and logP were reduced, and ligand efficiency was maintained (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). A loss of potency in exchange for improved physicochemical properties is an often overlooked yet powerful optimization strategy in medicinal chemistry. Lactam compound <b>8</b> was designed through analysis of the cocrystal structure of compound <b>1</b> and was 2.5-fold more active. This lactam was expected to have improved permeability due to the loss of one hydrogen bond donor. Furthermore, introduction of the lactam sp<sup>3</sup> carbon afforded vectors out of the aryl plane. We thought substitution of this buried methylene might force the bicyclic ring system to flip 180° accommodating the increased size of this substitution and accessing the p-loop, a rich source of kinase binding affinity. Compound <b>9</b> was 25-fold more potent than the original carboxamide <b>7</b>, and the cocrystal structure showed that the ring flip had indeed occurred relative to its unsubstituted counterpart compound <b>8</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Linkers between the pyrimidine and benzene rings other than nitrogen (i.e., C, O, or S) and replacement of the pyrimidine with pyridine consistently resulted in less active molecules likely due to reduced planarity.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/medium/jm-2017-01795d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0003.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Trajectory of the series based on each of the starting molecules. Plot generated by only showing data for compounds that improve potency over the proceeding compounds, otherwise the previous molecules data was plotted (an exception was made for the Cmpd 1 Series where the first loss in potency from deconstruction is plotted).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01795&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/medium/jm-2017-01795d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0004.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Comparison of the binding modes from cocrystal structures of compounds <b>8</b> (green, PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CJY">6CJY</a>) and <b>9</b> (salmon, PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CK3">6CK3</a>) confirming the ring flip and orientation of the sp<sup>3</sup> substituent toward the p-loop of MNK (p-loop located above the plane and not shown for clarity). The distance to the hinge Met226 NH for compound <b>9</b> was 3 Å vs 3.5 Å for compound <b>8</b> suggesting improved binding. The figure was generated by overlapping the protein C-alphas for each cocrystal structure of compounds <b>8</b> and <b>9</b>; only the protein for compound <b>9</b> is displayed.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01795&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Biochemical and Cellular Potency and Associated Physicochemical Properties of Key Compounds in the Primary Series<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/medium/jm-2017-01795d_0017.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup><sup>a</sup></sup><p class="last">LE = 1.36 × pIC<sub>50</sub>/HAC (HAC = heavy atom count); LLE = pIC<sub>50</sub> – clogP; XlogP = calculated using Dotmatics (IPCPU).</p></div></div><div></div></div><div class="NLM_p">As described previously, the sulfur of Cys225 can make favorable stereoelectronic interactions affording the potential to both increase potency and selectivity (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A).<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Heterocycles in general can interact positively with cysteines, and several tested were effective binders. A single attempt at covalent interaction with Cys225 with a α,β-unsaturated amide was unsuccessful, suggesting that Cys225 is not particularly reactive. Stereoelectronic interactions of atoms having free lone pairs of electrons with carbonyl groups in a manner similar to the Dunitz attack for amide hydrolysis are observed quite often in crystal structures both in the PDB and CSD databases.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40,41)</a> Highly polarizable chlorine and sulfur atoms are especially capable of engaging in this type of interaction, but it is also observed for fluorine, oxygen, and nitrogen. The pyridone ring system of <b>11</b> was designed to provide a stereoelectronic (Dunitz) interaction with Cys225 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A). While <b>11</b> was four-fold less active in terms of binding affinity, importantly, its clogP was almost two orders of magnitude lower (XlogP = −0.99, Dotmatics) than its benzene counterpart <b>7</b> as reflected in the 16-fold improvement in lipophilic ligand efficiency (LLE) (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, 6.5 – 5.3 = 1.2, 10<sup>1.2</sup> = 16).<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> This modest reduction in binding affinity commensurate with a 72-fold reduction in lipophilicity was a critical result in the overall optimization process. The <i>gem</i>-dimethyl pyridone, compound <b>12</b>, was equipotent with its benzene counterpart <b>10</b>, maintaining the 17-fold improvement in LLE. The cocrystal structure of <b>12</b> confirmed that atom distances and angles between the sulfur atom and carbonyl were consistent with a Dunitz interaction (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B). Comparison of the kinome profiles of <b>10</b> and <b>12</b> (>400 kinases) showed that the pyridone imparts selectivity over the benzene ring (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C). This trend for greater selectivity was observed across additional pyridone–benzene pairs.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/medium/jm-2017-01795d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0005.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Depiction of the Dunitz interaction between a sulfur atom and the LUMO of an amide bond as found in compound <b>11</b>. (B) Crystal structure of compound <b>12</b> bound to MNK2 showing the interaction of the Cys225 sulfur with the carbonyl carbon of the pyridone (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CKI">6CKI</a>). (C) Visual depiction of the kinome selectivity difference between compounds <b>10</b> and <b>12</b> (see data in <a href="/doi/suppl/10.1021/acs.jmedchem.7b01795/suppl_file/jm7b01795_si_002.pdf" class="ext-link">Table S3</a>). The plot shows the MNK2% inhibition of the first 100 kinases in a 419 kinase panel screen of compounds <b>10</b> and <b>12</b> at 1 μM. For each compound, the kinases were sorted by percent inhibition, numbered from 1 to 419, and the % inhibition for each is plotted by kinase number. Green vertical lines indicate MNK1 and MNK2 for each profile. The plot shows the first 100 kinases and reveals that area under the curve described by compound <b>12</b> is 20% less than that of compound <b>10</b>. In addition, compound <b>12</b> at 1 μM inhibited MNK1 and MNK2 at 83 and 68%, respectively, while inhibiting only five other kinases >40% and one at 86%. Conversely, compound <b>10</b> in the same experiment inhibited MNK1 and 2 at 84 and 66%, respectively, but inhibited nine other kinases >40% and two at 100 and 91%, respectively. A similar trend was observed for other pyridone/benzene pairs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01795&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Another advantage of the pyridone scaffold was its considerably more facile synthesis and exceptional chemical stability. The pyridone aminal could be readily substituted by simply heating the pyridone carboxamide with a ketone in strong acid (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A and <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>), a big improvement over the generally low yielding alkylation strategy required for the benzolactam. As a consequence of this simple condensation, greater diversity could now be incorporated at the aminal carbon as outlined in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A, facilitating the exploration of potential interactions with the p-loop.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/medium/jm-2017-01795d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0006.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Facile formation of stable pyridone–aminal via acid-catalyzed ketone condensation. (B) Properties of the structure-guided focused pyridone library (80 compounds). Note that the compounds that are exceptionally potent fall in the area of higher logP and molecular weight noted in light blue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01795&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Pyridone Cellular eIF4E-Ser209 Phosphorylation Potency</h3><div class="NLM_p">A focused protein structure-guided library was pursued, and the properties of this library are depicted in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B. The compounds are segregated by potency and substitution pattern and cover a spectrum of both clogP (XlogP) and MW.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Potential substituents off of the aminal carbon with MW < 200 were modeled into the MNK crystal structure, taking into account that the p-loop is quite flexible. Compounds that were exceptionally potent fell into the area of unfavorably high logP and high molecular weight (shaded area, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B). Highly substituted spirocyclic compounds were preferred, with six-membered rings showing the best kinome selectivity. Chiral compounds at the aminal carbon had no advantage in terms of potency or selectivity over achiral molecules so the latter became the focus of further design. The potencies of the compounds were routinely at the lower limit of the ATP competitive biochemical assay (ca. 1.5 nM) so the inhibition of eIF4E phosphorylation in cells was used to track potency. Cellular potency was improved 30–300-fold (cf. <b>12</b> to <b>17</b>) by incorporation of a cyclopropylamide in the 4-position of the pyrimidine <b>16</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). This moiety has led to improved potency in inhibitors targeting other kinases, e.g., JAK2, TYK2, bRAF, Abl, VEGFR2, etc.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Comparison of Biochemical, Cellular Potency (p-eIF4E), and Proliferation Data for Compounds <b>17</b>, <b>18</b>, and <b>19</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/medium/jm-2017-01795d_0018.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Fifty kinases tested at 1 μM compound.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">KDR, Abl1, RET, Flt3.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">Flt3, KDR, RET, YES1, ABL1, DYRK1A, PDGFRB, LCK, Aurora A, PDGFRA.</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">DYRK1A, Flt3, CDK2, CLK1, PDGFRB, PDGFRA, PlM1, CAMK2A, ROCK1, IRAK1, AMPK A1/B1/G1, LCK, TRKA, KDR, BRAF, MEK2, RSK1.</p></div></div><div></div></div><div class="NLM_p">Antiproliferative effects were correlated with lack of kinase selectivity. Compound <b>17</b>, having single digit nanomolar cell potency for eIF4E phosphorylation and good selectivity for MNK1/2, showed no antiproliferative effects in three solid tumor cell lines (PC3, HCT-116, SW-620). In contrast, compounds <b>18</b> and <b>19</b> with less MNK1/2 selectivity demonstrated antiproliferative effects across multiple cell lines (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Compound <b>18</b> is an example from the structure-guided library described above, which is potent; however, it is chiral, has higher MW, and has higher logP. Potent cellular inhibition of p-eIF4E along with the <i>absence</i> of an antiproliferative signal was used as a measure of on-target selectivity not usually possible in an oncology drug discovery program. Compound <b>17</b> demonstrated target engagement over the dosing period as measured by p-eIF4E reduction and, when dosed <i>in vivo</i>, showed antitumor activity.</div><div class="NLM_p">As described earlier, the ring flip observed for substituted lactams and aminals created an unfilled pocket adjacent to gatekeeper residue Phe159, which was our second residue of focus in the initial analysis. We hypothesized that this space might accommodate a single heavy atom positioned in the 5-position of the pyridone ring. A greater than 50-fold improvement in potency was observed with a 5-chlorine followed closely by a 5-methyl, whereas a 5-fluorine had significantly less benefit (compounds <b>15</b>, <b>14</b>, and <b>13</b> vs <b>12</b>, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <named-content content-type="anchor" rid="fig7" type="simple"></named-content><a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). The enhanced affinity of the chlorine and methyl group is consistent with their ability to interact with the negative potential of the Phe159 aryl face, as revealed by the electrostatic potential analysis (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A). The methyl substituent provided the best balance of kinome selectivity and potency enhancement overall.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/medium/jm-2017-01795d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0007.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) Cocrystal structure of <b>23</b> bound to MNK2 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CK6">6CK6</a>). Compound <b>23</b> makes H-bond interactions with both hinge residues, Lys161 and Met162. The pyridone methyl interacts with the face of Phe159, and the Cys225 sulfur makes a similar Dunitz interaction as seen for compound <b>12</b> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B). In addition, the five-membered ring amide nitrogen interacts with Asp226. (B) Kinome plot depicting the selectivity of <b>23</b> across >400 kinases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01795&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/medium/jm-2017-01795d_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0023.jpeg" id="gr101" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Plot showing the biochemical MNK IC<sub>50</sub> for compounds in the diarylamine series (including both pyridones and nonpyridones) leading up to <b>23</b>. The roadmap for the key molecules discussed in the text (circled in green) highlighting strategic potency loss (red vertical lines) and the key contenders for the candidate selection (circled in purple). Strategic potency losses: (A) Deconstruction of the hinge binder (increase in novelty); (B) incorporation of the pyridone (shift to lower logP); and (C) replacement of the 5-chloro on the pyridone ring with methyl (selectivity improvement). Note that for all of these key changes, the corresponding LE and LLE were largely maintained throughout the optimization.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01795&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Final Optimization and Identification of Compound <b>23</b></h3><div class="NLM_p">It was found that an unsubstituted 4-amino pyrimidine was able to maintain the hydrogen bond to Met162 backbone carbonyl as was observed with the cyclopropyl amide (cf. compound <b>20</b> vs <b>21</b>), but importantly, the free amino group abrogated metabolism observed for molecules with spirocarbocycles off the pyridone aminal. While the cyclopropylamide improved potency, it was also slightly less selective, adding five additional heavy atoms with an increased logP; therefore, we focused on 4-aminopyrimidines. A chlorine in the 5-position of the pyrimidine provided up to a log of additional affinity likely through a favorable interaction with the carbonyl of Leu90 (compound <b>22</b>, 84 pM cell activity, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_p">Starting with and maintaining good overall physicochemical properties along with the above potency enhancements provided a cohort of optimized molecules having low nanomolar cellular p-eIF4E potency, <i>in vivo</i> efficacy, good metabolic stability, and kinome selectivity. These were narrowed further based on multispecies pharmacokinetics (mouse, rat, dog, and monkey; <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Compound <b>23</b> had the best overall profile and was consistently the top performer in tumor growth inhibition (TGI) and pharmacokinetic/pharmacodynamic (PK/PD) studies and was therefore selected as the development candidate (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>). The crystal structure of compound <b>23</b> is shown in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A and confirms the pyridone’s involvement in a Dunitz interaction with the Cys225 sulfur.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/medium/jm-2017-01795d_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0008.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Compound <b>23</b> and some of its key properties.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01795&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Key Data for Compounds <b>21</b> and <b>23</b>–<b>26</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/medium/jm-2017-01795d_0019.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Percent compound remaining after 30 min incubation.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">From solution formulations using a 1 mg/kg IV dose.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">10 mg/kg oral dose.</p></div><div class="footnote" id="t3fn4"><sup><sup>d</sup></sup><p class="last">5 mg/kg oral dose.</p></div><div class="footnote" id="t3fn5"><sup><sup>e</sup></sup><p class="last">3 mg/kg oral dose.</p></div><div class="footnote" id="t3fn6"><sup><sup>f</sup></sup><p class="last">Determined at Absorbtion System, LLC.</p></div></div><div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Compound <b>23</b> Is a Potent Inhibitor of MNK1 and MNK2 Signaling and Tumor Growth</h3><div class="NLM_p">We examined the effect of compound <b>23</b> on eIF4E phosphorylation in an expanded set of tumor cell lines using the p-eIF4E Ser209 homogeneous time-resolved fluorescence (HTRF) assay. In all cell lines tested, compound <b>23</b> inhibited Ser209 phosphorylation of eIF4E with IC<sub>50</sub> values ranging from 1.4 to 22 nM (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01795/suppl_file/jm7b01795_si_002.pdf" class="ext-link">Table S1</a>). The effect of compound <b>23</b> on eIF4E Ser209 phosphorylation is specific to MNK1/2 inhibition, as overexpression of wild-type or a <b>23</b>-resistant allele of MNK2 (C225L) is sufficient to increase the <b>23</b> IC<sub>50</sub> 100- to 860-fold, respectively (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01795/suppl_file/jm7b01795_si_002.pdf" class="ext-link">Figure S2A</a>). Consistent with the HTRF results, potent dose-dependent inhibition of eIF4E Ser209 phosphorylation was observed by immunoblot analysis (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>A and <a href="/doi/suppl/10.1021/acs.jmedchem.7b01795/suppl_file/jm7b01795_si_002.pdf" class="ext-link">S2B</a>). In addition, compound <b>23</b> did not affect expression of 4E-BP1 or its phosphorylation at Thr37 or Thr46. Importantly, phosphorylation of MAPK at Thr202/Tyr204 was also unaffected by compound <b>23</b>, demonstrating that <b>23</b> did not impact the activation status of signaling pathways that lie upstream of MNK1/2. We next expanded our analysis to growth factor and cytokine signaling pathways following compound <b>23</b> treatment. Treatment of TMD8 cells with <b>23</b> led to a dose-dependent reduction in secreted IL-6, IL-8, and TNFα (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>B–D). Mechanistically, the decreased cytokine production arising from <b>23</b> treatment of TMD8 cells corresponded with reduced mRNA stability (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>E), which is consistent with previous reports implicating MNK kinases in regulating the phosphorylation of RNA binding proteins.<a onclick="showRef(event, 'ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14">(12−14)</a></div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/medium/jm-2017-01795d_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0009.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Compound <b>23</b> inhibits MNK signaling and the production of pro-inflammatory cytokines important for tumorigenesis. (A) TMD8 cells were treated with the indicated concentrations of <b>23</b> for 2 h. Cell lysates were analyzed by immunoblotting with the indicated antibodies. (B–D) TMD8 cells were treated with the indicated concentrations of <b>23</b> for 48 h. Cell supernatants were collected, and the indicated cytokines were quantitated by ELISA. (E) TMD8 cells were treated with 10 μM <b>23</b> for 24 h. Actinomycin D was added, and RNA was harvested from the cells at various time points (0–360 min). Quantitation of RNA was performed by TaqMan assay, and calculated mRNA half-lives are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01795&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Other small molecule inhibitors possessing activity against MNK1/2, such as cercosporamide, CGP57380, merestinib, and cabozatinib, show antiproliferative activity in cell-based assays, which could potentially be attributed to their broader kinome activity as we also observed similar effects with our less-selective MNK1/2 compounds.<a onclick="showRef(event, 'ref20 ref21 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref23 ref24">(20,21,23,24)</a> In contrast, compound <b>23</b> did not show antiproliferative activity in a panel of solid and hematological tumor cell lines (IC<sub>50</sub> > 30 μM), although modest sensitivity (IC<sub>50</sub> < 10 μM) was observed in a subset of DLBCL and a multiple myeloma cell line (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01795/suppl_file/jm7b01795_si_002.pdf" class="ext-link">Figure S3</a>). This finding is not surprising given that genetic studies demonstrate that MNK1/2 is dispensable for normal growth but required for oncogene-induced transformation as assessed by anchorage-independent growth <i>in vitro</i> or tumorigenesis <i>in vivo</i>. The sensitivity observed in the DLBCL cell lines is consistent with previous studies demonstrating a role for MNK kinases in integrating signals from TLRs to regulate pro-inflammatory cytokines.<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43,44)</a> In particular, TMD8 cells harbor activating mutations in myeloid differentiation primary response gene 88 and CD79 and exhibit constitutive TLR pathway signaling, consistent with their sensitivity to <b>23</b>. In addition, elevated levels of eIF4E have been observed in DLBCL patient samples.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></div><div class="NLM_p">Compound <b>23</b> potently inhibited eIF4E phosphorylation, select mRNA stability, and pro-inflammatory cytokine production in DLBCL cells; we therefore examined the efficacy of <b>23</b> in a TMD8 xenograft model. Compound <b>23</b> was well-tolerated at doses of 1 and 10 mg/kg QD as measured by lack of body weight loss (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01795/suppl_file/jm7b01795_si_002.pdf" class="ext-link">Figure S4</a>), which corresponds to a minimal therapeutic index of ≥10 in this model. Furthermore, <b>23</b> treatment produced significant TGI over a 10-fold dose range, achieving an average TGI of 71% and 75% when dosed orally at 1 and 10 mg/kg QD, respectively (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>A). We also observed similar activity in HBL-1 xenografts, an additional model of MyD88/CD79 mutant DLBCL (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>B). Again, compound <b>23</b> was well-tolerated in the animals, and treatment resulted in an average TGI of 66% and 96%, when dosed at 1 or 10 mg/kg QD, respectively. This activity is consistent with the hypothesis that MNK plays a significant role in mediating TLR-MyD88 signaling in DLBCL. Finally, we tested compound <b>23</b> in the MDA-MB-231 breast cancer xenograft model. Increased phosphorylation of eIF4E has been shown in breast cancer patients and has been linked to poorer clinical outcome.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> The growth of MDA-MB-231 xenografts <i>in vivo</i> was significantly inhibited (TGI > 100%) when animals were dosed with 1 or 10 mg/kg <b>23</b> QD (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>C). Consistent with the MNK phenotype previously observed with compound <b>23</b>, MDA-MB-231 cells did not show growth inhibition <i>in vitro</i>, underscoring the fact that tumor cell/tumor microenvironment (TME) interactions important for tumorigenesis may be regulated by MNK.</div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/medium/jm-2017-01795d_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0010.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Compound <b>23</b> is efficacious in tumor xenografts. (A) TMD8 xenografts (10 mice/group) were treated with the indicated dose/schedule/route of <b>23</b> for 14 days. (B) HBL-1 xenografts (10 mice/group) were treated with indicated dose/schedule/route of <b>23</b> for 12 days. (C) MDA-MB-231 xenografts (10 mice/group) were treated with indicated dose/schedule/route of <b>23</b> for 23 days. Error bars are SEM. (D) TMD8 xenograft-bearing animals were treated with 1 mg/kg of <b>23</b>, and tumor and plasma samples were harvested at time points (0.5–24 h) postdose. Phosphorylation of eIF4E in the tumor was measured by immunoblot (% inhibition, left axis), and <b>23</b> levels were measured in plasma (nM, right axis). (E) Exposure–response plot of all time points and dosing groups of the TMD8 PK/PD study plotted as a function of the corresponding <b>23</b> exposure in plasma.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01795&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In conjunction with the efficacy experiments, we assessed MNK inhibition through PK/PD measurement of p-eIF4E (Ser209) in the TMD8 xenografts at three dose levels (0.3, 1, and 10 mg/kg). In general, an oral dose of 1 mg/kg of <b>23</b> QD produced maximal efficacy and exhibited over 80% reduction in p-eIF4E for 8 h (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>D). Plotting of the aggregated data from the three dose groups to generate an exposure–response curve resulted in calculated IC<sub>50</sub> and IC<sub>90</sub> values of 15.8 and 376 nM, respectively, which are consistent with the p-eIF4E inhibition values obtained <i>in vitro</i> (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>E, <a href="/doi/suppl/10.1021/acs.jmedchem.7b01795/suppl_file/jm7b01795_si_002.pdf" class="ext-link">Table S1</a>). Importantly, these results demonstrate that p-eIF4E can be used as a PD marker for MNK inhibition <i>in vivo</i> and that ≥80% inhibition is associated with efficacy.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Synthetic Chemistry</h3><div class="NLM_p">All compounds described herein were prepared as outlined in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a>–<a class="ref internalNav" href="#sch6" aria-label="6">6</a>. Compound <b>4</b> was obtained in the following manner (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Heating of 2-aminonicotinonitrile <b>27</b> with aqueous 2-chloroacetaldehyde afforded imidazocarbonitrile <b>28</b>. Subsequent bromination followed by Suzuki coupling with pyridinyl-3-ylboronic acid yielded compound <b>30</b>, which was hydrolyzed with basic hydrogen peroxide to give final compound <b>4</b>. Final compound <b>5</b> was obtained in three steps by Boc protection of pyrrolidine <b>31</b>, followed by Suzuki coupling with a Boc-protected pyrazole boronic ester to form the protected pyrazole, which was bis-deprotected to afford final compound <b>5</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Pyrimidines <b>7</b> and <b>8</b> were prepared using conventional acid-catalyzed SNAr chemistry, from 4,6-dichloropyrimidine and 6-chloro-9<i>H</i>-purine <b>35</b>, respectively (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Monochloro pyrimidine <b>34</b> was dehalogenated via hydrogenolysis to produce final compound <b>7</b>. Final isoindolinone compounds <b>9</b> and <b>10</b> were prepared as outlined from the same bromomethylbenzoate <b>37</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). Coupling of <i>p</i>-methoxybenzylamine with <b>37</b> followed by ring closure produced PMB protected lactam <b>38</b>. Bis-methylation of <b>38</b> by heating with excess MeI in the presence of NaH, followed by Buchwald coupling with 4-aminopyrimidine and PMB deprotection gave final lactam compound <b>10</b>. Monomethylation of <b>38</b> was affected by treating with 1.5 equiv of MeI at room temperature to give <b>39</b>, which was subjected to the same two-step sequence of Buchwald coupling/PMB deprotection to yield final lactam compound <b>9</b>. Pyridone <b>11</b> was prepared beginning with esterification of 5-chloro-2-pyridine carboxylic acid <b>40</b> followed by oxidation to the <i>N</i>-oxide <b>41</b>. <i>N</i>-Oxide <b>41</b> was converted to the pyridone with trifluoroacetic anhydride followed by benzylic protection to give compound <b>42</b>. Buchwald coupling of <b>42</b> with 4-aminopyrimidine yielded <b>43</b>, which was debenzylated with triflic acid followed by aminolysis to afford final compound <b>11</b>.</div><figure id="sch1" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/medium/jm-2017-01795d_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0011.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Imidazopyridine <b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01795&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2-chloroacetaldehyde, ethanol, reflux, 86%; (b) NBS, DMF, 25 °C, 77%, (c) pyridine-3-ylboronic acid, Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane-H<sub>2</sub>O, 100 °C, 40%; (d) 30% H<sub>2</sub>O<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 0 to 25 °C, 28%.</p></p></figure><figure id="sch2" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/medium/jm-2017-01795d_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0012.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Pyrazole <b>5</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01795&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) di-<i>t</i>-butyl pyrocarbonate, 10% NaOH·H<sub>2</sub>O, 0 °C, 86%; (b) <i>t</i>-butyl-3,5-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole-1-carboxylate, tetrakis(triphenylphosphine)palladium(0), Na<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 100 °C, 24%. (c) HCl-1,4-dioxane, 0–25 °C, 42%.</p></p></figure><figure id="sch3" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/medium/jm-2017-01795d_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0013.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Benzamide <b>7</b> and Lactam <b>8</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01795&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 4,6-dichloropyrimidine, pTSA, toluene: 1,4-dioxane, 140 °C, 23%; (b) 10% Pd/C, H<sub>2</sub>, 1,4-dioxane/CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 15%; (c) camphorsulfonic acid, iPrOH, 100 °C, 58%.</p></p></figure><figure id="sch4" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/medium/jm-2017-01795d_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0014.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Lactams <b>9–11</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01795&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>p</i>-MeOBnNH<sub>2</sub>, DMF, Et<sub>3</sub>N, 65 °C, 75%; (b) NaH, MeI, THF, 25 °C, 57%; (c) 4-aminopyrimidine, NaO-<i>t</i>-Bu, XPhos, Pd<sub>2</sub>(dba)<sub>3</sub>, toluene, 110 °C, 58–65%; (d) TFA, 100 °C, 19–22%; (e) NaH, MeI, THF, 70 °C, 37%; (f) EtOH, H<sub>2</sub>SO<sub>4</sub>, 80 °C, 86%; (g) urea, H<sub>2</sub>O<sub>2</sub>, TFAA, CHCl<sub>3</sub>, 0–25 °C, 65%; (h) TFAA, DMF, 50 °C, 60%; (i) K<sub>2</sub>CO<sub>3</sub>, LiBr, Bu<sub>4</sub>NBr, BnBr, toluene–water, 80 °C, 65%; (j) 4-aminopyrimidine, Cs<sub>2</sub>CO<sub>3</sub>, xantphos, Pd<sub>2</sub>(dba)<sub>3</sub>, dioxane, 90 °C, 61%; (k) TfOH, toluene, 140 °C, MW, 61%; (i) NH<sub>4</sub>OH, 25 °C, 52%.</p></p></figure><div class="NLM_p">Pyridones <b>12</b>–<b>15</b>, <b>17</b>, <b>18</b>, and <b>20</b>–<b>26</b> were all prepared using the general procedure outlined in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>. The suitably substituted pyridone <b>44</b>, prepared in a similar fashion outlined for <b>42</b>, was subjected to aminolysis to give the key intermediate carboxamide <b>45</b>. Formation of the lactam structure <b>46</b> was carried out by simply heating the respective carboxamide <b>45</b> with the desired ketone (R<sub>1</sub>R<sub>2</sub>CO) in H<sub>2</sub>SO<sub>4</sub>/1,4-dioxane to afford good yields of the desired cyclized material. Buchwald coupling of the corresponding halo-lactam <b>46</b> with the required substituted 4-amino pyrimidine (R4), yielded the final compounds in good yields after either basic or acidic deprotection.</div><figure id="sch5" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/medium/jm-2017-01795d_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0015.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. General Synthesis of Lactams <b>12–15</b>, <b>17</b>, <b>18</b>, <b>20–26</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01795&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 30% NH<sub>4</sub>OH, 0–25 °C, 75%; (b) R<sub>1</sub>R<sub>2</sub>CO, 1,4-dioxane, H<sub>2</sub>SO<sub>4</sub>, 100 °C, 83%; (c) 4-amino-6-R<sub>4</sub>-pyrimidine, Pd(OAc)<sub>2</sub>, xantphos, Cs<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 95 °C, 10–61%; (d) deprotection, KOH, EtOH, THF, H<sub>2</sub>O, 25 °C or 4 M HCl, 1,4-dioxane, CH<sub>2</sub>Cl<sub>2</sub>, MeOH, 25 °C, 80%.</p></p></figure><div class="NLM_p">The remaining two compounds <b>16</b> and <b>19</b> were prepared as outlined in <a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>. 6-Chloro-2-aminopyrimidine <b>47</b> was bis-protected with Boc-anhydride and then coupled with cyclopropanecarboxamide under palladium catalysis to give amide <b>48</b>. Boc deprotection with acid followed by Buchwald coupling with PMB protected lactam <b>38</b>, and final deprotection yielded the final cyclopropylamide <b>16</b>. Suzuki coupling of bromide <b>50</b> with isoquinolin-6-ylboronic acid gave compound <b>52</b>. SNAr coupling of <i>t</i>-butyl-(3-hydroxycyclobutyl)carbamate, <b>52</b>, and sodium hydride yielded intermediate ether <b>53</b>, which was deprotected with aqueous HCl to provide final compound <b>19</b>.</div><figure id="sch6" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/medium/jm-2017-01795d_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0016.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Lactam <b>16</b> and Compound <b>19</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01795&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (Boc)<sub>2</sub>O, DMAP, THF, 25 °C, 51%; (b) cyclopropanecarboxamide, Cs<sub>2</sub>CO<sub>3</sub>, xantphos, Pd<sub>2</sub>(dba)<sub>3</sub>, 1,4-dioxane, 25 °C, 96%; (c) 4 N HCl, 1,4-dioxane, 25 °C; (d) <b>38</b>, Cs<sub>2</sub>CO<sub>3</sub>, Xphos, Pd<sub>2</sub>(dba)<sub>3</sub>, 1,4-dioxane, 90 °C, 42%, two steps; (e) TFA, reflux, 46%; (f) K<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, monoglyme-H<sub>2</sub>O, 85 °C, 62%; (g) <i>t</i>-butyl-(3-hydroxycyclobutyl)carbamate, NaH, THF, °C, 29%; (h) 4 N HCl, MeOH, 25 °C, 58%.</p></p></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Discussion and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21752" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21752" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Recruitment of mRNA to the ribosome is a fundamental component of mRNA translation and is regulated through translation initiation by eIF4E. Importantly, eIF4E has been shown to play a key role in the translation of proteins involved in driving tumorigenesis. While the MNKs are key modulators of eIF4E activity, the eIF4E protein has been targeted directly with an antisense oligonucleotide, ISIS 183750.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> In addition, small molecule inhibitors such as EGI-1, briciclib, and 4E1R-cat that block the binding of eIF4E to eIF4G have been pursued, yet only modest antitumor activity has been observed with these agents and little progress has been made clinically.<a onclick="showRef(event, 'ref48 ref49 ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref48 ref49 ref50 ref51">(48−51)</a> In addition, a number of MNK small molecule inhibitors have been described that are either less potent or lack selectivity against MNK1/2.<a onclick="showRef(event, 'ref20 ref21 ref22 ref23 ref25 ref26 ref52'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22 ref23 ref25 ref26 ref52">(20−23,25,26,52)</a> BAY1143269, which is more selective for MNK1, entered the clinic, but enrollment is currently suspended.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> There may be limitations with an MNK1 selective approach as MNK2 can function in a compensatory fashion. A dual MNK inhibitor has been reported to be in Phase 1 clinical trial in Singapore.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> A selective and potent dual MNK1/2 inhibitor represents a new therapeutic opportunity; yet, to date, compounds to definitively assess this potential have remained elusive.</div><div class="NLM_p">We have outlined the design of a very potent and selective dual MNK1/2 inhibitor, <b>23</b>, having a novel pyridone–aminal chemical structure described for the first time in the kinase literature, and the first dual MNK inhibitor to be tested clinically in the treatment of both solid and hematological malignancies. The design process leveraged specific stereoelectronic interactions with the unique active site of this kinase in an iterative structure-based approach employing 30 cocrystal structures. Potency was deliberately traded for drug-like properties (lower logP and MW) during optimization (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). Importantly, only 110 pyridone containing compounds were required to identify <b>23</b>, highlighting the efficient optimization approach employed and the value of beginning with and maintaining good physicochemical properties. A roadmap for the key molecules in the optimization process is outlined in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a> highlighting strategic potency loss (1–3, red vertical lines) and key contenders for candidate selection. During the course of optimization, cell potency closely tracked enzyme potency, LE was maintained finishing slightly higher (0.6), and final LLEs improved to >8.</div><div class="NLM_p">Compound <b>23</b> was designed to be equally effective against both MNK1 and MNK2 isoforms as they are generally coexpressed and can both serve to phosphorylate eIF4E at Ser209, implying that dual inhibition would be necessary to avoid compensatory signaling by either isoform. As such, inhibition of eIF4E phosphorylation was always commensurate with the activity against the less sensitive MNK isoform, suggesting that dual MNK1/2 engagement was critical for maximal reduction in p-eIF4E levels and robust efficacy. Importantly, <b>23</b> potently inhibits p-eIF4E in a range of solid and hematological tumor cell lines. In contrast to other small molecule inhibitors of MNK1/2, <b>23</b> does not cause inhibition of proliferation across a broad panel of tumor cell lines. This biology might have been masked by a less selective kinome profile and broad antiproliferative effects, and this understanding facilitated the design of <b>23</b>. Sufficient selectivity against the broader protein and lipid kinome is essential to understanding MNK pharmacology. Only two protein kinases outside of MNK were significantly inhibited by <b>23</b> in biochemical assays (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B): DRAK1/STK17A, a member of the death-associated protein family of serine/threonine kinases, has been shown to have a pro-apoptotic role in certain contexts, but a pro-tumorigenic effect in others;<a onclick="showRef(event, 'ref54 ref55 ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref54 ref55 ref56 ref57">(54−57)</a> and CLK4, a member of the cdc2/cdc28-like kinase family, plays a role in alternative mRNA splicing and in cytokinesis.<a onclick="showRef(event, 'ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref58 ref59">(58,59)</a> It is unclear whether <b>23</b> significantly inhibits DRAK1 and CLK4 in intact cells, and we do not see any cellular phenotypes consistent with inhibition of either kinase in tumor cells.</div><div class="NLM_p">DLBCL is currently defined by three main subtypes: activated B-cell (ABC), germinal center B-cell, and primary mediastinal B-cell lymphoma.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> Patients with ABC-DLBCL have the worst prognosis with <40% cure rate. ABC-DLBCL has been characterized by constitutive activation of NFkB signaling due to oncogenic mutations that activate B cell receptor signaling (e.g., CD79, CARD11, and A20).<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> In addition, activating mutations in MyD88 occur in ∼39% of ABC-DLBCL leading to NFkB activation that drives increased cytokine and chemokine production. MNK1/2 are recognized regulators of cytokine signaling and production. Pro-inflammatory cytokines are key survival factors for ABC-DLBCL tumors, and cytokine expression is associated with poor prognosis.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32,33)</a> Compound <b>23</b> is effective at blocking pro-inflammatory cytokine production in MyD88 mutant models of ABC-DLBCL. Post-transcriptional regulation of cytokine production is known to be regulated at the level of mRNA stability through adenylate–uridylate-rich elements in the 3′-untranslated regions of their mRNA.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> Compound <b>23</b> treatment results in a 1.5–2-fold decrease in cytokine mRNA half-life, consistent with the observed reduction in secreted cytokine proteins. Further testing of <b>23</b><i>in vivo</i> demonstrated significant efficacy in multiple MyD88 mutant DLBCL tumor models illustrating its potential as a novel therapeutic strategy for this disease (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>). Compound <b>23</b> is well tolerated at doses that deliver maximal efficacy and target engagement <i>in vivo</i> as measured by inhibition of p-eIF4E, consistent with normal viability and development of MNK1/2 double knockout mice.</div><div class="NLM_p">Tumor-promoting inflammation is recognized as an enabling characteristic of cancer.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Pro-inflammatory cytokines and chemokines are key mediators of this effect, impacting both tumor cell survival signaling and the composition and signaling of the TME. Compound <b>23</b> selectively regulates the production of pro-inflammatory cytokines and chemokines and has the potential to reshape the TME. This mechanism of action is likely contributing to the antitumor efficacy in both the DLBCL and MDA-MB-231 models and is the focus of continuing evaluation.</div><div class="NLM_p last">This work has highlighted the strong potential for agents that modulate dysregulated translation acting through eIF4E and also affecting mRNA stability. We have shown that potent MNK inhibition has significant effects on multiple pro-tumorigenic cytokines, such as TNFα, IL-6, and IL-8, which are, in turn, important mediators of oncogenesis and tumor progression.<a onclick="showRef(event, 'ref64 ref65'); return false;" href="javascript:void(0);" class="ref ref64 ref65">(64,65)</a> These profound effects, both intrinsic and extrinsic to the tumor, are particularly interesting given that a potent and selective dual MNK inhibitor does not display broad antiproliferative activity <i>in vitro</i>, yet demonstrates potent antitumor activity <i>in vivo</i> against models utilizing the same cell lines. These data are consistent with the phenotype of the MNK1/2 double knockout mouse, which develops normally. This also highlights the potential limitation of screening for anticancer activity in an <i>in vitro</i> antiproliferative setting alone, particularly for agents that might act via mechanisms extrinsic to the tumor. Based on the preclinical profile of <b>23</b> and demonstrated <i>in vivo</i> activity in multiple tumor models, selective inhibition of MNK1 and MNK2 has potential in the treatment of cancer. Compound <b>23</b> is currently under evaluation in Phase 2 clinical trials in patients with advanced solid tumors and lymphoma.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86281" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86281" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General</h3><div class="NLM_p">All reagents and solvents were used as purchased from commercial sources. Flash column chromatography was performed with a Teledyne ISCO CombiFlash Rf system using normal-phase silica columns (230–400 mesh). <sup>1</sup>H NMR spectra were recorded on a Bruker Advance-400 spectrometer at 400 MHz or a Bruker-Biospin AVANCE 500 MHz NMR spectrometer. Coupling constants (<i>J</i>) are expressed in hertz (Hz). Chemical shifts (δ) of NMR are reported in parts per million (ppm) units relative to an internal control (TMS). Microwave reactions were performed with a Biotage Initiator focused beam microwave reactor (300 W). HPLC purification was performed on a Waters automated purification system with 2767 sample controller and 2545 binary pump using Mass Lynx software and a Waters Sunfire C-18 (19 × 250 mm, 10 μm)/Waters X-Select Phenyl Hexyl (19 × 250 mm,5 μm) column. Analytical purity was assessed on a Waters Acquity Ultra Performance UPLC with 3100 SQD equipped with Acquity BEH C-18 (2.1 × 50 mm, 1.7 μm) column, and all compounds tested were determined to be >95% pure using this method. High resolution mass spectroscopy (HRMS) was performed using a Triple TOF 5600+ mass spectrometer (hybrid quadrupole time-of-flight platform; AB Sciex) connected to a 1290 UHPLC system (Agilent). The mass spectrometer was operated in electrospray positive ionization mode (ESI+). Acquisition was a full scan from <i>m</i>/<i>z</i> 100 to 1000 with a pulser frequency of 18.092 kHz and accumulation time of 75 ms. All animal studies were carried out in accordance with the guidelines established by the Institutional Animal Care and Use Committee at Explora BioLabs (San Diego, CA; Animal Care and Use Protocol (ACUP) #EB15–053).</div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 4-((7<i>H</i>-Purin-6-yl)amino)benzamide (<b>1</b>)</h4><div class="NLM_p last">See Oyarzabal et al.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Purchased from Ryan Scientific, Inc. Purity >95%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.30 (br s, 1 H), 10.07 (s, 1 H), 8.48 (s, 1 H), 8.36 (s, 1 H), 8.10 (d, <i>J</i> = 22 Hz, 1 H), 7.92–7.84 (m, 3 H), 7.30 (s, 1 H).</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 3-(Pyridin-4-yl)imidazo[1,2-<i>b</i>]pyridazine (<b>2</b>)</h4><div class="NLM_p last">See Oyarzabal et al.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> HPLC Purity 95.7%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.76 (dd, <i>J</i> = 8, 3 Hz, 1 H), 8.72 (d, <i>J</i> = 15 Hz, 2 H), 8.61 (s, 1 H), 8.34–8.26 (m, 3 H), 7.42 (dd, <i>J</i> = 23, 11 Hz, 1 H).</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 3-Phenyl-5-(pyridin-4-yl)-1<i>H</i>-indazole (<b>3</b>)</h4><div class="NLM_p last">See Reich et al.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> HPLC Purity >99%; the spectral data of the compound matched those in the reference.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 3-(Pyridin-4-yl)imidazo[1,2-<i>a</i>]pyridine-8-carboxamide (<b>4</b>)</h4><div class="NLM_p">Synthesized via the methodology described in Yang et al. (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a></div><div class="NLM_p">A mixture of 2-aminonicotinonitrile <b>27</b> (2.5 g, 21 mmol) and 40% aqueous 2-chloroacetaldehyde (18.8 mL, 94.88 mmol, 4.5 equiv) in ethanol (100 mL) was refluxed overnight. The volatiles were evaporated, and the residue was treated with ethyl acetate (20 mL). The solid was collected by filtration, washed with EtOAc (5 mL), and dried under vacuum to give the desired product as the HCl salt. The salt was treated with 2 N aqueous Na<sub>2</sub>CO<sub>3</sub> solution (20 mL), and extracted with DCM (50 mL × 2). The combined DCM solution was washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated to give imidazo[1,2-<i>a</i>]pyridine-8-carbonitrile <b>28</b> as a light brown solid (2.6 g, yield 86%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.88 (d, <i>J</i> = 16.9 Hz, 1H), 8.15 (s, 1H), 7.96 (d, <i>J</i> = 17.6 Hz, 1H), 7.73 (s, 1H), 7.06 (t, <i>J</i> = 17.3 Hz, 1H); MS (ESI) <i>m</i>/<i>z</i> 144.17 [M + H]<sup>+</sup>. To a stirred solution of 2-methylimidazo[1,2-<i>a</i>]pyridine-8-carbonitrile <b>28</b> (1.5 g, 9.5 mmol) in DMF (15 mL) at rt was added NBS (1.8 g, 10 mmol). The resulting mixture was stirred for 5 min and was diluted with water (150 mL). The mixture was extracted with EtOAc (100 mL × 2). The combined extracts were washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated to give the title compound <b>29</b> as a white solid (1.73 g, yield 77%). The compound was pure enough for the next reaction. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.69 (d, <i>J</i> = 17.2 Hz, 1H), 8.09 (d, <i>J</i> = 17.7 Hz, 1H), 7.91 (s, 1H), 7.23 (t, <i>J</i> = 17.6 Hz, 1H); MS (ESI) <i>m</i>/<i>z</i> 223.90 [M + H]<sup>+</sup>.</div><div class="NLM_p">To a mixture of 3-bromoimidazo[1,2-<i>a</i>]pyridine-8-carbonitrile <b>29</b> (0.5 g, 1 equiv), pyridin-3-ylboronic acid (1.1 equiv), and K<sub>2</sub>CO<sub>3</sub> (5 equiv) in 1,4-dioxane (10 mL) and water (2.5 mL) under nitrogen atmosphere was added Pd(dppf)Cl<sub>2</sub> (0.1 equiv). The resulting reaction mixture was heated at 100 °C overnight. The reaction was cooled to rt, diluted with water (30 mL), and extracted with EtOAc (30 mL × 2). The combined organic extracts were washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and evaporated to give the crude product, which was purified on a silica gel column to provide 3-(pyridin-3-yl)imidazo[1,2-<i>a</i>]pyridine-8-carbonitrile <b>30</b> in 40% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.90 (d, <i>J</i> = 4.6 Hz, 1H), 8.88 (d, <i>J</i> = 17.4 Hz, 1H), 8.68 (dd, <i>J</i> = 11.7, 2.9 Hz, 1H), 8.16 (dt, <i>J</i> = 15.4, 4.2 Hz, 1H), 8.06 (d, <i>J</i> = 17.6 Hz, 1H), 8.04 (s, 1H), 7.60 (dd, <i>J</i> = 19.6, 12.1 Hz, 1H), 7.12 (t, <i>J</i> = 17.6 Hz, 1H); MS (ESI) <i>m</i>/<i>z</i> 221.06 [M + H]<sup>+</sup>.</div><div class="NLM_p last">To a solution of 3-(pyridin-3-yl)imidazo[1,2-<i>a</i>]pyridine-8-carbonitrile <b>30</b> (0.15 g) in DMSO (3 mL) cooled with an ice water bath was added 30% H<sub>2</sub>O<sub>2</sub> (1.2 mL) and anhydrous K<sub>2</sub>CO<sub>3</sub> (0.2 g). The reaction mixture was allowed to warm to rt and stirred for 10 min. The reaction mixture was diluted with water (10 mL) and extracted with EtOAc. The ethyl acetate extracts were concentrated and the residue was purified on a silica gel column to provide 3-(pyridin-3-yl)imidazo[1,2-<i>a</i>]pyridine-8-carboxamide <b>4</b> as a light yellow solid in 28% yield. HPLC purity: 96.25%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>), δ 9.54 (br, 1H), 8.91 (d, <i>J</i> = 1.6 Hz, 1H), 8.78 (dd, <i>J</i> = 6.8, 0.8 Hz, 1H), 8.68 (dd, <i>J</i> = 4.8, 1.2 Hz, 1H), 8.17 (dt, <i>J</i> = 8.0, 2.0 Hz, 1H), 8.11 (dd, <i>J</i> = 7.2, 1.2 Hz, 1H), 8.05 (br, 1H), 8.01 (s, 1H), 7.61 (dd, <i>J</i> = 7.6, 5.2 Hz, 1H), 7.17 (t, <i>J</i> = 7.2 Hz, 1H); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 163.6, 149.2, 148.7, 144.0, 135.3, 132.4, 128.2, 127.6, 124.6, 124.0, 123.0, 121.0, 112.8; mass spectrometry atmospheric pressure ionization: <i>m</i>/<i>z</i> 239 [M + H]<sup>+</sup>. HRMS: measured <i>m</i>/<i>z</i> [M + H]<sup>+</sup> 239.0927 (calcd. for C<sub>13</sub>H<sub>11</sub>N<sub>4</sub>O: 239.0928).</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 3,5-Dimethyl-4-(4-(pyrrolidin-2-yl)phenyl)-1<i>H</i>-pyrazole (<b>5</b>)</h4><div class="NLM_p">To a solution of 2-(4-bromophenyl)pyrrolidine <b>31</b> (0.5 g, 2.20 mmol) in 1,4-dioxane (12.5 mL), 10% sodium hydroxide solution (2 mL) was added at 0 °C, and the mixture was stirred for 10 min (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Di-<i>t</i>-butyl pyrocarbonate (0.6 mL, 3.0 mmol) was added, and the reaction mixture was allowed to stir at rt for 3 h. The reaction mixture was diluted with water and extracted with ethyl acetate. The organic layer was separated, washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure to obtain a residue, which was purified by silica gel column chromatography to afford <i>t</i>-butyl 2-(4-bromophenyl)pyrrolidine-1-carboxylate <b>32</b>. Yield: 0.62 g, 86%; <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i><sub>1</sub>) δ 7.41 (d, <i>J</i> = 7.92 Hz, 2H) 7.05 (d, <i>J</i> = 7.92 Hz, 2H) 4.67–4.79 (m, 1H) 3.60–3.62 (m, 2H) 2.29–2.32 (m, 1H) 1.83–1.91 (m, 2H) 1.75–1.78 (m, 1H) 1.22 (s, 9H); MS (ESI) <i>m</i>/<i>z</i> 333 [M + H]<sup>+</sup>. A solution of <i>t</i>-butyl 2-(4-bromophenyl)pyrrolidine-1-carboxylate <b>32</b> (0.3 g, 0.93 mmol), <i>t</i>-butyl-3,5-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-carboxylate (0.303 g, 0.93 mmol), and 2 M sodium carbonate (0.3 g, 2.79 mmol) in 1,4-dioxane (12 mL) was degassed with argon for 30 min. Tetrakis(triphenylphosphine)palladium(0) (0.054 g, 0.046 mmol) was added, and the reaction mixture was further degassed for 15 min. The reaction mixture was heated at 100 °C for 16 h. The reaction mixture was filtered through Celite and washed with ethyl acetate. The filtrate was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography to afford <i>t</i>-butyl 4-(4-(1-(<i>t</i>-butoxycarbonyl)pyrrolidin-2-yl)phenyl)-3,5-dimethyl-1<i>H</i>-pyrazole-1-carboxylate. Yield: 0.1 g, 24%. MS (ESI) <i>m</i>/<i>z</i> 442 [M + H]<sup>+</sup>.</div><div class="NLM_p last">To a stirred solution of <i>t</i>-butyl 4-(4-(1-(<i>t</i>-butoxycarbonyl)pyrrolidin-2-yl)phenyl)-3,5-dimethyl-1<i>H</i>-pyrazole-1-carboxylate (0.1 g, 0.22 mmol) in 1,4-dioxane (8 mL), 4 M 1,4-dioxane/HCl (8 mL) was added at 0 °C, and the reaction mixture was stirred at rt for 15 h. After complete consumption of starting material, the solvent was removed under reduced pressure, and the residue was neutralized with sodium carbonate resin. The reaction mixture was filtered and concentrated under reduced pressure and purified by repeated washing with ether and pentane to obtain 3,5-dimethyl-4-(4-(pyrrolidin-2-yl)phenyl)-1<i>H</i>-pyrazole <b>5</b>. Yield: 0.03 g, 42%. HPLC purity: 98.37%; <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.52 (d, <i>J</i> = 7.9 Hz, 2H), 7.39 (d, <i>J</i> = 7.9 Hz, 2H), 4.59 (dd, <i>J</i> = 9.5, 6.5 Hz, 1H), 3.49–3.29 (m, 2H), 2.56–2.41 (m, 1H), 2.32–2.12 (m, 9H); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 142.8, 131.9, 128.2, 128.1, 126.5, 125.5, 116.7, 61.5, 54.3, 46.3, 34.5, 25.2, 11.3. MS (ESI) <i>m</i>/<i>z</i> 242 [M + H]<sup>+</sup> HRMS: measured <i>m</i>/<i>z</i> [M + H]<sup>+</sup> 242.1651 (calcd. for C<sub>15</sub>H<sub>20</sub>N<sub>3</sub>: 242.1654).</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 4-(3-(Piperidin-4-yl)-1<i>H</i>-pyrazol-5-yl)pyridine (<b>6</b>)</h4><div class="NLM_p last">Prepared as reported by Bilodeau et al.<a onclick="showRef(event, 'ref28 ref68'); return false;" href="javascript:void(0);" class="ref ref28 ref68">(28,68)</a> HPLC Purity 83%; the spectral data of the compound matched those in the reference.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 4-(Pyrimidin-4-ylamino)benzamide (<b>7</b>)</h4><div class="NLM_p">To a stirred suspension of 4,6-dichloropyrimidine (2 g, 13.51 mmol) and 4-aminobenzamide <b>33</b> (1.83 g, 13.51 mmol) in toluene-1,4-dioxane (20 mL, 1:1), <i>p</i>-toluenesulfonic acid (pTSA) (2.82 g, 14.86 mmol) was added, and the reaction mixture was heated at 140 °C for 5 h in a sealed tube (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). The reaction mixture was neutralized with saturated aqueous NaHCO<sub>3</sub> solution, and the compound was extracted with 10% methanol–DCM. The combined organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The resulting solid was washed with ethyl acetate to afford 4-((6-chloropyrimidin-4-yl)amino)benzamide <b>34</b> as a white solid. Yield: 0.68 g, 22.7%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.09 (s, 1H) 8.55 (s, 1H) 7.85–7.88 (m, 3H) 7.72 (d, <i>J</i> = 8.47 Hz, 2H) 7.24 (br s, 1H) 6.88 (s, 1H); MS (ESI) <i>m</i>/<i>z</i> 249 [M + H]<sup>+</sup>.</div><div class="NLM_p last">To a stirred suspension of 4-((6-chloropyrimidin-4-yl)amino)benzamide <b>34</b> (0.3 g, 1.21 mmol) in 1,4-dioxane/DCM/methanol (10 mL, 2:1:1) was added 10% Pd–C, and the reaction mixture was hydrogenated under 1 atm pressure at rt for 2 h. The reaction mixture was filtered through a Celite pad, and the pad was washed with methanol. The filtrate was concentrated under reduced pressure, taken up in a minimum amount of methanol, and refluxed to give a clear solution, which was cooled to rt. The obtained solid was filtered and dried to afford 4-(pyrimidin-4-ylamino)benzamide (<b>7</b>) as a white solid. Yield: 0.039 g, 15%. HPLC purity: 97.50%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.55 (s, 1H), 8.97 (s, 1H), 8.41 (dd, <i>J</i> = 7.0, 1.4 Hz, 1H), 7.99–7.90 (m, 3H), 7.79 (d, <i>J</i> = 8.5 Hz, 2H), 7.35 (s, 1H), 7.18 (d, <i>J</i> = 7.0 Hz, 1H); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.0, 161.5, 152.6, 144.3, 139.8, 130.6, 128.4, 120.9, 107.6. MS (ESI) <i>m</i>/<i>z</i> 215.09 [M + H]<sup>+</sup>; HRMS: measured <i>m</i>/<i>z</i> [M + H]<sup>+</sup> 215.0927 (calcd, for C<sub>11</sub>H<sub>11</sub>N<sub>4</sub>O: 215.0926).</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 5-((9<i>H</i>-Purin-6-yl)amino)isoindolin-1-one (<b>8</b>)</h4><div class="NLM_p last">Synthesized as reported in U.S. Patent Application No. WO2017075394.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> A mixture of 6-chloro-9<i>H</i>-purine <b>35</b> (0.15 g, 0.97 mmol), 5-aminoisoindoline-1-one <b>36</b> (0.14 g, 0.97 mmol), and (1<i>S</i>)-(+)-camphor-10-sulfonic acid (0.27 g, 1.16 mmol) in isopropanol (10 mL) was heated in a sealed tube at 100 °C for 4 h. After completion of the reaction, the mixture was concentrated, and the obtained solid was filtered and recrystallized from ethanol and isopropanol to afford 5-((9<i>H</i>-purin-6-yl)amino)isoindolin-1-one (<b>8</b>) as off-white solid. Yield: 0.15 g, 58%. HPLC purity: 99.92%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.01 (s, 1H), 8.66 (s, 2H), 8.44 (s, 1H), 8.31 (d, <i>J</i> = 1.9 Hz, 1H), 7.99 (dd, <i>J</i> = 8.3, 1.8 Hz, 1H), 7.67 (d, <i>J</i> = 8.3 Hz, 1H), 4.40 (s, 2H); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 169.5, 149.8, 149.7, 149.5, 141.2, 141.4, 127.9, 123.3, 120.1, 114.9, 114.3, 44.8. MS (ESI) <i>m</i>/<i>z</i> 267 [M + H]<sup>+</sup>. HRMS: measured <i>m</i>/<i>z</i> [M + H]<sup>+</sup> 267.0989 (calcd. for C<sub>13</sub>H<sub>11</sub>N<sub>6</sub>O: 267.0989).</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 3-Methyl-5-(pyrimidin-4-ylamino)isoindolin-1-one (<b>9</b>)</h4><div class="NLM_p">Synthesized as reported in U.S. Patent Application No. WO2017075394.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> To a stirred solution of ethyl 4-bromo-2-(bromomethyl)benzoate <b>37</b> (16 g, 52.1 mmol) in dimethylformamide (150 mL) at 0 °C, triethylamine (22 mL, 156.3 mmol) was added and stirred for 15 min, 4-methoxybenzylamine (8.84 mL, 67.7 mmol) was added, and the reaction mixture was stirred at rt for 30 min and then heated at 65 °C for 5 h (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). The reaction mixture was cooled, quenched with ice, and acidified with 1 N hydrochloric acid to pH = 3. The precipitated solid was filtered, dried, and purified by silica gel column chromatography using 30% ethyl acetate in hexane to afford 5-bromo-2-(4-methoxybenzyl)isoindolin-1-one <b>38</b>. Yield: 13.04 g, 75.4%. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i><sub>1</sub>) δ 7.74 (d, <i>J</i> = 8.0 Hz, 1H), 7.60 (d, <i>J</i> = 8.4 Hz, 1H), 7.53 (s, 1H), 7.22 (d, <i>J</i> = 8.4 Hz, 2H), 6.86 (d, <i>J</i> = 8.4 Hz, 2H), 4.72 (s, 2H), 4.22 (s, 2H), 3.79 (s, 3H); MS (ESI) <i>m</i>/<i>z</i> 332 [M + H]<sup>+</sup>.</div><div class="NLM_p">To an ice cooled suspension of sodium hydride (0.072 g, 60% dispersion in mineral oil, 1.8 mmol) in dry THF (5 mL) a solution of 5-bromo-2-(4-methoxybenzyl)isoindolin-1-one <b>38</b> (0.5 g, 1.5 mmol) in dry THF (5 mL) was added dropwise under nitrogen atmosphere. The reaction mixture was stirred for 1 h, and iodomethane (0.14 mL, 2.2 mmol) was added. The reaction mixture was stirred at rt for 2 h and then quenched with ice–water and extracted with ethyl acetate. The combined organic layer was dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography using 0–8% of ethyl acetate in hexane to afford 5-bromo-2-(4-methoxybenzyl)-3-methylisoindolin-1-one <b>39</b>. Yield: 0.29 g, 57%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.88 (s, 1H), 7.68 (m, 2H), 7.22 (d, <i>J</i> = 8.4 Hz, 2H), 6.89 (d, <i>J</i> = 8.8 Hz, 2H), 4.94 (d, <i>J</i> = 15.6 Hz, 1H), 4.38 (m, 1H), 4.31 (d, <i>J</i> = 15.2 Hz, 1H), 3.72 (s, 3H), 1.38 (d, <i>J</i> = 6.8 Hz, 3H); MS (ESI) <i>m</i>/<i>z</i> 246, 248 [M + H]<sup>+</sup>.</div><div class="NLM_p">A mixture of 5-bromo-2-(4-methoxybenzyl)-3-methylisoindolin-1-one <b>39</b> (0.2 g, 0.578 mmol), 4-aminopyrimidine (0.066 g, 0.693 mmol), sodium <i>t</i>-butoxide (0.111 g, 1.15 mmol) and X-Phos (0.027 g, 0.057 mmol) in toluene (2 mL) was degassed with argon for 30 min. Pd<sub>2</sub>(dba)<sub>3</sub> (0.053 g, 0.057 mmol) was added under argon atmosphere, and degassing was continued for another 10 min. The reaction mixture was heated at 110 °C for 4 h. After completion of the reaction (monitored by TLC), it was diluted with ethyl acetate and filtered through a Celite pad, and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography to afford 2-(4-methoxybenzyl)-3-methyl-5-(pyrimidin-4-ylamino)isoindolin-1-one. Yield: 0.12 g, 58%. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i><sub>1</sub>) δ 8.73–8.79 (m, 1H) 8.34 (d, <i>J</i> = 6.10 Hz, 1H) 7.84 (d, <i>J</i> = 8.28 Hz, 1H) 7.70 (s, 1H) 7.35–7.43 (m, 2H) 7.22 (d, <i>J</i> = 8.72 Hz, 2H) 6.84 (d, <i>J</i> = 8.72 Hz, 2H) 6.76 (dd, <i>J</i> = 6.10, 1.31 Hz, 1H) 5.30 (s, 2H) 4.38 (q, <i>J</i> = 6.54 Hz, 1H) 3.78 (s, 3H) 1.45 (d, <i>J</i> = 6.54 Hz, 3H); MS (ESI) <i>m</i>/<i>z</i> 361 [M + H]<sup>+</sup>.</div><div class="NLM_p last">A solution of 2-(4-methoxybenzyl)-3-methyl-5-(pyrimidin-4-ylamino)isoindolin-1-one (0.12 g, 0.332 mmol) in trifluoroacetic acid (2 mL) was heated at 100 °C for 18 h. After completion of reaction (monitored by TLC), the mixture was concentrated under reduced pressure. The residue was dissolved in methanol, and carbonate-supported polymer was added and stirred for 1 h. The mixture was filtered, and the filtrate was concentrated under reduced pressure. The crude material was purified by prep. HPLC to afford compound <b>9</b> as an off-white solid; Yield: 0.015 g, 19%. HPLC purity: 96.68%; <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.67 (s, 1H), 8.27 (d, <i>J</i> = 6.1 Hz, 1H), 8.13 (s, 1H), 7.74–7.61 (m, 2H), 6.86 (d, <i>J</i> = 6.0 Hz, 1H), 4.69 (q, <i>J</i> = 6.8 Hz, 1H), 1.48 (d, <i>J</i> = 6.7 Hz, 3H), 1.15 (d, <i>J</i> = 6.2 Hz, 1H); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 168.7, 159.6, 157.9, 155.5, 150.4, 142.9, 125.6, 123.3, 119.0, 112.6, 107.8, 51.4, 20.4. MS (ESI) <i>m</i>/<i>z</i> 241[M + H]<sup>+</sup>; HRMS: measured <i>m</i>/<i>z</i> [M + H]<sup>+</sup> 241.1083 (calcd. for C<sub>13</sub>H<sub>13</sub>N<sub>4</sub>O: 241.1085).</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 3,3-Dimethyl-5-(pyrimidin-4-ylamino)isoindolin-1-one (<b>10</b>)</h4><div class="NLM_p">Synthesized as reported in U.S. Patent Application No. WO2017075394.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> To a solution of 5-bromo-2-(4-methoxybenzyl)isoindolin-1-one <b>38</b> (1 g, 3 mmol) in THF (10 mL) at 0 °C, sodium hydride (0.3 g, 7.5 mmol) was added portion-wise, and the reaction mixture was allowed to stir at rt for 30 min. Methyl iodide (0.57 mL, 9 mmol) was added, and the reaction mixture was stirred at 70 °C for 16 h. The reaction mixture was quenched with water and extracted with ethyl acetate. The organic layer was separated, dried over sodium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography using 30% ethyl acetate in hexane to afford 5-bromo-2-(4-methoxybenzyl)-3,3-dimethylisoindolin-1-one. Yield: 0.4 g, 36.9%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.05 (s, 1H) 7.64–7.67 (m, 2H) 7.36 (d, <i>J</i> = 8.72 Hz, 2H) 6.84 (d, <i>J</i> = 8.72 Hz, 2H) 4.62 (s, 2H) 3.78 (s, 3H) 1.38 (s, 6H); MS (ESI) <i>m</i>/<i>z</i> 360 [M + H]<sup>+</sup>.</div><div class="NLM_p">To a solution of 2-(4-methoxybenzyl)-3,3-dimethyl-5-(pyrimidin-4-ylamino)isoindolin-1-one (0.3 g, 0.8 mmol) in toluene (6 mL), 4-aminopyrimidine (0.095 g, 0.99 mmol) and then sodium <i>t</i>-butoxide (0.16 g, 1.66 mmol) were added, and the reaction mixture was degassed with argon for 15 min. Pd<sub>2</sub>(dba)<sub>3</sub> (0.076 g, 0.08 mmol) and X-phos (0.039 g, 0.08 mmol) were added, and the reaction mixture was heated at 110 °C for 16 h. The reaction mixture was diluted with water and extracted with ethyl acetate. The organic layer was separated, dried over sodium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel chromatography using 5% methanol in DCM to afford 2-(4-methoxybenzyl)-3,3-dimethyl-5-(pyrimidin-4-ylamino)isoindolin-1-one. Yield: 0.2 g, 65%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.98 (brs, 1H) 8.72 (s, 1H) 8.32–8.38 (m, 1H) 7.98 (s, 1H) 7.64–7.76 (m, 2H) 7.36 (d, <i>J</i> = 8.72 Hz, 2H) 6.83–6.87 (m, 3H) 4.62 (s, 2H) 3.78 (s, 3H) 1.38 (s, 6H); MS (ESI) <i>m</i>/<i>z</i> 375 [M + H]<sup>+</sup>.</div><div class="NLM_p last">A solution of 2-(4-methoxybenzyl)-3,3-dimethyl-5-(pyrimidin-4-ylamino)isoindolin-1-one (0.26 g, 0.69 mmol) in trifluoroacetic acid (8 mL) was heated at 95 °C for 16 h. The reaction mixture was concentrated under reduced pressure, and the residue was basified with a saturated solution of sodium bicarbonate. The compound was extracted with 10% methanol in DCM. The organic layer was separated, dried over sodium sulfate, concentrated under reduced pressure, and the residue purified by silica gel column chromatography with 5% methanol in DCM to afford compound <b>10</b>. Yield: 0.038 g, 22%. HPLC purity: 97.84%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.89 (s, 1H), 8.66 (s, 1H), 8.42 (s, 1H), 8.30 (d, <i>J</i> = 5.9 Hz, 1H), 7.87 (d, <i>J</i> = 1.9 Hz, 1H), 7.69 (dd, <i>J</i> = 8.3, 1.9 Hz, 1H), 7.52 (d, <i>J</i> = 8.3 Hz, 1H), 6.83 (dd, <i>J</i> = 5.9, 1.3 Hz, 1H), 1.40 (s, 6H); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.5, 159.6, 157.9, 155.5, 154.4, 143.0, 124.8, 123.5, 119.0, 111.3, 107.9, 57.8, 27.6; MS (ESI) <i>m</i>/<i>z</i> 255 [M + H]<sup>+</sup>. HRMS: measured <i>m</i>/<i>z</i> [M + H]<sup>+</sup> 255.1240 (calcd. for C<sub>14</sub>H<sub>15</sub>N<sub>4</sub>O: 255.1240).</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 6-Oxo-5-(pyrimidin-4-ylamino)-1,6-dihydropyridine-2-carboxamide. (<b>11</b>)</h4><div class="NLM_p">To a solution of 5-chloro-2-pyridinecarboxylic acid <b>40</b> (5 g, 31.74 mmol) in ethanol (50 mL), conc. H<sub>2</sub>SO<sub>4</sub> (0.5 mL) was added, and the mixture was heated at 80 °C for 12 h. The reaction mixture was cooled to rt and concentrated under reduced pressure. The residue was dissolved in ethyl acetate and washed with saturated aqueous NaHCO<sub>3</sub> solution and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to afford ethyl 5-chloropicolinate as white crystalline solid. Yield: 5 g, 86%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.69 (m, 1H), 8.08 (m, 1H), 7.81 (m, 1H), 4.47 (m,2H), 1.43 (t, <i>J</i> = 7.2 Hz, 3H); MS (ESI) <i>m</i>/<i>z</i> 186 [M + H]<sup>+</sup>.</div><div class="NLM_p">To a solution of ethyl 5-chloropicolinate (5 g, 27 mmol) in chloroform (60 mL), urea hydrogen peroxide (5.08 g, 54.05 mmol) was added under ice cooling. Trifluoroacetic anhydride (7.5 mL, 54.0 mmol in CHCl<sub>3</sub> (60 mL)) was added dropwise over 30 min, and the mixture was stirred for 2 h at rt. A saturated aqueous sodium thiosulfate solution was added dropwise to the reaction mixture followed by extraction with chloroform, and the organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography using 0–50% ethyl acetate in hexanes to afford 5-chloro-2-(ethoxycarbonyl)pyridine 1-oxide <b>41</b>. Yield: 3.5 g, 64.8%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.65 (s, 1H),7.76 (m, 1H), 7.58 (m, 1H), 4.33 (m, 2H), 1.29 (m, 3H); MS (ESI) <i>m</i>/<i>z</i> 202 [M + H]<sup>+</sup>.</div><div class="NLM_p">Trifluoroacetic anhydride (8 mL, 57.71 mmol) was added dropwise to a solution of 5-chloro-2-(ethoxycarbonyl)pyridine 1-oxide <b>41</b> (2 g, 9.95 mmol) in DMF (12 mL) under ice cooling over 20 min, and the mixture was stirred at 50 °C for 1.5 h. The reaction mixture was cooled to 0 °C, water was added, and the mixture was neutralized with NaHCO<sub>3</sub> and extracted with DCM. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was triturated with ethyl acetate and <i>n</i>-pentane to afford ethyl 5-chloro-6-oxo-1,6-dihydropyridine-2-carboxylate. Yield: 1.3 g, 60%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.65(m,1H), 6.15 (m,1H), 4.43 (m, 2H), 1.43 (m, 3H); MS (ESI) <i>m</i>/<i>z</i> 202 [M + H]<sup>+</sup>.</div><div class="NLM_p">To a stirred suspension of ethyl 5-chloro-6-oxo-1,6-dihydropyridine-2-carboxylate (0.5 g, 2.48 mmol), K<sub>2</sub>CO<sub>3</sub> (0.684 g, 4.96 mmol), LiBr (0.43 g, 4.96 mmol), and tetrabutylammonium bromide (0.08g, 0.248 mmol) in toluene (13 mL) and water (0.13 mL), benzyl bromide (0.44 mL, 3.72 mmol) was added, and the resulting suspension was heated at 80 °C for 1 h. The mixture was allowed to reach rt, diluted with DCM, and filtered. The filtrate was concentrated <i>in vacuo</i>, and the residue was purified by silica gel column chromatography using 30% ethyl acetate in hexanes to afford ethyl 1-benzyl-5-chloro-6-oxo-1,6-dihydropyridine-2-carboxylate <b>42</b>. Yield: 0.47 g, 65.2%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.90 (d, <i>J</i> = 7.29 Hz, 1H) 7.29–7.35 (m, 2H) 7.26 (d, <i>J</i> = 7.29 Hz, 1H) 7.08 (d, <i>J</i> = 6.86 Hz, 2H) 6.84 (d, <i>J</i> = 7.72 Hz, 1H) 5.49 (s, 2H) 4.18 (q, <i>J</i> = 6.86 Hz, 2H) 1.12 (t, <i>J</i> = 7.29 Hz, 3H); MS (ESI) <i>m</i>/<i>z</i> 292 [M + H]<sup>+</sup>.</div><div class="NLM_p">A solution of ethyl 1-benzyl-5-chloro-6-oxo-1,6-dihydropyridine-2-carboxylate <b>42</b> (0.3 g, 1.028 mmol), 4-aminopyrimidine (0.117 g, 1.234 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (0.67 g, 2.05 mmol) in 1,4-dioxane (10 mL) was degassed with argon for 30 min. Pd<sub>2</sub>(dba)<sub>3</sub> (0.066 g, 0.071 mmol) and Xantphos (0.059 g, 0.102 mmol) were added under argon atmosphere, and the reaction mixture was heated at 90 °C for 15 h. The reaction mixture was cooled and filtered through a Celite pad. The filtrate was concentrated under reduced pressure and purified by silica gel column chromatography using 1–2% methanol in DCM to afford ethyl 1-benzyl-6-oxo-5-(pyrimidin-4-ylamino)-1,6-dihydropyridine-2-carboxylate <b>43</b>. Yield: 0.22 g, 61%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.58 (s, 1H) 8.79 (s, 1H) 8.64 (d, <i>J</i> = 8.14 Hz, 1H) 8.41 (d, <i>J</i> = 5.57 Hz, 1H) 7.41 (d, <i>J</i> = 5.57 Hz, 1H) 7.28–7.34 (m, 2H) 7.21–7.26 (m, 1H) 7.09–7.15 (m, 3H) 5.67 (s, 2H) 4.19 (q, <i>J</i> = 6.86 Hz, 2H) 1.16 (t, <i>J</i> = 7.07 Hz, 3H); MS (ESI) <i>m</i>/<i>z</i> 351 [M + H]<sup>+</sup>.</div><div class="NLM_p">To a mixture of ethyl 1-benzyl-6-oxo-5-(pyrimidin-4-ylamino)-1,6-dihydropyridine-2-carboxylate <b>43</b> (0.1 g, 0.285 mmol) in toluene (5 mL), trifluoromethanesulfonic acid (0.171 g, 1.14 mmol) was added, and the reaction mixture was heated at 140 °C in a microwave for 20 min. The reaction was concentrated under reduced pressure and partitioned between ethyl acetate and water. The aqueous layer was neutralized with sodium bicarbonate and extracted with ethyl acetate. The combined organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography using 1% methanol in DCM to afford ethyl 6-oxo-5-(pyrimidin-4-ylamino)-1,6-dihydropyridine-2-carboxylate. Yield: 0.045 g, 60.8%. MS (ESI) <i>m</i>/<i>z</i> 261 [M + H]<sup>+</sup>.</div><div class="NLM_p last">A mixture of ethyl 6-oxo-5-(pyrimidin-4-ylamino)-1,6-dihydropyridine-2-carboxylate (0.035 g, 0.1 mmol) and 25% ammonia in water (5 mL) was stirred at rt for 16 h. The mixture was concentrated under reduced pressure and triturated with DCM–pentane to afford 6-oxo-5-(pyrimidin-4-ylamino)-1,6-dihydropyridine-2-carboxamide <b>11</b> as light green solid. Yield: 0.012 g, 52.2%. HPLC purity: 99.09%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.27 (s, 1H), 9.35 (s, 1H), 8.75 (s, 1H), 8.61 (d, <i>J</i> = 7.7 Hz, 1H), 8.36 (d, <i>J</i> = 5.9 Hz, 1H), 8.06 (s, 1H), 7.67 (s, 1H), 7.38 (d, <i>J</i> = 5.9 Hz, 1H), 7.03 (d, <i>J</i> = 7.6 Hz, 1H); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 161.9, 159.5, 157.6, 156.6, 153.3, 133.0, 128.6, 119.3, 109.5, 107.1. MS (ESI) <i>m</i>/<i>z</i> 232[M + H] <sup>+</sup>. HRMS: measured <i>m</i>/<i>z</i> [M + H]<sup>+</sup> 232.0829 (calcd. for C<sub>10</sub>H<sub>10</sub>N<sub>5</sub>O<sub>2</sub>: 232.0830).</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 3,3-Dimethyl-6-(pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-<i>a</i>]pyridine-1,5-dione (<b>12</b>)</h4><div class="NLM_p">Prepared as in U.S. Patent 9,382,248 (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Aqueous ammonia (15 mL, 30% solution) was added to ethyl 5-chloro-6-oxo-1,6-dihydropyridine-2-carboxylate (0.65 g, 3.2 mmol) at 0 °C, and the reaction mixture was allowed to stir at rt for 16 h. The reaction mixture was concentrated under reduced pressure, and the residue was triturated with diethyl ether, filtered, and dried to afford 5-chloro-6-oxo-1,6-dihydropyridine-2-carboxamide. Yield: 0.43 g, 75%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.90 (s,1H), 7.53 (m, 1H, 7.38 (s, 1H), 6.81 (m, 1H), 5.9–6.2 (brs, 1H); MS (ESI) <i>m</i>/<i>z</i> 173 [M + H]<sup>+</sup>.</div><div class="NLM_p">Procedure A: To a solution of 5-chloro-6-oxo-1,6-dihydropyridine-2-carboxamide (1.4 g, 7.9 mmol) in 1,4-dioxane (20 mL), acetone (4.6 g, 79 mmol) and concentrated sulfuric acid (0.038 g, 0.39 mmol) were added at rt and the reaction mixture was heated at 100 °C for 8 h. The reaction mixture was concentrated under reduced pressure, and the residue was triturated with diethyl ether and hexane, filtered, and dried to afford 6-chloro-3,3-dimethyl-2,3-dihydroimidazo[1,5-<i>a</i>]pyridine-1,5-dione. Yield: 1.4 g, 83%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.99 (s, 1H), 7.93 (m, 1H), 6.71 (m, 1H), 1.76 (s, 6H); MS (ESI) <i>m</i>/<i>z</i> 213 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Procedure B: To a solution of 6-chloro-3,3-dimethyl-2,3-dihydroimidazo[1,5-<i>a</i>]pyridine-1,5-dione (0.25 g, 1.18 mmol) in 1,4-dioxane (8 mL), 4-aminopyrimidine (0.14 g, 1.41 mmol), Brettphos (0.19 g, 0.23 mmol), and cesium carbonate (0.76 g, 2.36 mmol) were added, and the reaction mixture was degassed with argon for 5 min. Tris dibenzylideneacetone dipalladium (0) (0.11 g, 0.12 mmol) was then added, and the reaction was degassed with argon for another 5 min and then stirred at 100 °C for 10 h. The reaction mixture was cooled to rt, filtered through Celite, and the filtrate concentrated under reduced pressure. The residue was purified by silica gel column chromatography using 5% methanol in DCM to afford 3,3-dimethyl-6-(pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-<i>a</i>]pyridine-1,5-dione <b>12</b> as a light yellow solid. Yield: 0.036 g, 11%. HPLC purity: 97.48%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.70 (s, 1H), 9.42 (s, 1H), 8.81–8.73 (m, 2H), 8.37 (d, <i>J</i> = 5.9 Hz, 1H), 7.40–7.34 (m, 1H), 6.87 (d, <i>J</i> = 7.7 Hz, 1H), 1.82 (s, 6H); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1659.6, 159.5, 157.6, 155.4, 154.1, 133.0, 128..2, 120.9, 109.6, 102.8, 77.0, 24.8. MS (ESI) <i>m</i>/<i>z</i> 272 [M + H]<sup>+</sup>. HRMS: measured <i>m</i>/<i>z</i> [M + H]<sup>+</sup> 272.1142 (calcd. for C<sub>13</sub>H<sub>14</sub>N<sub>5</sub>O<sub>2</sub>: 272.1139).</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 8-Fluoro-3,3-dimethyl-6-(pyrimidin-4-ylamino)-2<i>H</i>-imidazo[1,5-<i>a</i>]pyridine-1,5-dione (<b>13</b>)</h4><div class="NLM_p">Prepared as in U.S. Patent 9,382,248.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> To a stirred solution of 5-bromo-3-fluoro-pyridine-2-carboxylic acid (1.0 g, 4.55 mmol) in ethanol (20 mL) was added sulfuric acid (0.67 g, 6.82 mmol) at rt, and the reaction mixture was stirred at reflux overnight. The reaction mixture was cooled to rt, and the solvent was removed under vacuum. The residue was neutralized with a saturated aqueous sodium bicarbonate solution and extracted with ethyl acetate (2 × 100 mL). The organic layers were separated and dried with magnesium sulfate, filtered, and concentrated to afford ethyl 5-bromo-3-fluoro-pyridine-2-carboxylate as an off-white solid. Yield: 1.0 g, 89%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.61 (s, 1H), 7.77–7.75 (m, 1H), 4.51 (q, <i>J</i> = 7.16 Hz, 2H), 1.43 (t, <i>J</i> = 7.16 Hz, 3H).; MS (ESI) <i>m</i>/<i>z</i> 250 [M + H]<sup>+</sup>.</div><div class="NLM_p">To a stirred solution of ethyl 5-bromo-3-fluoro-pyridine-2-carboxylate (0.9 g, 3.63 mmol) in DCM (50 mL) at 0 °C was added trifluoroacetic anhydride (1.52 g, 7.26 mmol) and urea hydrogen peroxide (0.72 g, 7.62 mmol). The reaction mixture was stirred at rt overnight, and the reaction mixture was neutralized with a dipotassium hydrogen phosphate solution and then with a sodium bisulfite solution. The product was extracted with DCM (2 × 100 mL). The organic layers were separated, dried with magnesium sulfate, filtered, and concentrated to afford ethyl 5-bromo-3-fluoro-1-oxido-pyridin-1-ium-2-carboxylate as an off-white solid. Yield: 0.9 g, 89%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.22 (s, 1H), 7.30–7.26 (m, 1H), 4.50 (q, <i>J</i> = 7.2 Hz, 2H), 1.42 (t, <i>J</i> = 7.2 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> 266 [M + H]<sup>+</sup>.</div><div class="NLM_p">To a stirred solution of ethyl 5-bromo-3-fluoro-1-oxido-pyridin-1-ium-2-carboxylate (0.85 g, 3.21 mmol) in dimethylformamide (15 mL) was added trifluoroacetic anhydride (1.35 g, 6.42 mmol) at 0 °C. The reaction mixture was warmed to 50 °C and stirred for 1 h, quenched with saturated aqueous sodium bicarbonate solution, and extracted with DCM (2 × 100 mL). The organic layers were separated, dried with magnesium sulfate, filtered, and concentrated to afford ethyl 5-bromo-3-fluoro-6-oxo-1<i>H</i>-pyridine-2-carboxylate as a yellow solid. Yield: 0.8 g, 94%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.83 (d, <i>J</i> = 8.0 Hz,1H), 4.47 (q, <i>J</i> = 7.2 Hz, 2H), 1.43 (t, <i>J</i> = 7.2 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> 264 [M + H]<sup>+</sup>.</div><div class="NLM_p">In a flask charged with ethyl 5-bromo-3-fluoro-6-oxo-1<i>H</i>-pyridine-2-carboxylate (0.8 g, 3.03 mmol) at 0 °C was added liquid ammonia (15 mL, 3.03 mmol) in ethanol (5 mL). The stirred mixture was warmed to 45 °C for 2 h. The ammonia and ethanol were evaporated under reduced pressure, methanol was added, and the mixture was refluxed for 2 h and filtered while hot. The volume of the filtrate was reduced by 2/3 and to the remaining methanol was added diethyl ether until a solid precipitated. The solid was filtered and dried under vacuum to afford 5-bromo-3-fluoro-6-oxo-1<i>H</i>-pyridine-2-carboxamide as a light brown solid. Yield: 0.6 g, 85%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.88–7.86 (m, 1H), 7.67 (s, 1H), 7.50 (s, 1H).</div><div class="NLM_p">The synthesis of intermediate 6-bromo-8-fluoro-3,3-dimethyl-2H-imidazo[1,5-<i>a</i>]pyridine-1,5-dione was carried out as described above using Procedure A. Off-white solid; Yield: 0.24 g, 34%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.87 (d, <i>J</i> = 7.44 Hz, 1H), 7.06 (s, 1H), 1.96 (s, 6H); MS (ESI) <i>m</i>/<i>z</i> 275 [M + H]<sup>+</sup>.</div><div class="NLM_p last">The synthesis of compound <b>13</b> was carried out as described above using the general protocol of Procedure B. Off-white solid; Yield: 0.032 g, 13%. HPLC purity: 97.22%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.72 (s, 1H), 9.61 (s, 1H), 8.83 (d, <i>J</i> = 5.1 Hz, 1H), 8.79 (s, 1H), 8.45 (d, <i>J</i> = 5.7 Hz, 1H), 7.46 (d, <i>J</i> = 5.6 Hz, 1H), 1.82 (s, 6H); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.3, 157.5, 156.6 (d, <i>J</i> = 221 Hz), 152.2, 145.3, 143.5, 133.9 (d, <i>J</i> = 17.4 Hz), 113.1 (d, <i>J</i> = 27.5 Hz) 111.4 (d, <i>J</i> = 30 Hz) 110.0, 77.5, 24.7. HRMS: measured <i>m</i>/<i>z</i> [M + H]<sup>+</sup> 290.1053 (calcd. for C<sub>13</sub>H<sub>13</sub>FN<sub>5</sub>O<sub>2</sub>: 290.1048).</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 3,3,8-Trimethyl-6-(pyrimidin-4-ylamino)-2<i>H</i>-imidazo[1,5-<i>a</i>]pyridine-1,5-dione (<b>14</b>)</h4><div class="NLM_p last">Prepared as in U.S. Patent 9,382,248.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> A vial was charged with 8-chloro-3,3-dimethyl-6-(pyrimidin-4-ylamino)-2<i>H</i>-imidazo[1,5-<i>a</i>]pyridine-1,5-dione (0.20 g, 0.65 mmol), trimethylboroxine (0.16 g, 1.31 mmol), and potassium phosphate (0.28 g, 1.31 mmol) in 1,4-dioxane (10 mL) at rt under argon. Then reaction mixture was purged with argon for 10 min followed by addition of tris(dibenzylideneacetone)dipalladium(0) (60 mg, 0.07 mmol) and tricyclohexylphosphine (18 mg, 0.07 mmol). The vial was sealed and heated at 140 °C in a microwave reactor for 1 h. The reaction mixture was concentrated to dryness, and the crude residue was subjected to flash column chromatography using silica gel with a solvent gradient of 0.2–0.5% methanol in DCM. The solid obtained was stirred in <i>n</i>-pentane and filtered. The resulting product 3,3,8-trimethyl-6-(pyrimidin-4-ylamino)-2<i>H</i>-imidazo[1,5-<i>a</i>]pyridine-1,5-dione <b>14</b> was obtained as an off-white solid. Yield: 0.035 g, 18%. HPLC purity: 97.73; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.57 (s, 1H), 9.39 (s, 1H), 8.77 (s, 1H), 8.60 (s, 1H), 8.37 (d, <i>J</i> = 5.76 Hz, 1H), 7.77 (d, <i>J</i> = 5.64 Hz, 1H), 2.44 (s, 3H), 1.79 (s, 6H); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.8, 159.3, 157.6, 155.4, 153.4, 132.4, 123.6, 122.8, 116.2, 109.6, 75.2, 24.9, 13.6. HRMS: measured <i>m</i>/<i>z</i> [M + H]<sup>+</sup> 286.1302 (calcd. for C<sub>14</sub>H<sub>16</sub>N<sub>5</sub>O<sub>2</sub>: 286.1299).</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 8-Chloro-3,3-dimethyl-6-(pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-<i>a</i>]pyridine-1,5-dione (<b>15</b>)</h4><div class="NLM_p">Prepared as in U.S. Patent 9,382,248.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> To a stirred solution of 5-bromo-3-chloro-pyridine-2-carboxylic acid (150.0 g, 634.38 mmol) in ethanol (1.5 L) was added sulfuric acid (93.26 g, 951.58 mmol) at rt. The reaction was stirred at 80 °C overnight. The reaction mixture was cooled to rt, and solvent was removed under reduced pressure. The resulting residue was neutralized with saturated aqueous sodium bicarbonate solution and extracted with ethyl acetate (2 × 1 L). The organic layers were then separated, combined, dried with magnesium sulfate, and concentrated to dryness to afford ethyl 5-bromo-3-chloro-pyridine-2-carboxylate as an off white solid. Yield: 163 g, 97%. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i><sub>1</sub>) δ 8.26 (d, <i>J</i> = 0.8 Hz, 1H), 7.47 (d, <i>J</i> = 0.8 Hz, 1H), 4.49 (q, <i>J</i> = 7.2 Hz, 2H), 1.40 (t, <i>J</i> = 7.2 Hz, 3H).</div><div class="NLM_p">To a stirred solution of ethyl 5-bromo-3-chloro-pyridine-2-carboxylate (151.0 g, 570.89 mmol) in DCM (1.73 L) was added trifluoroacetic anhydride (30.0 mL, 1.14 mol) and urea hydrogen peroxide (112.69 g, 1.20 mol) at 0 °C. The reaction was stirred overnight at rt, and the reaction mixture was neutralized with a potassium phosphate dibasic solution. A sodium bisulfite solution was added followed by extraction with DCM (2 × 100 mL). The organic layers were separated, combined, dried with magnesium sulfate, filtered, and concentrated to afford ethyl 5-bromo-3-chloro-1-oxido-pyridin-1-ium-2-carboxylate as an off white solid. Yield: 150.5 g, 94%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.26 (d, <i>J</i> = 1.2 Hz, 1H), 7.48 (d, <i>J</i> = 1.2 Hz, 1H), 4.50 (q, <i>J</i> = 7.12 Hz, 2H), 1.42 (t, <i>J</i> = 12.12 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> 282 [M + H]<sup>+</sup>.</div><div class="NLM_p">To a stirred solution of ethyl 5-bromo-3-chloro-1-oxido-pyridin-1-ium-2-carboxylate (150 g, 534.8 mmol) in dimethylformamide (900 mL) at 0 °C was added trifluoroacetic anhydride (224.63 g, 1.07 mmol). The temperature of the reaction mixture was raised to 50 °C and stirring was continued for 1 h. After the oxidation was complete, the reaction was quenched with a saturated aqueous sodium bicarbonate solution and extracted with DCM (2 × 100 mL). The organic layers were separated, combined, dried with magnesium sulfate, and concentrated to afford ethyl 5-bromo-3-chloro-6-oxo-1<i>H</i>-pyridine-2-carboxylate as a yellow solid. Yield: 75 g, 50%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.44–10.02 (m, 1H), 7.86 (s, 1H), 4.47 (q, <i>J</i> = 7.2 Hz, 2H), 1.43 (t, <i>J</i> = 5.6 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> 282 [M + H]<sup>+</sup>.</div><div class="NLM_p">In a flask containing ethyl 5-bromo-3-chloro-6-oxo-1<i>H</i>-pyridine-2-carboxylate (75.0 g, 267.38 mmol) was added liquid ammonia (150.0 mL, 267.38 mmol) in ethanol (100 mL) at 0 °C. The reaction mixture was stirred at 45 °C for 2 h. At this time the mixture was concentrated to remove the ethanolic ammonia. The crude solids were washed with diethyl ether (500 mL) and dissolved in refluxing methanol (1 L) and filtered hot. The filtrate was concentrated under reduced pressure until 1/3 of solvent volume remained. Diethyl ether was added until all solids precipitated. The solid was filtered and dried under vacuum to afford 5-bromo-3-chloro-6-oxo-1<i>H</i>-pyridine-2-carboxamide as a light brown solid. Yield: 45 g, 69%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.92–7.82 (m, 1H), 7.61–7.59 (m, 1H), 7.36 (s, 1H). MS (ESI) <i>m</i>/<i>z</i> 249 [M – 1]<sup>−</sup>.</div><div class="NLM_p">The synthesis of intermediate 6-bromo-8-chloro-3,3-dimethyl-2<i>H</i>-imidazo[1,5-<i>a</i>]pyridine-1,5-dione was carried out as described above using the general protocol of Procedure A. White solid; Yield: 390 mg, 48%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.03 (s, 1H), 8.24 (s, 1H), 1.75 (s, 6H). MS (ESI) <i>m</i>/<i>z</i> 289 [M – 1]<sup>−</sup>.</div><div class="NLM_p last">The synthesis of compound <b>15</b> was carried out as described above using the general protocol of Procedure B. Off white solid; Yield: 0.020 g, 10%. HPLC purity: 99.24%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.78 (s, 1H), 9.64 (s, 1H), 8.84 (s, 1H), 8.79 (s, 1H), 8.43 (d, <i>J</i> = 5.6 Hz, 1H), 7.44 (d, <i>J</i> = 5.2 Hz, 1H), 1.81 (s, 6H); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.3, 158.1, 157.6, 155.7, 153.1, 133.4, 122.5, 121.0, 110.5, 109.9, 76.6, 24.7. HRMS: measured <i>m</i>/<i>z</i> [M + H]<sup>+</sup> 306.0755 (calcd. for C<sub>13</sub>H<sub>13</sub>ClN<sub>5</sub>O<sub>2</sub>: 306.0752).</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> <i>N</i>-(6-((1-Oxoisoindolin-5-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide (<b>16</b>)</h4><div class="NLM_p">Synthesized as reported in U.S. Patent Application No. WO2017075394 (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>).<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> To a stirred solution of 6-chloro-4-aminopyrimidine <b>47</b> (1 g, 7.75 mmol) in THF (20 mL), 4-(dimethylamino)pyridine (0.047 g, 0.387 mmol) and di-<i>t</i>-butyl dicarbonate (3.55 g, 16.27 mmol) were added dropwise, and the reaction mixture was stirred at rt for 16 h. The reaction mixture was diluted with water and extracted with ethyl acetate. The combined organic layer was washed with brine, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure to afford <i>t</i>-butyl <i>N</i>-<i>t</i>-butoxycarbonyl-<i>N</i>-(6-chloropyrimidin-4-yl)carbamate, which was used for the next step without further purification. Yield: 1.3 g, 51%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.668 (s, 1H), 7.857 (s, 1H), 1.68 (s, 18H); MS (ESI) <i>m</i>/<i>z</i> 330 [M + H]<sup>+</sup>.</div><div class="NLM_p">A mixture of <i>t</i>-butyl <i>N</i>-<i>t</i>-butoxycarbonyl-<i>N</i>-(6-chloropyrimidin-4-yl)carbamate (0.5 g, 1.51 mmol), cyclopropanecarboxamide (0.19 g, 2.27 mmol), cesium carbonate (0.69 g, 2.12 mmol), and Xantphos (0.13 g, 0.22 mmol) in 1,4-dioxane (8 mL) was degassed with argon for 15 min. Pd<sub>2</sub>(dba)<sub>3</sub> (0.069 g, 0.075 mmol) was added under an argon atmosphere, and the reaction mixture was stirred at 90 °C for 18 h. The reaction mixture was diluted with water and extracted with ethyl acetate, and the organic layer was washed with brine, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography using 0–40% ethyl acetate in hexane to afford <i>t</i>-butyl <i>N</i>-<i>t</i>-butoxycarbonyl-<i>N</i>-(6-(cyclopropanecarboxamido)pyrimidin-4-yl)carbamate <b>48</b> as a yellow solid; Yield: 0.55 g, 96%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.30 (s, 1H), 8.67 (m, 1H), 8.25 (m, 1H), 2.03 (m, 1H), 1.46 (s, 18H), 0.87 (m, 4H); MS (ESI) <i>m</i>/<i>z</i> 379 [M + H]<sup>+</sup>.</div><div class="NLM_p">Procedure C: A stirred solution of <i>t</i>-butyl <i>N</i>-<i>t</i>-butoxycarbonyl-<i>N</i>-(6-(cyclopropanecarboxamido)pyrimidin-4-yl)carbamate <b>48</b> (0.55 g, 1.45 mmol) and 4 M HCl in 1,4-dioxane (4 mL) was stirred at rt for 1 h. The reaction mixture was concentrated under reduced pressure, and the residue was triturated with diethyl ether and hexane to afford <i>N</i>-(6-aminopyrimidin-4-yl)cyclopropanecarboxamide as white solid, which was used for the next step without further purification. Yield: 0.3 g, crude. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.54 (s,1H), 8.10 (s,1H), 7.10 (m,1H), 6.73 (s,2H), 1.97 (m,1H), 0.78 (m, 4H); MS (ESI) <i>m</i>/<i>z</i> 179 [M + H]<sup>+</sup>.</div><div class="NLM_p">A mixture of <i>N</i>-(6-aminopyrimidin-4-yl)cyclopropanecarboxamide (0.3 g, 1.68 mmol), 5-bromo-2-(4-methoxybenzyl)isoindolin-1-one (0.61 g, 1.85 mmol), cesium carbonate (1.64 g, 5.05 mmol), and X-Phos (0.16 g, 0.33 mmol) in 1,4-dioxane (10 mL) was degassed with argon for 30 min. Pd<sub>2</sub>(dba)<sub>3</sub> (0.15 g, 0.16 mmol) was added under argon atmosphere. The reaction mixture was stirred at 90 °C for 18 h and was then diluted with water and extracted with ethyl acetate. The organic layer was washed with brine, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure, and the residue was purified by silica gel column chromatography using 0–5% methanol in DCM to afford <i>N</i>-(6-((2-(4-methoxybenzyl)-1-oxoisoindolin-5-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide <b>49</b>. Yield: 0.3 g, 42%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.88 (s, 1H) 9.92 (s, 1H) 8.45 (s, 1H) 7.97 (s, 1H) 7.72 (dd, <i>J</i> = 8.28, 1.41 Hz, 1H) 7.59–7.65 (m, 2H) 7.20 (d, <i>J</i> = 8.48 Hz, 2H) 6.90 (d, <i>J</i> = 8.48 Hz, 2H) 4.62 (s, 2H) 4.30 (s, 2H) 3.72 (s, 3H) 2.00–2.07 (m, 1H) 0.81–0.86 (m, 4H); MS (ESI) <i>m</i>/<i>z</i> 430 [M + H]<sup>+</sup>.</div><div class="NLM_p last">A solution of <i>N</i>-(6-((2-(4-methoxybenzyl)-1-oxoisoindolin-5-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide <b>49</b> (0.2 g, 0.466 mmol) in trifluoroacetic acid (3 mL) was heated at reflux overnight. The mixture was cooled to 0 °C and neutralized with aqueous 1 N sodium bicarbonate solution. The precipitated solid was filtered and washed with hexane-diethyl ether (1:1) to afford compound <b>16</b> as an off-white solid; Yield: 0.066 g, 46%. HPLC purity: 98.34%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.88 (s, 1H), 9.91 (s, 1H), 8.47 (d, <i>J</i> = 1.1 Hz, 1H), 8.32 (s, 1H), 8.10–8.05 (m, 1H), 7.69–7.53 (m, 3H), 4.34 (s, 2H), 2.03 (p, <i>J</i> = 6.2 Hz, 1H), 0.84 (d, <i>J</i> = 6.3 Hz, 4H); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 173.6, 169.9, 161.2, 157.5, 156.7, 145.3, 143.3, 125.9, 123.2, 118.7, 113.2, 93.7, 44.8, 14.3, 8.1. MS (ESI) <i>m</i>/<i>z</i> 310 [M + H]<sup>+</sup>. HRMS: measured <i>m</i>/<i>z</i> [M + H]<sup>+</sup> 310.1299 (calcd. for C<sub>16</sub>H<sub>16</sub>N<sub>5</sub>O<sub>2</sub>: 310.1300).</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> <i>N</i>-(6-((3,3-Dimethyl-1,5-dioxo-1,2,3,5-tetrahydroimidazo[1,5-<i>a</i>]pyridin-6-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide (<b>17</b>)</h4><div class="NLM_p last">Prepared as in U.S. Patent 9,382,248.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The synthesis of compound <b>17</b> was carried out as described above using the general protocol of Procedure B. Beige solid; Yield: 0.075 g, 15%. HPLC purity: 99.59%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.87 (s, 1H), 9.68 (s, 1H), 9.20 (s, 1H), 8.64 (d, <i>J</i> = 7.7 Hz, 1H), 8.51 (s, 1H), 7.88 (d, <i>J</i> = 1.0 Hz, 1H), 6.85 (d, <i>J</i> = 7.6 Hz, 1H), 2.04–2.01 (m, <i>J</i> = 6.2 Hz, 1H), 1.80 (s, 6H), 0.84 (d, <i>J</i> = 6.1 Hz, 4H); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.9, 159.6, 157.2, 156.8, 154.1, 133.3, 128.1, 120.1, 102.7, 954., 77.0, 24.8, 14.2, 8.0. HRMS: measured <i>m</i>/<i>z</i> [M + H]<sup>+</sup> 355.1519 (calcd. for C<sub>17</sub>H<sub>19</sub>N<sub>6</sub>O<sub>3</sub>: 355.1513).</div></div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> <i>N</i>-[6-[[8-Chloro-3-(3-chlorophenyl)-3-methyl-1,5-dioxo-2<i>H</i>-imidazo[1,5-<i>a</i>]pyridin-6-yl]amino]pyrimidin-4-yl]cyclopropanecarboxamide (<b>18</b>)</h4><div class="NLM_p last">Prepared as in U.S. Patent 9,382,248.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The synthesis of intermediate 6-bromo-8-chloro-3-(3-chlorophenyl)-3-methyl-2<i>H</i>-imidazo[1,5-<i>a</i>]pyridine-1,5-dione was carried out as described above using the general protocol of Procedure A. White solid; Yield: 0.13 g, 17%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.38 (s, 1H), 8.32 (s, 1H), 7.52 (s, 1H), 7.47–7.38 (m, 2H), 7.34 (d, <i>J</i> = 7.6 Hz, 1H), 2.18 (s, 3H); MS (ESI) <i>m</i>/<i>z</i> 386.83 [M + H]<sup>+</sup>. The synthesis of compound <b>18</b> was carried out as described above using the general protocol of Procedure B. Light yellow solid; Yield: 0.04 g, 25%. HPLC purity: 97.80%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.90 (s, 1H), 10.09 (s, 1H), 9.44 (s, 1H), 8.75 (s, 1H), 8.59 (s, 1H), 7.90 (s, 1H), 7.52 (s, 1H), 7.45–7.39 (m, 2H), 7.34 (d, <i>J</i> = 7.2 Hz, 1H), 2.23 (s, 3H), 2.02–1.97 (m, 1H), 0.82–0.81 (m, 4H); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 173.2, 160.7, 158.5, 157.2, 157.0, 152.4, 140.9, 134.1, 133.0, 130.9, 128.6, 126.4, 124.7, 121.8, 121.0, 111.2, 96.1, 77.0, 22.3, 14.7, 8.0. HRMS: measured <i>m</i>/<i>z</i> [M + H]<sup>+</sup> 485.0891 (calcd. for C<sub>22</sub>H<sub>19</sub>C<sub>l2</sub>N<sub>6</sub>O<sub>3</sub>: 485.0890).</div></div><div id="sec5_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 3-[3-(6-Isoquinolyl)imidazo[1,2-<i>b</i>]pyridazin-6-yl]oxycyclobutanamine. (<b>19</b>)</h4><div class="NLM_p">To a 40 mL vial was added 3-bromo-6-chloro-imidazo[1,2-<i>b</i>]pyridazine (100 mg, 0.43 mmol), potassium carbonate (176 mg, 1.27 mmol), and isoquinolin-6-ylboronic acid (119 mg, 0.69 mmol). Monoglyme (2 mL) and water (1 mL) were added, and the heterogeneous yellow reaction mixture was stirred at rt. Tetrakis(triphenylphosphine)palladium(0) (35 mg, 0.03 mmol) was added, the vial was purged with argon (×2), and the vial was heated at 85 °C overnight. After cooling to rt, the reaction was diluted with EtOAc and water (∼3:1 EtOAc/water) and extracted with EtOAc. The combined organics were then dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated to provide a yellow residue, which was purified on silica gel eluting with EtOAc affording 6-(6-chloroimidazo[1,2-<i>b</i>]pyridazin-3-yl)isoquinoline as a yellow solid (75 mg, 62% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.35 (s, 1H), 8.78 (s, 1H), 8.56–8.55 (m, 2H), 8.38–8.35 (m, 2H), 8.27 (d, <i>J</i> = 21.7 Hz, 1H), 7.90 (d, <i>J</i> = 14.2 Hz, 1H), 7.52 (d, <i>J</i> = 23.6 Hz, 1H); MS (ESI) <i>m</i>/<i>z</i> 282.96 [M + H]<sup>+</sup>.</div><div class="NLM_p">To a 10 mL flask was added sodium hydride (14 mg, 0.36 mmol), followed by THF (3.5 mL), and the flask was placed in a bath at 0 °C. <i>t</i>-Butyl <i>N</i>-(3-hydroxycyclobutyl)carbamate (67 mg, 0.36 mmol) was added slowly, the mixture was stirred for 15 min at 0 °C, then 6-(6-chloroimidazo[1,2-<i>b</i>]pyridazin-3-yl)isoquinoline (50 mg, 0.18 mmol) was added, and the reaction was stirred for 10 min at 0 °C and stirred at rt overnight. The reaction was quenched with water, diluted with half saturated brine, and extracted with DCM (3×). The organic layer was dried over sodium sulfate and concentrated and purified via column chromatography eluting with 0–10% MeOH/DCM affording <i>t</i>-butyl <i>N</i>-[3-[3-(6-isoquinolyl)imidazo[1,2-<i>b</i>]pyridazin-6-yl]oxycyclobutyl]carbamate as a pale yellow powder (45 mg, 29% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.32 (s, 1H), 8.93 (s, 1H), 8.53 (d, <i>J</i> = 14.2 Hz, 1H), 8.39 (s, 1H), 8.34 (d, <i>J</i> = 20.9 Hz, 1H), 8.21 (d, <i>J</i> = 21.6 Hz, 1H), 8.17 (d, <i>J</i> = 24.1 Hz, 1H), 7.87 (d, <i>J</i> = 13.3 Hz, 1H), 7.05 (d, <i>J</i> = 24.2 Hz, 1H), 5.39–5.38 (m, 1H), 4.20–4.18 (m, 1H), 2.60–2.57 (m, 4H), 1.41 (s, 9H); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.6, 146.9, 139.4, 144.0, 138.1, 134.8, 132.9, 131.9, 129.6, 129.4, 127.1, 126.9, 126.8, 126.5, 123.8, 118.2, 71.2, 42.5, 34.4. MS (ESI) <i>m</i>/<i>z</i> 432.17 [M + H]<sup>+</sup>.</div><div class="NLM_p last">To a 20 mL vial was added <i>t</i>-butyl <i>N</i>-[3-[3-(6-isoquinolyl)imidazo[1,2-<i>b</i>]pyridazin-6-yl]oxycyclobutyl]carbamate (43 mg, 0.10 mmol) and 1.5 mL of MeOH. To the stirring suspension was added 4 N HCl (0.12 mL, 0.50 mmol) in 1,4-dioxane, and the solution became homogeneous. The reaction was stirred at 23 °C overnight and concentrated and triturated with DCM. The resultant powder was then dried <i>in vacuo</i> to provide 3-[3-(6-isoquinolyl)imidazo[1,2-<i>b</i>]pyridazin-6-yl]oxycyclobutanamine <b>19</b>. Yield: 20 mg, 58%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.82 (s, 1H), 9.22 (s, 1H), 8.85 (d, <i>J</i> = 14.9 Hz, 1H), 8.68–8.60 (m, 6H), 8.28 (d, <i>J</i> = 23.9 Hz, 1H), 7.19 (d, <i>J</i> = 23.8 Hz, 1H), 5.80 (br s, 1H), 3.91 (br s, 1H), 2.86–2.81 (m, 2H), 2.70–2.66 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 332 [M + H]<sup>+</sup>; Anal. Calcd for C<sub>19</sub>H<sub>17</sub>N<sub>5</sub>O + 2.5HCl + 3.5H<sub>2</sub>O: C, 47.00; H, 5.50; N, 14.42. Found: C, 46.91; H, 5.49; N, 14.46. HRMS: measured <i>m</i>/<i>z</i> [M + H]<sup>+</sup> 332.1506 (calcd. for C<sub>19</sub>H<sub>18</sub>N<sub>5</sub>O: 332.1504)</div></div><div id="sec5_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> <i>N</i>-(6-((8′-Chloro-1′,5′-dioxo-1′,5′-dihydro-2′<i>H</i>-spiro[cyclohexane-1,3′-imidazo[1,5-<i>a</i>]pyridin]-6′-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide (<b>20</b>)</h4><div class="NLM_p">Prepared as in U.S. Patent 9,382,248.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The synthesis of intermediate 6′-bromo-8′-chloro-2′<i>H</i>-spiro[cyclohexane-1,3′-imidazo[1,5-<i>a</i>]pyridine]-1′,5′-dione was carried out as described above using the general protocol of Procedure A. Off white solid; Yield: 1.93 g, 64%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.59 (s, 1H), 8.24 (s, 1H), 2.84 (t, <i>J</i> = 10.7 Hz, 2H), 1.78–1.70 (m, 2H), 1.69–1.55 (m, 3H), 1.54–1.49 (m, 2H), 1.25–1.15 (m, 1H). MS (ESI) <i>m</i>/<i>z</i> 331 [M + H].</div><div class="NLM_p last">The synthesis of compound <b>20</b> was carried out as described above using the general protocol of Procedure B. Yellow solid; Yield: 0.051 g, 2.1%. HPLC purity: 98.19%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.93 (s, 1H), 10.29 (s, 1H), 9.43 (s, 1H), 8.70 (s, 1H), 8.58 (s,1H),7.97(s, 1H), 2.93 (t, <i>J</i> = 11.2 Hz, 2H), 2.02–1.92 (m, 1H), 1.76–1.73 (m, 2H), 1.68–1.58 (m, 3H), 1.58–1.46 (m, 2H), 1.21–1.19 (m, 1H), 0.85–0.83 (m, 4H); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 173.9, 162.9, 159.4, 157.8, 157.5, 153.7, 134.4, 122.8, 121.2, 111.1, 96.7, 80.3, 32.9, 24.7, 22.4, 14.8, 8.6. HRMS: measured <i>m</i>/<i>z</i> [M + H]<sup>+</sup> 429.1433 (calcd. for C<sub>20</sub>H<sub>22</sub>ClN<sub>6</sub>O<sub>3</sub>: 429.1436).</div></div><div id="sec5_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 6′-((6-Aminopyrimidin-4-yl)amino)-8′-chloro-2′<i>H</i>-spiro[cyclohexane-1,3′-imidazo[1,5-<i>a</i>]pyridine]-1′,5′-dione (<b>21</b>)</h4><div class="NLM_p last">Prepared as in U.S. Patent 9,382,248.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The synthesis of compound <b>21</b> was carried out as described above using the general protocol of Procedure B. Yield: 22 mg. HPLC purity: 99.31%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.22 (s, 1H), 8.90 (s, 1H), 8.63 (s, 1H), 8.20 (s, 1H), 6.61 (s, 2H), 6.24 (s, 1H), 2.94 (t, <i>J</i> = 11.36 Hz, 2H), 1.78–1.60 (m, 5H), 1.56–1.52 (d, <i>J</i> = 12.1 Hz, 2H), 1.27–1.18 (m, 1H); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.3, 158.7, 153.3, 152.6, 133.2, 123.3, 122.4, 110.3, 87.9, 79.9, 32.3, 24.1, 21.9. HRMS: measured <i>m</i>/<i>z</i> [M + H]<sup>+</sup> 361.1185 (calcd. for C<sub>16</sub>H<sub>18</sub>ClN<sub>6</sub>O<sub>2</sub>: 361.1174).</div></div><div id="sec5_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 6-[(6-Amino-5-chloro-pyrimidin-4-yl)amino]-8-chloro-spiro[2<i>H</i>-imidazo[1,5-<i>a</i>]pyridine-3,1′-cyclohexane]-1,5-dione Hydrochloride (<b>22</b>)</h4><div class="NLM_p">Prepared as in U.S. Patent 9,382,248.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> To a stirred solution of 4-amino-5,6-dichloropyrimidine (3.0 g, 18.29 mmol) in THF (30 mL), 4-dimethylaminopyridine (0.16 g, 1.31 mmol) and di-<i>t</i>-butyl dicarbonate (8.77 g, 40.2 mmol) were added at rt. The reaction was stirred at rt overnight and concentrated, and the residue was diluted with water and extracted with ethyl acetate (2 × 50 mL), dried (magnesium sulfate), and concentrated to afford ethyl <i>t</i>-butyl <i>N</i>-<i>t</i>-butoxycarbonyl-<i>N</i>-(5,6-dichloropyrimidin-4-yl)carbamate as a white solid. Yield: 3.1 g, 47%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.06 (s, 1H), 1.40 (s, 18H). MS (ESI) <i>m</i>/<i>z</i> 364.3 [M + H]<sup>+</sup>.</div><div class="NLM_p">The synthesis of intermediate <i>t</i>-butyl <i>N</i>-<i>t</i>-butoxycarbonyl-<i>N</i>-[5-chloro-6-[(8-chloro-1,5-dioxo-spiro[2<i>H</i>-imidazo[1,5-<i>a</i>]pyridine-3,1′-cyclohexane]-6-yl)amino]pyrimidin-4-yl]carbamate was carried out as described above using the general protocol of Procedure B. Yellow solid; Yield: 0.10 g, 26%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.46 (s, 1H), 8.99 (s, 1H), 8.95 (s, 1H), 8.66 (s, 1H), 2.90 (t, <i>J</i> = 10.74, 2H), 1.65 (m, 7H), 1.46 (m, 18H), 1.20 (m, 1H); MS (ESI) <i>m</i>/<i>z</i> 595.45 [M + H]<sup>+</sup>.</div><div class="NLM_p last">The synthesis of compound <b>22</b> was carried out as described above using the general protocol of Procedure C. Yellow solid; Yield: 0.059 g, 81%. HPLC purity: 97.48%; <sup>1</sup>H NMR: (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.35 (s, 1H), 8.62 (s, 1H), 8.55 (s, 1H), 8.23 (s, 2H), 7.27 (s, 1H), 2.91 (t, <i>J</i> = 2.28, 2H), 1.77–1.68 (m, 2H), 1.65–1.54 (m, 3H), 1.55–1.52 (m, 2H), 1.28–1.22 (m, 1H); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 158.7, 158.2, 153.9, 153.6, 153.2, 132.6, 122.8, 120.1, 111.0, 93.8, 80.0, 32.4, 24.1, 21.9. HRMS: measured <i>m</i>/<i>z</i> [M + H]<sup>+</sup> 395.0790 (calcd. for C<sub>16</sub>H<sub>17</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>2</sub>: 395.0712).</div></div><div id="sec5_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 6′-((6-Aminopyrimidin-4-yl)amino)-8′-methyl-2′<i>H</i>-spiro[cyclohexane-1,3′-imidazo[1,5-<i>a</i>]pyridine]-1′,5′-dione Hydrochloride (<b>23</b>)</h4><div class="NLM_p">Prepared as in U.S. Patent 9,382,248.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> To a stirred solution of 4-amino-6-chloropyrimidine (4900 g, 1 equiv, 37.08 mol) in THF (10 V, 50 L), at 0 °C was added <i>N</i>,<i>N</i>-dimethylaminopyridine (463 g, 0.1 equiv, 3.70 mol). Di-<i>t</i>-butyl dicarbonate (24.8 L, 3 equiv, 113.9 mol) was then added slowly over 1 h (gas evolution was observed) to the resultant reaction. The reaction mixture became dark brown with stirring at rt over a period of 16 h. The reaction mixture was poured into an ice/water mixture (30 L) and further stirred for 30 min prior to solvent extraction of the aqueous phase with ethyl acetate (10 L). The organic and aqueous phases were separated, and the resultant aqueous layer was extracted twice with ethyl acetate (2 × 10 L), the combined organic layer was washed twice with water (2 × 10 L), then brine (1 × 10 L), and dried over anhydrous sodium sulfate. The organic layer was concentrated under reduced pressure at 50 °C to obtain crude product, which was slurried with hexane (10 L) for 1 h, filtered, and dried under reduced pressure at 50 °C to obtain a brick red solid. Yield: 1030 g (82.6%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.86 (s, 1H), 7.85 (s, 1H), 1.48 (s, 18H). MS (ESI) <i>m</i>/<i>z</i> 330 [M + H]<sup>+</sup>.</div><div class="NLM_p">To a stirring solution of di-<i>t</i>-butyl (6-chloropyrimidin-4-yl) carbamate (5000 g, 1 equiv, 15.20 mol) in 1,4-dioxane (5 V, 25 L) at rt was added cyclopropanecarboxamide (1291 g, 1 equiv, 15.20 mol) followed by the addition of cesium carbonate (3950 g, 0.8 equiv, 12.15 mol). After purging the reaction mixture (dark brown solution) with argon for 30 min, Xantphos (120 g, 0.015 equiv, 0.23 mol) and palladium(II) acetate (51 g, 0.015 equiv, 0.23 mol) were added. Purging of the reaction with argon was continued for another 15 min, and the reaction mixture was then heated to 90 °C for 4 h, during which time the color of the reaction changed to orange. The reaction mixture was cooled to 50 °C and was filtered through a Celite bed and washed with EtOAc (3 × 10 L), and the combined organic layers were washed with water (2 × 10 L), dried over anhydrous sodium sulfate, and concentrated under reduced pressure to provide crude product (6200 g). Diethyl ether (6.0 L) was added, the mixture was stirred for 30 min, and the solid was filtered, washed with ether (2 × 1 L), and then dried to afford di-<i>t</i>-butyl (6-(cyclopropanecarboxamido) pyrimidin-4-yl) carbamate as an orange solid. This compound was used in the next step without further purification. Yield: 4500 g, (78.2%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.30 (s, 1H), 8.66 (s, 1H), 8.25 (s, 1H), 2.16–2.02 (m, 1H), 1.48–1.39 (m, 18H), 0.80–0.60 (m, 4H). MS (ESI) <i>m</i>/<i>z</i> 378.43 [M + H]<sup>+</sup>.</div><div class="NLM_p">Trifluoroacetic acid (16 L, 10 equiv, 212 mol) was slowly added over 1 h to a stirring solution of di-<i>t</i>-butyl (6-(cyclopropanecarboxamido) pyrimidin-4-yl) (8050 g, 1 equiv, 21.20 mol) in DCM (5 V, 40 L). Evolution of gas was observed during the addition of trifluoroacetic acid, and the reaction became dark brown when stirred continuously for 4 h at rt. The reaction was concentrated to dryness under reduced pressure, and DCM (25 L) was added to the residue. The mixture was cooled to 0 °C, and NH<sub>4</sub>OH (25% aq. solution, 6 L) was added slowly (pH = 10) over 30 min while stirring the reaction mixture continuously. The resulting mixture was stirred at 0 °C for an additional 30 min, and the solid formed was filtered and washed with water (2 × 10 L) followed by washing with methanol (2 × 2 L) and DCM (15 L). The washed solid was dried under high vacuum overnight to afford <i>N</i>-(6-aminopyrimidin-4-yl) cyclopropanecarboxamide as light yellow solid. Yield: 2320 g (61.0%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 10.54 (s, 1H), 8.10 (s, 1H), 7.10 (s, 1H), 6.72 (br, 2H), 2.00–1.94 (m, 1H), 0.81–0.78 (m, 4H). MS (ESI) <i>m</i>/<i>z</i> 178.19 [M + H]<sup>+</sup>. The title compound was prepared according to Procedure A using 5-bromo-3-methyl-6-oxo-1,6-dihydropyridine-2-carboxamide (prepared from 5-bromo-3-methylpicolinic acid in a similar fashion to that used for the preparation of ethyl 5-chloro-6-oxo-1,6-dihydropyridine-2-carboxylate). Off-white solid; Yield: 1280 g, 82%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.37 (s, 1H), 8.01 (s, 1H), 2.92–2.82 (m, 2H), 2.38 (s, 3H), 1.75–1.65 (m, 5H), 1.43 (d, <i>J</i> = 24 Hz, 2H), 1.25–1.15 (m, 1H). MS (ESI) <i>m/</i>z 311 [M + H]<sup>+</sup>.</div><div class="NLM_p">The title compound was prepared according to Procedure B using 6′-bromo-8′-methyl-2′<i>H</i>-spiro[cyclohexane-1,3′-imidazo[1,5-<i>a</i>]pyridine]-1′,5′-dione (1230 g) and <i>N</i>-(6-aminopyrimidin-4-yl)cyclopropanecarboxamide (650 g); 1420 g (98% yield). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.85 (br, 1H), 10.07 (br, 1H), 9.09 (s, 1H), 8.53 (s, 1H), 8.46 (s, 1H), 7.85 (s, 1H), 3.95–3.05 (m, 2H), 2.45 (s, 3H), 2.05–1.95 (m, 1H), 1.80–1.60 (m, 5H), 1.44 (d, <i>J</i> = 24 Hz, 2H), 1.25–1.15 (m, 1H), 0.89–0.80 (m, 4H).</div><div class="NLM_p last">Procedure D: <i>N</i>-(6-((8′-methyl-1′,5′-dioxo-1′,5′-dihydro-2′<i>H</i>-spiro[cyclohexane-1,3′-imidazo[1,5-<i>a</i>]pyridin]-6′-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide (1420 g), THF (5.7 L), and EtOH (5.7 L) were added to a 50 L reactor and agitated at 100 rpm. The temperature was adjusted to 20 °C. To a 45 L carboy was added water (5.7 L, deionized (DI)) and KOH (1170 g), and the contents of the carboy were agitated until a solution formed. The KOH solution was then added to the 50 L reactor followed by addition of ethylenediamine (2.83 L). After stirring for 16 h the pH was adjusted to 2 by the addition of concentrated HCl (1180 g), and the temperature was adjusted to 20 °C, the mixture was agitated, and the solid material was filtered through a Nutsche filter (18″). The reactor was then rinsed with water (14 L, DI), and the aqueous rinse was transferred to the filter while manually suspending the solid in the wash. A second rinse was performed using water (14 L, DI), and the rinse was transferred again to the filter while manually suspending the solid in the wash. Sodium bicarbonate (1300 g) and water (26.0 L, DI) were then added to the rinsed 50 L reactor, and the filter cake was slowly introduced into the reactor over a time period of about 30 min to avoid excess gas liberation. The resulting suspension was agitated for 2 h followed by filtration through a Nutsche filter (18″). The filter cake was washed with water (15.0 L) and allowed to condition overnight. The filter cake was once again suspended in an aqueous solution of sodium bicarbonate, agitated for 2 h, and filtered through a Nutsche filter (18″). Following washing with water, the filter cake was allowed to condition overnight and then transferred to drying trays and dried under vacuum at 45 °C. Yield: 1050 g, 80%. HPLC purity: 99.74%; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.20 (s, 1H), 9.68 (s, 1H), 8.47 (s, 1H), 8.09 (s, 1H), 7.97 (br, 2H), 6.42 (s, 1H), 3.00–2.90 (m, 2H), 2.43 (s, 3H), 1.80–1.60 (m, 5H), 1.5 (d, <i>J</i> = 24 Hz, 2H), 1.25–1.12 (m, 1H); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 163.8, 161.6, 159.2, 157.8, 153.4, 133.5, 121.5, 121.2, 116.6, 87.6, 78.8, 32.5, 24.2, 21.9, 13.8. HRMS: measured <i>m</i>/<i>z</i> [M + H]<sup>+</sup> 341.1729 (calcd. for C<sub>17</sub>H<sub>21</sub>N<sub>6</sub>O<sub>2</sub>: 341.1721).</div></div><div id="sec5_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 6-[(6-Aminopyrimidin-4-yl)amino]-8-chloro-3,3-dimethyl-2<i>H</i>-imidazo[1,5-<i>a</i>]pyridine-1,5-dione (<b>24</b>)</h4><div class="NLM_p">The synthesis of intermediate 6-bromo-8-chloro-3,3-dimethyl-2<i>H</i>-imidazo[1,5-<i>a</i>]pyridine-1,5-dione was carried out as described above using the general protocol of Procedure A. White solid; Yield: 390 mg, 48%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.03 (s, 1H), 8.24 (s, 1H), 1.75 (s, 6H); MS (ESI) <i>m</i>/<i>z</i> 289 [M-1]<sup>−</sup>.</div><div class="NLM_p">The synthesis of intermediate <i>N</i>-[6-[(8-chloro-3,3-dimethyl-1,5-dioxo-2<i>H</i>-imidazo[1,5-<i>a</i>]pyridin-6-yl)-amino]pyrimidin-4-yl]cyclopropanecarboxamide was carried out as described above using the general protocol of Procedure B. Light yellow solid; Yield: 42 mg, 17%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.92 (s, 1H), 9.74 (s, 1H), 9.49 (s, 1H), 8.70 (s, 1H), 8.59 (s, 1H), 7.98 (s, 1H), 2.16–2.02 (m, 1H), 1.79 (s, 6H), 0.84 (d, <i>J</i> = 6.0 Hz, 4H); MS (ESI) <i>m</i>/<i>z</i> 389.28 [M + H]<sup>+</sup>.</div><div class="NLM_p last">The synthesis of <b>24</b> was carried out as described in Procedure D above using <i>N</i>-[6-[(8-chloro-3,3-dimethyl-1,5-dioxo-2<i>H</i>-imidazo[1,5-<i>a</i>]pyridin-6-yl)amino]pyrimidin-4-yl]cyclopropanecarboxamide (0.25g, 0.64 mmol). Light yellow solid; Yield: 0.14 g, 68%. HPLC purity: 97.83%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.64 (s, 1H), 8.92 (s, 1H), 8.64 (s, 1H), 8.20 (s, 1H), 6.60 (s, 2H), 6.25 (s, 1H), 1.79 (s, 6H); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.4, 157.8, 156.1, 153.3, 150.6, 132.6, 142.1, 123.9, 109.8, 87.7, 76.7, 24.7. HRMS: measured <i>m</i>/<i>z</i> [M + H]<sup>+</sup> 321.0869 (calcd. for C<sub>13</sub>H<sub>14</sub>ClN<sub>6</sub>O<sub>2</sub>: 321.0861).</div></div><div id="sec5_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 6-[(6-Aminopyrimidin-4-yl)amino]-8-chloro-spiro[2<i>H</i>-imidazo[1,5-<i>a</i>]pyridine-3,1′-cyclopentane]-1,5-dione (<b>25</b>)</h4><div class="NLM_p">The synthesis of intermediate 6-bromo-8-chloro-spiro[2<i>H</i>-imidazo[1,5-<i>a</i>]pyridine-3,1′-cyclopentane]-1,5-dione was carried out as described above using the general protocol of Procedure A. Off-white solid; Yield: 380 mg; 60%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.39 (s, 1H), 8.25 (s, 1H), 2.73 (m, 4H), 2.21 (m, 2H), 1.93 (m, 2H); MS (ESI) <i>m</i>/<i>z</i> 315.06 [M – 1]<sup>−</sup>.</div><div class="NLM_p">The title compound was prepared according to the Procedure B using 6-bromo-8-chloro-spiro[2<i>H</i>-imidazo[1,5-<i>a</i>]pyridine-3,1′-cyclopentane]-1,5-dione (0.3 g, 0.94 mmol) and <i>t</i>-butyl <i>N</i>-(6-aminopyrimidin-4-yl)carbamate (178 mg, 0.85 mmol) to provide <i>t</i>-butyl <i>N</i>-[6-[(8-chloro-1,5-dioxo-spiro[2<i>H</i>-imidazo[1,5-<i>a</i>]pyridine-3,1′-cyclopentane]-6-yl)amino]pyrimidin-4-yl]carbamate. Light yellow solid; Yield: 0.30 g, 71%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.1–9.50 (bs, 2H), 8.67 (s, 1H), 8.50 (s, 1H), 7.79 (s, 1H), 3.56 (s, 1H), 2.86–2.70 (m, 2H), 2.05–1.90 (m, 2H), 1.85–1.75 (m, 2H), 1.73–1.60 (m, 2H), 1.48 (s, 9H); MS (ESI) <i>m</i>/<i>z</i> 447.10 [M + H]<sup>+</sup>.</div><div class="NLM_p last">The synthesis of compound <b>25</b> was carried out as described above using the general protocol of Procedure C. Light yellow solid; Yield: 0.07 g, 45%. HPLC purity: 98.50%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.04 (s, 1H), 9.15 (s, 1H), 8.60 (s, 1H), 8.26 (s, 1H), 6.85 (s, 2H), 6.30 (s, 1H), 2.77 (s, 2H), 1.97 (s, 2H), 1.90–1.70 (m, 4H); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.3, 158.1, 153.0, 133.5, 122.8, 121.4, 110.4, 88.0, 85.2, 70.0, 35.4, 26.3, 24.8. HRMS: measured <i>m</i>/<i>z</i> [M + H]<sup>+</sup> 347.1018 (calcd. for C<sub>15</sub>H<sub>16</sub>ClN<sub>6</sub>O<sub>2</sub>: 347.1023).</div></div><div id="sec5_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 6-[(6-Aminopyrimidin-4-yl)amino]-8-chloro-4′,4′-difluoro-spiro[2<i>H</i>-imidazo[1,5-<i>a</i>]pyridine-3,1′-cyclohexane]-1,5-dione (<b>26</b>)</h4><div class="NLM_p">The synthesis of intermediate 6-bromo-8-chloro-4′,4′-difluoro-spiro[2<i>H</i>-imidazo[1,5-<i>a</i>]pyridine-3,1′-cyclohexane]-1,5-dione was carried out as described above using the general protocol of Procedure A. Off-white solid; Yield: 5.9 g. 80%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.79 (s, 1H), 7.89 (s, 1H), 2.12 (m, 6H), 1.66 (m, 2H); MS (ESI) <i>m</i>/<i>z</i> 364.92 [M – 1]<sup>−</sup>.</div><div class="NLM_p">The synthesis of intermediate <i>N</i>-[6-[(8-chloro-4′,4′-difluoro-1,5-dioxo-spiro[2<i>H</i>-imidazo[1,5-<i>a</i>]pyridine-3,1′-cyclohexane]-6-yl)amino]pyrimidin-4-yl]cyclopropanecarboxamide was carried out as described above using the general protocol of Procedure B. Off-white solid; Yield: 4.71g, 63%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.92 (s, 1H), 10.47 (s, 1H), 9.51 (s, 1H), 8.71 (s, 1H), 8.59 (s, 1H), 7.98 (s, 1H), 3.32–3.25 (m, 2H), 2.28–2.17 (m, 4H), 2.16–2.02 (m, 1H), 1.79–1.70 (m, 2H), 0.84–0.81 (m,4H); MS (ESI) <i>m</i>/<i>z</i> 465.38 [M + H]<sup>+</sup>.</div><div class="NLM_p last">The synthesis of <b>26</b> was carried out as described above using the general protocol of Procedure D. Light yellow solid; Yield: 0.35g, 41%. HPLC purity: 97.85%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.56 (s, 1H), 9.87 (s, 1H), 8.51 (s, 1H), 8.43 (s, 1H), 7.89(s, 2H), 6.52 (s, 1H), 3.45–3.22 (m, 2H), 2.36–2.15 (m, 4H), 1.74 (d, <i>J</i> = 12.12 Hz, 2H); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 163.8, 161.8, 159.3, 157.5, 153.5, 133.7, 124.8, 122.9, 121.3, 121.2, 121.0, 117.3, 87.4, 76.9, 29.6 (t, <i>J</i> = 23 Hz), 28.8 (d, <i>J</i> = 10 Hz), 13.8. HRMS: measured <i>m</i>/<i>z</i> [M + H]<sup>+</sup> 377.1533 (calcd. for C<sub>17</sub>H<sub>19</sub>F<sub>2</sub>N<sub>6</sub>O<sub>2</sub>: 377.1538).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-4"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i47"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01795" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12668" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12668" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01795" class="ext-link">10.1021/acs.jmedchem.7b01795</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01795/suppl_file/jm7b01795_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Additional data regarding <i>in vitro</i> assays, <i>in vivo</i> efficacy, pharmacokinetic data, MNK2 protein expression, purification, crystallization, data collection, structure solution and refinement, characterization data, <sup>13</sup>C NMR, and HPLC for compounds <b>2</b>–<b>26</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01795/suppl_file/jm7b01795_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01795/suppl_file/jm7b01795_si_001.csv">jm7b01795_si_001.csv (1.19 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01795/suppl_file/jm7b01795_si_002.pdf">jm7b01795_si_002.pdf (8.27 MB)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">New protein–ligand coordinates have been deposited in the PDB with codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CJ5">6CJ5</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CJE">6CJE</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CJH">6CJH</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CJW">6CJW</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CJY">6CJY</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CK3">6CK3</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CK6">6CK6</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CKI">6CKI</a>.</p><div class="testing" data-doi="10.1021/acs.jmedchem.7b01795" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08885" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08885" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Siegfried H. Reich</span> - <span class="hlFld-Affiliation affiliation">eFFECTOR
Therapeutics, 11180 Roselle Street, San Diego, California 92121, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6840-2618" title="Orcid link">http://orcid.org/0000-0002-6840-2618</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#b3c0c1d6dad0dbf3d6d5d5d6d0c7dcc19dd0dcde"><span class="__cf_email__" data-cfemail="e69594838f858ea68380808385928994c885898b">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul A. Sprengeler</span> - <span class="hlFld-Affiliation affiliation">eFFECTOR
Therapeutics, 11180 Roselle Street, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gary G. Chiang</span> - <span class="hlFld-Affiliation affiliation">eFFECTOR
Therapeutics, 11180 Roselle Street, San Diego, California 92121, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3004-7400" title="Orcid link">http://orcid.org/0000-0003-3004-7400</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James R. Appleman</span> - <span class="hlFld-Affiliation affiliation">Primmune
Therapeutics, Inc., 3210
Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joan Chen</span> - <span class="hlFld-Affiliation affiliation">eFFECTOR
Therapeutics, 11180 Roselle Street, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeff Clarine</span> - <span class="hlFld-Affiliation affiliation">eFFECTOR
Therapeutics, 11180 Roselle Street, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Boreth Eam</span> - <span class="hlFld-Affiliation affiliation">eFFECTOR
Therapeutics, 11180 Roselle Street, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Justin T. Ernst</span> - <span class="hlFld-Affiliation affiliation">eFFECTOR
Therapeutics, 11180 Roselle Street, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qing Han</span> - <span class="hlFld-Affiliation affiliation">Structure-Based
Design, Inc., 6048 Cornerstone
Court West #D, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vikas K. Goel</span> - <span class="hlFld-Affiliation affiliation">eFFECTOR
Therapeutics, 11180 Roselle Street, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Edward Z. R. Han</span> - <span class="hlFld-Affiliation affiliation">Structure-Based
Design, Inc., 6048 Cornerstone
Court West #D, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vera Huang</span> - <span class="hlFld-Affiliation affiliation">Molecular
Stethoscope, 10835 Road
to the Cure #100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ivy N. J. Hung</span> - <span class="hlFld-Affiliation affiliation">eFFECTOR
Therapeutics, 11180 Roselle Street, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adrianna Jemison</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Pennsylvania, 231 South 34th Street, Philadelphia, Pennsylvania 19104, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katti A. Jessen</span> - <span class="hlFld-Affiliation affiliation">Oncternal
Therapeutics, 3525 Del
Mar Heights Road #821, San Diego, California 92130, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jolene Molter</span> - <span class="hlFld-Affiliation affiliation">eFFECTOR
Therapeutics, 11180 Roselle Street, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Douglas Murphy</span> - <span class="hlFld-Affiliation affiliation">Molcentrics,
Inc., 11835 Carmel Mountain
Road #1304-110, San Diego, California 92128, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Melissa Neal</span> - <span class="hlFld-Affiliation affiliation">eFFECTOR
Therapeutics, 11180 Roselle Street, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gregory S. Parker</span> - <span class="hlFld-Affiliation affiliation">eFFECTOR
Therapeutics, 11180 Roselle Street, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Shaghafi</span> - <span class="hlFld-Affiliation affiliation">Abide
Therapeutics, 10835 Road to the Cure, Suite 250, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Samuel Sperry</span> - <span class="hlFld-Affiliation affiliation">eFFECTOR
Therapeutics, 11180 Roselle Street, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jocelyn Staunton</span> - <span class="hlFld-Affiliation affiliation">eFFECTOR
Therapeutics, 11180 Roselle Street, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Craig R. Stumpf</span> - <span class="hlFld-Affiliation affiliation">eFFECTOR
Therapeutics, 11180 Roselle Street, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peggy A. Thompson</span> - <span class="hlFld-Affiliation affiliation">eFFECTOR
Therapeutics, 11180 Roselle Street, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chinh Tran</span> - <span class="hlFld-Affiliation affiliation">eFFECTOR
Therapeutics, 11180 Roselle Street, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen E. Webber</span> - <span class="hlFld-Affiliation affiliation">Polaris
Pharmaceuticals, 9373
Towne Centre Drive #150, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher J. Wegerski</span> - <span class="hlFld-Affiliation affiliation">eFFECTOR
Therapeutics, 11180 Roselle Street, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hong Zheng</span> - <span class="hlFld-Affiliation affiliation">Structure-Based
Design, Inc., 6048 Cornerstone
Court West #D, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin R. Webster</span> - <span class="hlFld-Affiliation affiliation">eFFECTOR
Therapeutics, 11180 Roselle Street, San Diego, California 92121, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): S.H.R., P.A.S., G.G.C., J.R.A., J.C., J.C., B.E., J.T.E., Q.H., V.K.G., E.Z.H., V.H., I.N.H., A.J., K.J., J.M., D.M., M.N., G.S.P., M.S., S.S., J.S., C.R.S., P.A.T., C.T., S.E.W., C.J.W., H.Z., and K.R.W. were employees and shareholders of eFFECTOR Therapeutics when the research was performed.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e5878-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i49">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71662" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71662" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We want to thank Kevan Shokat and Davide Ruggero for their support and helpful feedback on the manuscript. We also want to thank Theo Michels for helping with spectral analysis.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">ABC DLBCL</td><td class="NLM_def"><p class="first last">activated b-cell</p></td></tr><tr><td class="NLM_term">DI</td><td class="NLM_def"><p class="first last">deionized</p></td></tr><tr><td class="NLM_term">DLBCL</td><td class="NLM_def"><p class="first last">diffuse large cell B-cell lymphoma</p></td></tr><tr><td class="NLM_term">hnRNPA1</td><td class="NLM_def"><p class="first last">heterogeneous nuclear ribonucleoprotein A1</p></td></tr><tr><td class="NLM_term">HTRF</td><td class="NLM_def"><p class="first last">homogeneous time-resolved fluorescence</p></td></tr><tr><td class="NLM_term">IL-6</td><td class="NLM_def"><p class="first last">interleukin-6</p></td></tr><tr><td class="NLM_term">IL-8</td><td class="NLM_def"><p class="first last">interleukin-8</p></td></tr><tr><td class="NLM_term">LLE</td><td class="NLM_def"><p class="first last">lipophilic ligand efficiency</p></td></tr><tr><td class="NLM_term">MNK</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase interacting kinases</p></td></tr><tr><td class="NLM_term">PSF</td><td class="NLM_def"><p class="first last">protein-associated splicing factor</p></td></tr><tr><td class="NLM_term">PK/PD</td><td class="NLM_def"><p class="first last">pharmacokinetic/pharmacodynamics</p></td></tr><tr><td class="NLM_term">TGI</td><td class="NLM_def"><p class="first last">tumor growth inhibition</p></td></tr><tr><td class="NLM_term">TME</td><td class="NLM_def"><p class="first last">tumor microenvironment</p></td></tr><tr><td class="NLM_term">xlogP</td><td class="NLM_def"><p class="first last">calculated logarithm of octanol–water partition coefficient (Dotmatics)</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i51">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18338" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18338" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 69 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sendoel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunn, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurwitz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levorse, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dill, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schramek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molina, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weissman, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, E.</span></span> <span> </span><span class="NLM_article-title">Translation from unconventional 5′ start sites drives tumour initiation</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>541</i></span>,  <span class="NLM_fpage">494</span>– <span class="NLM_lpage">499</span>, <span class="refDoi"> DOI: 10.1038/nature21036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1038%2Fnature21036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=28077873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC2sXos1CltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=541&publication_year=2017&pages=494-499&author=A.+Sendoelauthor=J.+G.+Dunnauthor=E.+H.+Rodriguezauthor=S.+Naikauthor=N.+C.+Gomezauthor=B.+Hurwitzauthor=J.+Levorseauthor=B.+D.+Dillauthor=D.+Schramekauthor=H.+Molinaauthor=J.+S.+Weissmanauthor=E.+Fuchs&title=Translation+from+unconventional+5%E2%80%B2+start+sites+drives+tumour+initiation&doi=10.1038%2Fnature21036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Translation from unconventional 5' start sites drives tumor initiation</span></div><div class="casAuthors">Sendoel, Ataman; Dunn, Joshua G.; Rodriguez, Edwin H.; Naik, Shruti; Gomez, Nicholas C.; Hurwitz, Brian; Levorse, John; Dill, Brian D.; Schramek, Daniel; Molina, Henrik; Weissman, Jonathan S.; Fuchs, Elaine</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">541</span>
        (<span class="NLM_cas:issue">7638</span>),
    <span class="NLM_cas:pages">494-499</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We are just beginning to understand how translational control affects tumor initiation and malignancy.  Here we use an epidermis-specific, in vivo ribosome profiling strategy to investigate the translational landscape during the transition from normal homeostasis to malignancy.  Using a mouse model of inducible SOX2, which is broadly expressed in oncogenic RAS-assocd. cancers, we show that despite widespread redns. in translation and protein synthesis, certain oncogenic mRNAs are spared.  During tumor initiation, the translational app. is redirected towards unconventional upstream initiation sites, enhancing the translational efficiency of oncogenic mRNAs.  An in vivo RNA interference screen of translational regulators revealed that depletion of conventional eIF2 complexes has adverse effects on normal but not oncogenic growth.  Conversely, the alternative initiation factor eIF2A is essential for cancer progression, during which it mediates initiation at these upstream sites, differentially skewing translation and protein expression.  Our findings unveil a role for the translation of 5' untranslated regions in cancer, and expose new targets for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9_HpXewJ0wLVg90H21EOLACvtfcHk0ljhQnaAJAf6Yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXos1CltA%253D%253D&md5=58b04f0f20c9c6b80893bef52758e8c6</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnature21036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature21036%26sid%3Dliteratum%253Aachs%26aulast%3DSendoel%26aufirst%3DA.%26aulast%3DDunn%26aufirst%3DJ.%2BG.%26aulast%3DRodriguez%26aufirst%3DE.%2BH.%26aulast%3DNaik%26aufirst%3DS.%26aulast%3DGomez%26aufirst%3DN.%2BC.%26aulast%3DHurwitz%26aufirst%3DB.%26aulast%3DLevorse%26aufirst%3DJ.%26aulast%3DDill%26aufirst%3DB.%2BD.%26aulast%3DSchramek%26aufirst%3DD.%26aulast%3DMolina%26aufirst%3DH.%26aulast%3DWeissman%26aufirst%3DJ.%2BS.%26aulast%3DFuchs%26aufirst%3DE.%26atitle%3DTranslation%2520from%2520unconventional%25205%25E2%2580%25B2%2520start%2520sites%2520drives%2520tumour%2520initiation%26jtitle%3DNature%26date%3D2017%26volume%3D541%26spage%3D494%26epage%3D499%26doi%3D10.1038%2Fnature21036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graff, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruggero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonenberg, N.</span></span> <span> </span><span class="NLM_article-title">Targeting the eIF4F translation initiation complex: a critical nexus for cancer development</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">250</span>– <span class="NLM_lpage">263</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-14-2789</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1158%2F0008-5472.CAN-14-2789" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=250-263&author=J.+Pelletierauthor=J.+Graffauthor=D.+Ruggeroauthor=N.+Sonenberg&title=Targeting+the+eIF4F+translation+initiation+complex%3A+a+critical+nexus+for+cancer+development&doi=10.1158%2F0008-5472.CAN-14-2789"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-2789&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-2789%26sid%3Dliteratum%253Aachs%26aulast%3DPelletier%26aufirst%3DJ.%26aulast%3DGraff%26aufirst%3DJ.%26aulast%3DRuggero%26aufirst%3DD.%26aulast%3DSonenberg%26aufirst%3DN.%26atitle%3DTargeting%2520the%2520eIF4F%2520translation%2520initiation%2520complex%253A%2520a%2520critical%2520nexus%2520for%2520cancer%2520development%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26spage%3D250%26epage%3D263%26doi%3D10.1158%2F0008-5472.CAN-14-2789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robichaud, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulea, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonenberg, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Topisirovic, I.</span></span> <span> </span><span class="NLM_article-title">Targeting the translation machinery in cancer</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">261</span>– <span class="NLM_lpage">278</span>, <span class="refDoi"> DOI: 10.1038/nrd4505</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1038%2Fnrd4505" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=25743081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjvFOgs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=261-278&author=M.+Bhatauthor=N.+Robichaudauthor=L.+Huleaauthor=N.+Sonenbergauthor=J.+Pelletierauthor=I.+Topisirovic&title=Targeting+the+translation+machinery+in+cancer&doi=10.1038%2Fnrd4505"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the translation machinery in cancer</span></div><div class="casAuthors">Bhat, Mamatha; Robichaud, Nathaniel; Hulea, Laura; Sonenberg, Nahum; Pelletier, Jerry; Topisirovic, Ivan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">261-278</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Dysregulation of mRNA translation is a frequent feature of neoplasia.  Many oncogenes and tumor suppressors affect the translation machinery, making aberrant translation a widespread characteristic of tumor cells, independent of the genetic make-up of the cancer.  Therefore, therapeutic agents that target components of the protein synthesis app. hold promise as novel anticancer drugs that can overcome intra-tumor heterogeneity.  In this Review, we discuss the role of translation in cancer, with a particular focus on the eIF4F (eukaryotic translation initiation factor 4F) complex, and provide an overview of recent efforts aiming to 'translate' these results to the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7a57QrdxxsbVg90H21EOLACvtfcHk0ljhQnaAJAf6Yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjvFOgs70%253D&md5=51625a521b1d4f18887142383a8d28e8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrd4505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4505%26sid%3Dliteratum%253Aachs%26aulast%3DBhat%26aufirst%3DM.%26aulast%3DRobichaud%26aufirst%3DN.%26aulast%3DHulea%26aufirst%3DL.%26aulast%3DSonenberg%26aufirst%3DN.%26aulast%3DPelletier%26aufirst%3DJ.%26aulast%3DTopisirovic%26aufirst%3DI.%26atitle%3DTargeting%2520the%2520translation%2520machinery%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26spage%3D261%26epage%3D278%26doi%3D10.1038%2Fnrd4505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dreas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikulski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabritius, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brzozka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rzymski, T.</span></span> <span> </span><span class="NLM_article-title">Mitogen-activated protein kinase (MAPK) interacting kinases 1 and 2 (MNK1 and MNK2) as targets for cancer therapy: recent progress in the development of MNK inhibitors</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3025</span>– <span class="NLM_lpage">3053</span>, <span class="refDoi"> DOI: 10.2174/0929867324666170203123427</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.2174%2F0929867324666170203123427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=28164761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1SqsrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=3025-3053&author=A.+Dreasauthor=M.+Mikulskiauthor=M.+Milikauthor=C.+H.+Fabritiusauthor=K.+Brzozkaauthor=T.+Rzymski&title=Mitogen-activated+protein+kinase+%28MAPK%29+interacting+kinases+1+and+2+%28MNK1+and+MNK2%29+as+targets+for+cancer+therapy%3A+recent+progress+in+the+development+of+MNK+inhibitors&doi=10.2174%2F0929867324666170203123427"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Mitogen-activated Protein Kinase (MAPK) Interacting Kinases 1 and 2 (MNK1 and MNK2) as Targets for Cancer Therapy: Recent Progress in the Development of MNK Inhibitors</span></div><div class="casAuthors">Dreas, Agnieszka; Mikulski, Maciej; Milik, Mariusz; Fabritius, Charles-Henry; Brzozka, Krzysztof; Rzymski, Tomasz</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">3025-3053</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">MAP kinase-interacting kinases (MNK1 and MNK2) are often activated downstream of ERK and p38 MAPK in the MAP kinase family.  The role of MNKs in the development and progression of solid tumors and hematol. malignancies has been widely discussed, particularly in the context of cap dependent translation, regulated by phosphorylation of eIF4E.  MNK/eIF4E axis is involved in the expression of pro angiogenic, antiapoptotic, cell cycle, and motility proteins, such as MCL1, VEGF, MMP3, SNAIL, SMAD2, β-catenin or cyclin D1, and is essential during Ras and c Myc-induced transformation.  MNK1/2 emerged as eligible targets for drug discovery in oncol., based on the antitumor effects obsd. in genetic knockout and RNA interference expts. and at the same time lack of adverse effects in dual knockout animals. </P><P> There is a high interest in the development of pharmacol. inhibitors of MNK1/2 as not only tools for further basic research studies but also potential drugs in diseases characterized by deregulated translation.  Unfortunately, the role of MNK1/2 in cancer still remains elusive due to the absence of potent and selective probes.  Moreover, in many instances, hypotheses have been built reliant upon unspecific MNK1/2 inhibitors such as CGP57380 or cercosporamide.  Lately, the first two clin. programs targeting MNKs in oncol. have been revealed (eFT508 and BAY 1143269), although several other MNK programs are currently running at the preclin. stage.  This review aims to provide an overview of recent progress in the development of MNK inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjWDeCrlHD07Vg90H21EOLACvtfcHk0lgBCFaHj31f3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1SqsrnI&md5=c2a37d37d69521b11a38bb100e7964af</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2174%2F0929867324666170203123427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867324666170203123427%26sid%3Dliteratum%253Aachs%26aulast%3DDreas%26aufirst%3DA.%26aulast%3DMikulski%26aufirst%3DM.%26aulast%3DMilik%26aufirst%3DM.%26aulast%3DFabritius%26aufirst%3DC.%2BH.%26aulast%3DBrzozka%26aufirst%3DK.%26aulast%3DRzymski%26aufirst%3DT.%26atitle%3DMitogen-activated%2520protein%2520kinase%2520%2528MAPK%2529%2520interacting%2520kinases%25201%2520and%25202%2520%2528MNK1%2520and%2520MNK2%2529%2520as%2520targets%2520for%2520cancer%2520therapy%253A%2520recent%2520progress%2520in%2520the%2520development%2520of%2520MNK%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2017%26volume%3D24%26spage%3D3025%26epage%3D3053%26doi%3D10.2174%2F0929867324666170203123427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Truitt, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruggero, D.</span></span> <span> </span><span class="NLM_article-title">New frontiers in translational control of the cancer genome</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">288</span>– <span class="NLM_lpage">304</span>, <span class="refDoi"> DOI: 10.1038/nrc.2016.27</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1038%2Fnrc.2016.27" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=27112207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC28Xms1Omsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=288-304&author=M.+L.+Truittauthor=D.+Ruggero&title=New+frontiers+in+translational+control+of+the+cancer+genome&doi=10.1038%2Fnrc.2016.27"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">New frontiers in translational control of the cancer genome</span></div><div class="casAuthors">Truitt, Morgan L.; Ruggero, Davide</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">288-304</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The past several years have seen dramatic leaps in our understanding of how gene expression is rewired at the translation level during tumorigenesis to support the transformed phenotype.  This work has been driven by an explosion in technol. advances and is revealing previously unimagined regulatory mechanisms that dictate functional expression of the cancer genome.  In this Review we discuss emerging trends and exciting new discoveries that reveal how this translational circuitry contributes to specific aspects of tumorigenesis and cancer cell function, with a particular focus on recent insights into the role of translational control in the adaptive response to oncogenic stress conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWAtdm1QpVuLVg90H21EOLACvtfcHk0lgBCFaHj31f3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xms1Omsr0%253D&md5=ed2f746a30588ab8c00022d696861ceb</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrc.2016.27&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc.2016.27%26sid%3Dliteratum%253Aachs%26aulast%3DTruitt%26aufirst%3DM.%2BL.%26aulast%3DRuggero%26aufirst%3DD.%26atitle%3DNew%2520frontiers%2520in%2520translational%2520control%2520of%2520the%2520cancer%2520genome%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2016%26volume%3D16%26spage%3D288%26epage%3D304%26doi%3D10.1038%2Fnrc.2016.27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korneeva, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gram, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edens, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhoads, R. E.</span></span> <span> </span><span class="NLM_article-title">Inhibition of mitogen-activated protein kinase (MAPK)-interacting kinase (MNK) preferentially affects translation of mRNAs containing both a 5′-terminal cap and hairpin</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>291</i></span>,  <span class="NLM_fpage">3455</span>– <span class="NLM_lpage">3467</span>, <span class="refDoi"> DOI: 10.1074/jbc.M115.694190</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1074%2Fjbc.M115.694190" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=3455-3467&author=N.+L.+Korneevaauthor=A.+Songauthor=H.+Gramauthor=M.+A.+Edensauthor=R.+E.+Rhoads&title=Inhibition+of+mitogen-activated+protein+kinase+%28MAPK%29-interacting+kinase+%28MNK%29+preferentially+affects+translation+of+mRNAs+containing+both+a+5%E2%80%B2-terminal+cap+and+hairpin&doi=10.1074%2Fjbc.M115.694190"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.694190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.694190%26sid%3Dliteratum%253Aachs%26aulast%3DKorneeva%26aufirst%3DN.%2BL.%26aulast%3DSong%26aufirst%3DA.%26aulast%3DGram%26aufirst%3DH.%26aulast%3DEdens%26aufirst%3DM.%2BA.%26aulast%3DRhoads%26aufirst%3DR.%2BE.%26atitle%3DInhibition%2520of%2520mitogen-activated%2520protein%2520kinase%2520%2528MAPK%2529-interacting%2520kinase%2520%2528MNK%2529%2520preferentially%2520affects%2520translation%2520of%2520mRNAs%2520containing%2520both%2520a%25205%25E2%2580%25B2-terminal%2520cap%2520and%2520hairpin%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26spage%3D3455%26epage%3D3467%26doi%3D10.1074%2Fjbc.M115.694190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe-Fukunaga, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuyama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukunaga, R.</span></span> <span> </span><span class="NLM_article-title">MNK2 and MNK1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">6539</span>– <span class="NLM_lpage">6549</span>, <span class="refDoi"> DOI: 10.1128/MCB.24.15.6539-6549.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1128%2FMCB.24.15.6539-6549.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=15254222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtlKltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=6539-6549&author=T.+Uedaauthor=R.+Watanabe-Fukunagaauthor=H.+Fukuyamaauthor=S.+Nagataauthor=R.+Fukunaga&title=MNK2+and+MNK1+are+essential+for+constitutive+and+inducible+phosphorylation+of+eukaryotic+initiation+factor+4E+but+not+for+cell+growth+or+development&doi=10.1128%2FMCB.24.15.6539-6549.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development</span></div><div class="casAuthors">Ueda, Takeshi; Watanabe-Fukunaga, Rie; Fukuyama, Hidehiro; Nagata, Shigekazu; Fukunaga, Rikiro</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6539-6549</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Mnk1 and Mnk2 are protein kinases that are directly phosphorylated and activated by extracellular signal-regulated kinase (ERK) or p38 mitogen-activated protein (MAP) kinases and implicated in the regulation of protein synthesis through their phosphorylation of eukaryotic translation initiation factor 4E (eIF4E) at Ser209.  To investigate their physiol. functions, we generated mice lacking the Mnk1 or Mnk2 gene or both; the resulting KO mice were viable, fertile, and developed normally.  In embryonic fibroblasts prepd. from Mnk1-Mnk2 DKO mice, eIF4E was not detectably phosphorylated at Ser209, even when the ERK and/or p38 MAP kinases were activated.  Anal. of embryonic fibroblasts from single KO mice revealed that Mnk1 is responsible for the inducible phosphorylation of eIF4E in response to MAP kinase activation, whereas Mnk2 mainly contributes to eIF4E's basal, constitutive phosphorylation.  Lipopolysaccharide (LPS)- or insulin-induced upregulation of eIF4E phosphorylation in the spleen, liver, or skeletal muscle was abolished in Mnk1-/- mice, whereas the basal eIF4E phosphorylation levels were decreased in Mnk2-/- mice.  In Mnk1-Mnk2 DKO mice, no phosphorylated eIF4E was detected in any tissue studied, even after LPS or insulin injection.  However, neither general protein synthesis nor cap-dependent translation, as assayed by a bicistronic reporter assay system, was affected in Mnk-deficient embryonic fibroblasts, despite the absence of phosphorylated eIF4E.  Thus, Mnk1 and Mnk2 are exclusive eIF4E kinases both in cultured fibroblasts and adult tissues, and they regulate inducible and constitutive eIF4E phosphorylation, resp.  These results strongly suggest that eIF4E phosphorylation at Ser209 is not essential for cell growth during development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6LIGS-bIJs7Vg90H21EOLACvtfcHk0lgYvIENVHVsHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtlKltLw%253D&md5=8ad9391afbf76148f4609f38d60b82aa</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1128%2FMCB.24.15.6539-6549.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.24.15.6539-6549.2004%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DT.%26aulast%3DWatanabe-Fukunaga%26aufirst%3DR.%26aulast%3DFukuyama%26aufirst%3DH.%26aulast%3DNagata%26aufirst%3DS.%26aulast%3DFukunaga%26aufirst%3DR.%26atitle%3DMNK2%2520and%2520MNK1%2520are%2520essential%2520for%2520constitutive%2520and%2520inducible%2520phosphorylation%2520of%2520eukaryotic%2520initiation%2520factor%25204E%2520but%2520not%2520for%2520cell%2520growth%2520or%2520development%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2004%26volume%3D24%26spage%3D6539%26epage%3D6549%26doi%3D10.1128%2FMCB.24.15.6539-6549.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wendel, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe-Fukunaga, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukunaga, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teruya-Feldstein, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, S. W.</span></span> <span> </span><span class="NLM_article-title">Dissecting eIF4E action in tumorigenesis</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">3232</span>– <span class="NLM_lpage">3237</span>, <span class="refDoi"> DOI: 10.1101/gad.1604407</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1101%2Fgad.1604407" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=3232-3237&author=H.+G.+Wendelauthor=R.+L.+Silvaauthor=A.+Malinaauthor=J.+R.+Millsauthor=H.+Zhuauthor=T.+Uedaauthor=R.+Watanabe-Fukunagaauthor=R.+Fukunagaauthor=J.+Teruya-Feldsteinauthor=J.+Pelletierauthor=S.+W.+Lowe&title=Dissecting+eIF4E+action+in+tumorigenesis&doi=10.1101%2Fgad.1604407"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1101%2Fgad.1604407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.1604407%26sid%3Dliteratum%253Aachs%26aulast%3DWendel%26aufirst%3DH.%2BG.%26aulast%3DSilva%26aufirst%3DR.%2BL.%26aulast%3DMalina%26aufirst%3DA.%26aulast%3DMills%26aufirst%3DJ.%2BR.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DUeda%26aufirst%3DT.%26aulast%3DWatanabe-Fukunaga%26aufirst%3DR.%26aulast%3DFukunaga%26aufirst%3DR.%26aulast%3DTeruya-Feldstein%26aufirst%3DJ.%26aulast%3DPelletier%26aufirst%3DJ.%26aulast%3DLowe%26aufirst%3DS.%2BW.%26atitle%3DDissecting%2520eIF4E%2520action%2520in%2520tumorigenesis%26jtitle%3DGenes%2520Dev.%26date%3D2007%26volume%3D21%26spage%3D3232%26epage%3D3237%26doi%3D10.1101%2Fgad.1604407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Furic, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koumakpayi, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brueschke, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petroulakis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robichaud, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaboury, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandolfi, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saad, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonenberg, N.</span></span> <span> </span><span class="NLM_article-title">eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">14134</span>– <span class="NLM_lpage">14139</span>, <span class="refDoi"> DOI: 10.1073/pnas.1005320107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1073%2Fpnas.1005320107" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=14134-14139&author=L.+Furicauthor=L.+Rongauthor=O.+Larssonauthor=I.+H.+Koumakpayiauthor=K.+Yoshidaauthor=A.+Brueschkeauthor=E.+Petroulakisauthor=N.+Robichaudauthor=M.+Pollakauthor=L.+A.+Gabouryauthor=P.+P.+Pandolfiauthor=F.+Saadauthor=N.+Sonenberg&title=eIF4E+phosphorylation+promotes+tumorigenesis+and+is+associated+with+prostate+cancer+progression&doi=10.1073%2Fpnas.1005320107"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1005320107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1005320107%26sid%3Dliteratum%253Aachs%26aulast%3DFuric%26aufirst%3DL.%26aulast%3DRong%26aufirst%3DL.%26aulast%3DLarsson%26aufirst%3DO.%26aulast%3DKoumakpayi%26aufirst%3DI.%2BH.%26aulast%3DYoshida%26aufirst%3DK.%26aulast%3DBrueschke%26aufirst%3DA.%26aulast%3DPetroulakis%26aufirst%3DE.%26aulast%3DRobichaud%26aufirst%3DN.%26aulast%3DPollak%26aufirst%3DM.%26aulast%3DGaboury%26aufirst%3DL.%2BA.%26aulast%3DPandolfi%26aufirst%3DP.%2BP.%26aulast%3DSaad%26aufirst%3DF.%26aulast%3DSonenberg%26aufirst%3DN.%26atitle%3DeIF4E%2520phosphorylation%2520promotes%2520tumorigenesis%2520and%2520is%2520associated%2520with%2520prostate%2520cancer%2520progression%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D14134%26epage%3D14139%26doi%3D10.1073%2Fpnas.1005320107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diab, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumarasiri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proud, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milne, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">MAP kinase-interacting kinases-emerging targets against cancer</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">441</span>– <span class="NLM_lpage">452</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2014.01.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1016%2Fj.chembiol.2014.01.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=24613018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjslyitb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=441-452&author=S.+Diabauthor=M.+Kumarasiriauthor=M.+Yuauthor=T.+Teoauthor=C.+Proudauthor=R.+Milneauthor=S.+Wang&title=MAP+kinase-interacting+kinases-emerging+targets+against+cancer&doi=10.1016%2Fj.chembiol.2014.01.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">MAP Kinase-Interacting Kinases-Emerging Targets against Cancer</span></div><div class="casAuthors">Diab, Sarah; Kumarasiri, Malika; Yu, Mingfeng; Teo, Theodosia; Proud, Christopher; Milne, Robert; Wang, Shudong</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">441-452</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Mitogen-activated protein kinase (MAPK)-interacting kinases (Mnks) regulate the initiation of translation through phosphorylation of eukaryotic initiation factor 4E (eIF4E).  Mnk-mediated eIF4E activation promotes cancer development and progression.  While the phosphorylation of eIF4E is necessary for oncogenic transformation, the kinase activity of Mnks seems dispensable for normal development.  For this reason, pharmacol. inhibition of Mnks could represent an ideal mechanism-based and nontoxic therapeutic strategy for cancer treatment.  In this review, we discuss the current understanding of Mnk biol. roles, structures, and functions, as well as clin. implications.  Importantly, we propose different strategies for identification of highly selective small mol. inhibitors of Mnks, including exploring a structural feature of their kinase domain, DFD motif, which is unique within the human kinome.  We also argue that a combined targeting of Mnks and other pathways should be considered given the complexity of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8J4FNfWRq27Vg90H21EOLACvtfcHk0lh6mJD2vtgAJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjslyitb0%253D&md5=472ef0f62dc9dc457139367b3a573c49</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2014.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2014.01.011%26sid%3Dliteratum%253Aachs%26aulast%3DDiab%26aufirst%3DS.%26aulast%3DKumarasiri%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DTeo%26aufirst%3DT.%26aulast%3DProud%26aufirst%3DC.%26aulast%3DMilne%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DMAP%2520kinase-interacting%2520kinases-emerging%2520targets%2520against%2520cancer%26jtitle%3DChem.%2520Biol.%26date%3D2014%26volume%3D21%26spage%3D441%26epage%3D452%26doi%3D10.1016%2Fj.chembiol.2014.01.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Piccirillo, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjur, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Topisirovic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonenberg, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, O.</span></span> <span> </span><span class="NLM_article-title">Translational control of immune responses: from transcripts to translatomes</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">503</span>– <span class="NLM_lpage">511</span>, <span class="refDoi"> DOI: 10.1038/ni.2891</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1038%2Fni.2891" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=24840981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC2cXot1yls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=503-511&author=C.+A.+Piccirilloauthor=E.+Bjurauthor=I.+Topisirovicauthor=N.+Sonenbergauthor=O.+Larsson&title=Translational+control+of+immune+responses%3A+from+transcripts+to+translatomes&doi=10.1038%2Fni.2891"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Translational control of immune responses: from transcripts to translatomes</span></div><div class="casAuthors">Piccirillo, Ciriaco A.; Bjur, Eva; Topisirovic, Ivan; Sonenberg, Nahum; Larsson, Ola</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">503-511</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Selective translational control of gene expression is emerging as a principal mechanism for the regulation of protein abundance that dets. a variety of functions in both the adaptive immune system and the innate immune system.  The translation-initiation factor eIF4E acts as a node for such regulation, but non-eIF4E mechanisms are also prevalent.  Studies of 'translatomes' (genome-wide pools of translated mRNA) have facilitated mechanistic discoveries by identifying key regulatory components, including transcription factors, that are under translational control.  Here we review the current knowledge on mechanisms that regulate translation and thereby modulate immunol. function.  We further describe approaches for measuring and analyzing translatomes and how such powerful tools can facilitate future insights on the role of translational control in the immune system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9UoBa7zbAT7Vg90H21EOLACvtfcHk0lh6mJD2vtgAJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXot1yls74%253D&md5=483f95cf6f868e2a6eff19c3d1bf2e0f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fni.2891&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.2891%26sid%3Dliteratum%253Aachs%26aulast%3DPiccirillo%26aufirst%3DC.%2BA.%26aulast%3DBjur%26aufirst%3DE.%26aulast%3DTopisirovic%26aufirst%3DI.%26aulast%3DSonenberg%26aufirst%3DN.%26aulast%3DLarsson%26aufirst%3DO.%26atitle%3DTranslational%2520control%2520of%2520immune%2520responses%253A%2520from%2520transcripts%2520to%2520translatomes%26jtitle%3DNat.%2520Immunol.%26date%3D2014%26volume%3D15%26spage%3D503%26epage%3D511%26doi%3D10.1038%2Fni.2891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buxade, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrice, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krebs, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proud, C. G.</span></span> <span> </span><span class="NLM_article-title">The PSF.p54nrb complex is a novel MNK substrate that binds the mRNA for tumor necrosis factor alpha</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">57</span>– <span class="NLM_lpage">65</span>, <span class="refDoi"> DOI: 10.1074/jbc.M705286200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1074%2Fjbc.M705286200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=57-65&author=M.+Buxadeauthor=N.+Morriceauthor=D.+L.+Krebsauthor=C.+G.+Proud&title=The+PSF.p54nrb+complex+is+a+novel+MNK+substrate+that+binds+the+mRNA+for+tumor+necrosis+factor+alpha&doi=10.1074%2Fjbc.M705286200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M705286200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M705286200%26sid%3Dliteratum%253Aachs%26aulast%3DBuxade%26aufirst%3DM.%26aulast%3DMorrice%26aufirst%3DN.%26aulast%3DKrebs%26aufirst%3DD.%2BL.%26aulast%3DProud%26aufirst%3DC.%2BG.%26atitle%3DThe%2520PSF.p54nrb%2520complex%2520is%2520a%2520novel%2520MNK%2520substrate%2520that%2520binds%2520the%2520mRNA%2520for%2520tumor%2520necrosis%2520factor%2520alpha%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D57%26epage%3D65%26doi%3D10.1074%2Fjbc.M705286200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buxade, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parra, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rousseau, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shpiro, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrice, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bain, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proud, C. G.</span></span> <span> </span><span class="NLM_article-title">The Mnks are novel components in the control of TNF alpha biosynthesis and phosphorylate and regulate hnRNP A1</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">177</span>– <span class="NLM_lpage">189</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2005.06.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1016%2Fj.immuni.2005.06.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=177-189&author=M.+Buxadeauthor=J.+L.+Parraauthor=S.+Rousseauauthor=N.+Shpiroauthor=R.+Marquezauthor=N.+Morriceauthor=J.+Bainauthor=E.+Espelauthor=C.+G.+Proud&title=The+Mnks+are+novel+components+in+the+control+of+TNF+alpha+biosynthesis+and+phosphorylate+and+regulate+hnRNP+A1&doi=10.1016%2Fj.immuni.2005.06.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2005.06.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2005.06.009%26sid%3Dliteratum%253Aachs%26aulast%3DBuxade%26aufirst%3DM.%26aulast%3DParra%26aufirst%3DJ.%2BL.%26aulast%3DRousseau%26aufirst%3DS.%26aulast%3DShpiro%26aufirst%3DN.%26aulast%3DMarquez%26aufirst%3DR.%26aulast%3DMorrice%26aufirst%3DN.%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DEspel%26aufirst%3DE.%26aulast%3DProud%26aufirst%3DC.%2BG.%26atitle%3DThe%2520Mnks%2520are%2520novel%2520components%2520in%2520the%2520control%2520of%2520TNF%2520alpha%2520biosynthesis%2520and%2520phosphorylate%2520and%2520regulate%2520hnRNP%2520A1%26jtitle%3DImmunity%26date%3D2005%26volume%3D23%26spage%3D177%26epage%3D189%26doi%3D10.1016%2Fj.immuni.2005.06.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Edwin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ying, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, T. B.</span></span> <span> </span><span class="NLM_article-title">Intermolecular interactions of sprouty proteins and their implications in development and disease</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">679</span>– <span class="NLM_lpage">691</span>, <span class="refDoi"> DOI: 10.1124/mol.109.055848</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1124%2Fmol.109.055848" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2009&pages=679-691&author=F.+Edwinauthor=K.+Andersonauthor=C.+Yingauthor=T.+B.+Patel&title=Intermolecular+interactions+of+sprouty+proteins+and+their+implications+in+development+and+disease&doi=10.1124%2Fmol.109.055848"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1124%2Fmol.109.055848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.109.055848%26sid%3Dliteratum%253Aachs%26aulast%3DEdwin%26aufirst%3DF.%26aulast%3DAnderson%26aufirst%3DK.%26aulast%3DYing%26aufirst%3DC.%26aulast%3DPatel%26aufirst%3DT.%2BB.%26atitle%3DIntermolecular%2520interactions%2520of%2520sprouty%2520proteins%2520and%2520their%2520implications%2520in%2520development%2520and%2520disease%26jtitle%3DMol.%2520Pharmacol.%26date%3D2009%26volume%3D76%26spage%3D679%26epage%3D691%26doi%3D10.1124%2Fmol.109.055848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Panel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boelle, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayala-Sanmartin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jouniaux, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamelin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masliah, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trugnan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flejou, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendum, D.</span></span> <span> </span><span class="NLM_article-title">Cytoplasmic phospholipase A2 expression in human colon adenocarcinoma is correlated with cyclooxygenase-2 expression and contributes to prostaglandin E2 production</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>243</i></span>,  <span class="NLM_fpage">255</span>– <span class="NLM_lpage">263</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2005.11.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1016%2Fj.canlet.2005.11.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=16458424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVGitr%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=243&publication_year=2006&pages=255-263&author=V.+Panelauthor=P.+Y.+Boelleauthor=J.+Ayala-Sanmartinauthor=A.+M.+Jouniauxauthor=R.+Hamelinauthor=J.+Masliahauthor=G.+Trugnanauthor=J.+F.+Flejouauthor=D.+Wendum&title=Cytoplasmic+phospholipase+A2+expression+in+human+colon+adenocarcinoma+is+correlated+with+cyclooxygenase-2+expression+and+contributes+to+prostaglandin+E2+production&doi=10.1016%2Fj.canlet.2005.11.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Cytoplasmic phospholipase A2 expression in human colon adenocarcinoma is correlated with cyclooxygenase-2 expression and contributes to prostaglandin E2 production</span></div><div class="casAuthors">Panel, Valentine; Boelle, Pierre-Yves; Ayala-Sanmartin, Jesus; Jouniaux, Anne-Marie; Hamelin, Richard; Masliah, Joelle; Trugnan, Germain; Flejou, Jean-Francois; Wendum, Dominique</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">243</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">255-263</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cytoplasmic phospholipase A2 (cPLA2) has a key role in prostaglandin prodn.  The role of cPLA2 in intestinal tumorigenesis has been suggested, however, contradictory data are found in the literature.  We evaluated cPLA2 and cyclooxygenase-2 (COX-2) protein expression in 65 colon carcinomas by immunohistochem., and in eight colorectal cancer cell lines by Western Blot.  PGE2 prodn. was evaluated by enzyme-immunoassay in the cell lines.  We demonstrate that cPLA2 is overexpressed in approx. 50% of colon cancers and cell lines. cPLA2 expression is correlated with COX-2 expression.  Both cPLA2 and COX-2 expressions are important in regard to PGE2 prodn.  Our data suggest that cPLA2 might be involved in colon tumor development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxgx_93uVh-rVg90H21EOLACvtfcHk0ljlAo9gNOKmBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVGitr%252FF&md5=cf63d75a6214bb9a1d4b36c2c0a5ef9a</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2005.11.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2005.11.045%26sid%3Dliteratum%253Aachs%26aulast%3DPanel%26aufirst%3DV.%26aulast%3DBoelle%26aufirst%3DP.%2BY.%26aulast%3DAyala-Sanmartin%26aufirst%3DJ.%26aulast%3DJouniaux%26aufirst%3DA.%2BM.%26aulast%3DHamelin%26aufirst%3DR.%26aulast%3DMasliah%26aufirst%3DJ.%26aulast%3DTrugnan%26aufirst%3DG.%26aulast%3DFlejou%26aufirst%3DJ.%2BF.%26aulast%3DWendum%26aufirst%3DD.%26atitle%3DCytoplasmic%2520phospholipase%2520A2%2520expression%2520in%2520human%2520colon%2520adenocarcinoma%2520is%2520correlated%2520with%2520cyclooxygenase-2%2520expression%2520and%2520contributes%2520to%2520prostaglandin%2520E2%2520production%26jtitle%3DCancer%2520Lett.%26date%3D2006%26volume%3D243%26spage%3D255%26epage%3D263%26doi%3D10.1016%2Fj.canlet.2005.11.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jean-Philippe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caputi, M.</span></span> <span> </span><span class="NLM_article-title">hnRNP A1: the Swiss army knife of gene expression</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">18999</span>– <span class="NLM_lpage">19024</span>, <span class="refDoi"> DOI: 10.3390/ijms140918999</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.3390%2Fijms140918999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=24065100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlCgsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=18999-19024&author=J.+Jean-Philippeauthor=S.+Pazauthor=M.+Caputi&title=hnRNP+A1%3A+the+Swiss+army+knife+of+gene+expression&doi=10.3390%2Fijms140918999"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">hnRNP A1: the swiss army knife of gene expression</span></div><div class="casAuthors">Jean-Philippe, Jacques; Paz, Sean; Caputi, Massimo</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">18999-19024, 26 pp.</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Eukaryotic cells express a large variety of RNA binding proteins (RBPs), with diverse affinities and specificities towards target RNAs.  These proteins play a crucial role in almost every aspect of RNA biogenesis, expression and function.  The heterogeneous nuclear ribonucleoproteins (hnRNPs) are a complex and diverse family of RNA binding proteins.  HnRNPs display multiple functions in the processing of heterogeneous nuclear RNAs into mature mRNAs.  HnRNP A1 is one of the most abundant and ubiquitously expressed members of this protein family.  HnRNP A1 plays multiple roles in gene expression by regulating major steps in the processing of nascent RNA transcripts.  The transcription, splicing, stability, export through nuclear pores and translation of cellular and viral transcripts are all mechanisms modulated by this protein.  The diverse functions played by hnRNP A1 are not limited to mRNA biogenesis, but extend to the processing of microRNAs, telomere maintenance and the regulation of transcription factor activity.  Genomic approaches have recently uncovered the extent of hnRNP A1 roles in the development and differentiation of living organisms.  The aim of this review is to highlight recent developments in the study of this protein and to describe its functions in cellular and viral gene expression and its role in human pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCCTVp4ClGErVg90H21EOLACvtfcHk0ljlAo9gNOKmBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlCgsro%253D&md5=ad3ddc1ad1a95151409f3723f9cb4d14</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.3390%2Fijms140918999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms140918999%26sid%3Dliteratum%253Aachs%26aulast%3DJean-Philippe%26aufirst%3DJ.%26aulast%3DPaz%26aufirst%3DS.%26aulast%3DCaputi%26aufirst%3DM.%26atitle%3DhnRNP%2520A1%253A%2520the%2520Swiss%2520army%2520knife%2520of%2520gene%2520expression%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2013%26volume%3D14%26spage%3D18999%26epage%3D19024%26doi%3D10.3390%2Fijms140918999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platanias, L. C.</span></span> <span> </span><span class="NLM_article-title">MNK kinase pathway: Cellular functions and biological outcomes</span>. <i>World J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">321</span>– <span class="NLM_lpage">333</span>, <span class="refDoi"> DOI: 10.4331/wjbc.v5.i3.321</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.4331%2Fwjbc.v5.i3.321" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=25225600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A280%3ADC%252BC2M7hvVCgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=321-333&author=S.+Joshiauthor=L.+C.+Platanias&title=MNK+kinase+pathway%3A+Cellular+functions+and+biological+outcomes&doi=10.4331%2Fwjbc.v5.i3.321"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Mnk kinase pathway: Cellular functions and biological outcomes</span></div><div class="casAuthors">Joshi Sonali; Platanias Leonidas C</div><div class="citationInfo"><span class="NLM_cas:title">World journal of biological chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">321-33</span>
        ISSN:<span class="NLM_cas:issn">1949-8454</span>.
    </div><div class="casAbstract">The mitogen-activated protein kinase (MAPK) interacting protein kinases 1 and 2 (Mnk1 and Mnk2) play important roles in controlling signals involved in mRNA translation.  In addition to the MAPKs (p38 or Erk), multiple studies suggest that the Mnk kinases can be regulated by other known kinases such as Pak2 and/or other unidentified kinases by phosphorylation of residues distinct from the sites phosphorylated by the MAPKs.  Several studies have established multiple Mnk protein targets, including PSF, heterogenous nuclear ribonucleoprotein A1, Sprouty 2 and have lead to the identification of distinct biological functions and substrate specificity for the Mnk kinases.  In this review we discuss the pathways regulating the Mnk kinases, their known substrates as well as the functional consequences of engagement of pathways controlled by Mnk kinases.  These kinases play an important role in mRNA translation via their regulation of eukaryotic initiation factor 4E (eIF4E) and their functions have important implications in tumor biology as well as the regulation of drug resistance to anti-oncogenic therapies.  Other studies have identified a role for the Mnk kinases in cap-independent mRNA translation, suggesting that the Mnk kinases can exert important functional effects independently of the phosphorylation of eIF4E.  The role of Mnk kinases in inflammation and inflammation-induced malignancies is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTQFICkwsHpykh5eUSa2oe_fW6udTcc2eZI1EFymNLczbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7hvVCgtQ%253D%253D&md5=765d4facdd3bb2c0c393ef6f8d0b8fc8</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.4331%2Fwjbc.v5.i3.321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4331%252Fwjbc.v5.i3.321%26sid%3Dliteratum%253Aachs%26aulast%3DJoshi%26aufirst%3DS.%26aulast%3DPlatanias%26aufirst%3DL.%2BC.%26atitle%3DMNK%2520kinase%2520pathway%253A%2520Cellular%2520functions%2520and%2520biological%2520outcomes%26jtitle%3DWorld%2520J.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D5%26spage%3D321%26epage%3D333%26doi%3D10.4331%2Fwjbc.v5.i3.321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elia, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chio, I. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukunaga, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span> <span> </span><span class="NLM_article-title">Combined deficiency for MAP kinase-interacting kinase 1 and 2 (MNK1 and MNK2) delays tumor development</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">13984</span>– <span class="NLM_lpage">13990</span>, <span class="refDoi"> DOI: 10.1073/pnas.1008136107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1073%2Fpnas.1008136107" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=13984-13990&author=T.+Uedaauthor=M.+Sasakiauthor=A.+J.+Eliaauthor=I.+I.+Chioauthor=K.+Hamadaauthor=R.+Fukunagaauthor=T.+W.+Mak&title=Combined+deficiency+for+MAP+kinase-interacting+kinase+1+and+2+%28MNK1+and+MNK2%29+delays+tumor+development&doi=10.1073%2Fpnas.1008136107"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1008136107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1008136107%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DT.%26aulast%3DSasaki%26aufirst%3DM.%26aulast%3DElia%26aufirst%3DA.%2BJ.%26aulast%3DChio%26aufirst%3DI.%2BI.%26aulast%3DHamada%26aufirst%3DK.%26aulast%3DFukunaga%26aufirst%3DR.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DCombined%2520deficiency%2520for%2520MAP%2520kinase-interacting%2520kinase%25201%2520and%25202%2520%2528MNK1%2520and%2520MNK2%2529%2520delays%2520tumor%2520development%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D13984%26epage%3D13990%26doi%3D10.1073%2Fpnas.1008136107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lazaris-Karatzas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montine, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonenberg, N.</span></span> <span> </span><span class="NLM_article-title">Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>345</i></span>,  <span class="NLM_fpage">544</span>– <span class="NLM_lpage">547</span>, <span class="refDoi"> DOI: 10.1038/345544a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1038%2F345544a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=2348862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADyaK3cXktlygsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=345&publication_year=1990&pages=544-547&author=A.+Lazaris-Karatzasauthor=K.+S.+Montineauthor=N.+Sonenberg&title=Malignant+transformation+by+a+eukaryotic+initiation+factor+subunit+that+binds+to+mRNA+5%E2%80%B2+cap&doi=10.1038%2F345544a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap</span></div><div class="casAuthors">Lazaris-Karatzas, Anthoula; Montine, Kathleen S.; Sonenberg, Nahum</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">345</span>
        (<span class="NLM_cas:issue">6275</span>),
    <span class="NLM_cas:pages">544-7</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Overexpression of the translation factor eIF-4E from exogenous cDNA in rodent cell lines caused tumorigenic transformation, as detd. by 3 criteria: formation of transformed foci on a monolayer of cells, anchorage-independent growth, and tumor formation in nude mice.  An eIF-4E mutant whose serine 53 codon was mutated to alanine did not cause tumor formation in nude mice.  The mechanism by which eIF-4E transforms cells is not clear.  The expression of certain oncogenes or growth factors might be tightly controlled at the translational level by the availability of eIF-4E.  Increasing the level of eIF-4E might relieve translational repression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC3QZOSYEW5LVg90H21EOLACvtfcHk0lh5uEagLJMkJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXktlygsrg%253D&md5=b074e125f2b7c237ba1f646814493064</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2F345544a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F345544a0%26sid%3Dliteratum%253Aachs%26aulast%3DLazaris-Karatzas%26aufirst%3DA.%26aulast%3DMontine%26aufirst%3DK.%2BS.%26aulast%3DSonenberg%26aufirst%3DN.%26atitle%3DMalignant%2520transformation%2520by%2520a%2520eukaryotic%2520initiation%2520factor%2520subunit%2520that%2520binds%2520to%2520mRNA%25205%25E2%2580%25B2%2520cap%26jtitle%3DNature%26date%3D1990%26volume%3D345%26spage%3D544%26epage%3D547%26doi%3D10.1038%2F345544a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Konicek, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephens, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNulty, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robichaud, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peery, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumstorf, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowless, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iversen, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCann, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furic, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yingling, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stancato, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonenberg, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graff, J. R.</span></span> <span> </span><span class="NLM_article-title">Therapeutic inhibition of MAP kinase interacting kinase blocks eukaryotic initiation factor 4E phosphorylation and suppresses outgrowth of experimental lung metastases</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">1849</span>– <span class="NLM_lpage">1857</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-10-3298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1158%2F0008-5472.CAN-10-3298" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=1849-1857&author=B.+W.+Konicekauthor=J.+R.+Stephensauthor=A.+M.+McNultyauthor=N.+Robichaudauthor=R.+B.+Peeryauthor=C.+A.+Dumstorfauthor=M.+S.+Dowlessauthor=P.+W.+Iversenauthor=S.+Parsonsauthor=K.+E.+Ellisauthor=D.+J.+McCannauthor=J.+Pelletierauthor=L.+Furicauthor=J.+M.+Yinglingauthor=L.+F.+Stancatoauthor=N.+Sonenbergauthor=J.+R.+Graff&title=Therapeutic+inhibition+of+MAP+kinase+interacting+kinase+blocks+eukaryotic+initiation+factor+4E+phosphorylation+and+suppresses+outgrowth+of+experimental+lung+metastases&doi=10.1158%2F0008-5472.CAN-10-3298"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-3298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-3298%26sid%3Dliteratum%253Aachs%26aulast%3DKonicek%26aufirst%3DB.%2BW.%26aulast%3DStephens%26aufirst%3DJ.%2BR.%26aulast%3DMcNulty%26aufirst%3DA.%2BM.%26aulast%3DRobichaud%26aufirst%3DN.%26aulast%3DPeery%26aufirst%3DR.%2BB.%26aulast%3DDumstorf%26aufirst%3DC.%2BA.%26aulast%3DDowless%26aufirst%3DM.%2BS.%26aulast%3DIversen%26aufirst%3DP.%2BW.%26aulast%3DParsons%26aufirst%3DS.%26aulast%3DEllis%26aufirst%3DK.%2BE.%26aulast%3DMcCann%26aufirst%3DD.%2BJ.%26aulast%3DPelletier%26aufirst%3DJ.%26aulast%3DFuric%26aufirst%3DL.%26aulast%3DYingling%26aufirst%3DJ.%2BM.%26aulast%3DStancato%26aufirst%3DL.%2BF.%26aulast%3DSonenberg%26aufirst%3DN.%26aulast%3DGraff%26aufirst%3DJ.%2BR.%26atitle%3DTherapeutic%2520inhibition%2520of%2520MAP%2520kinase%2520interacting%2520kinase%2520blocks%2520eukaryotic%2520initiation%2520factor%25204E%2520phosphorylation%2520and%2520suppresses%2520outgrowth%2520of%2520experimental%2520lung%2520metastases%26jtitle%3DCancer%2520Res.%26date%3D2011%26volume%3D71%26spage%3D1849%26epage%3D1857%26doi%3D10.1158%2F0008-5472.CAN-10-3298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knauf, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschopp, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gram, H.</span></span> <span> </span><span class="NLM_article-title">Negative regulation of protein translation by mitogen-activated protein kinase-interacting kinases 1 and 2</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">5500</span>– <span class="NLM_lpage">5511</span>, <span class="refDoi"> DOI: 10.1128/MCB.21.16.5500-5511.2001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1128%2FMCB.21.16.5500-5511.2001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=11463832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlslOjtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=5500-5511&author=U.+Knaufauthor=C.+Tschoppauthor=H.+Gram&title=Negative+regulation+of+protein+translation+by+mitogen-activated+protein+kinase-interacting+kinases+1+and+2&doi=10.1128%2FMCB.21.16.5500-5511.2001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Negative regulation of protein translation by mitogen-activated protein kinase-interacting kinases 1 and 2</span></div><div class="casAuthors">Knauf, Ursula; Tschopp, Claude; Gram, Hermann</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5500-5511</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Eukaryotic initiation factor 4E (eIF4E) is a key component of the translational machinery and an important modulator of cell growth and proliferation.  The activity of eIF4E is thought to be regulated by interaction with inhibitory binding proteins (4E-BPs) and phosphorylation by mitogen-activated protein (MAP) kinase-interacting kinase (MNK) on Ser209 in response to mitogens and cellular stress.  Here we demonstrate that phosphorylation of eIF4E via MNK1 is mediated via the activation of either the Erk or p38 pathway.  We further show that expression of active mutants of MNK1 and MNK2 in 293 cells diminishes cap-dependent translation relative to cap-independent translation in a transient reporter assay.  The same effect on cap-dependent translation was obsd. when MNK1 was activated by the Erk or p38 pathway.  In line with these findings, addn. of recombinant active MNK1 to rabbit reticulocyte lysate resulted in a reduced protein synthesis in vitro, and overexpression of MNK2 caused a decreased rate of protein synthesis in 293 cells.  By using CGP 57380, a novel low-mol.-wt. kinase inhibitor of MNK1, we demonstrate that eIF4E phosphorylation is not crucial to the formation of the initiation complex, mitogen-stimulated increase in cap-dependent translation, and cell proliferation.  Our results imply that activation of MNK by MAP kinase pathways does not constitute a pos. regulatory mechanism to cap-dependent translation.  Instead, we propose that the kinase activity of MNKs, eventually through phosphorylation of eIF4E, may serve to limit cap-dependent translation under physiol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruNOjANWg6jLVg90H21EOLACvtfcHk0lhjGZ5PLOj1Nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlslOjtb0%253D&md5=e50d12905c25505de246ca9a80e3da83</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1128%2FMCB.21.16.5500-5511.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.21.16.5500-5511.2001%26sid%3Dliteratum%253Aachs%26aulast%3DKnauf%26aufirst%3DU.%26aulast%3DTschopp%26aufirst%3DC.%26aulast%3DGram%26aufirst%3DH.%26atitle%3DNegative%2520regulation%2520of%2520protein%2520translation%2520by%2520mitogen-activated%2520protein%2520kinase-interacting%2520kinases%25201%2520and%25202%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2001%26volume%3D21%26spage%3D5500%26epage%3D5511%26doi%3D10.1128%2FMCB.21.16.5500-5511.2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basnet, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillam, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumarasiri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diab, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albrecht, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sykes, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">An integrated approach for discovery of highly potent and selective MNK inhibitors: screening, synthesis and SAR analysis</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">539</span>– <span class="NLM_lpage">550</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.09.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1016%2Fj.ejmech.2015.09.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2015&pages=539-550&author=T.+Teoauthor=Y.+Yangauthor=M.+Yuauthor=S.+K.+Basnetauthor=T.+Gillamauthor=J.+Houauthor=R.+M.+Schmidauthor=M.+Kumarasiriauthor=S.+Diabauthor=H.+Albrechtauthor=M.+J.+Sykesauthor=S.+Wang&title=An+integrated+approach+for+discovery+of+highly+potent+and+selective+MNK+inhibitors%3A+screening%2C+synthesis+and+SAR+analysis&doi=10.1016%2Fj.ejmech.2015.09.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DTeo%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DBasnet%26aufirst%3DS.%2BK.%26aulast%3DGillam%26aufirst%3DT.%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DSchmid%26aufirst%3DR.%2BM.%26aulast%3DKumarasiri%26aufirst%3DM.%26aulast%3DDiab%26aufirst%3DS.%26aulast%3DAlbrecht%26aufirst%3DH.%26aulast%3DSykes%26aufirst%3DM.%2BJ.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DAn%2520integrated%2520approach%2520for%2520discovery%2520of%2520highly%2520potent%2520and%2520selective%2520MNK%2520inhibitors%253A%2520screening%252C%2520synthesis%2520and%2520SAR%2520analysis%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D103%26spage%3D539%26epage%3D550%26doi%3D10.1016%2Fj.ejmech.2015.09.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kosciuczuk, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saleiro, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroczynska, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauchamp, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckerdt, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blyth, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abedin, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giles, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altman, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platanias, L. C.</span></span> <span> </span><span class="NLM_article-title">Merestinib blocks MNK kinase activity in acute myeloid leukemia progenitors and exhibits antileukemic effects in vitro and in vivo</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">410</span>– <span class="NLM_lpage">414</span>, <span class="refDoi"> DOI: 10.1182/blood-2016-02-698704</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1182%2Fblood-2016-02-698704" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=27307295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVymu7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2016&pages=410-414&author=E.+M.+Kosciuczukauthor=D.+Saleiroauthor=B.+Kroczynskaauthor=E.+M.+Beauchampauthor=F.+Eckerdtauthor=G.+T.+Blythauthor=S.+M.+Abedinauthor=F.+J.+Gilesauthor=J.+K.+Altmanauthor=L.+C.+Platanias&title=Merestinib+blocks+MNK+kinase+activity+in+acute+myeloid+leukemia+progenitors+and+exhibits+antileukemic+effects+in+vitro+and+in+vivo&doi=10.1182%2Fblood-2016-02-698704"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Merestinib blocks Mnk kinase activity in acute myeloid leukemia progenitors and exhibits antileukemic effects in vitro and in vivo</span></div><div class="casAuthors">Kosciuczuk, Ewa M.; Saleiro, Diana; Kroczynska, Barbara; Beauchamp, Elspeth M.; Eckerdt, Frank; Blyth, Gavin T.; Abedin, Sameem M.; Giles, Francis J.; Altman, Jessica K.; Platanias, Leonidas C.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">410-414</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">1528-0020</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Mitogen-activated protein kinase interacting protein kinases (Mnks) play important roles in the development and progression of acute myeloid leukemia (AML) by regulating eukaryotic translation initiation factor 4E (eIF4E) activation.  Inhibiting Mnk1/2-induced phosphorylation of eIF4E may represent a unique approach for the treatment of AML.  We provide evidence for antileukemic effects of merestinib, an orally bioavailable multikinase inhibitor with suppressive effects on Mnk activity.  Our studies show that merestinib effectively blocks eIF4E phosphorylation in AML cells and suppresses primitive leukemic progenitors from AML patients in vitro and in an AML xenograft model in vivo.  Our findings provide evidence for potent preclin. antileukemic properties of merestinib and support its clin. development for the treatment of patients with AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEFrhJ4BiK57Vg90H21EOLACvtfcHk0lhjGZ5PLOj1Nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVymu7jE&md5=e1034d2ea79d51ffc297d86a6ae4b737</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1182%2Fblood-2016-02-698704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2016-02-698704%26sid%3Dliteratum%253Aachs%26aulast%3DKosciuczuk%26aufirst%3DE.%2BM.%26aulast%3DSaleiro%26aufirst%3DD.%26aulast%3DKroczynska%26aufirst%3DB.%26aulast%3DBeauchamp%26aufirst%3DE.%2BM.%26aulast%3DEckerdt%26aufirst%3DF.%26aulast%3DBlyth%26aufirst%3DG.%2BT.%26aulast%3DAbedin%26aufirst%3DS.%2BM.%26aulast%3DGiles%26aufirst%3DF.%2BJ.%26aulast%3DAltman%26aufirst%3DJ.%2BK.%26aulast%3DPlatanias%26aufirst%3DL.%2BC.%26atitle%3DMerestinib%2520blocks%2520MNK%2520kinase%2520activity%2520in%2520acute%2520myeloid%2520leukemia%2520progenitors%2520and%2520exhibits%2520antileukemic%2520effects%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DBlood%26date%3D2016%26volume%3D128%26spage%3D410%26epage%3D414%26doi%3D10.1182%2Fblood-2016-02-698704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Durante, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verrienti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filetti, S.</span></span> <span> </span><span class="NLM_article-title">XL184 (cabozantinib) for medullary thyroid carcinoma</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">407</span>– <span class="NLM_lpage">413</span>, <span class="refDoi"> DOI: 10.1517/13543784.2011.559163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1517%2F13543784.2011.559163" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=407-413&author=C.+Duranteauthor=D.+Russoauthor=A.+Verrientiauthor=S.+Filetti&title=XL184+%28cabozantinib%29+for+medullary+thyroid+carcinoma&doi=10.1517%2F13543784.2011.559163"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1517%2F13543784.2011.559163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2011.559163%26sid%3Dliteratum%253Aachs%26aulast%3DDurante%26aufirst%3DC.%26aulast%3DRusso%26aufirst%3DD.%26aulast%3DVerrienti%26aufirst%3DA.%26aulast%3DFiletti%26aufirst%3DS.%26atitle%3DXL184%2520%2528cabozantinib%2529%2520for%2520medullary%2520thyroid%2520carcinoma%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2011%26volume%3D20%26spage%3D407%26epage%3D413%26doi%3D10.1517%2F13543784.2011.559163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfister, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warne, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aikawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amiri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appleton, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuart, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanidi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shafer, C. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of a selective and potent Inhibitor of mitogen-activated protein kinase-interacting kinases 1 and 2 (MNK1/2) utilizing structure-based drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">3034</span>– <span class="NLM_lpage">3045</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01657</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01657" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC28Xks1eit7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3034-3045&author=W.+Hanauthor=Y.+Dingauthor=Y.+Xuauthor=K.+Pfisterauthor=S.+Zhuauthor=B.+Warneauthor=M.+Doyleauthor=M.+Aikawaauthor=P.+Amiriauthor=B.+Appletonauthor=D.+D.+Stuartauthor=A.+Fanidiauthor=C.+M.+Shafer&title=Discovery+of+a+selective+and+potent+Inhibitor+of+mitogen-activated+protein+kinase-interacting+kinases+1+and+2+%28MNK1%2F2%29+utilizing+structure-based+drug+design&doi=10.1021%2Facs.jmedchem.5b01657"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Selective and Potent Inhibitor of Mitogen-Activated Protein Kinase-Interacting Kinases 1 and 2 (MNK1/2) Utilizing Structure-Based Drug Design</span></div><div class="casAuthors">Han, Wooseok; Ding, Yu; Xu, Yongjin; Pfister, Keith; Zhu, Shejin; Warne, Bob; Doyle, Mike; Aikawa, Mina; Amiri, Payman; Appleton, Brent; Stuart, Darrin D.; Fanidi, Abdallah; Shafer, Cynthia M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3034-3045</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of a highly potent and selective small mol. inhibitor I for in vitro target validation of MNK1/2 kinases is described.  The aminopyrazine benzimidazole series was derived from an HTS hit and optimized by utilization of a docking model, conformation anal., and binding pocket comparison against antitargets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBT5jenqIBHLVg90H21EOLACvtfcHk0lhI3SSQZ8V1Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xks1eit7s%253D&md5=b4c3eb8122635da657fa52daddb6879a</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01657%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DW.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DPfister%26aufirst%3DK.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DWarne%26aufirst%3DB.%26aulast%3DDoyle%26aufirst%3DM.%26aulast%3DAikawa%26aufirst%3DM.%26aulast%3DAmiri%26aufirst%3DP.%26aulast%3DAppleton%26aufirst%3DB.%26aulast%3DStuart%26aufirst%3DD.%2BD.%26aulast%3DFanidi%26aufirst%3DA.%26aulast%3DShafer%26aufirst%3DC.%2BM.%26atitle%3DDiscovery%2520of%2520a%2520selective%2520and%2520potent%2520Inhibitor%2520of%2520mitogen-activated%2520protein%2520kinase-interacting%2520kinases%25201%2520and%25202%2520%2528MNK1%252F2%2529%2520utilizing%2520structure-based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3034%26epage%3D3045%26doi%3D10.1021%2Facs.jmedchem.5b01657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basnet, S. K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumarasiri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diab, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albrecht, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of 4-(dihydropyridinon-3-yl)amino-5-methylthieno[2,3-d]pyrimidine derivatives as potent MNK inhibitors: synthesis, structure-activity relationship analysis and biological evaluation</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">116</span>– <span class="NLM_lpage">126</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.03.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1016%2Fj.ejmech.2015.03.032" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2015&pages=116-126&author=M.+Yuauthor=P.+Liauthor=S.+K.+C.+Basnetauthor=M.+Kumarasiriauthor=S.+Diabauthor=T.+Teoauthor=H.+Albrechtauthor=S.+Wang&title=Discovery+of+4-%28dihydropyridinon-3-yl%29amino-5-methylthieno%5B2%2C3-d%5Dpyrimidine+derivatives+as+potent+MNK+inhibitors%3A+synthesis%2C+structure-activity+relationship+analysis+and+biological+evaluation&doi=10.1016%2Fj.ejmech.2015.03.032"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.03.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.03.032%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DBasnet%26aufirst%3DS.%2BK.%2BC.%26aulast%3DKumarasiri%26aufirst%3DM.%26aulast%3DDiab%26aufirst%3DS.%26aulast%3DTeo%26aufirst%3DT.%26aulast%3DAlbrecht%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDiscovery%2520of%25204-%2528dihydropyridinon-3-yl%2529amino-5-methylthieno%255B2%252C3-d%255Dpyrimidine%2520derivatives%2520as%2520potent%2520MNK%2520inhibitors%253A%2520synthesis%252C%2520structure-activity%2520relationship%2520analysis%2520and%2520biological%2520evaluation%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D95%26spage%3D116%26epage%3D126%26doi%3D10.1016%2Fj.ejmech.2015.03.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santag, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wengner, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lange, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bomer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puhler, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lienau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergemann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michels, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Nussbaum, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mumberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, K.</span></span> <span> </span><span class="NLM_article-title">BAY 1143269, a novel MNK1 inhibitor, targets oncogenic protein expression and shows potent anti-tumor activity</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>390</i></span>,  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">29</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2016.12.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1016%2Fj.canlet.2016.12.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=28043914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlt12ksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=390&publication_year=2017&pages=21-29&author=S.+Santagauthor=F.+Siegelauthor=A.+M.+Wengnerauthor=C.+Langeauthor=U.+Bomerauthor=K.+Eisauthor=F.+Puhlerauthor=P.+Lienauauthor=L.+Bergemannauthor=M.+Michelsauthor=F.+von+Nussbaumauthor=D.+Mumbergauthor=K.+Petersen&title=BAY+1143269%2C+a+novel+MNK1+inhibitor%2C+targets+oncogenic+protein+expression+and+shows+potent+anti-tumor+activity&doi=10.1016%2Fj.canlet.2016.12.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">BAY 1143269, a novel MNK1 inhibitor, targets oncogenic protein expression and shows potent anti-tumor activity</span></div><div class="casAuthors">Santag, Susann; Siegel, Franziska; Wengner, Antje M.; Lange, Claudia; Boemer, Ulf; Eis, Knut; Puehler, Florian; Lienau, Philip; Bergemann, Linda; Michels, Martin; von Nussbaum, Franz; Mumberg, Dominik; Petersen, Kirstin</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">390</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">21-29</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The initiation of mRNA translation has received increasing attention as an attractive target for cancer treatment in the recent years.  The oncogenic eukaryotic translation initiation factor 4E (eIF4E) is the major substrate of MAP kinase-interacting kinase 1 (MNK1), and it is located at the junction of the cancer-assocd. PI3K and MAPK pathways.  The fact that MNK1 is linked to cell transformation and tumorigenesis renders the kinase a promising target for cancer therapy.  We identified a novel small mol. MNK1 inhibitor, BAY 1143269, by high-throughput screening and lead optimization.  In kinase assays, BAY 1143269 showed potent and selective inhibition of MNK1.  By targeting MNK1 activity, BAY 1143269 strongly regulated downstream factors involved in cell cycle regulation, apoptosis, immune response and epithelial-mesenchymal transition in vitro or in vivo.  In addn., BAY 1143269 demonstrated strong efficacy in monotherapy in cell line and patient-derived non-small cell lung cancer xenograft models as well as delayed tumor regrowth in combination treatment with std. of care chemotherapeutics.  In summary, the inhibition of MNK1 activity with a highly potent and selective inhibitor BAY 1143269 may provide an innovative approach for anti-cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy6F-tMblwNrVg90H21EOLACvtfcHk0lhI3SSQZ8V1Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlt12ksg%253D%253D&md5=dadb4b5f5043263f22bc227950eef1cb</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2016.12.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2016.12.029%26sid%3Dliteratum%253Aachs%26aulast%3DSantag%26aufirst%3DS.%26aulast%3DSiegel%26aufirst%3DF.%26aulast%3DWengner%26aufirst%3DA.%2BM.%26aulast%3DLange%26aufirst%3DC.%26aulast%3DBomer%26aufirst%3DU.%26aulast%3DEis%26aufirst%3DK.%26aulast%3DPuhler%26aufirst%3DF.%26aulast%3DLienau%26aufirst%3DP.%26aulast%3DBergemann%26aufirst%3DL.%26aulast%3DMichels%26aufirst%3DM.%26aulast%3Dvon%2BNussbaum%26aufirst%3DF.%26aulast%3DMumberg%26aufirst%3DD.%26aulast%3DPetersen%26aufirst%3DK.%26atitle%3DBAY%25201143269%252C%2520a%2520novel%2520MNK1%2520inhibitor%252C%2520targets%2520oncogenic%2520protein%2520expression%2520and%2520shows%2520potent%2520anti-tumor%2520activity%26jtitle%3DCancer%2520Lett.%26date%3D2017%26volume%3D390%26spage%3D21%26epage%3D29%26doi%3D10.1016%2Fj.canlet.2016.12.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oyarzabal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarich, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albarran, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palacios, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbano-Cuadrado, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mateos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reymundo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabal, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salgado, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corrionero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fominaya, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bischoff, J. R.</span></span> <span> </span><span class="NLM_article-title">Discovery of mitogen-activated protein kinase-interacting kinase 1 inhibitors by a comprehensive fragment-oriented virtual screening approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">6618</span>– <span class="NLM_lpage">6628</span>, <span class="refDoi"> DOI: 10.1021/jm1005513</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1005513" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVCns7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6618-6628&author=J.+Oyarzabalauthor=N.+Zarichauthor=M.+I.+Albarranauthor=I.+Palaciosauthor=M.+Urbano-Cuadradoauthor=G.+Mateosauthor=I.+Reymundoauthor=O.+Rabalauthor=A.+Salgadoauthor=A.+Corrioneroauthor=J.+Fominayaauthor=J.+Pastorauthor=J.+R.+Bischoff&title=Discovery+of+mitogen-activated+protein+kinase-interacting+kinase+1+inhibitors+by+a+comprehensive+fragment-oriented+virtual+screening+approach&doi=10.1021%2Fjm1005513"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Mitogen-Activated Protein Kinase-Interacting Kinase 1 Inhibitors by a Comprehensive Fragment-Oriented Virtual Screening Approach</span></div><div class="casAuthors">Oyarzabal, Julen; Zarich, Natasha; Albarran, Maria Isabel; Palacios, Irene; Urbano-Cuadrado, Manuel; Mateos, Genoveva; Reymundo, Isabel; Rabal, Obdulia; Salgado, Antonio; Corrionero, Ana; Fominaya, Jesus; Pastor, Joaquin; Bischoff, James R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6618-6628</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mitogen-activated protein kinase-interacting kinases 1 and 2 (MNK1 and MNK2) phosphorylate the oncogene eIF4E on serine 209.  This phosphorylation has been reported to be required for its oncogenic activity.  To investigate if pharmacol. inhibition of MNK1 could be useful for the treatment of cancers, we pursued a comprehensive virtual screening approach to rapidly identify pharmacol. tools for target validation and to find optimal starting points for a plausible medicinal chem. project.  A collection of 1236 compds., selected from a library of 42 168 compds. and a database of 18.8 million structures, were assayed.  Of the identified hits, 26 were found to have IC50 values less than 10 μM (2.10% hit rate).  The most potent compd. had an IC50 value of 117 nM, and 73.1% of these hits were fragments.  The hits were characterized by a high ligand efficiency (0.32-0.52 kcal/mol per heavy atom).  Ten different chem. scaffolds were represented, giving a chemotype/hit ratio of 0.38.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWli1zSitx8LVg90H21EOLACvtfcHk0lg6t3A3Cu9_Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVCns7nM&md5=2ce8787b149c9175c52b01b2ea4adb3b</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm1005513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1005513%26sid%3Dliteratum%253Aachs%26aulast%3DOyarzabal%26aufirst%3DJ.%26aulast%3DZarich%26aufirst%3DN.%26aulast%3DAlbarran%26aufirst%3DM.%2BI.%26aulast%3DPalacios%26aufirst%3DI.%26aulast%3DUrbano-Cuadrado%26aufirst%3DM.%26aulast%3DMateos%26aufirst%3DG.%26aulast%3DReymundo%26aufirst%3DI.%26aulast%3DRabal%26aufirst%3DO.%26aulast%3DSalgado%26aufirst%3DA.%26aulast%3DCorrionero%26aufirst%3DA.%26aulast%3DFominaya%26aufirst%3DJ.%26aulast%3DPastor%26aufirst%3DJ.%26aulast%3DBischoff%26aufirst%3DJ.%2BR.%26atitle%3DDiscovery%2520of%2520mitogen-activated%2520protein%2520kinase-interacting%2520kinase%25201%2520inhibitors%2520by%2520a%2520comprehensive%2520fragment-oriented%2520virtual%2520screening%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6618%26epage%3D6628%26doi%3D10.1021%2Fjm1005513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Webster, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goel, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, I. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staunton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jessen, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wegerski, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appleman, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webber, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sprengeler, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reich, S. H.</span></span> <span> </span><span class="NLM_article-title">eFT508, a potent and selective mitogen-activated protein kinase interacting kinase (MNK) 1 and 2 inhibitor, is efficacious in preclinical models of diffuse large B-cell lymphoma (DLBCL)</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">1554</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2015&pages=1554&author=K.+R.+Websterauthor=V.+K.+Goelauthor=I.+N.+Hungauthor=G.+Parkerauthor=J.+Stauntonauthor=M.+Nealauthor=J.+Molterauthor=G.+G.+Chiangauthor=K.+A.+Jessenauthor=C.+J.+Wegerskiauthor=S.+Sperryauthor=V.+Huangauthor=J.+Chenauthor=P.+A.+Thompsonauthor=J.+R.+Applemanauthor=S.+E.+Webberauthor=P.+A.+Sprengelerauthor=S.+H.+Reich&title=eFT508%2C+a+potent+and+selective+mitogen-activated+protein+kinase+interacting+kinase+%28MNK%29+1+and+2+inhibitor%2C+is+efficacious+in+preclinical+models+of+diffuse+large+B-cell+lymphoma+%28DLBCL%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWebster%26aufirst%3DK.%2BR.%26aulast%3DGoel%26aufirst%3DV.%2BK.%26aulast%3DHung%26aufirst%3DI.%2BN.%26aulast%3DParker%26aufirst%3DG.%26aulast%3DStaunton%26aufirst%3DJ.%26aulast%3DNeal%26aufirst%3DM.%26aulast%3DMolter%26aufirst%3DJ.%26aulast%3DChiang%26aufirst%3DG.%2BG.%26aulast%3DJessen%26aufirst%3DK.%2BA.%26aulast%3DWegerski%26aufirst%3DC.%2BJ.%26aulast%3DSperry%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DThompson%26aufirst%3DP.%2BA.%26aulast%3DAppleman%26aufirst%3DJ.%2BR.%26aulast%3DWebber%26aufirst%3DS.%2BE.%26aulast%3DSprengeler%26aufirst%3DP.%2BA.%26aulast%3DReich%26aufirst%3DS.%2BH.%26atitle%3DeFT508%252C%2520a%2520potent%2520and%2520selective%2520mitogen-activated%2520protein%2520kinase%2520interacting%2520kinase%2520%2528MNK%2529%25201%2520and%25202%2520inhibitor%252C%2520is%2520efficacious%2520in%2520preclinical%2520models%2520of%2520diffuse%2520large%2520B-cell%2520lymphoma%2520%2528DLBCL%2529%26jtitle%3DBlood%26date%3D2015%26volume%3D126%26spage%3D1554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reich, S. H.</span>; <span class="NLM_string-name">Sprengeler, P. A.</span>; <span class="NLM_string-name">Webber, S. E.</span>; <span class="NLM_string-name">Xiang, A. X.</span>; <span class="NLM_string-name">Ernst, J.</span></span> <span> </span><span class="NLM_article-title">MNK Inhibitors and Methods Related Thereto</span>. U.S. Patent <span class="NLM_patent">9,382,248</span>, July 5, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=S.+H.+Reich&author=P.+A.+Sprengeler&author=S.+E.+Webber&author=A.+X.+Xiang&author=J.+Ernst&title=MNK+Inhibitors+and+Methods+Related+Thereto"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DReich%26aufirst%3DS.%2BH.%26atitle%3DMNK%2520Inhibitors%2520and%2520Methods%2520Related%2520Thereto%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raheem, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walji, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abeywickrema, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbe, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Childers, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clas, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubost, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Embrey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grobler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hafey, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartingh, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazuda, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuethe, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCabe Dunn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolting, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pajkovic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rada, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rearden, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreier, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sisko, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steele, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truchon, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, P. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of 2-pyridinone aminals: a prodrug strategy to advance a second generation of HIV-1 integrase strand transfer inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8154</span>– <span class="NLM_lpage">8165</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01037</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01037" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFersrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8154-8165&author=I.+T.+Raheemauthor=A.+M.+Waljiauthor=D.+Kleinauthor=J.+M.+Sandersauthor=D.+A.+Powellauthor=P.+Abeywickremaauthor=G.+Barbeauthor=A.+Bennetauthor=K.+Childersauthor=M.+Christensenauthor=S.+D.+Clasauthor=D.+Dubostauthor=M.+Embreyauthor=J.+Groblerauthor=M.+J.+Hafeyauthor=T.+J.+Hartinghauthor=D.+J.+Hazudaauthor=J.+T.+Kuetheauthor=J.+McCabe+Dunnauthor=M.+D.+Millerauthor=K.+P.+Mooreauthor=A.+Noltingauthor=N.+Pajkovicauthor=S.+Patelauthor=Z.+Pengauthor=V.+Radaauthor=P.+Reardenauthor=J.+D.+Schreierauthor=J.+Siskoauthor=T.+G.+Steeleauthor=J.+F.+Truchonauthor=J.+Waiauthor=M.+Xuauthor=P.+J.+Coleman&title=Discovery+of+2-pyridinone+aminals%3A+a+prodrug+strategy+to+advance+a+second+generation+of+HIV-1+integrase+strand+transfer+inhibitors&doi=10.1021%2Facs.jmedchem.5b01037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 2-Pyridinone Aminals: A Prodrug Strategy to Advance a Second Generation of HIV-1 Integrase Strand Transfer Inhibitors</span></div><div class="casAuthors">Raheem, Izzat T.; Walji, Abbas M.; Klein, Daniel; Sanders, John M.; Powell, David A.; Abeywickrema, Pravien; Barbe, Guillaume; Bennet, Amrith; Childers, Karla; Christensen, Melodie; Clas, Sophie-Dorothee; Dubost, David; Embrey, Mark; Grobler, Jay; Hafey, Michael J.; Hartingh, Timothy J.; Hazuda, Daria J.; Kuethe, Jeffrey T.; Dunn, Jamie McCabe; Miller, Michael D.; Moore, Keith P.; Nolting, Andrew; Pajkovic, Natasa; Patel, Sangita; Peng, Zuihui; Rada, Vanessa; Rearden, Paul; Schreier, John D.; Sisko, John; Steele, Thomas G.; Truchon, Jean-Francois; Wai, John; Xu, Min; Coleman, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8154-8165</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The search for new mol. constructs that resemble the crit. two-metal binding pharmacophore required for HIV integrase strand transfer inhibition represents a vibrant area of research within drug discovery.  Here the authors present the discovery of a new class of HIV integrase strand transfer inhibitors based on the 2-pyridinone core of MK-0536.  These efforts led to the identification of two lead compds. I and II with excellent antiviral activity and preclin. pharmacokinetic profiles to support a once-daily human dose prediction.  Dose escalating PK studies in dog revealed significant issues with limited oral absorption and required an innovative prodrug strategy to enhance the high-dose plasma exposures of the parent mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGEsuT4C8WELVg90H21EOLACvtfcHk0lixMdt8MNZjxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFersrvJ&md5=bec0c2f7710a1e4e8cc3a502067a2236</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01037%26sid%3Dliteratum%253Aachs%26aulast%3DRaheem%26aufirst%3DI.%2BT.%26aulast%3DWalji%26aufirst%3DA.%2BM.%26aulast%3DKlein%26aufirst%3DD.%26aulast%3DSanders%26aufirst%3DJ.%2BM.%26aulast%3DPowell%26aufirst%3DD.%2BA.%26aulast%3DAbeywickrema%26aufirst%3DP.%26aulast%3DBarbe%26aufirst%3DG.%26aulast%3DBennet%26aufirst%3DA.%26aulast%3DChilders%26aufirst%3DK.%26aulast%3DChristensen%26aufirst%3DM.%26aulast%3DClas%26aufirst%3DS.%2BD.%26aulast%3DDubost%26aufirst%3DD.%26aulast%3DEmbrey%26aufirst%3DM.%26aulast%3DGrobler%26aufirst%3DJ.%26aulast%3DHafey%26aufirst%3DM.%2BJ.%26aulast%3DHartingh%26aufirst%3DT.%2BJ.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DKuethe%26aufirst%3DJ.%2BT.%26aulast%3DMcCabe%2BDunn%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DM.%2BD.%26aulast%3DMoore%26aufirst%3DK.%2BP.%26aulast%3DNolting%26aufirst%3DA.%26aulast%3DPajkovic%26aufirst%3DN.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DPeng%26aufirst%3DZ.%26aulast%3DRada%26aufirst%3DV.%26aulast%3DRearden%26aufirst%3DP.%26aulast%3DSchreier%26aufirst%3DJ.%2BD.%26aulast%3DSisko%26aufirst%3DJ.%26aulast%3DSteele%26aufirst%3DT.%2BG.%26aulast%3DTruchon%26aufirst%3DJ.%2BF.%26aulast%3DWai%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520of%25202-pyridinone%2520aminals%253A%2520a%2520prodrug%2520strategy%2520to%2520advance%2520a%2520second%2520generation%2520of%2520HIV-1%2520integrase%2520strand%2520transfer%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8154%26epage%3D8165%26doi%3D10.1021%2Facs.jmedchem.5b01037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, R. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, R. P.</span></span> <span> </span><span class="NLM_article-title">Cytokines in cancer drug resistance: cues to new therapeutic strategies</span>. <i>Biochim. Biophys. Acta, Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>1865</i></span>,  <span class="NLM_fpage">255</span>– <span class="NLM_lpage">265</span>, <span class="refDoi"> DOI: 10.1016/j.bbcan.2016.03.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1016%2Fj.bbcan.2016.03.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=26993403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC28XksVWmsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1865&publication_year=2016&pages=255-265&author=V.+S.+Jonesauthor=R.+Y.+Huangauthor=L.+P.+Chenauthor=Z.+S.+Chenauthor=L.+Fuauthor=R.+P.+Huang&title=Cytokines+in+cancer+drug+resistance%3A+cues+to+new+therapeutic+strategies&doi=10.1016%2Fj.bbcan.2016.03.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Cytokines in cancer drug resistance: Cues to new therapeutic strategies</span></div><div class="casAuthors">Jones, Valerie Sloane; Huang, Ren-Yu; Chen, Li-Pai; Chen, Zhe-Sheng; Fu, Liwu; Huang, Ruo-Pan</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Reviews on Cancer</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1865</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">255-265</span>CODEN:
                <span class="NLM_cas:coden">BBACEU</span>;
        ISSN:<span class="NLM_cas:issn">0304-419X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The development of oncoprotein-targeted anticancer drugs is an invaluable weapon in the war against cancer.  However, cancers do not give up without a fight.  They may develop multiple mechanisms of drug resistance, including apoptosis inhibition, drug expulsion, and increased proliferation that reduce the effectiveness of the drug.  The collective work of researchers has highlighted the role of cytokines in the mechanisms of cancer drug resistance, as well as in cancer cell progression.  Furthermore, recent studies have described how specific cytokines secreted by cancer stromal cells confer resistance to chemotherapeutic treatments.  In order to gain a better understanding of mechanism of cancer drug resistance and a prediction of treatment outcome, it is imperative that correlations are established between global cytokine profiles and cancer drug resistance.  Here we discuss the recent discoveries in this field of research and discuss their implications for the future development of effective anti-cancer medicines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIYFeodi3D6LVg90H21EOLACvtfcHk0lixMdt8MNZjxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksVWmsbw%253D&md5=6457c45b3cb9d451c5082db397fd831a</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bbcan.2016.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbcan.2016.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DV.%2BS.%26aulast%3DHuang%26aufirst%3DR.%2BY.%26aulast%3DChen%26aufirst%3DL.%2BP.%26aulast%3DChen%26aufirst%3DZ.%2BS.%26aulast%3DFu%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DR.%2BP.%26atitle%3DCytokines%2520in%2520cancer%2520drug%2520resistance%253A%2520cues%2520to%2520new%2520therapeutic%2520strategies%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Rev.%2520Cancer%26date%3D2016%26volume%3D1865%26spage%3D255%26epage%3D265%26doi%3D10.1016%2Fj.bbcan.2016.03.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karin, M.</span></span> <span> </span><span class="NLM_article-title">A cytokine-mediated link between innate immunity, inflammation, and cancer</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">1175</span>– <span class="NLM_lpage">1183</span>, <span class="refDoi"> DOI: 10.1172/JCI31537</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1172%2FJCI31537" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2007&pages=1175-1183&author=W.+W.+Linauthor=M.+Karin&title=A+cytokine-mediated+link+between+innate+immunity%2C+inflammation%2C+and+cancer&doi=10.1172%2FJCI31537"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1172%2FJCI31537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI31537%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DW.%2BW.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DA%2520cytokine-mediated%2520link%2520between%2520innate%2520immunity%252C%2520inflammation%252C%2520and%2520cancer%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2007%26volume%3D117%26spage%3D1175%26epage%3D1183%26doi%3D10.1172%2FJCI31537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaikuad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span> <span> </span><span class="NLM_article-title">The ins and outs of selective kinase inhibitor development</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">818</span>– <span class="NLM_lpage">821</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1938</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1038%2Fnchembio.1938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=26485069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1ykt7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=818-821&author=S.+Mullerauthor=A.+Chaikuadauthor=N.+S.+Grayauthor=S.+Knapp&title=The+ins+and+outs+of+selective+kinase+inhibitor+development&doi=10.1038%2Fnchembio.1938"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The ins and outs of selective kinase inhibitor development</span></div><div class="casAuthors">Muller, Susanne; Chaikuad, Apirat; Gray, Nathanael S.; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">818-821</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protein kinases have emerged as one of the most successful families of drug targets.  To date, most selective kinase inhibitors have been discovered serendipitously either through broad selectivity screening or through the discovery of unique binding modes.  Here the authors discuss design strategies that could lead to a broader coverage of the kinome with selective inhibitors and to a more rational approach for developing them.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQzaMrxSYx_rVg90H21EOLACvtfcHk0ljP73WDvdX50Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1ykt7fF&md5=f5adf0bbaa388c87b26bae23cfad0bae</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1938%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DS.%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DThe%2520ins%2520and%2520outs%2520of%2520selective%2520kinase%2520inhibitor%2520development%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3D818%26epage%3D821%26doi%3D10.1038%2Fnchembio.1938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bissantz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M.</span></span> <span> </span><span class="NLM_article-title">A medicinal chemist’s guide to molecular interactions</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">5061</span>– <span class="NLM_lpage">5084</span>, <span class="refDoi"> DOI: 10.1021/jm100112j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100112j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvFKjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5061-5084&author=C.+Bissantzauthor=B.+Kuhnauthor=M.+Stahl&title=A+medicinal+chemist%E2%80%99s+guide+to+molecular+interactions&doi=10.1021%2Fjm100112j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">A Medicinal Chemist's Guide to Molecular Interactions</span></div><div class="casAuthors">Bissantz, Caterina; Kuhn, Bernd; Stahl, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5061-5084</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraV8HPbwsihbVg90H21EOLACvtfcHk0ljP73WDvdX50Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvFKjtbs%253D&md5=f39cf8700267cdc311c73de4d433bab0</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm100112j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100112j%26sid%3Dliteratum%253Aachs%26aulast%3DBissantz%26aufirst%3DC.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DA%2520medicinal%2520chemist%25E2%2580%2599s%2520guide%2520to%2520molecular%2520interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5061%26epage%3D5084%26doi%3D10.1021%2Fjm100112j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fufezan, C.</span></span> <span> </span><span class="NLM_article-title">The role of Buergi-Dunitz interactions in the structural stability of proteins</span>. <i>Proteins: Struct., Funct., Genet.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">2831</span>– <span class="NLM_lpage">2838</span>, <span class="refDoi"> DOI: 10.1002/prot.22800</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1002%2Fprot.22800" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=20635415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGqs73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2010&pages=2831-2838&author=C.+Fufezan&title=The+role+of+Buergi-Dunitz+interactions+in+the+structural+stability+of+proteins&doi=10.1002%2Fprot.22800"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">The role of Buergi-Dunitz interactions in the structural stability of proteins</span></div><div class="casAuthors">Fufezan, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Bioinformatics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2831-2838</span>CODEN:
                <span class="NLM_cas:coden">PSFBAF</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Non-bonding interactions are essential for protein stability and maintenance of secondary structure.  Their strength, however, is not always exptl. accessible.  One example is the stability of collagen, which is in part due to Buergi-Dunitz or n → π* interactions between the peptide backbone atoms.  Here, the overall frequency of n → π* interactions in proteins has been investigated.  The anal. of a non-redundant set of protein structures showed that 45.1% of all residues have a backbone conformation favoring a n → π* nucleophilic attack between the carbonyl oxygen of residue i - 1 and the carbonyl carbon of residue i.  These residues form a substantial fraction of right- and left-handed α helixes, 310 helixes, π helixes, and hydrogen bonded turns.  Simulations showed that there are only four regions in Ramachandran space that favor backbone ni-1 → πi* interactions and these Φ, Ψ combinations are obsd. with high frequencies in the non-redundant protein structure set.  Anal. of carbonyl carbon displacements out of the peptide plane in ultra-high resoln. protein structures indeed reveals the presence of the Buergi-Dunitz trajectory.  The Buergi-Dunitz interaction thus appears to play an important and general role in protein structure stability that has not hitherto been fully explored.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroccrxMw9b1rVg90H21EOLACvtfcHk0ljP73WDvdX50Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGqs73N&md5=58b891d088dcd9828da546d4b1a1e97a</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2Fprot.22800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.22800%26sid%3Dliteratum%253Aachs%26aulast%3DFufezan%26aufirst%3DC.%26atitle%3DThe%2520role%2520of%2520Buergi-Dunitz%2520interactions%2520in%2520the%2520structural%2520stability%2520of%2520proteins%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2010%26volume%3D78%26spage%3D2831%26epage%3D2838%26doi%3D10.1002%2Fprot.22800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paulini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, F.</span></span> <span> </span><span class="NLM_article-title">Orthogonal multipolar interactions in structural chemistry and biology</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">1788</span>– <span class="NLM_lpage">1805</span>, <span class="refDoi"> DOI: 10.1002/anie.200462213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1002%2Fanie.200462213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BD2MXislWkt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=1788-1805&author=R.+Pauliniauthor=K.+Mullerauthor=F.+Diederich&title=Orthogonal+multipolar+interactions+in+structural+chemistry+and+biology&doi=10.1002%2Fanie.200462213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Orthogonal multipolar interactions in structural chemistry and biology</span></div><div class="casAuthors">Paulini, Ralph; Mueller, Klaus; Diederich, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1788-1805</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The past few decades of mol. recognition studies have greatly enhanced our knowledge on apolar, ion-dipole, and hydrogen-bonding interactions.  However, much less attention has been given to the role that multipolar interactions, in particular those with orthogonal dipolar alignment, play in organizing a crystal lattice or stabilizing complexes involving biol. receptors.  By using results from database mining, this review attempts to give an overview of types and structural features of these previously rather overlooked interactions.  A no. of illustrative examples of these interactions found in X-ray crystal structures of small mols. and protein-ligand complexes demonstrate their propensity and thus potential importance for both, chem. and biol. mol. recognition processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTGHoutIq12LVg90H21EOLACvtfcHk0liccucTtecEfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXislWkt7s%253D&md5=6ad842547313b27fc1676e9c3a001909</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2Fanie.200462213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200462213%26sid%3Dliteratum%253Aachs%26aulast%3DPaulini%26aufirst%3DR.%26aulast%3DMuller%26aufirst%3DK.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DOrthogonal%2520multipolar%2520interactions%2520in%2520structural%2520chemistry%2520and%2520biology%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2005%26volume%3D44%26spage%3D1788%26epage%3D1805%26doi%3D10.1002%2Fanie.200462213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jauch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Netter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aicher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackle, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahl, M. C.</span></span> <span> </span><span class="NLM_article-title">Crystal structures of the MNK2 kinase domain reveal an inhibitory conformation and a zinc binding site</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1559</span>– <span class="NLM_lpage">1568</span>, <span class="refDoi"> DOI: 10.1016/j.str.2005.07.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1016%2Fj.str.2005.07.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=1559-1568&author=R.+Jauchauthor=S.+Jakelauthor=C.+Netterauthor=K.+Schreiterauthor=B.+Aicherauthor=H.+Jackleauthor=M.+C.+Wahl&title=Crystal+structures+of+the+MNK2+kinase+domain+reveal+an+inhibitory+conformation+and+a+zinc+binding+site&doi=10.1016%2Fj.str.2005.07.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2005.07.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2005.07.013%26sid%3Dliteratum%253Aachs%26aulast%3DJauch%26aufirst%3DR.%26aulast%3DJakel%26aufirst%3DS.%26aulast%3DNetter%26aufirst%3DC.%26aulast%3DSchreiter%26aufirst%3DK.%26aulast%3DAicher%26aufirst%3DB.%26aulast%3DJackle%26aufirst%3DH.%26aulast%3DWahl%26aufirst%3DM.%2BC.%26atitle%3DCrystal%2520structures%2520of%2520the%2520MNK2%2520kinase%2520domain%2520reveal%2520an%2520inhibitory%2520conformation%2520and%2520a%2520zinc%2520binding%2520site%26jtitle%3DStructure%26date%3D2005%26volume%3D13%26spage%3D1559%26epage%3D1568%26doi%3D10.1016%2Fj.str.2005.07.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeqiraj, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jha, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlicky, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thevakumaran, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talukdar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pillon, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceccarelli, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juang, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaughan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinton, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perelygin, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kourinov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guarne, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sicheri, F.</span></span> <span> </span><span class="NLM_article-title">Dimeric structure of pseudokinase RNase L bound to 2–5A reveals a basis for interferon-induced antiviral activity</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">221</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2013.12.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1016%2Fj.molcel.2013.12.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=24462203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1GrtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=221-234&author=H.+Huangauthor=E.+Zeqirajauthor=B.+Dongauthor=B.+K.+Jhaauthor=N.+M.+Duffyauthor=S.+Orlickyauthor=N.+Thevakumaranauthor=M.+Talukdarauthor=M.+C.+Pillonauthor=D.+F.+Ceccarelliauthor=L.+C.+Wanauthor=Y.+C.+Juangauthor=D.+Y.+Maoauthor=C.+Gaughanauthor=M.+A.+Brintonauthor=A.+A.+Perelyginauthor=I.+Kourinovauthor=A.+Guarneauthor=R.+H.+Silvermanauthor=F.+Sicheri&title=Dimeric+structure+of+pseudokinase+RNase+L+bound+to+2%E2%80%935A+reveals+a+basis+for+interferon-induced+antiviral+activity&doi=10.1016%2Fj.molcel.2013.12.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Dimeric Structure of Pseudokinase RNase L Bound to 2-5A Reveals a Basis for Interferon-Induced Antiviral Activity</span></div><div class="casAuthors">Huang, Hao; Zeqiraj, Elton; Dong, Beihua; Jha, Babal Kant; Duffy, Nicole M.; Orlicky, Stephen; Thevakumaran, Neroshan; Talukdar, Manisha; Pillon, Monica C.; Ceccarelli, Derek F.; Wan, Leo C. K.; Juang, Yu-Chi; Mao, Daniel Y. L.; Gaughan, Christina; Brinton, Margo A.; Perelygin, Andrey A.; Kourinov, Igor; Guarne, Alba; Silverman, Robert H.; Sicheri, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">221-234</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">RNase L is an ankyrin repeat domain-contg. dual endoribonuclease-pseudokinase that is activated by unusual 2,'5'-oligoadenylate (2-5A) second messengers and which impedes viral infections in higher vertebrates.  Despite its importance in interferon-regulated antiviral innate immunity, relatively little is known about its precise mechanism of action.  Here we present a functional characterization of 2.5 Å and 3.25 Å X-ray crystal and small-angle X-ray scattering structures of RNase L bound to a natural 2-5A activator with and without ADP or the nonhydrolysable ATP mimetic AMP-PNP.  These studies reveal how recognition of 2-5A through interactions with the ankyrin repeat domain and the pseudokinase domain, together with nucleotide binding, imposes a rigid intertwined dimer configuration that is essential for RNase catalytic and antiviral functions.  The involvement of the pseudokinase domain of RNase L in 2-5A sensing, nucleotide binding, dimerization, and RNase functions highlights the evolutionary adaptability of the eukaryotic protein kinase fold.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxh3n6FswZu7Vg90H21EOLACvtfcHk0liccucTtecEfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1GrtL8%253D&md5=14c2856a405ae2308c2d37592241a593</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2013.12.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2013.12.025%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DZeqiraj%26aufirst%3DE.%26aulast%3DDong%26aufirst%3DB.%26aulast%3DJha%26aufirst%3DB.%2BK.%26aulast%3DDuffy%26aufirst%3DN.%2BM.%26aulast%3DOrlicky%26aufirst%3DS.%26aulast%3DThevakumaran%26aufirst%3DN.%26aulast%3DTalukdar%26aufirst%3DM.%26aulast%3DPillon%26aufirst%3DM.%2BC.%26aulast%3DCeccarelli%26aufirst%3DD.%2BF.%26aulast%3DWan%26aufirst%3DL.%2BC.%26aulast%3DJuang%26aufirst%3DY.%2BC.%26aulast%3DMao%26aufirst%3DD.%2BY.%26aulast%3DGaughan%26aufirst%3DC.%26aulast%3DBrinton%26aufirst%3DM.%2BA.%26aulast%3DPerelygin%26aufirst%3DA.%2BA.%26aulast%3DKourinov%26aufirst%3DI.%26aulast%3DGuarne%26aufirst%3DA.%26aulast%3DSilverman%26aufirst%3DR.%2BH.%26aulast%3DSicheri%26aufirst%3DF.%26atitle%3DDimeric%2520structure%2520of%2520pseudokinase%2520RNase%2520L%2520bound%2520to%25202%25E2%2580%25935A%2520reveals%2520a%2520basis%2520for%2520interferon-induced%2520antiviral%2520activity%26jtitle%3DMol.%2520Cell%26date%3D2014%26volume%3D53%26spage%3D221%26epage%3D234%26doi%3D10.1016%2Fj.molcel.2013.12.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berman, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westbrook, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilliland, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weissig, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shindyalov, I. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourne, P. E.</span></span> <span> </span><span class="NLM_article-title">The Protein Data Bank</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">242</span>, <span class="refDoi"> DOI: 10.1093/nar/28.1.235</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1093%2Fnar%2F28.1.235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10592235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvVKjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=235-242&author=H.+M.+Bermanauthor=J.+Westbrookauthor=Z.+Fengauthor=G.+Gillilandauthor=T.+N.+Bhatauthor=H.+Weissigauthor=I.+N.+Shindyalovauthor=P.+E.+Bourne&title=The+Protein+Data+Bank&doi=10.1093%2Fnar%2F28.1.235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Data Bank</span></div><div class="casAuthors">Berman, Helen M.; Westbrook, John; Feng, Zukang; Gilliland, Gary; Bhat, T. N.; Weissig, Helge; Shindyalov, Ilya N.; Bourne, Philip E.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The Protein Data Bank (PDB; http://www.rcsb.org/pdb/)is the single worldwide archive of structural data of biol. macromols.  This paper describes the goals of the PDB, the systems in place for data deposition and access, how to obtain further information, and near-term plans for the future development of the resource.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpStGCxT8QzirVg90H21EOLACvtfcHk0lgZrqHn0gypHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvVKjt7w%253D&md5=227fb393f754be2be375ab727bfd05dc</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1093%2Fnar%2F28.1.235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252F28.1.235%26sid%3Dliteratum%253Aachs%26aulast%3DBerman%26aufirst%3DH.%2BM.%26aulast%3DWestbrook%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DGilliland%26aufirst%3DG.%26aulast%3DBhat%26aufirst%3DT.%2BN.%26aulast%3DWeissig%26aufirst%3DH.%26aulast%3DShindyalov%26aufirst%3DI.%2BN.%26aulast%3DBourne%26aufirst%3DP.%2BE.%26atitle%3DThe%2520Protein%2520Data%2520Bank%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2000%26volume%3D28%26spage%3D235%26epage%3D242%26doi%3D10.1093%2Fnar%2F28.1.235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Groom, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruno, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lightfoot, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, S. C.</span></span> <span> </span><span class="NLM_article-title">The Cambridge Structural Database</span>. <i>Acta Crystallogr., Sect. B: Struct. Sci., Cryst. Eng. Mater.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">171</span>– <span class="NLM_lpage">179</span>, <span class="refDoi"> DOI: 10.1107/S2052520616003954</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1107%2FS2052520616003954" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=27048719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC28Xls1Kntro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2016&pages=171-179&author=C.+R.+Groomauthor=I.+J.+Brunoauthor=M.+P.+Lightfootauthor=S.+C.+Ward&title=The+Cambridge+Structural+Database&doi=10.1107%2FS2052520616003954"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The Cambridge Structural Database</span></div><div class="casAuthors">Groom, Colin R.; Bruno, Ian J.; Lightfoot, Matthew P.; Ward, Suzanna C.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section B: Structural Science, Crystal Engineering and Materials</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">171-179</span>CODEN:
                <span class="NLM_cas:coden">ACSBDA</span>;
        ISSN:<span class="NLM_cas:issn">2052-5206</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The Cambridge Structural Database (CSD) contains a complete record of all published org. and metal-org. small-mol. crystal structures.  The database has been in operation for over 50 years and continues to be the primary means of sharing structural chem. data and knowledge across disciplines.  As well as structures that are made public to support scientific articles, it includes many structures published directly as CSD Communications.  All structures are processed both computationally and by expert structural chem. editors prior to entering the database.  A key component of this processing is the reliable assocn. of the chem. identity of the structure studied with the exptl. data.  This important step helps ensure that data is widely discoverable and readily reusable.  Content is further enriched through selective inclusion of addnl. exptl. data.  Entries are available to anyone through free CSD community web services.  Linking services developed and maintained by the CCDC, combined with the use of std. identifiers, facilitate discovery from other resources.  Data can also be accessed through CCDC and third party software applications and through an application programming interface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvlnx06ebv_bVg90H21EOLACvtfcHk0lgZrqHn0gypHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xls1Kntro%253D&md5=f9c65ab86fc9db429588c95b0da3f9b2</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1107%2FS2052520616003954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2052520616003954%26sid%3Dliteratum%253Aachs%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DBruno%26aufirst%3DI.%2BJ.%26aulast%3DLightfoot%26aufirst%3DM.%2BP.%26aulast%3DWard%26aufirst%3DS.%2BC.%26atitle%3DThe%2520Cambridge%2520Structural%2520Database%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520B%253A%2520Struct.%2520Sci.%252C%2520Cryst.%2520Eng.%2520Mater.%26date%3D2016%26volume%3D72%26spage%3D171%26epage%3D179%26doi%3D10.1107%2FS2052520616003954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, L.</span></span> <span> </span><span class="NLM_article-title">Calculating partition coefficient by atom-additive method</span>. <i>Perspect. Drug Discovery Des.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">47</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1023/A:1008763405023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1023%2FA%3A1008763405023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=47-66&author=R.+Wangauthor=Y.+Gaoauthor=L.+Lai&title=Calculating+partition+coefficient+by+atom-additive+method&doi=10.1023%2FA%3A1008763405023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1023%2FA%3A1008763405023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1008763405023%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DR.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DLai%26aufirst%3DL.%26atitle%3DCalculating%2520partition%2520coefficient%2520by%2520atom-additive%2520method%26jtitle%3DPerspect.%2520Drug%2520Discovery%2520Des.%26date%3D2000%26volume%3D19%26spage%3D47%26epage%3D66%26doi%3D10.1023%2FA%3A1008763405023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platanias, L. C.</span></span> <span> </span><span class="NLM_article-title">MNK kinases in cytokine signaling and regulation of cytokine responses</span>. <i>Biomol. Concepts</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">139</span>, <span class="refDoi"> DOI: 10.1515/bmc-2011-1057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1515%2Fbmc-2011-1057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=23710261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsFejsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=127-139&author=S.+Joshiauthor=L.+C.+Platanias&title=MNK+kinases+in+cytokine+signaling+and+regulation+of+cytokine+responses&doi=10.1515%2Fbmc-2011-1057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Mnk kinases in cytokine signaling and regulation of cytokine responses</span></div><div class="casAuthors">Joshi, Sonali; Platanias, Leonidas C.</div><div class="citationInfo"><span class="NLM_cas:title">Biomolecular Concepts</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">127-139</span>CODEN:
                <span class="NLM_cas:coden">BCIOB8</span>;
        ISSN:<span class="NLM_cas:issn">1868-5021</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH</span>)
        </div><div class="casAbstract">A review.  The kinases Mnk1 and Mnk2 are activated downstream of the p38 MAPK and MEK/ERK signaling pathways.  Extensive work over the years has shown that these kinases control phosphorylation of the eukaryotic initiation factor 4E (eIF4E) and regulate engagement of other effector elements, including hnRNPA1 and PSF.  Mnk kinases are ubiquitously expressed and play crit. roles in signaling for various cytokine receptors, while there is emerging evidence that they have important functions as mediators of pro-inflammatory cytokine prodn.  In this review the mechanisms of activation of MNK pathways by cytokine receptors are addressed and their roles in diverse cytokine-dependent biol. processes are reviewed.  The clin.-translational implications of such work and the relevance of future development of specific MNK inhibitors for the treatment of malignancies and auto-immune disorders are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxR8pAs-R4DrVg90H21EOLACvtfcHk0lgZrqHn0gypHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsFejsbY%253D&md5=dbc78d19a43b77cccb3499c7863ad3bc</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1515%2Fbmc-2011-1057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fbmc-2011-1057%26sid%3Dliteratum%253Aachs%26aulast%3DJoshi%26aufirst%3DS.%26aulast%3DPlatanias%26aufirst%3DL.%2BC.%26atitle%3DMNK%2520kinases%2520in%2520cytokine%2520signaling%2520and%2520regulation%2520of%2520cytokine%2520responses%26jtitle%3DBiomol.%2520Concepts%26date%3D2012%26volume%3D3%26spage%3D127%26epage%3D139%26doi%3D10.1515%2Fbmc-2011-1057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rowlett, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chrestensen, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyce, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harp, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelo, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cominelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizarro, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturgill, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Worthington, M. T.</span></span> <span> </span><span class="NLM_article-title">MNK kinases regulate multiple TLR pathways and innate proinflammatory cytokines in macrophages</span>. <i>Am. J. Physiol. Gastrointest. Liver Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>294</i></span>,  <span class="NLM_fpage">G452</span>– <span class="NLM_lpage">459</span>, <span class="refDoi"> DOI: 10.1152/ajpgi.00077.2007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1152%2Fajpgi.00077.2007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2008&pages=G452-459&author=R.+M.+Rowlettauthor=C.+A.+Chrestensenauthor=M.+Nyceauthor=M.+G.+Harpauthor=J.+W.+Peloauthor=F.+Cominelliauthor=P.+B.+Ernstauthor=T.+T.+Pizarroauthor=T.+W.+Sturgillauthor=M.+T.+Worthington&title=MNK+kinases+regulate+multiple+TLR+pathways+and+innate+proinflammatory+cytokines+in+macrophages&doi=10.1152%2Fajpgi.00077.2007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1152%2Fajpgi.00077.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpgi.00077.2007%26sid%3Dliteratum%253Aachs%26aulast%3DRowlett%26aufirst%3DR.%2BM.%26aulast%3DChrestensen%26aufirst%3DC.%2BA.%26aulast%3DNyce%26aufirst%3DM.%26aulast%3DHarp%26aufirst%3DM.%2BG.%26aulast%3DPelo%26aufirst%3DJ.%2BW.%26aulast%3DCominelli%26aufirst%3DF.%26aulast%3DErnst%26aufirst%3DP.%2BB.%26aulast%3DPizarro%26aufirst%3DT.%2BT.%26aulast%3DSturgill%26aufirst%3DT.%2BW.%26aulast%3DWorthington%26aufirst%3DM.%2BT.%26atitle%3DMNK%2520kinases%2520regulate%2520multiple%2520TLR%2520pathways%2520and%2520innate%2520proinflammatory%2520cytokines%2520in%2520macrophages%26jtitle%3DAm.%2520J.%2520Physiol.%2520Gastrointest.%2520Liver%2520Physiol.%26date%3D2008%26volume%3D294%26spage%3DG452%26epage%3D459%26doi%3D10.1152%2Fajpgi.00077.2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Landon, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muniandy, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shetty, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehrmann, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volpon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peroutka, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazan-Mamczarz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinhardt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahurkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borden, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gartenhaus, R. B.</span></span> <span> </span><span class="NLM_article-title">MNKs act as a regulatory switch for eIF4E1 and eIF4E3 driven mRNA translation in DLBCL</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">5413</span>, <span class="refDoi"> DOI: 10.1038/ncomms6413</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1038%2Fncomms6413" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=25403230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A280%3ADC%252BC2M3ptVOnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=5413&author=A.+L.+Landonauthor=P.+A.+Muniandyauthor=A.+C.+Shettyauthor=E.+Lehrmannauthor=L.+Volponauthor=S.+Houngauthor=Y.+Zhangauthor=B.+Daiauthor=R.+Peroutkaauthor=K.+Mazan-Mamczarzauthor=J.+Steinhardtauthor=A.+Mahurkarauthor=K.+G.+Beckerauthor=K.+L.+Bordenauthor=R.+B.+Gartenhaus&title=MNKs+act+as+a+regulatory+switch+for+eIF4E1+and+eIF4E3+driven+mRNA+translation+in+DLBCL&doi=10.1038%2Fncomms6413"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">MNKs act as a regulatory switch for eIF4E1 and eIF4E3 driven mRNA translation in DLBCL</span></div><div class="casAuthors">Landon Ari L; Peroutka Raymond; Mazan-Mamczarz Krystyna; Steinhardt James; Muniandy Parameswary A; Houng Simone; Dai Bojie; Gartenhaus Ronald B; Shetty Amol C; Mahurkar Anup; Lehrmann Elin; Zhang Yongqing; Becker Kevin G; Volpon Laurent; Borden Katherine L</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5413</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The phosphorylation of eIF4E1 at serine 209 by MNK1 or MNK2 has been shown to initiate oncogenic mRNA translation, a process that favours cancer development and maintenance.  Here, we interrogate the MNK-eIF4E axis in diffuse large B-cell lymphoma (DLBCL) and show a distinct distribution of MNK1 and MNK2 in germinal centre B-cell (GCB) and activated B-cell (ABC) DLBCL.  Despite displaying a differential distribution in GCB and ABC, both MNKs functionally complement each other to sustain cell survival.  MNK inhibition ablates eIF4E1 phosphorylation and concurrently enhances eIF4E3 expression.  Loss of MNK protein itself downregulates total eIF4E1 protein level by reducing eIF4E1 mRNA polysomal loading without affecting total mRNA level or stability.  Enhanced eIF4E3 expression marginally suppresses eIF4E1-driven translation but exhibits a unique translatome that unveils a novel role for eIF4E3 in translation initiation.  We propose that MNKs can modulate oncogenic translation by regulating eIF4E1-eIF4E3 levels and activity in DLBCL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRRAX0_1tXXk2gRQsDqrjW_fW6udTcc2ea0qK3D2pBXArntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M3ptVOnuw%253D%253D&md5=c74031f79715242324239fc9022c5cc6</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fncomms6413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms6413%26sid%3Dliteratum%253Aachs%26aulast%3DLandon%26aufirst%3DA.%2BL.%26aulast%3DMuniandy%26aufirst%3DP.%2BA.%26aulast%3DShetty%26aufirst%3DA.%2BC.%26aulast%3DLehrmann%26aufirst%3DE.%26aulast%3DVolpon%26aufirst%3DL.%26aulast%3DHoung%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DDai%26aufirst%3DB.%26aulast%3DPeroutka%26aufirst%3DR.%26aulast%3DMazan-Mamczarz%26aufirst%3DK.%26aulast%3DSteinhardt%26aufirst%3DJ.%26aulast%3DMahurkar%26aufirst%3DA.%26aulast%3DBecker%26aufirst%3DK.%2BG.%26aulast%3DBorden%26aufirst%3DK.%2BL.%26aulast%3DGartenhaus%26aufirst%3DR.%2BB.%26atitle%3DMNKs%2520act%2520as%2520a%2520regulatory%2520switch%2520for%2520eIF4E1%2520and%2520eIF4E3%2520driven%2520mRNA%2520translation%2520in%2520DLBCL%26jtitle%3DNat.%2520Commun.%26date%3D2014%26volume%3D5%26spage%3D5413%26doi%3D10.1038%2Fncomms6413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wheater, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaydes, J. P.</span></span> <span> </span><span class="NLM_article-title">The role of MNK proteins and eIF4E phosphorylation in breast cancer cell proliferation and survival</span>. <i>Cancer Biol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">728</span>– <span class="NLM_lpage">735</span>, <span class="refDoi"> DOI: 10.4161/cbt.10.7.12965</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.4161%2Fcbt.10.7.12965" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=20686366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVKrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=728-735&author=M.+J.+Wheaterauthor=P.+W.+Johnsonauthor=J.+P.+Blaydes&title=The+role+of+MNK+proteins+and+eIF4E+phosphorylation+in+breast+cancer+cell+proliferation+and+survival&doi=10.4161%2Fcbt.10.7.12965"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The role of MNK proteins and eIF4E phosphorylation in breast cancer cell proliferation and survival</span></div><div class="casAuthors">Wheater, Matthew J.; Johnson, Peter W. M.; Blaydes, Jeremy P.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">728-735</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">EIF4E is overexpressed in many tumors, including a high proportion of breast cancers.  EIF4E is an oncogene, and signaling pathways which promote eIF4E activity represent potential targets for therapeutic intervention in cancer.  MNKs phosphorylate eIF4E on serine 209, a modification that can be required for eIF4E-dependent cell transformation.  There is therefore a clear requirement to det. the role of MNKs in the proliferation and survival of cells from the major human tumors, such as breast cancer.  Phosphorylated eIF4E protein was readily detectable in some breast tumor samples, but was below the limits of detection in others.  Of six breast cancer cell lines representing the major subtypes of breast cancer, phosphorylated eIF4E was readily detectable in five of them, with MCF-7 cells displaying markedly lower levels.  Long term colony forming assays demonstrated that all the five lines with high levels of phosphorylated eIF4E were highly sensitive to a MNK inhibitor.  In short term assays, a range of responses was revealed.  MCF-7 cells were insensitive in both assays.  The anti-proliferative effects of the MNK inhibitor in breast cancer cells are primarily cytostatic, rather than cytotoxic, and are potentially due to the inhibition of cyclin D1 synthesis.  Our data provide evidence that the sensitivity of breast cancer cells to MNK inhibition may correlate with baseline levels of eIF4E phosphorylation, and suggest that a proportion of breast cancers could be sensitive to inhibiting MNK kinase activity, and that the presence of phosphorylated eIF4E could provide a biomarker for the identification of responsive tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV-LNAQtLdjbVg90H21EOLACvtfcHk0lgobbYu-kyFCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVKrtQ%253D%253D&md5=b2ad022bde5142aa92b6e46d32c36c01</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.4161%2Fcbt.10.7.12965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.10.7.12965%26sid%3Dliteratum%253Aachs%26aulast%3DWheater%26aufirst%3DM.%2BJ.%26aulast%3DJohnson%26aufirst%3DP.%2BW.%26aulast%3DBlaydes%26aufirst%3DJ.%2BP.%26atitle%3DThe%2520role%2520of%2520MNK%2520proteins%2520and%2520eIF4E%2520phosphorylation%2520in%2520breast%2520cancer%2520cell%2520proliferation%2520and%2520survival%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2010%26volume%3D10%26spage%3D728%26epage%3D735%26doi%3D10.4161%2Fcbt.10.7.12965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makarova-Rusher, O. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulahannan, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahma, O. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fioravanti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdullah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raffeld, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abi-Jaoudeh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trepel, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinberg, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Revenko, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacLeod, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peer, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figg, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greten, T. F.</span></span> <span> </span><span class="NLM_article-title">Modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750-an antisense oligonucleotide against eIF4E-in combination with irinotecan in solid tumors and irinotecan-refractory colorectal cancer</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">1648</span>– <span class="NLM_lpage">1657</span>, <span class="refDoi"> DOI: 10.1002/ijc.30199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1002%2Fijc.30199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=27194579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVCktrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2016&pages=1648-1657&author=A.+G.+Duffyauthor=O.+V.+Makarova-Rusherauthor=S.+V.+Ulahannanauthor=O.+E.+Rahmaauthor=S.+Fioravantiauthor=M.+Walkerauthor=S.+Abdullahauthor=M.+Raffeldauthor=V.+Andersonauthor=N.+Abi-Jaoudehauthor=E.+Levyauthor=B.+J.+Woodauthor=S.+Leeauthor=Y.+Tomitaauthor=J.+B.+Trepelauthor=S.+M.+Steinbergauthor=A.+S.+Revenkoauthor=A.+R.+MacLeodauthor=C.+J.+Peerauthor=W.+D.+Figgauthor=T.+F.+Greten&title=Modulation+of+tumor+eIF4E+by+antisense+inhibition%3A+A+phase+I%2FII+translational+clinical+trial+of+ISIS+183750-an+antisense+oligonucleotide+against+eIF4E-in+combination+with+irinotecan+in+solid+tumors+and+irinotecan-refractory+colorectal+cancer&doi=10.1002%2Fijc.30199"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750-an antisense oligonucleotide against eIF4E-in combination with irinotecan in solid tumors and irinotecan-refractory colorectal cancer</span></div><div class="casAuthors">Duffy, A. G.; Makarova-Rusher, O. V.; Ulahannan, S. V.; Rahma, O. E.; Fioravanti, S.; Walker, M.; Abdullah, S.; Raffeld, M.; Anderson, V.; Abi-Jaoudeh, N.; Levy, E.; Wood, B. J.; Lee, S.; Tomita, Y.; Trepel, J. B.; Steinberg, S. M.; Revenko, A. S.; MacLeod, A. R.; Peer, C. J.; Figg, W. D.; Greten, T. F.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1648-1657</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The eukaryotic translation initiation factor 4E (eIF4E) is a potent oncogene that is found to be dysregulated in 30% of human cancer, including colorectal carcinogenesis (CRC).  ISIS 183750 is a second-generation antisense oligonucleotide (ASO) designed to inhibit the prodn. of the eIF4E protein.  In preclin. studies we found that EIF4e ASOs reduced expression of EIF4e mRNA and inhibited proliferation of colorectal carcinoma cells.  An additive antiproliferative effect was obsd. in combination with irinotecan.  We then performed a clin. trial evaluating this combination in patients with refractory cancer.  No dose-limiting toxicities were seen but based on pharmacokinetic data and tolerability the dose of irinotecan was reduced to 160 mg/m2 biweekly.  Efficacy was evaluated in 15 patients with irinotecan-refractory colorectal cancer.  The median time of disease control was 22.1 wk.  After ISIS 183750 treatment, peripheral blood levels of eIF4E mRNA were decreased in 13 of 19 patients.  Matched pre- and posttreatment tumor biopsies showed decreased eIF4E mRNA levels in five of nine patients.  In tumor tissue, the intracellular and stromal presence of ISIS 183750 was detected by IHC in all biopsied patients.  Although there were no objective responses stable disease was seen in seven of 15 (47%) patients who were progressing before study entry, six of whom were stable at the time of the week 16 CT scan.  We were also able to confirm through mandatory pre- and posttherapy tumor biopsies penetration of the ASO into the site of metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJBZIx5IBc87Vg90H21EOLACvtfcHk0ljfmIkLheHj0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVCktrjM&md5=3e81c31e018e29f8a4233b9edfcd0372</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2Fijc.30199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.30199%26sid%3Dliteratum%253Aachs%26aulast%3DDuffy%26aufirst%3DA.%2BG.%26aulast%3DMakarova-Rusher%26aufirst%3DO.%2BV.%26aulast%3DUlahannan%26aufirst%3DS.%2BV.%26aulast%3DRahma%26aufirst%3DO.%2BE.%26aulast%3DFioravanti%26aufirst%3DS.%26aulast%3DWalker%26aufirst%3DM.%26aulast%3DAbdullah%26aufirst%3DS.%26aulast%3DRaffeld%26aufirst%3DM.%26aulast%3DAnderson%26aufirst%3DV.%26aulast%3DAbi-Jaoudeh%26aufirst%3DN.%26aulast%3DLevy%26aufirst%3DE.%26aulast%3DWood%26aufirst%3DB.%2BJ.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DTomita%26aufirst%3DY.%26aulast%3DTrepel%26aufirst%3DJ.%2BB.%26aulast%3DSteinberg%26aufirst%3DS.%2BM.%26aulast%3DRevenko%26aufirst%3DA.%2BS.%26aulast%3DMacLeod%26aufirst%3DA.%2BR.%26aulast%3DPeer%26aufirst%3DC.%2BJ.%26aulast%3DFigg%26aufirst%3DW.%2BD.%26aulast%3DGreten%26aufirst%3DT.%2BF.%26atitle%3DModulation%2520of%2520tumor%2520eIF4E%2520by%2520antisense%2520inhibition%253A%2520A%2520phase%2520I%252FII%2520translational%2520clinical%2520trial%2520of%2520ISIS%2520183750-an%2520antisense%2520oligonucleotide%2520against%2520eIF4E-in%2520combination%2520with%2520irinotecan%2520in%2520solid%2520tumors%2520and%2520irinotecan-refractory%2520colorectal%2520cancer%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2016%26volume%3D139%26spage%3D1648%26epage%3D1657%26doi%3D10.1002%2Fijc.30199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aktas, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahoo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denoyelle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kabha, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freedman, R. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supko, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chorev, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halperin, J. A.</span></span> <span> </span><span class="NLM_article-title">Tumor suppression by small molecule inhibitors of translation initiation</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">869</span>– <span class="NLM_lpage">881</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.598</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.18632%2Foncotarget.598" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=869-881&author=L.+Chenauthor=B.+H.+Aktasauthor=Y.+Wangauthor=X.+Heauthor=R.+Sahooauthor=N.+Zhangauthor=S.+Denoyelleauthor=E.+Kabhaauthor=H.+Yangauthor=R.+Y.+Freedmanauthor=J.+G.+Supkoauthor=M.+Chorevauthor=G.+Wagnerauthor=J.+A.+Halperin&title=Tumor+suppression+by+small+molecule+inhibitors+of+translation+initiation&doi=10.18632%2Foncotarget.598"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.598%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DAktas%26aufirst%3DB.%2BH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DSahoo%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DDenoyelle%26aufirst%3DS.%26aulast%3DKabha%26aufirst%3DE.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DFreedman%26aufirst%3DR.%2BY.%26aulast%3DSupko%26aufirst%3DJ.%2BG.%26aulast%3DChorev%26aufirst%3DM.%26aulast%3DWagner%26aufirst%3DG.%26aulast%3DHalperin%26aufirst%3DJ.%2BA.%26atitle%3DTumor%2520suppression%2520by%2520small%2520molecule%2520inhibitors%2520of%2520translation%2520initiation%26jtitle%3DOncotarget%26date%3D2012%26volume%3D3%26spage%3D869%26epage%3D881%26doi%3D10.18632%2Foncotarget.598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cencic, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robert, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurtkaya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dingledine, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozakov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vajda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, J.</span></span> <span> </span><span class="NLM_article-title">Reversing chemoresistance by small molecule inhibition of the translation initiation complex eIF4F</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">1046</span>– <span class="NLM_lpage">1051</span>, <span class="refDoi"> DOI: 10.1073/pnas.1011477108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1073%2Fpnas.1011477108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=21191102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlWrsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=1046-1051&author=R.+Cencicauthor=D.+R.+Hallauthor=F.+Robertauthor=Y.+Duauthor=J.+Minauthor=L.+Liauthor=M.+Quiauthor=I.+Lewisauthor=S.+Kurtkayaauthor=R.+Dingledineauthor=H.+Fuauthor=D.+Kozakovauthor=S.+Vajdaauthor=J.+Pelletier&title=Reversing+chemoresistance+by+small+molecule+inhibition+of+the+translation+initiation+complex+eIF4F&doi=10.1073%2Fpnas.1011477108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Reversing chemoresistance by small molecule inhibition of the translation initiation complex eIF4F</span></div><div class="casAuthors">Cencic, Regina; Hall, David R.; Robert, Francis; Du, Yuhong; Min, Jaeki; Li, Lian; Qui, Min; Lewis, Iestyn; Kurtkaya, Serdar; Dingledine, Ray; Fu, Haian; Kozakov, Dima; Vajda, Sandor; Pelletier, Jerry</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1046-1051, S1046/1-S1046/7</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Deregulation of cap-dependent translation is assocd. with cancer initiation and progression.  The rate-limiting step of protein synthesis is the loading of ribosomes onto mRNA templates stimulated by the heterotrimeric complex, eukaryotic initiation factor (elF)4F.  This step represents an attractive target for anticancer drug discovery because it resides at the nexus of the TOR signaling pathway.  We have undertaken an ultra-high-throughput screen to identify inhibitors that prevent assembly of the eIF4F complex.  One of the identified compds. blocks interaction between two subunits of elF4F.  As a consequence, cap-dependent translation is inhibited.  This compd. can reverse tumor chemoresistance in a genetically engineered lymphoma mouse model by sensitizing cells to the proapoptotic action of DNA damage.  Mol. modeling expts. provide insight into the mechanism of action of this small mol. inhibitor.  Our expts. validate targeting the eIF4F complex as a strategy for cancer therapy to modulate chemo-sensitivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp523wPn1DaGbVg90H21EOLACvtfcHk0ljfmIkLheHj0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlWrsrs%253D&md5=8b9fa0bf7dc5638b9a85e1a8e1556088</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1011477108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1011477108%26sid%3Dliteratum%253Aachs%26aulast%3DCencic%26aufirst%3DR.%26aulast%3DHall%26aufirst%3DD.%2BR.%26aulast%3DRobert%26aufirst%3DF.%26aulast%3DDu%26aufirst%3DY.%26aulast%3DMin%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DQui%26aufirst%3DM.%26aulast%3DLewis%26aufirst%3DI.%26aulast%3DKurtkaya%26aufirst%3DS.%26aulast%3DDingledine%26aufirst%3DR.%26aulast%3DFu%26aufirst%3DH.%26aulast%3DKozakov%26aufirst%3DD.%26aulast%3DVajda%26aufirst%3DS.%26aulast%3DPelletier%26aufirst%3DJ.%26atitle%3DReversing%2520chemoresistance%2520by%2520small%2520molecule%2520inhibition%2520of%2520the%2520translation%2520initiation%2520complex%2520eIF4F%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D1046%26epage%3D1051%26doi%3D10.1073%2Fpnas.1011477108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallireddigari, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosenza, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallela, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robell, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, E. P.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of (E)-styrylbenzylsulfones as novel anticancer agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">86</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1021/jm701077b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701077b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=86-100&author=M.+V.+Reddyauthor=M.+R.+Mallireddigariauthor=S.+C.+Cosenzaauthor=V.+R.+Pallelaauthor=N.+M.+Iqbalauthor=K.+A.+Robellauthor=A.+D.+Kangauthor=E.+P.+Reddy&title=Design%2C+synthesis%2C+and+biological+evaluation+of+%28E%29-styrylbenzylsulfones+as+novel+anticancer+agents&doi=10.1021%2Fjm701077b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm701077b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701077b%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DM.%2BV.%26aulast%3DMallireddigari%26aufirst%3DM.%2BR.%26aulast%3DCosenza%26aufirst%3DS.%2BC.%26aulast%3DPallela%26aufirst%3DV.%2BR.%26aulast%3DIqbal%26aufirst%3DN.%2BM.%26aulast%3DRobell%26aufirst%3DK.%2BA.%26aulast%3DKang%26aufirst%3DA.%2BD.%26aulast%3DReddy%26aufirst%3DE.%2BP.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520%2528E%2529-styrylbenzylsulfones%2520as%2520novel%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D86%26epage%3D100%26doi%3D10.1021%2Fjm701077b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sekiyama, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arthanari, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Mias, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leger-Abraham, M.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanism of the dual activity of 4EGI-1: Dissociating eIF4G from eIF4E but stabilizing the binding of unphosphorylated 4E-BP1</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">E4036</span>– <span class="NLM_lpage">4045</span>, <span class="refDoi"> DOI: 10.1073/pnas.1512118112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1073%2Fpnas.1512118112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=26170285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFGktr3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=E4036-4045&author=N.+Sekiyamaauthor=H.+Arthanariauthor=E.+Papadopoulosauthor=R.+A.+Rodriguez-Miasauthor=G.+Wagnerauthor=M.+Leger-Abraham&title=Molecular+mechanism+of+the+dual+activity+of+4EGI-1%3A+Dissociating+eIF4G+from+eIF4E+but+stabilizing+the+binding+of+unphosphorylated+4E-BP1&doi=10.1073%2Fpnas.1512118112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanism of the dual activity of 4EGI-1: Dissociating eIF4G from eIF4E but stabilizing the binding of unphosphorylated 4E-BP1</span></div><div class="casAuthors">Sekiyama, Naotaka; Arthanari, Haribabu; Papadopoulos, Evangelos; Rodriguez-Mias, Ricard A.; Wagner, Gerhard; Leger-Abraham, Melissa</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">E4036-E4045</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The eIF4E-binding protein (4E-BP) is a phosphorylation-dependent regulator of protein synthesis.  The nonphosphorylated or minimally phosphorylated form binds translation initiation factor 4E (eIF4E), preventing binding of eIF4G and the recruitment of the small ribosomal subunit.  Signaling events stimulate serial phosphorylation of 4E-BP, primarily by mammalian target of rapamycin complex 1 (mTORC1) at residues T37/T46, followed by T70 and S65.  Hyperphosphorylated 4E-BP dissocs. from eIF4E, allowing eIF4E to interact with eIF4G and translation initiation to resume.  Because overexpression of eIF4E is linked to cellular transformation, 4E-BP is a tumor suppressor, and up-regulation of its activity is a goal of interest for cancer therapy.  A recently discovered small mol., eIF4E/eIF4G interaction inhibitor 1 (4EGI-1), disrupts the eIF4E/eIF4G interaction and promotes binding of 4E-BP1 to eIF4E.  Structures of 14- to 16-residue 4E-BP fragments bound to eIF4E contain the eIF4E consensus binding motif, 54YXXXXLΦ60 (motif 1) but lack known phosphorylation sites.  We report here a 2.1-Å crystal structure of mouse eIF4E in complex with m7GTP and with a fragment of human 4E-BP1, extended C-terminally from the consensus-binding motif (4E-BP150-84).  The extension, which includes a proline-turn-helix segment (motif 2) followed by a loop of irregular structure, reveals the location of two phosphorylation sites (S65 and T70).  Our major finding is that the C-terminal extension (motif 3) is crit. to 4E-BP1-mediated cell cycle arrest and that it partially overlaps with the binding site of 4EGI-1.  The binding of 4E-BP1 and 4EGI-1 to eIF4E is therefore not mutually exclusive, and both ligands contribute to shift the equil. toward the inhibition of translation initiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5UX9gpOLePrVg90H21EOLACvtfcHk0ljOHN9_U4BSOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFGktr3K&md5=4b08a4764b5c8b6557f9266402c00dd2</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1512118112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1512118112%26sid%3Dliteratum%253Aachs%26aulast%3DSekiyama%26aufirst%3DN.%26aulast%3DArthanari%26aufirst%3DH.%26aulast%3DPapadopoulos%26aufirst%3DE.%26aulast%3DRodriguez-Mias%26aufirst%3DR.%2BA.%26aulast%3DWagner%26aufirst%3DG.%26aulast%3DLeger-Abraham%26aufirst%3DM.%26atitle%3DMolecular%2520mechanism%2520of%2520the%2520dual%2520activity%2520of%25204EGI-1%253A%2520Dissociating%2520eIF4G%2520from%2520eIF4E%2520but%2520stabilizing%2520the%2520binding%2520of%2520unphosphorylated%25204E-BP1%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3DE4036%26epage%3D4045%26doi%3D10.1073%2Fpnas.1512118112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lock, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingraham, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maertens, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weledji, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Legius, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konicek, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graff, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cichowski, K.</span></span> <span> </span><span class="NLM_article-title">Cotargeting MNK and MEK kinases induces the regression of NF1-mutant cancers</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">2181</span>– <span class="NLM_lpage">2190</span>, <span class="refDoi"> DOI: 10.1172/JCI85183</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1172%2FJCI85183" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2016&pages=2181-2190&author=R.+Lockauthor=R.+Ingrahamauthor=O.+Maertensauthor=A.+L.+Millerauthor=N.+Weledjiauthor=E.+Legiusauthor=B.+M.+Konicekauthor=S.+C.+Yanauthor=J.+R.+Graffauthor=K.+Cichowski&title=Cotargeting+MNK+and+MEK+kinases+induces+the+regression+of+NF1-mutant+cancers&doi=10.1172%2FJCI85183"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1172%2FJCI85183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI85183%26sid%3Dliteratum%253Aachs%26aulast%3DLock%26aufirst%3DR.%26aulast%3DIngraham%26aufirst%3DR.%26aulast%3DMaertens%26aufirst%3DO.%26aulast%3DMiller%26aufirst%3DA.%2BL.%26aulast%3DWeledji%26aufirst%3DN.%26aulast%3DLegius%26aufirst%3DE.%26aulast%3DKonicek%26aufirst%3DB.%2BM.%26aulast%3DYan%26aufirst%3DS.%2BC.%26aulast%3DGraff%26aufirst%3DJ.%2BR.%26aulast%3DCichowski%26aufirst%3DK.%26atitle%3DCotargeting%2520MNK%2520and%2520MEK%2520kinases%2520induces%2520the%2520regression%2520of%2520NF1-mutant%2520cancers%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2016%26volume%3D126%26spage%3D2181%26epage%3D2190%26doi%3D10.1172%2FJCI85183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cherian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nacro, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poh, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeyaraj, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joy, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwek, Z. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wee, J. L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ong, E. H. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choong, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pendharkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manoharan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chew, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangthongpitag, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ong, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, T. H.</span></span> <span> </span><span class="NLM_article-title">Structure–activity relationship studies of mitogen activated protein kinase interacting kinase (MNK) 1 and 2 and BCR-ABL1 inhibitors targeting chronic myeloid leukemic cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">3063</span>– <span class="NLM_lpage">3078</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01712</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01712" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3063-3078&author=J.+Cherianauthor=K.+Nacroauthor=Z.+Y.+Pohauthor=S.+Guoauthor=D.+A.+Jeyarajauthor=Y.+X.+Wongauthor=M.+Hoauthor=H.+Y.+Yangauthor=J.+K.+Joyauthor=Z.+P.+Kwekauthor=B.+Liuauthor=J.+L.+K.+Weeauthor=E.+H.+Q.+Ongauthor=M.+L.+Choongauthor=A.+Poulsenauthor=M.+A.+Leeauthor=V.+Pendharkarauthor=L.+J.+Dingauthor=V.+Manoharanauthor=Y.+S.+Chewauthor=K.+Sangthongpitagauthor=S.+Limauthor=S.+T.+Ongauthor=J.+Hillauthor=T.+H.+Keller&title=Structure%E2%80%93activity+relationship+studies+of+mitogen+activated+protein+kinase+interacting+kinase+%28MNK%29+1+and+2+and+BCR-ABL1+inhibitors+targeting+chronic+myeloid+leukemic+cells&doi=10.1021%2Facs.jmedchem.5b01712"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01712%26sid%3Dliteratum%253Aachs%26aulast%3DCherian%26aufirst%3DJ.%26aulast%3DNacro%26aufirst%3DK.%26aulast%3DPoh%26aufirst%3DZ.%2BY.%26aulast%3DGuo%26aufirst%3DS.%26aulast%3DJeyaraj%26aufirst%3DD.%2BA.%26aulast%3DWong%26aufirst%3DY.%2BX.%26aulast%3DHo%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DH.%2BY.%26aulast%3DJoy%26aufirst%3DJ.%2BK.%26aulast%3DKwek%26aufirst%3DZ.%2BP.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DWee%26aufirst%3DJ.%2BL.%2BK.%26aulast%3DOng%26aufirst%3DE.%2BH.%2BQ.%26aulast%3DChoong%26aufirst%3DM.%2BL.%26aulast%3DPoulsen%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DM.%2BA.%26aulast%3DPendharkar%26aufirst%3DV.%26aulast%3DDing%26aufirst%3DL.%2BJ.%26aulast%3DManoharan%26aufirst%3DV.%26aulast%3DChew%26aufirst%3DY.%2BS.%26aulast%3DSangthongpitag%26aufirst%3DK.%26aulast%3DLim%26aufirst%3DS.%26aulast%3DOng%26aufirst%3DS.%2BT.%26aulast%3DHill%26aufirst%3DJ.%26aulast%3DKeller%26aufirst%3DT.%2BH.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520studies%2520of%2520mitogen%2520activated%2520protein%2520kinase%2520interacting%2520kinase%2520%2528MNK%2529%25201%2520and%25202%2520and%2520BCR-ABL1%2520inhibitors%2520targeting%2520chronic%2520myeloid%2520leukemic%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3063%26epage%3D3078%26doi%3D10.1021%2Facs.jmedchem.5b01712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanjo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akira, S.</span></span> <span> </span><span class="NLM_article-title">DRAKs, novel serine/threonine kinases related to death-associated protein kinase that trigger apoptosis</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>273</i></span>,  <span class="NLM_fpage">29066</span>– <span class="NLM_lpage">29071</span>, <span class="refDoi"> DOI: 10.1074/jbc.273.44.29066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1074%2Fjbc.273.44.29066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=9786912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADyaK1cXntlaht7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=29066-29071&author=H.+Sanjoauthor=T.+Kawaiauthor=S.+Akira&title=DRAKs%2C+novel+serine%2Fthreonine+kinases+related+to+death-associated+protein+kinase+that+trigger+apoptosis&doi=10.1074%2Fjbc.273.44.29066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">DRAKs, novel serine/threonine kinases related to death-associated protein kinase that trigger apoptosis</span></div><div class="casAuthors">Sanjo, Hideki; Kawai, Taro; Akira, Shizuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">29066-29071</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The present study describes the cloning of two novel serine/threonine kinases termed DRAK1 and DRAK2, whose catalytic domains are related to that of death-assocd. protein kinase, a serine/threonine kinase involved in apoptosis.  Both DRAKs are composed of the N-terminal catalytic domain and the C-terminal domain that is responsible for regulation of kinase activity.  DRAK1 and DRAK2 show 59.7% identity and display ubiquitous expression.  An in vitro kinase assay revealed that both DRAKs are autophosphorylated and phosphorylate myosin light chain as an exogenous substrate, although the kinase activity of DRAK2 is significantly lower than that of DRAK1.  Both DRAKs are exclusively localized to the nucleus.  Furthermore, overexpression of both DRAKs induces the morphol. changes of apoptosis in NIH 3T3 cells, suggesting the role of DRAKs in apoptotic signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmFXOHrs4s2bVg90H21EOLACvtfcHk0ljSd-XXUp5MDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXntlaht7s%253D&md5=6b17b0e7dd8e61ec3b435b245cbcb627</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1074%2Fjbc.273.44.29066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.273.44.29066%26sid%3Dliteratum%253Aachs%26aulast%3DSanjo%26aufirst%3DH.%26aulast%3DKawai%26aufirst%3DT.%26aulast%3DAkira%26aufirst%3DS.%26atitle%3DDRAKs%252C%2520novel%2520serine%252Fthreonine%2520kinases%2520related%2520to%2520death-associated%2520protein%2520kinase%2520that%2520trigger%2520apoptosis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D29066%26epage%3D29071%26doi%3D10.1074%2Fjbc.273.44.29066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hever, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niemaszyk, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haghkerdar, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yanco, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyrouthy, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerley-Hamilton, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freemantle, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spinella, M. J.</span></span> <span> </span><span class="NLM_article-title">Serine/threonine kinase 17A is a novel p53 target gene and modulator of cisplatin toxicity and reactive oxygen species in testicular cancer cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">19381</span>– <span class="NLM_lpage">19391</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.218040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1074%2Fjbc.M111.218040" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=19381-19391&author=P.+Maoauthor=M.+P.+Heverauthor=L.+M.+Niemaszykauthor=J.+M.+Haghkerdarauthor=E.+G.+Yancoauthor=D.+Desaiauthor=M.+J.+Beyrouthyauthor=J.+S.+Kerley-Hamiltonauthor=S.+J.+Freemantleauthor=M.+J.+Spinella&title=Serine%2Fthreonine+kinase+17A+is+a+novel+p53+target+gene+and+modulator+of+cisplatin+toxicity+and+reactive+oxygen+species+in+testicular+cancer+cells&doi=10.1074%2Fjbc.M111.218040"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.218040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.218040%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DP.%26aulast%3DHever%26aufirst%3DM.%2BP.%26aulast%3DNiemaszyk%26aufirst%3DL.%2BM.%26aulast%3DHaghkerdar%26aufirst%3DJ.%2BM.%26aulast%3DYanco%26aufirst%3DE.%2BG.%26aulast%3DDesai%26aufirst%3DD.%26aulast%3DBeyrouthy%26aufirst%3DM.%2BJ.%26aulast%3DKerley-Hamilton%26aufirst%3DJ.%2BS.%26aulast%3DFreemantle%26aufirst%3DS.%2BJ.%26aulast%3DSpinella%26aufirst%3DM.%2BJ.%26atitle%3DSerine%252Fthreonine%2520kinase%252017A%2520is%2520a%2520novel%2520p53%2520target%2520gene%2520and%2520modulator%2520of%2520cisplatin%2520toxicity%2520and%2520reactive%2520oxygen%2520species%2520in%2520testicular%2520cancer%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D19381%26epage%3D19391%26doi%3D10.1074%2Fjbc.M111.218040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hever-Jardine, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahme, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biswal, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fadul, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaur, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Israel, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spinella, M. J.</span></span> <span> </span><span class="NLM_article-title">Serine/threonine kinase 17A is a novel candidate for therapeutic targeting in glioblastoma</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e81803</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0081803</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1371%2Fjournal.pone.0081803" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e81803&author=P.+Maoauthor=M.+P.+Hever-Jardineauthor=G.+J.+Rahmeauthor=E.+Yangauthor=J.+Tamauthor=A.+Kodaliauthor=B.+Biswalauthor=C.+E.+Fadulauthor=A.+Gaurauthor=M.+A.+Israelauthor=M.+J.+Spinella&title=Serine%2Fthreonine+kinase+17A+is+a+novel+candidate+for+therapeutic+targeting+in+glioblastoma&doi=10.1371%2Fjournal.pone.0081803"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0081803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0081803%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DP.%26aulast%3DHever-Jardine%26aufirst%3DM.%2BP.%26aulast%3DRahme%26aufirst%3DG.%2BJ.%26aulast%3DYang%26aufirst%3DE.%26aulast%3DTam%26aufirst%3DJ.%26aulast%3DKodali%26aufirst%3DA.%26aulast%3DBiswal%26aufirst%3DB.%26aulast%3DFadul%26aufirst%3DC.%2BE.%26aulast%3DGaur%26aufirst%3DA.%26aulast%3DIsrael%26aufirst%3DM.%2BA.%26aulast%3DSpinella%26aufirst%3DM.%2BJ.%26atitle%3DSerine%252Fthreonine%2520kinase%252017A%2520is%2520a%2520novel%2520candidate%2520for%2520therapeutic%2520targeting%2520in%2520glioblastoma%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De81803%26doi%3D10.1371%2Fjournal.pone.0081803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. J.</span></span> <span> </span><span class="NLM_article-title">Cytoplasmic DRAK1 overexpressed in head and neck cancers inhibits TGF-beta1 tumor suppressor activity by binding to SMAD3 to interrupt its complex formation with SMAD4</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">5037</span>– <span class="NLM_lpage">5045</span>, <span class="refDoi"> DOI: 10.1038/onc.2014.423</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1038%2Fonc.2014.423" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=5037-5045&author=Y.+Parkauthor=W.+Kimauthor=J.+M.+Leeauthor=J.+Parkauthor=J.+K.+Choauthor=K.+Pangauthor=J.+Leeauthor=D.+Kimauthor=S.+W.+Parkauthor=K.+M.+Yangauthor=S.+J.+Kim&title=Cytoplasmic+DRAK1+overexpressed+in+head+and+neck+cancers+inhibits+TGF-beta1+tumor+suppressor+activity+by+binding+to+SMAD3+to+interrupt+its+complex+formation+with+SMAD4&doi=10.1038%2Fonc.2014.423"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1038%2Fonc.2014.423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2014.423%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DW.%26aulast%3DLee%26aufirst%3DJ.%2BM.%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DCho%26aufirst%3DJ.%2BK.%26aulast%3DPang%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DPark%26aufirst%3DS.%2BW.%26aulast%3DYang%26aufirst%3DK.%2BM.%26aulast%3DKim%26aufirst%3DS.%2BJ.%26atitle%3DCytoplasmic%2520DRAK1%2520overexpressed%2520in%2520head%2520and%2520neck%2520cancers%2520inhibits%2520TGF-beta1%2520tumor%2520suppressor%2520activity%2520by%2520binding%2520to%2520SMAD3%2520to%2520interrupt%2520its%2520complex%2520formation%2520with%2520SMAD4%26jtitle%3DOncogene%26date%3D2015%26volume%3D34%26spage%3D5037%26epage%3D5045%26doi%3D10.1038%2Fonc.2014.423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hagiwara, M.</span></span> <span> </span><span class="NLM_article-title">Alternative splicing: a new drug target of the post-genome era</span>. <i>Biochim. Biophys. Acta, Proteins Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>1754</i></span>,  <span class="NLM_fpage">324</span>– <span class="NLM_lpage">331</span>, <span class="refDoi"> DOI: 10.1016/j.bbapap.2005.09.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1016%2Fj.bbapap.2005.09.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=16260193" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlags7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1754&publication_year=2005&pages=324-331&author=M.+Hagiwara&title=Alternative+splicing%3A+a+new+drug+target+of+the+post-genome+era&doi=10.1016%2Fj.bbapap.2005.09.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Alternative splicing: A new drug target of the post-genome era</span></div><div class="casAuthors">Hagiwara, Masatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1754</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">324-331</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Alternative splicing allows for the creation of multiple distinct mRNA transcripts from a given gene in a multicellular organism.  Pre-mRNA splicing is catalyzed by a multi-mol. complex, including serine/arginine-rich (SR) proteins, which are highly phosphorylated in living cells, and thought to play crucial roles in spliceosomal formation and in the regulation of alternative splicing.  Recently, reports of low mol. compds., which alter splicing pattern of genes, have been accumulated.  A benzothiazole compd. TG003, a kinase inhibitor that targets Clk1 and Clk4, suppressed dissocn. of nuclear speckles, altered the splicing patterns, and rescued the embryonic defects induced by excessive Clk activity.  The emerging inhibitors of the signal transduction pathways regulating pre-mRNA alternative splicing may open the way to therapies against diseases caused by missplicing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqz8eRhyUntS7Vg90H21EOLACvtfcHk0ljSd-XXUp5MDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlags7fL&md5=d2f7ac7d230d7145395f7a76907e1593</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2005.09.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2005.09.010%26sid%3Dliteratum%253Aachs%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DAlternative%2520splicing%253A%2520a%2520new%2520drug%2520target%2520of%2520the%2520post-genome%2520era%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2005%26volume%3D1754%26spage%3D324%26epage%3D331%26doi%3D10.1016%2Fj.bbapap.2005.09.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petsalaki, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zachos, G.</span></span> <span> </span><span class="NLM_article-title">Clks 1, 2 and 4 prevent chromatin breakage by regulating the aurora b-dependent abscission checkpoint</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">11451</span>, <span class="refDoi"> DOI: 10.1038/ncomms11451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1038%2Fncomms11451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=27126587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC28XntVChs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=11451&author=E.+Petsalakiauthor=G.+Zachos&title=Clks+1%2C+2+and+4+prevent+chromatin+breakage+by+regulating+the+aurora+b-dependent+abscission+checkpoint&doi=10.1038%2Fncomms11451"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Clks 1, 2 and 4 prevent chromatin breakage by regulating the Aurora B-dependent abscission checkpoint</span></div><div class="casAuthors">Petsalaki, Eleni; Zachos, George</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11451</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">When chromatin is trapped at the intercellular bridge, cells delay completion of cytokinesis (abscission) to prevent chromosome breakage.  Here we show that inhibition of Cdc-like kinases (Clks) 1, 2 or 4 accelerates midbody resoln. in normally segregating cells and correlates with premature abscission, chromatin breakage and generation of DNA damage in cytokinesis with trapped chromatin.  Clk1, Clk2 and Clk4 localize to the midbody in an interdependent manner, assoc. with Aurora B kinase and are required for Aurora B-serine 331 (S331) phosphorylation and complete Aurora B activation in late cytokinesis.  Phosphorylated Aurora B-S331 localizes to the midbody center and is required for phosphorylation and optimal localization of the abscission protein Chmp4c.  In addn., expression of phosphomimetic mutants Aurora B-S331E or Chmp4c-S210D delays midbody disassembly and prevents chromatin breakage in Clk-deficient cells.  We propose that Clks 1, 2 and 4 impose the abscission checkpoint by phosphorylating Aurora B-S331 at the midbody.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFOFFAoNsM2rVg90H21EOLACvtfcHk0lhwbGfeGxruvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntVChs7c%253D&md5=5894acf24c2720cf4c020fceaf1e34e3</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1038%2Fncomms11451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms11451%26sid%3Dliteratum%253Aachs%26aulast%3DPetsalaki%26aufirst%3DE.%26aulast%3DZachos%26aufirst%3DG.%26atitle%3DClks%25201%252C%25202%2520and%25204%2520prevent%2520chromatin%2520breakage%2520by%2520regulating%2520the%2520aurora%2520b-dependent%2520abscission%2520checkpoint%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D11451%26doi%3D10.1038%2Fncomms11451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lenz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emre, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohlhammer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dave, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carty, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaffer, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenwald, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ott, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller-Hermelink, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gascoyne, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connors, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaffe, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delabie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smeland, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rimsza, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weisenburger, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staudt, L. M.</span></span> <span> </span><span class="NLM_article-title">Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">13520</span>– <span class="NLM_lpage">13525</span>, <span class="refDoi"> DOI: 10.1073/pnas.0804295105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1073%2Fpnas.0804295105" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=13520-13525&author=G.+Lenzauthor=G.+W.+Wrightauthor=N.+C.+Emreauthor=H.+Kohlhammerauthor=S.+S.+Daveauthor=R.+E.+Davisauthor=S.+Cartyauthor=L.+T.+Lamauthor=A.+L.+Shafferauthor=W.+Xiaoauthor=J.+Powellauthor=A.+Rosenwaldauthor=G.+Ottauthor=H.+K.+Muller-Hermelinkauthor=R.+D.+Gascoyneauthor=J.+M.+Connorsauthor=E.+Campoauthor=E.+S.+Jaffeauthor=J.+Delabieauthor=E.+B.+Smelandauthor=L.+M.+Rimszaauthor=R.+I.+Fisherauthor=D.+D.+Weisenburgerauthor=W.+C.+Chanauthor=L.+M.+Staudt&title=Molecular+subtypes+of+diffuse+large+B-cell+lymphoma+arise+by+distinct+genetic+pathways&doi=10.1073%2Fpnas.0804295105"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0804295105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0804295105%26sid%3Dliteratum%253Aachs%26aulast%3DLenz%26aufirst%3DG.%26aulast%3DWright%26aufirst%3DG.%2BW.%26aulast%3DEmre%26aufirst%3DN.%2BC.%26aulast%3DKohlhammer%26aufirst%3DH.%26aulast%3DDave%26aufirst%3DS.%2BS.%26aulast%3DDavis%26aufirst%3DR.%2BE.%26aulast%3DCarty%26aufirst%3DS.%26aulast%3DLam%26aufirst%3DL.%2BT.%26aulast%3DShaffer%26aufirst%3DA.%2BL.%26aulast%3DXiao%26aufirst%3DW.%26aulast%3DPowell%26aufirst%3DJ.%26aulast%3DRosenwald%26aufirst%3DA.%26aulast%3DOtt%26aufirst%3DG.%26aulast%3DMuller-Hermelink%26aufirst%3DH.%2BK.%26aulast%3DGascoyne%26aufirst%3DR.%2BD.%26aulast%3DConnors%26aufirst%3DJ.%2BM.%26aulast%3DCampo%26aufirst%3DE.%26aulast%3DJaffe%26aufirst%3DE.%2BS.%26aulast%3DDelabie%26aufirst%3DJ.%26aulast%3DSmeland%26aufirst%3DE.%2BB.%26aulast%3DRimsza%26aufirst%3DL.%2BM.%26aulast%3DFisher%26aufirst%3DR.%2BI.%26aulast%3DWeisenburger%26aufirst%3DD.%2BD.%26aulast%3DChan%26aufirst%3DW.%2BC.%26aulast%3DStaudt%26aufirst%3DL.%2BM.%26atitle%3DMolecular%2520subtypes%2520of%2520diffuse%2520large%2520B-cell%2520lymphoma%2520arise%2520by%2520distinct%2520genetic%2520pathways%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D13520%26epage%3D13525%26doi%3D10.1073%2Fpnas.0804295105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staudt, L. M.</span></span> <span> </span><span class="NLM_article-title">Targeting pathological B cell receptor signalling in lymphoid malignancies</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">229</span>– <span class="NLM_lpage">243</span>, <span class="refDoi"> DOI: 10.1038/nrd3937</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1038%2Fnrd3937" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=229-243&author=R.+M.+Youngauthor=L.+M.+Staudt&title=Targeting+pathological+B+cell+receptor+signalling+in+lymphoid+malignancies&doi=10.1038%2Fnrd3937"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1038%2Fnrd3937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3937%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%2BM.%26aulast%3DStaudt%26aufirst%3DL.%2BM.%26atitle%3DTargeting%2520pathological%2520B%2520cell%2520receptor%2520signalling%2520in%2520lymphoid%2520malignancies%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26spage%3D229%26epage%3D243%26doi%3D10.1038%2Fnrd3937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, P.</span></span> <span> </span><span class="NLM_article-title">Post-transcriptional regulons coordinate the initiation and resolution of inflammation</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">24</span>– <span class="NLM_lpage">35</span>, <span class="refDoi"> DOI: 10.1038/nri2685</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1038%2Fnri2685" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=20029446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsF2hsL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=24-35&author=P.+Anderson&title=Post-transcriptional+regulons+coordinate+the+initiation+and+resolution+of+inflammation&doi=10.1038%2Fnri2685"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Post-transcriptional regulons coordinate the initiation and resolution of inflammation</span></div><div class="casAuthors">Anderson, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">24-35</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Transcriptional control mechanisms chart the course of the inflammatory response by synthesizing mRNAs encoding proteins that promote or inhibit inflammation.  Because these mRNAs can be long-lived, turning off their synthesis does not rapidly stop or change the direction of inflammation.  Post-transcriptional mechanisms that modify mRNA stability and/or translation provide more rapid and flexible control of this process and are particularly important in coordinating the initiation and resoln. of inflammation.  Here, the author reviews the surprising variety of post-transcriptional control mechanisms that regulate the initiation and resoln. of inflammation and discuss how these mechanisms are integrated to coordinate this essential process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDDA-upgugSbVg90H21EOLACvtfcHk0ljvyC0h35m-hQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsF2hsL7E&md5=57f2eee1e6b9d8049d8fccdbfef81faa</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fnri2685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2685%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DP.%26atitle%3DPost-transcriptional%2520regulons%2520coordinate%2520the%2520initiation%2520and%2520resolution%2520of%2520inflammation%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2010%26volume%3D10%26spage%3D24%26epage%3D35%26doi%3D10.1038%2Fnri2685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palucka, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coussens, L. M.</span></span> <span> </span><span class="NLM_article-title">The basis of oncoimmunology</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>164</i></span>,  <span class="NLM_fpage">1233</span>– <span class="NLM_lpage">1247</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2016.01.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1016%2Fj.cell.2016.01.049" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2016&pages=1233-1247&author=A.+K.+Paluckaauthor=L.+M.+Coussens&title=The+basis+of+oncoimmunology&doi=10.1016%2Fj.cell.2016.01.049"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2016.01.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2016.01.049%26sid%3Dliteratum%253Aachs%26aulast%3DPalucka%26aufirst%3DA.%2BK.%26aulast%3DCoussens%26aufirst%3DL.%2BM.%26atitle%3DThe%2520basis%2520of%2520oncoimmunology%26jtitle%3DCell%26date%3D2016%26volume%3D164%26spage%3D1233%26epage%3D1247%26doi%3D10.1016%2Fj.cell.2016.01.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robichaud, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Rincon, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huor, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alain, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petruccelli, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hearnden, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goncalves, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grotegut, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spruck, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furic, L.</span></span> <span> </span><span class="NLM_article-title">Phosphorylation of eIF4E promotes EMT and metastasis via translational control of SNAIL and MMP-3</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">2032</span>– <span class="NLM_lpage">2042</span>, <span class="refDoi"> DOI: 10.1038/onc.2014.146</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1038%2Fonc.2014.146" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=2032-2042&author=N.+Robichaudauthor=S.+V.+Del+Rinconauthor=B.+Huorauthor=T.+Alainauthor=L.+A.+Petruccelliauthor=J.+Hearndenauthor=C.+Goncalvesauthor=S.+Grotegutauthor=C.+H.+Spruckauthor=L.+Furic&title=Phosphorylation+of+eIF4E+promotes+EMT+and+metastasis+via+translational+control+of+SNAIL+and+MMP-3&doi=10.1038%2Fonc.2014.146"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1038%2Fonc.2014.146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2014.146%26sid%3Dliteratum%253Aachs%26aulast%3DRobichaud%26aufirst%3DN.%26aulast%3DDel%2BRincon%26aufirst%3DS.%2BV.%26aulast%3DHuor%26aufirst%3DB.%26aulast%3DAlain%26aufirst%3DT.%26aulast%3DPetruccelli%26aufirst%3DL.%2BA.%26aulast%3DHearnden%26aufirst%3DJ.%26aulast%3DGoncalves%26aufirst%3DC.%26aulast%3DGrotegut%26aufirst%3DS.%26aulast%3DSpruck%26aufirst%3DC.%2BH.%26aulast%3DFuric%26aufirst%3DL.%26atitle%3DPhosphorylation%2520of%2520eIF4E%2520promotes%2520EMT%2520and%2520metastasis%2520via%2520translational%2520control%2520of%2520SNAIL%2520and%2520MMP-3%26jtitle%3DOncogene%26date%3D2015%26volume%3D34%26spage%3D2032%26epage%3D2042%26doi%3D10.1038%2Fonc.2014.146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Topisirovic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz-Gutierrez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borden, K. L.</span></span> <span> </span><span class="NLM_article-title">Phosphorylation of the eukaryotic translation initiation factor eIF4E contributes to its transformation and mRNA transport activities</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">8639</span>– <span class="NLM_lpage">8642</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-04-2677</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1158%2F0008-5472.CAN-04-2677" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=8639-8642&author=I.+Topisirovicauthor=M.+Ruiz-Gutierrezauthor=K.+L.+Borden&title=Phosphorylation+of+the+eukaryotic+translation+initiation+factor+eIF4E+contributes+to+its+transformation+and+mRNA+transport+activities&doi=10.1158%2F0008-5472.CAN-04-2677"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-2677&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-2677%26sid%3Dliteratum%253Aachs%26aulast%3DTopisirovic%26aufirst%3DI.%26aulast%3DRuiz-Gutierrez%26aufirst%3DM.%26aulast%3DBorden%26aufirst%3DK.%2BL.%26atitle%3DPhosphorylation%2520of%2520the%2520eukaryotic%2520translation%2520initiation%2520factor%2520eIF4E%2520contributes%2520to%2520its%2520transformation%2520and%2520mRNA%2520transport%2520activities%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D8639%26epage%3D8642%26doi%3D10.1158%2F0008-5472.CAN-04-2677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reich, S. H.</span>; <span class="NLM_string-name">Bleckman, T. M.</span>; <span class="NLM_string-name">Kephart, S. E.</span>; <span class="NLM_string-name">Romines, W. H.</span>; <span class="NLM_string-name">Wallace, M. B.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Disubstituted Indazole Compounds as Cyclin Dependent Kinase Inhibitors and Methods of Inhibiting Cell Proliferation</span>. <span class="NLM_patent">WO2001053268</span>, <span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=S.+H.+Reich&author=T.+M.+Bleckman&author=S.+E.+Kephart&author=W.+H.+Romines&author=M.+B.+Wallace&title=Synthesis+of+Disubstituted+Indazole+Compounds+as+Cyclin+Dependent+Kinase+Inhibitors+and+Methods+of+Inhibiting+Cell+Proliferation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DReich%26aufirst%3DS.%2BH.%26atitle%3DSynthesis%2520of%2520Disubstituted%2520Indazole%2520Compounds%2520as%2520Cyclin%2520Dependent%2520Kinase%2520Inhibitors%2520and%2520Methods%2520of%2520Inhibiting%2520Cell%2520Proliferation%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konze, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meslamani, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrowsmith, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaniskan, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vedadi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship studies for enhancer of zeste homologue 2 (EZH2) and enhancer of zeste homologue 1 (EZH1) inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">7617</span>– <span class="NLM_lpage">7633</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00855</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00855" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Gmtr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7617-7633&author=X.+Yangauthor=F.+Liauthor=K.+D.+Konzeauthor=J.+Meslamaniauthor=A.+Maauthor=P.+J.+Brownauthor=M.+M.+Zhouauthor=C.+H.+Arrowsmithauthor=H.+U.+Kaniskanauthor=M.+Vedadiauthor=J.+Jin&title=Structure-activity+relationship+studies+for+enhancer+of+zeste+homologue+2+%28EZH2%29+and+enhancer+of+zeste+homologue+1+%28EZH1%29+inhibitors&doi=10.1021%2Facs.jmedchem.6b00855"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationship Studies for Enhancer of Zeste Homologue 2 (EZH2) and Enhancer of Zeste Homologue 1 (EZH1) Inhibitors</span></div><div class="casAuthors">Yang, Xiaobao; Li, Fengling; Konze, Kyle D.; Meslamani, Jamel; Ma, Anqi; Brown, Peter J.; Zhou, Ming-Ming; Arrowsmith, Cheryl H.; Kaniskan, H. Umit; Vedadi, Masoud; Jin, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7617-7633</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">EZH2 or EZH1 (enhancer of zeste homolog 2 or 1) is the catalytic subunit of polycomb repressive complex 2 (PRC2) that catalyzes methylation of histone H3 lysine 27 (H3K27).  PRC2 hyperactivity and/or hypertrimethylation of H3K27 are assocd. with numerous human cancers, therefore inhibition of PRC2 complex has emerged as a promising therapeutic approach.  Recent studies have shown that EZH2 and EZH1 are not functionally redundant and inhibition of both EZH2 and EZH1 is necessary to block the progression of certain cancers such as MLL (mixed-lineage leukemia)-rearranged leukemias.  Despite the significant advances in discovery of EZH2 inhibitors, there has not been a systematic structure-activity relation (SAR) study to investigate the selectivity between EZH2 and EZH1 inhibition.  Here, the authors report the authors SAR studies that focus on modifications to various regions of the EZH2/1 inhibitor UNC1999 (5) to investigate the impact of the structural changes on EZH2 and EZH1 inhibition and selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7AOr5A2kOH7Vg90H21EOLACvtfcHk0lg10fCBLLc5vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Gmtr3P&md5=14d5dba978adc28baaf2b781ae9a1541</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00855%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DKonze%26aufirst%3DK.%2BD.%26aulast%3DMeslamani%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DA.%26aulast%3DBrown%26aufirst%3DP.%2BJ.%26aulast%3DZhou%26aufirst%3DM.%2BM.%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DKaniskan%26aufirst%3DH.%2BU.%26aulast%3DVedadi%26aufirst%3DM.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DStructure-activity%2520relationship%2520studies%2520for%2520enhancer%2520of%2520zeste%2520homologue%25202%2520%2528EZH2%2529%2520and%2520enhancer%2520of%2520zeste%2520homologue%25201%2520%2528EZH1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7617%26epage%3D7633%26doi%3D10.1021%2Facs.jmedchem.6b00855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bilodeau, M. T.</span>; <span class="NLM_string-name">Duggan, M. E.</span>; <span class="NLM_string-name">Hartnett, J. C.</span>; <span class="NLM_string-name">Lindsley, C. W.</span>; <span class="NLM_string-name">Wu, Z.</span>; <span class="NLM_string-name">Zhao, Z.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of Akt Activity</span>. U.S. Patent <span class="NLM_patent">7,579,355</span>, August 5, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=M.+T.+Bilodeau&author=M.+E.+Duggan&author=J.+C.+Hartnett&author=C.+W.+Lindsley&author=Z.+Wu&author=Z.+Zhao&title=Inhibitors+of+Akt+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26atitle%3DInhibitors%2520of%2520Akt%2520Activity%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sprengeler, P. A.</span>; <span class="NLM_string-name">Reich, S. H.</span>; <span class="NLM_string-name">Ernst, J. T.</span>; <span class="NLM_string-name">Webber, S. E.</span>; <span class="NLM_string-name">Shaghafi, M.</span>; <span class="NLM_string-name">Murphy, D.</span>; <span class="NLM_string-name">Tran, C.</span></span> <span> </span><span class="NLM_article-title">Preparation of Isoindoline, Azaisoindoline, Dihydroindenone and Dihydroazaindenone Inhibitors of MNK1 and MNK2</span>. <span class="NLM_patent">WO 2017075394</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=P.+A.+Sprengeler&author=S.+H.+Reich&author=J.+T.+Ernst&author=S.+E.+Webber&author=M.+Shaghafi&author=D.+Murphy&author=C.+Tran&title=Preparation+of+Isoindoline%2C+Azaisoindoline%2C+Dihydroindenone+and+Dihydroazaindenone+Inhibitors+of+MNK1+and+MNK2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSprengeler%26aufirst%3DP.%2BA.%26atitle%3DPreparation%2520of%2520Isoindoline%252C%2520Azaisoindoline%252C%2520Dihydroindenone%2520and%2520Dihydroazaindenone%2520Inhibitors%2520of%2520MNK1%2520and%2520MNK2%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 68 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yong-Jin Wu, <span class="NLM_string-name hlFld-ContribAuthor">Nicholas A. Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">Geminal Diheteroatomic Motifs: Some Applications of Acetals, Ketals, and Their Sulfur and Nitrogen Homologues in Medicinal Chemistry and Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (14)
                                     , 9786-9874. <a href="https://doi.org/10.1021/acs.jmedchem.1c00790" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00790</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00790%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DGeminal%252BDiheteroatomic%252BMotifs%25253A%252BSome%252BApplications%252Bof%252BAcetals%25252C%252BKetals%25252C%252Band%252BTheir%252BSulfur%252Band%252BNitrogen%252BHomologues%252Bin%252BMedicinal%252BChemistry%252Band%252BDrug%252BDesign%26aulast%3DWu%26aufirst%3DYong-Jin%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D30042021%26date%3D02072021%26volume%3D64%26issue%3D14%26spage%3D9786%26epage%3D9874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ye-bin Wu, You-zhi Wu, Jian Wu, Dan Xu, Hui Jiang, Wen-wu Chang, <span class="NLM_string-name hlFld-ContribAuthor">Chang-you Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-Catalyzed Regioselective Coupling of Tosylhydrazones and 2-Pyridones: A Strategy for the Production of N-Alkylated Compounds. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>86 </em>
                                    (9)
                                     , 6918-6926. <a href="https://doi.org/10.1021/acs.joc.1c00009" title="DOI URL">https://doi.org/10.1021/acs.joc.1c00009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.1c00009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.1c00009%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DCopper-Catalyzed%252BRegioselective%252BCoupling%252Bof%252BTosylhydrazones%252Band%252B2-Pyridones%25253A%252BA%252BStrategy%252Bfor%252Bthe%252BProduction%252Bof%252BN-Alkylated%252BCompounds%26aulast%3DWu%26aufirst%3DYe-bin%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D06022021%26date%3D14042021%26volume%3D86%26issue%3D9%26spage%3D6918%26epage%3D6926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Changjiang Liu, Paolo Elvati, <span class="NLM_string-name hlFld-ContribAuthor">Angela Violi</span>. </span><span class="cited-content_cbyCitation_article-title">On Drug-Membrane Permeability of Antivirals for SARS-CoV-2. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Physical Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (5)
                                     , 1384-1389. <a href="https://doi.org/10.1021/acs.jpclett.0c02397" title="DOI URL">https://doi.org/10.1021/acs.jpclett.0c02397</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jpclett.0c02397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jpclett.0c02397%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Physical%2520Chemistry%2520Letters%26atitle%3DOn%252BDrug-Membrane%252BPermeability%252Bof%252BAntivirals%252Bfor%252BSARS-CoV-2%26aulast%3DLiu%26aufirst%3DChangjiang%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D05082020%26date%3D12012021%26date%3D28012021%26volume%3D12%26issue%3D5%26spage%3D1384%26epage%3D1389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kerstin Hiesinger, Dmitry Dar’in, Ewgenij Proschak, <span class="NLM_string-name hlFld-ContribAuthor">Mikhail Krasavin</span>. </span><span class="cited-content_cbyCitation_article-title">Spirocyclic Scaffolds in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (1)
                                     , 150-183. <a href="https://doi.org/10.1021/acs.jmedchem.0c01473" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01473</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01473%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSpirocyclic%252BScaffolds%252Bin%252BMedicinal%252BChemistry%26aulast%3DHiesinger%26aufirst%3DKerstin%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D24082020%26date%3D31122020%26volume%3D64%26issue%3D1%26spage%3D150%26epage%3D183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Guangyang Xu, Ying Shao, Shengbiao Tang, Qun Chen, <span class="NLM_string-name hlFld-ContribAuthor">Jiangtao Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Dearomative Migratory Rearrangement of 2-Oxypyridines Enabled by α-Imino Rhodium Carbene. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (23)
                                     , 9303-9307. <a href="https://doi.org/10.1021/acs.orglett.0c03533" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c03533</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c03533&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c03533%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DDearomative%252BMigratory%252BRearrangement%252Bof%252B2-Oxypyridines%252BEnabled%252Bby%252B%2525CE%2525B1-Imino%252BRhodium%252BCarbene%26aulast%3DXu%26aufirst%3DGuangyang%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D23102020%26date%3D24112020%26volume%3D22%26issue%3D23%26spage%3D9303%26epage%3D9307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Liang-Chieh Chen, Han-Li Huang, Wei-Chun HuangFu, Shih-Chung Yen, Sin-Ting Ngo, Yi-Wen Wu, Tony Eight Lin, Tzu-Ying Sung, Ssu-Ting Lien, Hui-Ju Tseng, Shiow-Lin Pan, Wei-Jan Huang, <span class="NLM_string-name hlFld-ContribAuthor">Kai-Cheng Hsu</span>. </span><span class="cited-content_cbyCitation_article-title">Biological Evaluation of Selected Flavonoids as Inhibitors of MNKs Targeting Acute Myeloid Leukemia. </span><span class="cited-content_cbyCitation_journal-name">Journal of Natural Products</span><span> <strong>2020,</strong> <em>83 </em>
                                    (10)
                                     , 2967-2975. <a href="https://doi.org/10.1021/acs.jnatprod.0c00516" title="DOI URL">https://doi.org/10.1021/acs.jnatprod.0c00516</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jnatprod.0c00516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jnatprod.0c00516%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Natural%2520Products%26atitle%3DBiological%252BEvaluation%252Bof%252BSelected%252BFlavonoids%252Bas%252BInhibitors%252Bof%252BMNKs%252BTargeting%252BAcute%252BMyeloid%252BLeukemia%26aulast%3DChen%26aufirst%3DLiang-Chieh%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D08052020%26date%3D07102020%26volume%3D83%26issue%3D10%26spage%3D2967%26epage%3D2975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Justin T. Ernst, Peggy A. Thompson, Christian Nilewski, Paul A. Sprengeler, Samuel Sperry, Garrick Packard, Theodore Michels, Alan Xiang, Chinh Tran, Christopher J. Wegerski, Boreth Eam, Nathan P. Young, Sarah Fish, Joan Chen, Haleigh Howard, Jocelyn Staunton, Jolene Molter, Jeff Clarine, Andres Nevarez, Gary G. Chiang, Jim R. Appleman, Kevin R. Webster, <span class="NLM_string-name hlFld-ContribAuthor">Siegfried H. Reich</span>. </span><span class="cited-content_cbyCitation_article-title">Design of Development Candidate eFT226, a First in Class Inhibitor of Eukaryotic Initiation Factor 4A RNA Helicase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (11)
                                     , 5879-5955. <a href="https://doi.org/10.1021/acs.jmedchem.0c00182" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00182</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00182%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Bof%252BDevelopment%252BCandidate%252BeFT226%25252C%252Ba%252BFirst%252Bin%252BClass%252BInhibitor%252Bof%252BEukaryotic%252BInitiation%252BFactor%252B4A%252BRNA%252BHelicase%26aulast%3DErnst%26aufirst%3DJustin%2BT.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D01022020%26date%3D29052020%26volume%3D63%26issue%3D11%26spage%3D5879%26epage%3D5955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Daniel A. Erlanson, Iwan J. P. de Esch, Wolfgang Jahnke, Christopher N. Johnson, <span class="NLM_string-name hlFld-ContribAuthor">Paul N. Mortenson</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-to-Lead Medicinal Chemistry Publications in 2018. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (9)
                                     , 4430-4444. <a href="https://doi.org/10.1021/acs.jmedchem.9b01581" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01581</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01581%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFragment-to-Lead%252BMedicinal%252BChemistry%252BPublications%252Bin%252B2018%26aulast%3DErlanson%26aufirst%3DDaniel%2BA.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D22092019%26date%3D22012020%26date%3D08012020%26volume%3D63%26issue%3D9%26spage%3D4430%26epage%3D4444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jacek Kwiatkowski, Boping Liu, Shermaine Pang, Nur Huda Binte Ahmad, Gang Wang, Anders Poulsen, Haiyan Yang, Yong Rui Poh, Doris Hui Ying Tee, Esther Ong, Priya Retna, Nurul Dinie, Perlyn Kwek, John Liang Kuan Wee, Vithya Manoharan, Choon Bing Low, Peck Gee Seah, Vishal Pendharkar, Kanda Sangthongpitag, Joma Joy, Nithya Baburajendran, Anna Elisabet Jansson, Kassoum Nacro, Jeffrey Hill, Thomas H. Keller, <span class="NLM_string-name hlFld-ContribAuthor">Alvin W. Hung</span>. </span><span class="cited-content_cbyCitation_article-title">Stepwise Evolution of Fragment Hits against MAPK Interacting Kinases 1 and 2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (2)
                                     , 621-637. <a href="https://doi.org/10.1021/acs.jmedchem.9b01582" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01582</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01582%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStepwise%252BEvolution%252Bof%252BFragment%252BHits%252Bagainst%252BMAPK%252BInteracting%252BKinases%252B1%252Band%252B2%26aulast%3DKwiatkowski%26aufirst%3DJacek%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D23092019%26date%3D07012020%26volume%3D63%26issue%3D2%26spage%3D621%26epage%3D637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Haiyan Yang, Lohitha Rao Chennamaneni, Melvyn Wai Tuck Ho, Shi Hua Ang, Eldwin Sum Wai Tan, Duraiswamy Athisayamani Jeyaraj, Yoon Sheng Yeap, Boping Liu, Esther Hq Ong, Joma Kanikadu Joy, John Liang Kuan Wee, Perlyn Kwek, Priya Retna, Nurul Dinie, Thuy Thi Hanh Nguyen, Shi Jing Tai, Vithya Manoharan, Vishal Pendharkar, Choon Bing Low, Yun Shan Chew, Susmitha Vuddagiri, Kanda Sangthongpitag, Meng Ling Choong, May Ann Lee, Srinivasaraghavan Kannan, Chandra S. Verma, Anders Poulsen, Sharon Lim, Charles Chuah, Tiong Sin Ong, Jeffrey Hill, Alex Matter, <span class="NLM_string-name hlFld-ContribAuthor">Kassoum Nacro</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of Selective Mitogen-Activated Protein Kinase Interacting Kinases 1 and 2 Inhibitors for the Treatment of Blast Crisis Leukemia. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (10)
                                     , 4348-4369. <a href="https://doi.org/10.1021/acs.jmedchem.7b01714" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01714</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01714&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01714%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252BSelective%252BMitogen-Activated%252BProtein%252BKinase%252BInteracting%252BKinases%252B1%252Band%252B2%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BBlast%252BCrisis%252BLeukemia%26aulast%3DYang%26aufirst%3DHaiyan%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D22112017%26date%3D07052018%26date%3D23042018%26volume%3D61%26issue%3D10%26spage%3D4348%26epage%3D4369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ping  Song</span>, <span class="hlFld-ContribAuthor ">Fan  Yang</span>, <span class="hlFld-ContribAuthor ">Hongchuan  Jin</span>, <span class="hlFld-ContribAuthor ">Xian  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">The regulation of protein translation and its implications for cancer. </span><span class="cited-content_cbyCitation_journal-name">Signal Transduction and Targeted Therapy</span><span> <strong>2021,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41392-020-00444-9" title="DOI URL">https://doi.org/10.1038/s41392-020-00444-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41392-020-00444-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41392-020-00444-9%26sid%3Dliteratum%253Aachs%26jtitle%3DSignal%2520Transduction%2520and%2520Targeted%2520Therapy%26atitle%3DThe%252Bregulation%252Bof%252Bprotein%252Btranslation%252Band%252Bits%252Bimplications%252Bfor%252Bcancer%26aulast%3DSong%26aufirst%3DPing%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammad Kaisarul  Islam</span>, <span class="hlFld-ContribAuthor ">Johnson  Stanslas</span>. </span><span class="cited-content_cbyCitation_article-title">Peptide-based and small molecule PD-1 and PD-L1 pharmacological modulators in the treatment of cancer. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2021,</strong> <em>227 </em>, 107870. <a href="https://doi.org/10.1016/j.pharmthera.2021.107870" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2021.107870</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2021.107870&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2021.107870%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DPeptide-based%252Band%252Bsmall%252Bmolecule%252BPD-1%252Band%252BPD-L1%252Bpharmacological%252Bmodulators%252Bin%252Bthe%252Btreatment%252Bof%252Bcancer%26aulast%3DIslam%26aufirst%3DMohammad%2BKaisarul%26date%3D2021%26volume%3D227%26spage%3D107870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai  Wang</span>, <span class="hlFld-ContribAuthor ">Ziye  Liu</span>, <span class="hlFld-ContribAuthor ">Guangyang  Xu</span>, <span class="hlFld-ContribAuthor ">Ying  Shao</span>, <span class="hlFld-ContribAuthor ">Shengbiao  Tang</span>, <span class="hlFld-ContribAuthor ">Ping  Chen</span>, <span class="hlFld-ContribAuthor ">Xinhao  Zhang</span>, <span class="hlFld-ContribAuthor ">Jiangtao  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Chemo‐ and Enantioselective Insertion of Furyl Carbene into the N−H Bond of 2‐Pyridones. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2021,</strong> <em>133 </em>
                                    (31)
                                     , 17079-17083. <a href="https://doi.org/10.1002/ange.202104708" title="DOI URL">https://doi.org/10.1002/ange.202104708</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202104708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202104708%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DChemo%2525E2%252580%252590%252Band%252BEnantioselective%252BInsertion%252Bof%252BFuryl%252BCarbene%252Binto%252Bthe%252BN%2525E2%252588%252592H%252BBond%252Bof%252B2%2525E2%252580%252590Pyridones%26aulast%3DWang%26aufirst%3DKai%26date%3D2021%26date%3D2021%26volume%3D133%26issue%3D31%26spage%3D17079%26epage%3D17083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai  Wang</span>, <span class="hlFld-ContribAuthor ">Ziye  Liu</span>, <span class="hlFld-ContribAuthor ">Guangyang  Xu</span>, <span class="hlFld-ContribAuthor ">Ying  Shao</span>, <span class="hlFld-ContribAuthor ">Shengbiao  Tang</span>, <span class="hlFld-ContribAuthor ">Ping  Chen</span>, <span class="hlFld-ContribAuthor ">Xinhao  Zhang</span>, <span class="hlFld-ContribAuthor ">Jiangtao  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Chemo‐ and Enantioselective Insertion of Furyl Carbene into the N−H Bond of 2‐Pyridones. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2021,</strong> <em>60 </em>
                                    (31)
                                     , 16942-16946. <a href="https://doi.org/10.1002/anie.202104708" title="DOI URL">https://doi.org/10.1002/anie.202104708</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202104708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202104708%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DChemo%2525E2%252580%252590%252Band%252BEnantioselective%252BInsertion%252Bof%252BFuryl%252BCarbene%252Binto%252Bthe%252BN%2525E2%252588%252592H%252BBond%252Bof%252B2%2525E2%252580%252590Pyridones%26aulast%3DWang%26aufirst%3DKai%26date%3D2021%26date%3D2021%26volume%3D60%26issue%3D31%26spage%3D16942%26epage%3D16946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kirk B  Jensen</span>, <span class="hlFld-ContribAuthor ">B Kate  Dredge</span>, <span class="hlFld-ContribAuthor ">John  Toubia</span>, <span class="hlFld-ContribAuthor ">Xin  Jin</span>, <span class="hlFld-ContribAuthor ">Valentina  Iadevaia</span>, <span class="hlFld-ContribAuthor ">Gregory J  Goodall</span>, <span class="hlFld-ContribAuthor ">Christopher G  Proud</span>. </span><span class="cited-content_cbyCitation_article-title">capCLIP: a new tool to probe translational control in human cells through capture and identification of the eIF4E–mRNA interactome. </span><span class="cited-content_cbyCitation_journal-name">Nucleic Acids Research</span><span> <strong>2021,</strong> <em>11 </em><a href="https://doi.org/10.1093/nar/gkab604" title="DOI URL">https://doi.org/10.1093/nar/gkab604</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/nar/gkab604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fnar%2Fgkab604%26sid%3Dliteratum%253Aachs%26jtitle%3DNucleic%2520Acids%2520Research%26atitle%3DcapCLIP%25253A%252Ba%252Bnew%252Btool%252Bto%252Bprobe%252Btranslational%252Bcontrol%252Bin%252Bhuman%252Bcells%252Bthrough%252Bcapture%252Band%252Bidentification%252Bof%252Bthe%252BeIF4E%2525E2%252580%252593mRNA%252Binteractome%26aulast%3DJensen%26aufirst%3DKirk%2BB%26date%3D2021%26date%3D2021%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Jin</span>, <span class="hlFld-ContribAuthor ">Rilei  Yu</span>, <span class="hlFld-ContribAuthor ">Xuemin  Wang</span>, <span class="hlFld-ContribAuthor ">Christopher G.  Proud</span>, <span class="hlFld-ContribAuthor ">Tao  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Progress in developing MNK inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>219 </em>, 113420. <a href="https://doi.org/10.1016/j.ejmech.2021.113420" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113420</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113420%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DProgress%252Bin%252Bdeveloping%252BMNK%252Binhibitors%26aulast%3DJin%26aufirst%3DXin%26date%3D2021%26volume%3D219%26spage%3D113420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhi-Zheng  Wang</span>, <span class="hlFld-ContribAuthor ">Xing-Xing  Shi</span>, <span class="hlFld-ContribAuthor ">Guang-Yi  Huang</span>, <span class="hlFld-ContribAuthor ">Ge-Fei  Hao</span>, <span class="hlFld-ContribAuthor ">Guang-Fu  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-based drug design facilitates selective kinase inhibitor discovery. </span><span class="cited-content_cbyCitation_journal-name">Trends in Pharmacological Sciences</span><span> <strong>2021,</strong> <em>42 </em>
                                    (7)
                                     , 551-565. <a href="https://doi.org/10.1016/j.tips.2021.04.001" title="DOI URL">https://doi.org/10.1016/j.tips.2021.04.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tips.2021.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tips.2021.04.001%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Pharmacological%2520Sciences%26atitle%3DFragment-based%252Bdrug%252Bdesign%252Bfacilitates%252Bselective%252Bkinase%252Binhibitor%252Bdiscovery%26aulast%3DWang%26aufirst%3DZhi-Zheng%26date%3D2021%26volume%3D42%26issue%3D7%26spage%3D551%26epage%3D565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianling  Xie</span>, <span class="hlFld-ContribAuthor ">Eric P.  Kusnadi</span>, <span class="hlFld-ContribAuthor ">Luc  Furic</span>, <span class="hlFld-ContribAuthor ">Luke A.  Selth</span>. </span><span class="cited-content_cbyCitation_article-title">Regulation of mRNA Translation by Hormone Receptors in Breast and Prostate Cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (13)
                                     , 3254. <a href="https://doi.org/10.3390/cancers13133254" title="DOI URL">https://doi.org/10.3390/cancers13133254</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13133254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13133254%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DRegulation%252Bof%252BmRNA%252BTranslation%252Bby%252BHormone%252BReceptors%252Bin%252BBreast%252Band%252BProstate%252BCancer%26aulast%3DXie%26aufirst%3DJianling%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D13%26spage%3D3254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eclair Venturini  Filho</span>, <span class="hlFld-ContribAuthor ">Erick M.C.  Pinheiro</span>, <span class="hlFld-ContribAuthor ">Sergio  Pinheiro</span>, <span class="hlFld-ContribAuthor ">Sandro J.  Greco</span>. </span><span class="cited-content_cbyCitation_article-title">Aminopyrimidines: Recent synthetic procedures and anticancer activities. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2021,</strong> <em>92 </em>, 132256. <a href="https://doi.org/10.1016/j.tet.2021.132256" title="DOI URL">https://doi.org/10.1016/j.tet.2021.132256</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2021.132256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2021.132256%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DAminopyrimidines%25253A%252BRecent%252Bsynthetic%252Bprocedures%252Band%252Banticancer%252Bactivities%26aulast%3DFilho%26aufirst%3DEclair%2BVenturini%26date%3D2021%26volume%3D92%26spage%3D132256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amit  Kumawat</span>, <span class="hlFld-ContribAuthor ">Sadanandam  Namsani</span>, <span class="hlFld-ContribAuthor ">Debabrata  Pramanik</span>, <span class="hlFld-ContribAuthor ">Sudip  Roy</span>, <span class="hlFld-ContribAuthor ">Jayant K.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Integrated docking and enhanced sampling-based selection of repurposing drugs for SARS-CoV-2 by targeting host dependent factors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>2 </em>, 1-12. <a href="https://doi.org/10.1080/07391102.2021.1937319" title="DOI URL">https://doi.org/10.1080/07391102.2021.1937319</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2021.1937319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2021.1937319%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DIntegrated%252Bdocking%252Band%252Benhanced%252Bsampling-based%252Bselection%252Bof%252Brepurposing%252Bdrugs%252Bfor%252BSARS-CoV-2%252Bby%252Btargeting%252Bhost%252Bdependent%252Bfactors%26aulast%3DKumawat%26aufirst%3DAmit%26date%3D2021%26date%3D2021%26volume%3D2%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giulia  Lucibello</span>, <span class="hlFld-ContribAuthor ">Baharia  Mograbi</span>, <span class="hlFld-ContribAuthor ">Gerard  Milano</span>, <span class="hlFld-ContribAuthor ">Paul  Hofman</span>, <span class="hlFld-ContribAuthor ">Patrick  Brest</span>. </span><span class="cited-content_cbyCitation_article-title">PD-L1 regulation revisited: impact on immunotherapeutic strategies. </span><span class="cited-content_cbyCitation_journal-name">Trends in Molecular Medicine</span><span> <strong>2021,</strong> <em>562 </em><a href="https://doi.org/10.1016/j.molmed.2021.06.005" title="DOI URL">https://doi.org/10.1016/j.molmed.2021.06.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molmed.2021.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molmed.2021.06.005%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Molecular%2520Medicine%26atitle%3DPD-L1%252Bregulation%252Brevisited%25253A%252Bimpact%252Bon%252Bimmunotherapeutic%252Bstrategies%26aulast%3DLucibello%26aufirst%3DGiulia%26date%3D2021%26volume%3D562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Milagros  Suarez</span>, <span class="hlFld-ContribAuthor ">Gavin T.  Blyth</span>, <span class="hlFld-ContribAuthor ">Alain A.  Mina</span>, <span class="hlFld-ContribAuthor ">Ewa M.  Kosciuczuk</span>, <span class="hlFld-ContribAuthor ">Blazej  Dolniak</span>, <span class="hlFld-ContribAuthor ">Shira  Dinner</span>, <span class="hlFld-ContribAuthor ">Jessica K.  Altman</span>, <span class="hlFld-ContribAuthor ">Elizabeth A.  Eklund</span>, <span class="hlFld-ContribAuthor ">Diana  Saleiro</span>, <span class="hlFld-ContribAuthor ">Elspeth M.  Beauchamp</span>, <span class="hlFld-ContribAuthor ">Leonidas C.  Platanias</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitory effects of Tomivosertib in acute myeloid leukemia. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2021,</strong> <em>12 </em>
                                    (10)
                                     , 955-966. <a href="https://doi.org/10.18632/oncotarget.27952" title="DOI URL">https://doi.org/10.18632/oncotarget.27952</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.27952&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.27952%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DInhibitory%252Beffects%252Bof%252BTomivosertib%252Bin%252Bacute%252Bmyeloid%252Bleukemia%26aulast%3DSuarez%26aufirst%3DMilagros%26date%3D2021%26volume%3D12%26issue%3D10%26spage%3D955%26epage%3D966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John R.P.  Knight</span>, <span class="hlFld-ContribAuthor ">Constantinos  Alexandrou</span>, <span class="hlFld-ContribAuthor ">George L.  Skalka</span>, <span class="hlFld-ContribAuthor ">Nikola  Vlahov</span>, <span class="hlFld-ContribAuthor ">Kathryn  Pennel</span>, <span class="hlFld-ContribAuthor ">Leah  Officer</span>, <span class="hlFld-ContribAuthor ">Ana  Teodosio</span>, <span class="hlFld-ContribAuthor ">Georgios  Kanellos</span>, <span class="hlFld-ContribAuthor ">David M.  Gay</span>, <span class="hlFld-ContribAuthor ">Sebastian  May-Wilson</span>, <span class="hlFld-ContribAuthor ">Ewan M.  Smith</span>, <span class="hlFld-ContribAuthor ">Arafath K.  Najumudeen</span>, <span class="hlFld-ContribAuthor ">Kathryn  Gilroy</span>, <span class="hlFld-ContribAuthor ">Rachel A.  Ridgway</span>, <span class="hlFld-ContribAuthor ">Dustin J.  Flanagan</span>, <span class="hlFld-ContribAuthor ">Rachael C.L.  Smith</span>, <span class="hlFld-ContribAuthor ">Laura  McDonald</span>, <span class="hlFld-ContribAuthor ">Craig  MacKay</span>, <span class="hlFld-ContribAuthor ">Anne  Cheasty</span>, <span class="hlFld-ContribAuthor ">Kerri  McArthur</span>, <span class="hlFld-ContribAuthor ">Emma  Stanway</span>, <span class="hlFld-ContribAuthor ">Joshua D.  Leach</span>, <span class="hlFld-ContribAuthor ">Rene  Jackstadt</span>, <span class="hlFld-ContribAuthor ">Joseph A.  Waldron</span>, <span class="hlFld-ContribAuthor ">Andrew D.  Campbell</span>, <span class="hlFld-ContribAuthor ">Georgios  Vlachogiannis</span>, <span class="hlFld-ContribAuthor ">Nicola  Valeri</span>, <span class="hlFld-ContribAuthor ">Kevin M.  Haigis</span>, <span class="hlFld-ContribAuthor ">Nahum  Sonenberg</span>, <span class="hlFld-ContribAuthor ">Christopher G.  Proud</span>, <span class="hlFld-ContribAuthor ">Neil P.  Jones</span>, <span class="hlFld-ContribAuthor ">Martin E.  Swarbrick</span>, <span class="hlFld-ContribAuthor ">Heather J.  McKinnon</span>, <span class="hlFld-ContribAuthor ">William J.  Faller</span>, <span class="hlFld-ContribAuthor ">John  Le Quesne</span>, <span class="hlFld-ContribAuthor ">Joanne  Edwards</span>, <span class="hlFld-ContribAuthor ">Anne E.  Willis</span>, <span class="hlFld-ContribAuthor ">Martin  Bushell</span>, <span class="hlFld-ContribAuthor ">Owen J.  Sansom</span>. </span><span class="cited-content_cbyCitation_article-title">MNK Inhibition Sensitizes
              KRAS
              -Mutant Colorectal Cancer to mTORC1 Inhibition by Reducing eIF4E Phosphorylation and c-MYC Expression. </span><span class="cited-content_cbyCitation_journal-name">Cancer Discovery</span><span> <strong>2021,</strong> <em>11 </em>
                                    (5)
                                     , 1228-1247. <a href="https://doi.org/10.1158/2159-8290.CD-20-0652" title="DOI URL">https://doi.org/10.1158/2159-8290.CD-20-0652</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/2159-8290.CD-20-0652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F2159-8290.CD-20-0652%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Discovery%26atitle%3DMNK%252BInhibition%252BSensitizes%252BKRAS%252B-Mutant%252BColorectal%252BCancer%252Bto%252BmTORC1%252BInhibition%252Bby%252BReducing%252BeIF4E%252BPhosphorylation%252Band%252Bc-MYC%252BExpression%26aulast%3DKnight%26aufirst%3DJohn%2BR.P.%26date%3D2021%26date%3D2020%26volume%3D11%26issue%3D5%26spage%3D1228%26epage%3D1247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dhanusha  Yesudhas</span>, <span class="hlFld-ContribAuthor ">Ambuj  Srivastava</span>, <span class="hlFld-ContribAuthor ">M. Michael  Gromiha</span>. </span><span class="cited-content_cbyCitation_article-title">COVID-19 outbreak: history, mechanism, transmission, structural studies and therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Infection</span><span> <strong>2021,</strong> <em>49 </em>
                                    (2)
                                     , 199-213. <a href="https://doi.org/10.1007/s15010-020-01516-2" title="DOI URL">https://doi.org/10.1007/s15010-020-01516-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s15010-020-01516-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs15010-020-01516-2%26sid%3Dliteratum%253Aachs%26jtitle%3DInfection%26atitle%3DCOVID-19%252Boutbreak%25253A%252Bhistory%25252C%252Bmechanism%25252C%252Btransmission%25252C%252Bstructural%252Bstudies%252Band%252Btherapeutics%26aulast%3DYesudhas%26aufirst%3DDhanusha%26date%3D2021%26date%3D2020%26volume%3D49%26issue%3D2%26spage%3D199%26epage%3D213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alisa D.  Kharlamova</span>, <span class="hlFld-ContribAuthor ">Anton S.  Abel</span>, <span class="hlFld-ContribAuthor ">Alexei D.  Averin</span>, <span class="hlFld-ContribAuthor ">Olga A.  Maloshitskaya</span>, <span class="hlFld-ContribAuthor ">Vitaly A.  Roznyatovskiy</span>, <span class="hlFld-ContribAuthor ">Evgenii N.  Savelyev</span>, <span class="hlFld-ContribAuthor ">Boris S.  Orlinson</span>, <span class="hlFld-ContribAuthor ">Ivan A.  Novakov</span>, <span class="hlFld-ContribAuthor ">Irina P.  Beletskaya</span>. </span><span class="cited-content_cbyCitation_article-title">Mono- and Diamination of 4,6-Dichloropyrimidine, 2,6-Dichloropyrazine and 1,3-Dichloroisoquinoline with Adamantane-Containing Amines. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (7)
                                     , 1910. <a href="https://doi.org/10.3390/molecules26071910" title="DOI URL">https://doi.org/10.3390/molecules26071910</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26071910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26071910%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DMono-%252Band%252BDiamination%252Bof%252B4%25252C6-Dichloropyrimidine%25252C%252B2%25252C6-Dichloropyrazine%252Band%252B1%25252C3-Dichloroisoquinoline%252Bwith%252BAdamantane-Containing%252BAmines%26aulast%3DKharlamova%26aufirst%3DAlisa%2BD.%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D7%26spage%3D1910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liang  Xu</span>, <span class="hlFld-ContribAuthor ">Ye  Chen</span>, <span class="hlFld-ContribAuthor ">Yulun  Huang</span>, <span class="hlFld-ContribAuthor ">Edwin  Sandanaraj</span>, <span class="hlFld-ContribAuthor ">John S.  Yu</span>, <span class="hlFld-ContribAuthor ">Ruby Yu-Tong  Lin</span>, <span class="hlFld-ContribAuthor ">Pushkar  Dakle</span>, <span class="hlFld-ContribAuthor ">Xin-Yu  Ke</span>, <span class="hlFld-ContribAuthor ">Yuk Kien  Chong</span>, <span class="hlFld-ContribAuthor ">Lynnette  Koh</span>, <span class="hlFld-ContribAuthor ">Anand  Mayakonda</span>, <span class="hlFld-ContribAuthor ">Kassoum  Nacro</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Hill</span>, <span class="hlFld-ContribAuthor ">Mo-Li  Huang</span>, <span class="hlFld-ContribAuthor ">Sigal  Gery</span>, <span class="hlFld-ContribAuthor ">See Wee  Lim</span>, <span class="hlFld-ContribAuthor ">Zhengyun  Huang</span>, <span class="hlFld-ContribAuthor ">Ying  Xu</span>, <span class="hlFld-ContribAuthor ">Jianxiang  Chen</span>, <span class="hlFld-ContribAuthor ">Longchuan  Bai</span>, <span class="hlFld-ContribAuthor ">Shaomeng  Wang</span>, <span class="hlFld-ContribAuthor ">Hiroaki  Wakimoto</span>, <span class="hlFld-ContribAuthor ">Tseng Tsai  Yeo</span>, <span class="hlFld-ContribAuthor ">Beng Ti  Ang</span>, <span class="hlFld-ContribAuthor ">Markus  Müschen</span>, <span class="hlFld-ContribAuthor ">Carol  Tang</span>, <span class="hlFld-ContribAuthor ">Tuan Zea  Tan</span>, <span class="hlFld-ContribAuthor ">H. Phillip  Koeffler</span>. </span><span class="cited-content_cbyCitation_article-title">Topography of transcriptionally active chromatin in glioblastoma. </span><span class="cited-content_cbyCitation_journal-name">Science Advances</span><span> <strong>2021,</strong> <em>7 </em>
                                    (18)
                                     , eabd4676. <a href="https://doi.org/10.1126/sciadv.abd4676" title="DOI URL">https://doi.org/10.1126/sciadv.abd4676</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/sciadv.abd4676&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fsciadv.abd4676%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%2520Advances%26atitle%3DTopography%252Bof%252Btranscriptionally%252Bactive%252Bchromatin%252Bin%252Bglioblastoma%26aulast%3DXu%26aufirst%3DLiang%26date%3D2021%26date%3D2021%26volume%3D7%26issue%3D18%26spage%3Deabd4676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lee-or  Herzog</span>, <span class="hlFld-ContribAuthor ">Beth  Walters</span>, <span class="hlFld-ContribAuthor ">Roberta  Buono</span>, <span class="hlFld-ContribAuthor ">J. Scott  Lee</span>, <span class="hlFld-ContribAuthor ">Sharmila  Mallya</span>, <span class="hlFld-ContribAuthor ">Amos  Fung</span>, <span class="hlFld-ContribAuthor ">Honyin  Chiu</span>, <span class="hlFld-ContribAuthor ">Nancy  Nguyen</span>, <span class="hlFld-ContribAuthor ">Boyang  Li</span>, <span class="hlFld-ContribAuthor ">Anthony B.  Pinkerton</span>, <span class="hlFld-ContribAuthor ">Michael R.  Jackson</span>, <span class="hlFld-ContribAuthor ">Robert J.  Schneider</span>, <span class="hlFld-ContribAuthor ">Ze’ev A.  Ronai</span>, <span class="hlFld-ContribAuthor ">David A.  Fruman</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting eIF4F translation initiation complex with SBI-756 sensitises B lymphoma cells to venetoclax. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Cancer</span><span> <strong>2021,</strong> <em>124 </em>
                                    (6)
                                     , 1098-1109. <a href="https://doi.org/10.1038/s41416-020-01205-9" title="DOI URL">https://doi.org/10.1038/s41416-020-01205-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41416-020-01205-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41416-020-01205-9%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Cancer%26atitle%3DTargeting%252BeIF4F%252Btranslation%252Binitiation%252Bcomplex%252Bwith%252BSBI-756%252Bsensitises%252BB%252Blymphoma%252Bcells%252Bto%252Bvenetoclax%26aulast%3DHerzog%26aufirst%3DLee-or%26date%3D2021%26date%3D2020%26volume%3D124%26issue%3D6%26spage%3D1098%26epage%3D1109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jerry  Pelletier</span>, <span class="hlFld-ContribAuthor ">T. Martin  Schmeing</span>, <span class="hlFld-ContribAuthor ">Nahum  Sonenberg</span>. </span><span class="cited-content_cbyCitation_article-title">The multifaceted eukaryotic cap structure. </span><span class="cited-content_cbyCitation_journal-name">WIREs RNA</span><span> <strong>2021,</strong> <em>12 </em>
                                    (2)
                                     <a href="https://doi.org/10.1002/wrna.1636" title="DOI URL">https://doi.org/10.1002/wrna.1636</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/wrna.1636&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fwrna.1636%26sid%3Dliteratum%253Aachs%26jtitle%3DWIREs%2520RNA%26atitle%3DThe%252Bmultifaceted%252Beukaryotic%252Bcap%252Bstructure%26aulast%3DPelletier%26aufirst%3DJerry%26date%3D2021%26date%3D2020%26volume%3D12%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Agnieszka  Dreas</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Kucwaj-Brysz</span>, <span class="hlFld-ContribAuthor ">Karolina  Pyziak</span>, <span class="hlFld-ContribAuthor ">Urszula  Kulesza</span>, <span class="hlFld-ContribAuthor ">Ewelina  Wincza</span>, <span class="hlFld-ContribAuthor ">Charles-Henry  Fabritius</span>, <span class="hlFld-ContribAuthor ">Kinga  Michalik</span>, <span class="hlFld-ContribAuthor ">Ewelina  Gabor-Worwa</span>, <span class="hlFld-ContribAuthor ">Aniela  Gołas</span>, <span class="hlFld-ContribAuthor ">Mariusz  Milik</span>, <span class="hlFld-ContribAuthor ">Magdalena  Masiejczyk</span>, <span class="hlFld-ContribAuthor ">Eliza  Majewska</span>, <span class="hlFld-ContribAuthor ">Kazimiera  Pyśniak</span>, <span class="hlFld-ContribAuthor ">Urszula  Wójcik-Trechcińska</span>, <span class="hlFld-ContribAuthor ">Zuzanna  Sandowska-Markiewicz</span>, <span class="hlFld-ContribAuthor ">Krzysztof  Brzózka</span>, <span class="hlFld-ContribAuthor ">Jerzy  Ostrowski</span>, <span class="hlFld-ContribAuthor ">Tomasz  Rzymski</span>, <span class="hlFld-ContribAuthor ">Michal  Mikula</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of indazole-pyridinone derivatives as a novel class of potent and selective MNK1/2 kinase inhibitors that protecting against endotoxin-induced septic shock. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>213 </em>, 113057. <a href="https://doi.org/10.1016/j.ejmech.2020.113057" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113057%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bindazole-pyridinone%252Bderivatives%252Bas%252Ba%252Bnovel%252Bclass%252Bof%252Bpotent%252Band%252Bselective%252BMNK1%25252F2%252Bkinase%252Binhibitors%252Bthat%252Bprotecting%252Bagainst%252Bendotoxin-induced%252Bseptic%252Bshock%26aulast%3DDreas%26aufirst%3DAgnieszka%26date%3D2021%26volume%3D213%26spage%3D113057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hermann AM  Mucke</span>. </span><span class="cited-content_cbyCitation_article-title">Patent highlights October–November 2020. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Patent Analyst</span><span> <strong>2021,</strong> <em>10 </em>
                                    (2)
                                     , 51-58. <a href="https://doi.org/10.4155/ppa-2021-0003" title="DOI URL">https://doi.org/10.4155/ppa-2021-0003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/ppa-2021-0003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Fppa-2021-0003%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Patent%2520Analyst%26atitle%3DPatent%252Bhighlights%252BOctober%2525E2%252580%252593November%252B2020%26aulast%3DMucke%26aufirst%3DHermann%2BAM%26date%3D2021%26volume%3D10%26issue%3D2%26spage%3D51%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Douglas S.  Micalizzi</span>, <span class="hlFld-ContribAuthor ">Richard Y.  Ebright</span>, <span class="hlFld-ContribAuthor ">Daniel A.  Haber</span>, <span class="hlFld-ContribAuthor ">Shyamala  Maheswaran</span>. </span><span class="cited-content_cbyCitation_article-title">Translational Regulation of Cancer Metastasis. </span><span class="cited-content_cbyCitation_journal-name">Cancer Research</span><span> <strong>2021,</strong> <em>81 </em>
                                    (3)
                                     , 517-524. <a href="https://doi.org/10.1158/0008-5472.CAN-20-2720" title="DOI URL">https://doi.org/10.1158/0008-5472.CAN-20-2720</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/0008-5472.CAN-20-2720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F0008-5472.CAN-20-2720%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Research%26atitle%3DTranslational%252BRegulation%252Bof%252BCancer%252BMetastasis%26aulast%3DMicalizzi%26aufirst%3DDouglas%2BS.%26date%3D2021%26date%3D2021%26volume%3D81%26issue%3D3%26spage%3D517%26epage%3D524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingya  Yang</span>, <span class="hlFld-ContribAuthor ">Ganggang  Wang</span>, <span class="hlFld-ContribAuthor ">Hongyan  Zhou</span>, <span class="hlFld-ContribAuthor ">Zhifeng  Li</span>, <span class="hlFld-ContribAuthor ">Ben  Ma</span>, <span class="hlFld-ContribAuthor ">Menghui  Song</span>, <span class="hlFld-ContribAuthor ">Rongxia  Sun</span>, <span class="hlFld-ContribAuthor ">Congde  Huo</span>. </span><span class="cited-content_cbyCitation_article-title">Visible-light-promoted selective
              O
              -alkylation of 2-pyridones with α-aryldiazoacetates. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2021,</strong> <em>19 </em>
                                    (2)
                                     , 394-398. <a href="https://doi.org/10.1039/D0OB02350G" title="DOI URL">https://doi.org/10.1039/D0OB02350G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB02350G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB02350G%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DVisible-light-promoted%252Bselective%252BO%252B-alkylation%252Bof%252B2-pyridones%252Bwith%252B%2525CE%2525B1-aryldiazoacetates%26aulast%3DYang%26aufirst%3DJingya%26date%3D2021%26date%3D2021%26volume%3D19%26issue%3D2%26spage%3D394%26epage%3D398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianling  Xie</span>, <span class="hlFld-ContribAuthor ">Kaikai  Shen</span>, <span class="hlFld-ContribAuthor ">Ashley T.  Jones</span>, <span class="hlFld-ContribAuthor ">Jian  Yang</span>, <span class="hlFld-ContribAuthor ">Andrew R.  Tee</span>, <span class="hlFld-ContribAuthor ">Ming Hong  Shen</span>, <span class="hlFld-ContribAuthor ">Mengyuan  Yu</span>, <span class="hlFld-ContribAuthor ">Swati  Irani</span>, <span class="hlFld-ContribAuthor ">Derick  Wong</span>, <span class="hlFld-ContribAuthor ">James E.  Merrett</span>, <span class="hlFld-ContribAuthor ">Roman V.  Lenchine</span>, <span class="hlFld-ContribAuthor ">Stuart  De Poi</span>, <span class="hlFld-ContribAuthor ">Kirk B.  Jensen</span>, <span class="hlFld-ContribAuthor ">Paul J.  Trim</span>, <span class="hlFld-ContribAuthor ">Marten F.  Snel</span>, <span class="hlFld-ContribAuthor ">Makoto  Kamei</span>, <span class="hlFld-ContribAuthor ">Sally Kim  Martin</span>, <span class="hlFld-ContribAuthor ">Stephen  Fitter</span>, <span class="hlFld-ContribAuthor ">Shuye  Tian</span>, <span class="hlFld-ContribAuthor ">Xuemin  Wang</span>, <span class="hlFld-ContribAuthor ">Lisa M.  Butler</span>, <span class="hlFld-ContribAuthor ">Andrew C. W.  Zannettino</span>, <span class="hlFld-ContribAuthor ">Christopher G.  Proud</span>. </span><span class="cited-content_cbyCitation_article-title">Reciprocal signaling between mTORC1 and MNK2 controls cell growth and oncogenesis. </span><span class="cited-content_cbyCitation_journal-name">Cellular and Molecular Life Sciences</span><span> <strong>2021,</strong> <em>78 </em>
                                    (1)
                                     , 249-270. <a href="https://doi.org/10.1007/s00018-020-03491-1" title="DOI URL">https://doi.org/10.1007/s00018-020-03491-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00018-020-03491-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00018-020-03491-1%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520and%2520Molecular%2520Life%2520Sciences%26atitle%3DReciprocal%252Bsignaling%252Bbetween%252BmTORC1%252Band%252BMNK2%252Bcontrols%252Bcell%252Bgrowth%252Band%252Boncogenesis%26aulast%3DXie%26aufirst%3DJianling%26date%3D2021%26date%3D2020%26volume%3D78%26issue%3D1%26spage%3D249%26epage%3D270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muhammad Saad  Yousuf</span>, <span class="hlFld-ContribAuthor ">Stephanie I.  Shiers</span>, <span class="hlFld-ContribAuthor ">James J.  Sahn</span>, <span class="hlFld-ContribAuthor ">Theodore J.  Price</span>, . </span><span class="cited-content_cbyCitation_article-title">Pharmacological Manipulation of Translation as a Therapeutic Target for Chronic Pain. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Reviews</span><span> <strong>2021,</strong> <em>73 </em>
                                    (1)
                                     , 59-88. <a href="https://doi.org/10.1124/pharmrev.120.000030" title="DOI URL">https://doi.org/10.1124/pharmrev.120.000030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/pharmrev.120.000030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fpharmrev.120.000030%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Reviews%26atitle%3DPharmacological%252BManipulation%252Bof%252BTranslation%252Bas%252Ba%252BTherapeutic%252BTarget%252Bfor%252BChronic%252BPain%26aulast%3DYousuf%26aufirst%3DMuhammad%2BSaad%26date%3D2021%26date%3D2020%26volume%3D73%26issue%3D1%26spage%3D59%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed M  Abdelaziz</span>, <span class="hlFld-ContribAuthor ">Mingfeng  Yu</span>, <span class="hlFld-ContribAuthor ">Shudong  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Mnk inhibitors: a patent review. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Patent Analyst</span><span> <strong>2021,</strong> <em>10 </em>
                                    (1)
                                     , 25-35. <a href="https://doi.org/10.4155/ppa-2020-0028" title="DOI URL">https://doi.org/10.4155/ppa-2020-0028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/ppa-2020-0028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Fppa-2020-0028%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Patent%2520Analyst%26atitle%3DMnk%252Binhibitors%25253A%252Ba%252Bpatent%252Breview%26aulast%3DAbdelaziz%26aufirst%3DAhmed%2BM%26date%3D2021%26volume%3D10%26issue%3D1%26spage%3D25%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shi-Long  Jiang</span>, <span class="hlFld-ContribAuthor ">Jun-Luan  Mo</span>, <span class="hlFld-ContribAuthor ">Ji  Peng</span>, <span class="hlFld-ContribAuthor ">Lin  Lei</span>, <span class="hlFld-ContribAuthor ">Ji-Ye  Yin</span>, <span class="hlFld-ContribAuthor ">Hong-Hao  Zhou</span>, <span class="hlFld-ContribAuthor ">Zhao-Qian  Liu</span>, <span class="hlFld-ContribAuthor ">Wen-Xu  Hong</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting translation regulators improves cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Genomics</span><span> <strong>2021,</strong> <em>113 </em>
                                    (1)
                                     , 1247-1256. <a href="https://doi.org/10.1016/j.ygeno.2020.11.011" title="DOI URL">https://doi.org/10.1016/j.ygeno.2020.11.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ygeno.2020.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ygeno.2020.11.011%26sid%3Dliteratum%253Aachs%26jtitle%3DGenomics%26atitle%3DTargeting%252Btranslation%252Bregulators%252Bimproves%252Bcancer%252Btherapy%26aulast%3DJiang%26aufirst%3DShi-Long%26date%3D2021%26volume%3D113%26issue%3D1%26spage%3D1247%26epage%3D1256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lauren Y.  Sandeman</span>, <span class="hlFld-ContribAuthor ">Wan Xian  Kang</span>, <span class="hlFld-ContribAuthor ">Xuemin  Wang</span>, <span class="hlFld-ContribAuthor ">Kirk B.  Jensen</span>, <span class="hlFld-ContribAuthor ">Derick  Wong</span>, <span class="hlFld-ContribAuthor ">Tao  Bo</span>, <span class="hlFld-ContribAuthor ">Ling  Gao</span>, <span class="hlFld-ContribAuthor ">Jiajun  Zhao</span>, <span class="hlFld-ContribAuthor ">Christopher D.  Byrne</span>, <span class="hlFld-ContribAuthor ">Amanda J.  Page</span>, <span class="hlFld-ContribAuthor ">Christopher G.  Proud</span>. </span><span class="cited-content_cbyCitation_article-title">Disabling MNK protein kinases promotes oxidative metabolism and protects against diet-induced obesity. </span><span class="cited-content_cbyCitation_journal-name">Molecular Metabolism</span><span> <strong>2020,</strong> <em>42 </em>, 101054. <a href="https://doi.org/10.1016/j.molmet.2020.101054" title="DOI URL">https://doi.org/10.1016/j.molmet.2020.101054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molmet.2020.101054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molmet.2020.101054%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Metabolism%26atitle%3DDisabling%252BMNK%252Bprotein%252Bkinases%252Bpromotes%252Boxidative%252Bmetabolism%252Band%252Bprotects%252Bagainst%252Bdiet-induced%252Bobesity%26aulast%3DSandeman%26aufirst%3DLauren%2BY.%26date%3D2020%26volume%3D42%26spage%3D101054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Wu</span>, <span class="hlFld-ContribAuthor ">Jianling  Xie</span>, <span class="hlFld-ContribAuthor ">Xin  Jin</span>, <span class="hlFld-ContribAuthor ">Roman V.  Lenchine</span>, <span class="hlFld-ContribAuthor ">Xuemin  Wang</span>, <span class="hlFld-ContribAuthor ">Danielle M.  Fang</span>, <span class="hlFld-ContribAuthor ">Zeyad D.  Nassar</span>, <span class="hlFld-ContribAuthor ">Lisa M.  Butler</span>, <span class="hlFld-ContribAuthor ">Jing  Li</span>, <span class="hlFld-ContribAuthor ">Christopher G.  Proud</span>. </span><span class="cited-content_cbyCitation_article-title">eEF2K enhances expression of PD-L1 by promoting the translation of its mRNA. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Journal</span><span> <strong>2020,</strong> <em>477 </em>
                                    (22)
                                     , 4367-4381. <a href="https://doi.org/10.1042/BCJ20200697" title="DOI URL">https://doi.org/10.1042/BCJ20200697</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/BCJ20200697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FBCJ20200697%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Journal%26atitle%3DeEF2K%252Benhances%252Bexpression%252Bof%252BPD-L1%252Bby%252Bpromoting%252Bthe%252Btranslation%252Bof%252Bits%252BmRNA%26aulast%3DWu%26aufirst%3DYu%26date%3D2020%26date%3D2020%26volume%3D477%26issue%3D22%26spage%3D4367%26epage%3D4381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pradipta R.  Ray</span>, <span class="hlFld-ContribAuthor ">Andi  Wangzhou</span>, <span class="hlFld-ContribAuthor ">Nizar  Ghneim</span>, <span class="hlFld-ContribAuthor ">Muhammad S.  Yousuf</span>, <span class="hlFld-ContribAuthor ">Candler  Paige</span>, <span class="hlFld-ContribAuthor ">Diana  Tavares-Ferreira</span>, <span class="hlFld-ContribAuthor ">Juliet M.  Mwirigi</span>, <span class="hlFld-ContribAuthor ">Stephanie  Shiers</span>, <span class="hlFld-ContribAuthor ">Ishwarya  Sankaranarayanan</span>, <span class="hlFld-ContribAuthor ">Amelia J.  McFarland</span>, <span class="hlFld-ContribAuthor ">Sanjay V.  Neerukonda</span>, <span class="hlFld-ContribAuthor ">Steve  Davidson</span>, <span class="hlFld-ContribAuthor ">Gregory  Dussor</span>, <span class="hlFld-ContribAuthor ">Michael D.  Burton</span>, <span class="hlFld-ContribAuthor ">Theodore J.  Price</span>. </span><span class="cited-content_cbyCitation_article-title">A pharmacological interactome between COVID-19 patient samples and human sensory neurons reveals potential drivers of neurogenic pulmonary dysfunction. </span><span class="cited-content_cbyCitation_journal-name">Brain, Behavior, and Immunity</span><span> <strong>2020,</strong> <em>89 </em>, 559-568. <a href="https://doi.org/10.1016/j.bbi.2020.05.078" title="DOI URL">https://doi.org/10.1016/j.bbi.2020.05.078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbi.2020.05.078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbi.2020.05.078%26sid%3Dliteratum%253Aachs%26jtitle%3DBrain%252C%2520Behavior%252C%2520and%2520Immunity%26atitle%3DA%252Bpharmacological%252Binteractome%252Bbetween%252BCOVID-19%252Bpatient%252Bsamples%252Band%252Bhuman%252Bsensory%252Bneurons%252Breveals%252Bpotential%252Bdrivers%252Bof%252Bneurogenic%252Bpulmonary%252Bdysfunction%26aulast%3DRay%26aufirst%3DPradipta%2BR.%26date%3D2020%26volume%3D89%26spage%3D559%26epage%3D568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kun  Xing</span>, <span class="hlFld-ContribAuthor ">Jian  Zhang</span>, <span class="hlFld-ContribAuthor ">Yu  Han</span>, <span class="hlFld-ContribAuthor ">Tong  Tong</span>, <span class="hlFld-ContribAuthor ">Dan  Liu</span>, <span class="hlFld-ContribAuthor ">Linxiang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Bioactivity Evaluation of 4,6-Disubstituted Pyrido[3,2-d]pyrimidine Derivatives as Mnk and HDAC Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (18)
                                     , 4318. <a href="https://doi.org/10.3390/molecules25184318" title="DOI URL">https://doi.org/10.3390/molecules25184318</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25184318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25184318%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BBioactivity%252BEvaluation%252Bof%252B4%25252C6-Disubstituted%252BPyrido%25255B3%25252C2-d%25255Dpyrimidine%252BDerivatives%252Bas%252BMnk%252Band%252BHDAC%252BInhibitors%26aulast%3DXing%26aufirst%3DKun%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D18%26spage%3D4318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thao N.D.  Pham</span>, <span class="hlFld-ContribAuthor ">Christina  Spaulding</span>, <span class="hlFld-ContribAuthor ">Hidayatullah G.  Munshi</span>. </span><span class="cited-content_cbyCitation_article-title">Controlling TIME: How MNK Kinases Function to Shape Tumor Immunity. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (8)
                                     , 2096. <a href="https://doi.org/10.3390/cancers12082096" title="DOI URL">https://doi.org/10.3390/cancers12082096</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12082096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12082096%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DControlling%252BTIME%25253A%252BHow%252BMNK%252BKinases%252BFunction%252Bto%252BShape%252BTumor%252BImmunity%26aulast%3DPham%26aufirst%3DThao%2BN.D.%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D8%26spage%3D2096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James E.  Merrett</span>, <span class="hlFld-ContribAuthor ">Jianling  Xie</span>, <span class="hlFld-ContribAuthor ">Peter J.  Psaltis</span>, <span class="hlFld-ContribAuthor ">Christopher G.  Proud</span>. </span><span class="cited-content_cbyCitation_article-title">MAPK-interacting kinase 2 (MNK2) regulates adipocyte metabolism independently of its catalytic activity. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Journal</span><span> <strong>2020,</strong> <em>477 </em>
                                    (14)
                                     , 2735-2754. <a href="https://doi.org/10.1042/BCJ20200433" title="DOI URL">https://doi.org/10.1042/BCJ20200433</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/BCJ20200433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FBCJ20200433%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Journal%26atitle%3DMAPK-interacting%252Bkinase%252B2%252B%252528MNK2%252529%252Bregulates%252Badipocyte%252Bmetabolism%252Bindependently%252Bof%252Bits%252Bcatalytic%252Bactivity%26aulast%3DMerrett%26aufirst%3DJames%2BE.%26date%3D2020%26date%3D2020%26volume%3D477%26issue%3D14%26spage%3D2735%26epage%3D2754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vivek  Jeevakumar</span>, <span class="hlFld-ContribAuthor ">Aysha Khalid  Al Sardar</span>, <span class="hlFld-ContribAuthor ">Farah  Mohamed</span>, <span class="hlFld-ContribAuthor ">Clay Matthew  Smithhart</span>, <span class="hlFld-ContribAuthor ">Theodore  Price</span>, <span class="hlFld-ContribAuthor ">Gregory  Dussor</span>. </span><span class="cited-content_cbyCitation_article-title">IL-6 induced upregulation of T-type Ca
              2+
              currents and sensitization of DRG nociceptors is attenuated by MNK inhibition. </span><span class="cited-content_cbyCitation_journal-name">Journal of Neurophysiology</span><span> <strong>2020,</strong> <em>124 </em>
                                    (1)
                                     , 274-283. <a href="https://doi.org/10.1152/jn.00188.2020" title="DOI URL">https://doi.org/10.1152/jn.00188.2020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1152/jn.00188.2020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1152%2Fjn.00188.2020%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Neurophysiology%26atitle%3DIL-6%252Binduced%252Bupregulation%252Bof%252BT-type%252BCa%252B2%25252B%252Bcurrents%252Band%252Bsensitization%252Bof%252BDRG%252Bnociceptors%252Bis%252Battenuated%252Bby%252BMNK%252Binhibition%26aulast%3DJeevakumar%26aufirst%3DVivek%26date%3D2020%26volume%3D124%26issue%3D1%26spage%3D274%26epage%3D283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David C.  Young</span>, <span class="hlFld-ContribAuthor ">Mariusz  Tasior</span>, <span class="hlFld-ContribAuthor ">Adèle D.  Laurent</span>, <span class="hlFld-ContribAuthor ">Łukasz  Dobrzycki</span>, <span class="hlFld-ContribAuthor ">Michał K.  Cyrański</span>, <span class="hlFld-ContribAuthor ">Nikolai  Tkachenko</span>, <span class="hlFld-ContribAuthor ">Denis  Jacquemin</span>, <span class="hlFld-ContribAuthor ">Daniel T.  Gryko</span>. </span><span class="cited-content_cbyCitation_article-title">Photostable orange-red fluorescent unsymmetrical diketopyrrolopyrrole–BF
              2
              hybrids. </span><span class="cited-content_cbyCitation_journal-name">Journal of Materials Chemistry C</span><span> <strong>2020,</strong> <em>8 </em>
                                    (23)
                                     , 7708-7717. <a href="https://doi.org/10.1039/D0TC01202E" title="DOI URL">https://doi.org/10.1039/D0TC01202E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0TC01202E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0TC01202E%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Materials%2520Chemistry%2520C%26atitle%3DPhotostable%252Borange-red%252Bfluorescent%252Bunsymmetrical%252Bdiketopyrrolopyrrole%2525E2%252580%252593BF%252B2%252Bhybrids%26aulast%3DYoung%26aufirst%3DDavid%2BC.%26date%3D2020%26date%3D2020%26volume%3D8%26issue%3D23%26spage%3D7708%26epage%3D7717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefanie  Schmidt</span>, <span class="hlFld-ContribAuthor ">Sarah  Denk</span>, <span class="hlFld-ContribAuthor ">Armin  Wiegering</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Protein Synthesis in Colorectal Cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (5)
                                     , 1298. <a href="https://doi.org/10.3390/cancers12051298" title="DOI URL">https://doi.org/10.3390/cancers12051298</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12051298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12051298%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DTargeting%252BProtein%252BSynthesis%252Bin%252BColorectal%252BCancer%26aulast%3DSchmidt%26aufirst%3DStefanie%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D5%26spage%3D1298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Celia  Pinto-Díez</span>, <span class="hlFld-ContribAuthor ">Raquel  Ferreras-Martín</span>, <span class="hlFld-ContribAuthor ">Rebeca  Carrión-Marchante</span>, <span class="hlFld-ContribAuthor ">Víctor M.  González</span>, <span class="hlFld-ContribAuthor ">María Elena  Martín</span>. </span><span class="cited-content_cbyCitation_article-title">Deeping in the Role of the MAP-Kinases Interacting Kinases (MNKs) in Cancer. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (8)
                                     , 2967. <a href="https://doi.org/10.3390/ijms21082967" title="DOI URL">https://doi.org/10.3390/ijms21082967</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21082967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21082967%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DDeeping%252Bin%252Bthe%252BRole%252Bof%252Bthe%252BMAP-Kinases%252BInteracting%252BKinases%252B%252528MNKs%252529%252Bin%252BCancer%26aulast%3DPinto-D%25C3%25ADez%26aufirst%3DCelia%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D8%26spage%3D2967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joe  Taylor</span>, <span class="hlFld-ContribAuthor ">Alison M  Yeomans</span>, <span class="hlFld-ContribAuthor ">Graham  Packham</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted inhibition of mRNA translation initiation factors as a novel therapeutic strategy for mature B-cell neoplasms. </span><span class="cited-content_cbyCitation_journal-name">Exploration of Targeted Anti-tumor Therapy</span><span> <strong>2020,</strong> <em>1 </em>
                                    (1)
                                     , 3-25. <a href="https://doi.org/10.37349/etat.2020.00002" title="DOI URL">https://doi.org/10.37349/etat.2020.00002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.37349/etat.2020.00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.37349%2Fetat.2020.00002%26sid%3Dliteratum%253Aachs%26jtitle%3DExploration%2520of%2520Targeted%2520Anti-tumor%2520Therapy%26atitle%3DTargeted%252Binhibition%252Bof%252BmRNA%252Btranslation%252Binitiation%252Bfactors%252Bas%252Ba%252Bnovel%252Btherapeutic%252Bstrategy%252Bfor%252Bmature%252BB-cell%252Bneoplasms%26aulast%3DTaylor%26aufirst%3DJoe%26date%3D2020%26date%3D2020%26volume%3D1%26issue%3D1%26spage%3D3%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephanie  Shiers</span>, <span class="hlFld-ContribAuthor ">Juliet  Mwirigi</span>, <span class="hlFld-ContribAuthor ">Grishma  Pradhan</span>, <span class="hlFld-ContribAuthor ">Moeno  Kume</span>, <span class="hlFld-ContribAuthor ">Bryan  Black</span>, <span class="hlFld-ContribAuthor ">Paulino  Barragan-Iglesias</span>, <span class="hlFld-ContribAuthor ">Jamie K.  Moy</span>, <span class="hlFld-ContribAuthor ">Gregory  Dussor</span>, <span class="hlFld-ContribAuthor ">Joseph J.  Pancrazio</span>, <span class="hlFld-ContribAuthor ">Sven  Kroener</span>, <span class="hlFld-ContribAuthor ">Theodore J.  Price</span>. </span><span class="cited-content_cbyCitation_article-title">Reversal of peripheral nerve injury-induced neuropathic pain and cognitive dysfunction via genetic and tomivosertib targeting of MNK. </span><span class="cited-content_cbyCitation_journal-name">Neuropsychopharmacology</span><span> <strong>2020,</strong> <em>45 </em>
                                    (3)
                                     , 524-533. <a href="https://doi.org/10.1038/s41386-019-0537-y" title="DOI URL">https://doi.org/10.1038/s41386-019-0537-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41386-019-0537-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41386-019-0537-y%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropsychopharmacology%26atitle%3DReversal%252Bof%252Bperipheral%252Bnerve%252Binjury-induced%252Bneuropathic%252Bpain%252Band%252Bcognitive%252Bdysfunction%252Bvia%252Bgenetic%252Band%252Btomivosertib%252Btargeting%252Bof%252BMNK%26aulast%3DShiers%26aufirst%3DStephanie%26date%3D2020%26date%3D2019%26volume%3D45%26issue%3D3%26spage%3D524%26epage%3D533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K. Alison  Rinderspacher</span>. </span><span class="cited-content_cbyCitation_article-title">Six-Membered Ring Systems: Diazines and Benzo Derivatives. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 465-504. <a href="https://doi.org/10.1016/B978-0-12-819962-6.00013-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-819962-6.00013-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-819962-6.00013-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-819962-6.00013-0%26sid%3Dliteratum%253Aachs%26atitle%3DSix-Membered%252BRing%252BSystems%25253A%252BDiazines%252Band%252BBenzo%252BDerivatives%26aulast%3DRinderspacher%26aufirst%3DK.%2BAlison%26date%3D2020%26spage%3D465%26epage%3D504%26pub%3DElsevier%26date%3D2020%26volume%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jilly F.  Evans</span>, <span class="hlFld-ContribAuthor ">Ryan W.  Rue</span>, <span class="hlFld-ContribAuthor ">Alexander R.  Mukhitov</span>, <span class="hlFld-ContribAuthor ">Kseniya  Obraztsova</span>, <span class="hlFld-ContribAuthor ">Carly J.  Smith</span>, <span class="hlFld-ContribAuthor ">Vera P.  Krymskaya</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of Growth of TSC2-Null Cells by a PI3K/mTOR Inhibitor but Not by a Selective MNK1/2 Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     , 28. <a href="https://doi.org/10.3390/biom10010028" title="DOI URL">https://doi.org/10.3390/biom10010028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom10010028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom10010028%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DInhibition%252Bof%252BGrowth%252Bof%252BTSC2-Null%252BCells%252Bby%252Ba%252BPI3K%25252FmTOR%252BInhibitor%252Bbut%252BNot%252Bby%252Ba%252BSelective%252BMNK1%25252F2%252BInhibitor%26aulast%3DEvans%26aufirst%3DJilly%2BF.%26date%3D2020%26date%3D2019%26volume%3D10%26issue%3D1%26spage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandra M.  Mihail</span>, <span class="hlFld-ContribAuthor ">Andi  Wangzhou</span>, <span class="hlFld-ContribAuthor ">Kumud K.  Kunjilwar</span>, <span class="hlFld-ContribAuthor ">Jamie K.  Moy</span>, <span class="hlFld-ContribAuthor ">Gregory  Dussor</span>, <span class="hlFld-ContribAuthor ">Edgar T.  Walters</span>, <span class="hlFld-ContribAuthor ">Theodore J.  Price</span>. </span><span class="cited-content_cbyCitation_article-title">MNK-eIF4E signalling is a highly conserved mechanism for sensory neuron axonal plasticity: evidence from
              Aplysia californica. </span><span class="cited-content_cbyCitation_journal-name">Philosophical Transactions of the Royal Society B: Biological Sciences</span><span> <strong>2019,</strong> <em>374 </em>
                                    (1785)
                                     , 20190289. <a href="https://doi.org/10.1098/rstb.2019.0289" title="DOI URL">https://doi.org/10.1098/rstb.2019.0289</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1098/rstb.2019.0289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1098%2Frstb.2019.0289%26sid%3Dliteratum%253Aachs%26jtitle%3DPhilosophical%2520Transactions%2520of%2520the%2520Royal%2520Society%2520B%253A%2520Biological%2520Sciences%26atitle%3DMNK-eIF4E%252Bsignalling%252Bis%252Ba%252Bhighly%252Bconserved%252Bmechanism%252Bfor%252Bsensory%252Bneuron%252Baxonal%252Bplasticity%25253A%252Bevidence%252Bfrom%252BAplysia%252Bcalifornica%26aulast%3DMihail%26aufirst%3DSandra%2BM.%26date%3D2019%26date%3D2019%26volume%3D374%26issue%3D1785%26spage%3D20190289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ashley  Jarvis</span>, <span class="hlFld-ContribAuthor ">Gilles  Ouvry</span>. </span><span class="cited-content_cbyCitation_article-title">Essential ingredients for rational drug design. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (20)
                                     , 126674. <a href="https://doi.org/10.1016/j.bmcl.2019.126674" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126674</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126674%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DEssential%252Bingredients%252Bfor%252Brational%252Bdrug%252Bdesign%26aulast%3DJarvis%26aufirst%3DAshley%26date%3D2019%26volume%3D29%26issue%3D20%26spage%3D126674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Theodore J  Price</span>, <span class="hlFld-ContribAuthor ">Pradipta R  Ray</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances toward understanding the mysteries of the acute to chronic pain transition. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Physiology</span><span> <strong>2019,</strong> <em>11 </em>, 42-50. <a href="https://doi.org/10.1016/j.cophys.2019.05.015" title="DOI URL">https://doi.org/10.1016/j.cophys.2019.05.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cophys.2019.05.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cophys.2019.05.015%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Physiology%26atitle%3DRecent%252Badvances%252Btoward%252Bunderstanding%252Bthe%252Bmysteries%252Bof%252Bthe%252Bacute%252Bto%252Bchronic%252Bpain%252Btransition%26aulast%3DPrice%26aufirst%3DTheodore%2BJ%26date%3D2019%26volume%3D11%26spage%3D42%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rama K.  Mishra</span>, <span class="hlFld-ContribAuthor ">Matthew R.  Clutter</span>, <span class="hlFld-ContribAuthor ">Gavin T.  Blyth</span>, <span class="hlFld-ContribAuthor ">Ewa M.  Kosciuczuk</span>, <span class="hlFld-ContribAuthor ">Amy Z.  Blackburn</span>, <span class="hlFld-ContribAuthor ">Elspeth M.  Beauchamp</span>, <span class="hlFld-ContribAuthor ">Gary E.  Schiltz</span>, <span class="hlFld-ContribAuthor ">Leonidas C.  Platanias</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel Mnk inhibitors using mutation‐based induced‐fit virtual high‐throughput screening. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2019,</strong> <em>94 </em>
                                    (4)
                                     , 1813-1823. <a href="https://doi.org/10.1111/cbdd.13585" title="DOI URL">https://doi.org/10.1111/cbdd.13585</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13585%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DDiscovery%252Bof%252Bnovel%252BMnk%252Binhibitors%252Busing%252Bmutation%2525E2%252580%252590based%252Binduced%2525E2%252580%252590fit%252Bvirtual%252Bhigh%2525E2%252580%252590throughput%252Bscreening%26aulast%3DMishra%26aufirst%3DRama%2BK.%26date%3D2019%26date%3D2019%26volume%3D94%26issue%3D4%26spage%3D1813%26epage%3D1823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed M.  Abdelaziz</span>, <span class="hlFld-ContribAuthor ">Sunita K.C.  Basnet</span>, <span class="hlFld-ContribAuthor ">Saiful  Islam</span>, <span class="hlFld-ContribAuthor ">Manjun  Li</span>, <span class="hlFld-ContribAuthor ">Solomon  Tadesse</span>, <span class="hlFld-ContribAuthor ">Hugo  Albrecht</span>, <span class="hlFld-ContribAuthor ">Cobus  Gerber</span>, <span class="hlFld-ContribAuthor ">Mingfeng  Yu</span>, <span class="hlFld-ContribAuthor ">Shudong  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of 2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione derivatives as Mnk inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (18)
                                     , 2650-2654. <a href="https://doi.org/10.1016/j.bmcl.2019.07.043" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.07.043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.07.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.07.043%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252B2%2525E2%252580%2525B2H-spiro%25255Bcyclohexane-1%25252C3%2525E2%252580%2525B2-imidazo%25255B1%25252C5-a%25255Dpyridine%25255D-1%2525E2%252580%2525B2%25252C5%2525E2%252580%2525B2-dione%252Bderivatives%252Bas%252BMnk%252Binhibitors%26aulast%3DAbdelaziz%26aufirst%3DAhmed%2BM.%26date%3D2019%26volume%3D29%26issue%3D18%26spage%3D2650%26epage%3D2654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed M.  Abdelaziz</span>, <span class="hlFld-ContribAuthor ">Sarah  Diab</span>, <span class="hlFld-ContribAuthor ">Saiful  Islam</span>, <span class="hlFld-ContribAuthor ">Sunita K.C.  Basnet</span>, <span class="hlFld-ContribAuthor ">Benjamin  Noll</span>, <span class="hlFld-ContribAuthor ">Peng  Li</span>, <span class="hlFld-ContribAuthor ">Laychiluh B.  Mekonnen</span>, <span class="hlFld-ContribAuthor ">Jingfeng  Lu</span>, <span class="hlFld-ContribAuthor ">Hugo  Albrecht</span>, <span class="hlFld-ContribAuthor ">Robert W.  Milne</span>, <span class="hlFld-ContribAuthor ">Cobus  Gerber</span>, <span class="hlFld-ContribAuthor ">Mingfeng  Yu</span>, <span class="hlFld-ContribAuthor ">Shudong  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of N-Phenyl-4-(1H-pyrrol-3-yl)pyrimidin-2-amine Derivatives as Potent Mnk2 Inhibitors: Design, Synthesis, SAR Analysis, and Evaluation of in vitro Anti-leukaemic Activity. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry</span><span> <strong>2019,</strong> <em>15 </em>
                                    (6)
                                     , 602-623. <a href="https://doi.org/10.2174/1573406415666181219111511" title="DOI URL">https://doi.org/10.2174/1573406415666181219111511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1573406415666181219111511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1573406415666181219111511%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BN-Phenyl-4-%2525281H-pyrrol-3-yl%252529pyrimidin-2-amine%252BDerivatives%252Bas%252BPotent%252BMnk2%252BInhibitors%25253A%252BDesign%25252C%252BSynthesis%25252C%252BSAR%252BAnalysis%25252C%252Band%252BEvaluation%252Bof%252Bin%252Bvitro%252BAnti-leukaemic%252BActivity%26aulast%3DAbdelaziz%26aufirst%3DAhmed%2BM.%26date%3D2019%26volume%3D15%26issue%3D6%26spage%3D602%26epage%3D623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yasushi  Yoshida</span>, <span class="hlFld-ContribAuthor ">Kazuki  Omori</span>, <span class="hlFld-ContribAuthor ">Tomohiko  Hiroshige</span>, <span class="hlFld-ContribAuthor ">Takashi  Mino</span>, <span class="hlFld-ContribAuthor ">Masami  Sakamoto</span>. </span><span class="cited-content_cbyCitation_article-title">Chemoselective Catalytic Asymmetric Synthesis of Functionalized Aminals Through the Umpolung Organocascade Reaction of α‐Imino Amides. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – An Asian Journal</span><span> <strong>2019,</strong> <em>14 </em>
                                    (15)
                                     , 2737-2743. <a href="https://doi.org/10.1002/asia.201900764" title="DOI URL">https://doi.org/10.1002/asia.201900764</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/asia.201900764&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fasia.201900764%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520An%2520Asian%2520Journal%26atitle%3DChemoselective%252BCatalytic%252BAsymmetric%252BSynthesis%252Bof%252BFunctionalized%252BAminals%252BThrough%252Bthe%252BUmpolung%252BOrganocascade%252BReaction%252Bof%252B%2525CE%2525B1%2525E2%252580%252590Imino%252BAmides%26aulast%3DYoshida%26aufirst%3DYasushi%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D15%26spage%3D2737%26epage%3D2743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ipsita  Pal</span>, <span class="hlFld-ContribAuthor ">Maryam  Safari</span>, <span class="hlFld-ContribAuthor ">Marko  Jovanovic</span>, <span class="hlFld-ContribAuthor ">Susan E.  Bates</span>, <span class="hlFld-ContribAuthor ">Changchun  Deng</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Translation of mRNA as a Therapeutic Strategy in Cancer. </span><span class="cited-content_cbyCitation_journal-name">Current Hematologic Malignancy Reports</span><span> <strong>2019,</strong> <em>14 </em>
                                    (4)
                                     , 219-227. <a href="https://doi.org/10.1007/s11899-019-00530-y" title="DOI URL">https://doi.org/10.1007/s11899-019-00530-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11899-019-00530-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11899-019-00530-y%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Hematologic%2520Malignancy%2520Reports%26atitle%3DTargeting%252BTranslation%252Bof%252BmRNA%252Bas%252Ba%252BTherapeutic%252BStrategy%252Bin%252BCancer%26aulast%3DPal%26aufirst%3DIpsita%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D4%26spage%3D219%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonathan  Oliva</span>, <span class="hlFld-ContribAuthor ">Scott  Galasinski</span>, <span class="hlFld-ContribAuthor ">Amelia  Richey</span>, <span class="hlFld-ContribAuthor ">Amy E.  Campbell</span>, <span class="hlFld-ContribAuthor ">Marvin J.  Meyers</span>, <span class="hlFld-ContribAuthor ">Neal  Modi</span>, <span class="hlFld-ContribAuthor ">Jun Wen  Zhong</span>, <span class="hlFld-ContribAuthor ">Rabi  Tawil</span>, <span class="hlFld-ContribAuthor ">Stephen J.  Tapscott</span>, <span class="hlFld-ContribAuthor ">Francis M.  Sverdrup</span>. </span><span class="cited-content_cbyCitation_article-title">Clinically Advanced p38 Inhibitors Suppress DUX4 Expression in Cellular and Animal Models of Facioscapulohumeral Muscular Dystrophy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2019,</strong> <em>370 </em>
                                    (2)
                                     , 219-230. <a href="https://doi.org/10.1124/jpet.119.259663" title="DOI URL">https://doi.org/10.1124/jpet.119.259663</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.119.259663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.119.259663%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DClinically%252BAdvanced%252Bp38%252BInhibitors%252BSuppress%252BDUX4%252BExpression%252Bin%252BCellular%252Band%252BAnimal%252BModels%252Bof%252BFacioscapulohumeral%252BMuscular%252BDystrophy%26aulast%3DOliva%26aufirst%3DJonathan%26date%3D2019%26date%3D2019%26volume%3D370%26issue%3D2%26spage%3D219%26epage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min  Zhang</span>, <span class="hlFld-ContribAuthor ">Li  Jiang</span>, <span class="hlFld-ContribAuthor ">Jia  Tao</span>, <span class="hlFld-ContribAuthor ">Zhaoping  Pan</span>, <span class="hlFld-ContribAuthor ">Mingyao  He</span>, <span class="hlFld-ContribAuthor ">Dongyuan  Su</span>, <span class="hlFld-ContribAuthor ">Gu  He</span>, <span class="hlFld-ContribAuthor ">Qinglin  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of 4-aniline-thieno[2,3-d]pyrimidine derivatives as MNK1 inhibitors against renal cell carcinoma and nasopharyngeal carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (11)
                                     , 2268-2279. <a href="https://doi.org/10.1016/j.bmc.2019.04.022" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.04.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.04.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.04.022%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B4-aniline-thieno%25255B2%25252C3-d%25255Dpyrimidine%252Bderivatives%252Bas%252BMNK1%252Binhibitors%252Bagainst%252Brenal%252Bcell%252Bcarcinoma%252Band%252Bnasopharyngeal%252Bcarcinoma%26aulast%3DZhang%26aufirst%3DMin%26date%3D2019%26volume%3D27%26issue%3D11%26spage%3D2268%26epage%3D2279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xinrui  Yuan</span>, <span class="hlFld-ContribAuthor ">Hanshu  Wu</span>, <span class="hlFld-ContribAuthor ">Hong  Bu</span>, <span class="hlFld-ContribAuthor ">Peiyuan  Zheng</span>, <span class="hlFld-ContribAuthor ">Jinpei  Zhou</span>, <span class="hlFld-ContribAuthor ">Huibin  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of pyridone–aminal derivatives as MNK1/2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (7)
                                     , 1211-1225. <a href="https://doi.org/10.1016/j.bmc.2019.02.007" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.02.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.02.007%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bpyridone%2525E2%252580%252593aminal%252Bderivatives%252Bas%252BMNK1%25252F2%252Binhibitors%26aulast%3DYuan%26aufirst%3DXinrui%26date%3D2019%26volume%3D27%26issue%3D7%26spage%3D1211%26epage%3D1225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianling  Xie</span>, <span class="hlFld-ContribAuthor ">James E.  Merrett</span>, <span class="hlFld-ContribAuthor ">Kirk B.  Jensen</span>, <span class="hlFld-ContribAuthor ">Christopher G.  Proud</span>. </span><span class="cited-content_cbyCitation_article-title">The MAP kinase-interacting kinases (MNKs) as targets in oncology. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Targets</span><span> <strong>2019,</strong> <em>23 </em>
                                    (3)
                                     , 187-199. <a href="https://doi.org/10.1080/14728222.2019.1571043" title="DOI URL">https://doi.org/10.1080/14728222.2019.1571043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14728222.2019.1571043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14728222.2019.1571043%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Targets%26atitle%3DThe%252BMAP%252Bkinase-interacting%252Bkinases%252B%252528MNKs%252529%252Bas%252Btargets%252Bin%252Boncology%26aulast%3DXie%26aufirst%3DJianling%26date%3D2019%26date%3D2019%26volume%3D23%26issue%3D3%26spage%3D187%26epage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Senthilmurugan  Ramalingam</span>, <span class="hlFld-ContribAuthor ">Vidya  Ramamurthy</span>, <span class="hlFld-ContribAuthor ">Lalji  Gediya</span>, <span class="hlFld-ContribAuthor ">Francis  Murigi</span>, <span class="hlFld-ContribAuthor ">Puranik  Purushottamachar</span>, <span class="hlFld-ContribAuthor ">Weiliang  Huang</span>, <span class="hlFld-ContribAuthor ">Eun  Choi</span>, <span class="hlFld-ContribAuthor ">Yuji  Zhang</span>, <span class="hlFld-ContribAuthor ">Tadas  Vasaitis</span>, <span class="hlFld-ContribAuthor ">Maureen  Kane</span>, <span class="hlFld-ContribAuthor ">Rena  Lapidus</span>, <span class="hlFld-ContribAuthor ">Vincent  Njar</span>. </span><span class="cited-content_cbyCitation_article-title">The Novel Mnk1/2 Degrader and Apoptosis Inducer VNLG-152 Potently Inhibits TNBC Tumor Growth and Metastasis. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2019,</strong> <em>11 </em>
                                    (3)
                                     , 299. <a href="https://doi.org/10.3390/cancers11030299" title="DOI URL">https://doi.org/10.3390/cancers11030299</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers11030299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers11030299%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DThe%252BNovel%252BMnk1%25252F2%252BDegrader%252Band%252BApoptosis%252BInducer%252BVNLG-152%252BPotently%252BInhibits%252BTNBC%252BTumor%252BGrowth%252Band%252BMetastasis%26aulast%3DRamalingam%26aufirst%3DSenthilmurugan%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D3%26spage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guangyang  Xu</span>, <span class="hlFld-ContribAuthor ">Ping  Chen</span>, <span class="hlFld-ContribAuthor ">Pei  Liu</span>, <span class="hlFld-ContribAuthor ">Shengbiao  Tang</span>, <span class="hlFld-ContribAuthor ">Xinhao  Zhang</span>, <span class="hlFld-ContribAuthor ">Jiangtao  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Access to N-Substituted 2-Pyridones by Catalytic Intermolecular Dearomatization and 1,4-Acyl Transfer. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2019,</strong> <em>131 </em>
                                    (7)
                                     , 2002-2006. <a href="https://doi.org/10.1002/ange.201812937" title="DOI URL">https://doi.org/10.1002/ange.201812937</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201812937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201812937%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DAccess%252Bto%252BN-Substituted%252B2-Pyridones%252Bby%252BCatalytic%252BIntermolecular%252BDearomatization%252Band%252B1%25252C4-Acyl%252BTransfer%26aulast%3DXu%26aufirst%3DGuangyang%26date%3D2019%26date%3D2018%26volume%3D131%26issue%3D7%26spage%3D2002%26epage%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guangyang  Xu</span>, <span class="hlFld-ContribAuthor ">Ping  Chen</span>, <span class="hlFld-ContribAuthor ">Pei  Liu</span>, <span class="hlFld-ContribAuthor ">Shengbiao  Tang</span>, <span class="hlFld-ContribAuthor ">Xinhao  Zhang</span>, <span class="hlFld-ContribAuthor ">Jiangtao  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Access to N-Substituted 2-Pyridones by Catalytic Intermolecular Dearomatization and 1,4-Acyl Transfer. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2019,</strong> <em>58 </em>
                                    (7)
                                     , 1980-1984. <a href="https://doi.org/10.1002/anie.201812937" title="DOI URL">https://doi.org/10.1002/anie.201812937</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201812937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201812937%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DAccess%252Bto%252BN-Substituted%252B2-Pyridones%252Bby%252BCatalytic%252BIntermolecular%252BDearomatization%252Band%252B1%25252C4-Acyl%252BTransfer%26aulast%3DXu%26aufirst%3DGuangyang%26date%3D2019%26date%3D2018%26volume%3D58%26issue%3D7%26spage%3D1980%26epage%3D1984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yichen  Xu</span>, <span class="hlFld-ContribAuthor ">Mauro  Poggio</span>, <span class="hlFld-ContribAuthor ">Hyun Yong  Jin</span>, <span class="hlFld-ContribAuthor ">Zhen  Shi</span>, <span class="hlFld-ContribAuthor ">Craig M.  Forester</span>, <span class="hlFld-ContribAuthor ">Ying  Wang</span>, <span class="hlFld-ContribAuthor ">Craig R.  Stumpf</span>, <span class="hlFld-ContribAuthor ">Lingru  Xue</span>, <span class="hlFld-ContribAuthor ">Emily  Devericks</span>, <span class="hlFld-ContribAuthor ">Lomon  So</span>, <span class="hlFld-ContribAuthor ">Hao G.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Alice  Griselin</span>, <span class="hlFld-ContribAuthor ">John D.  Gordan</span>, <span class="hlFld-ContribAuthor ">Sarah E  Umetsu</span>, <span class="hlFld-ContribAuthor ">Siegfried H.  Reich</span>, <span class="hlFld-ContribAuthor ">Stephen T.  Worland</span>, <span class="hlFld-ContribAuthor ">Saurabh  Asthana</span>, <span class="hlFld-ContribAuthor ">Maria  Barna</span>, <span class="hlFld-ContribAuthor ">Kevin R.  Webster</span>, <span class="hlFld-ContribAuthor ">John T.  Cunningham</span>, <span class="hlFld-ContribAuthor ">Davide  Ruggero</span>. </span><span class="cited-content_cbyCitation_article-title">Translation control of the immune checkpoint in cancer and its therapeutic targeting. </span><span class="cited-content_cbyCitation_journal-name">Nature Medicine</span><span> <strong>2019,</strong> <em>25 </em>
                                    (2)
                                     , 301-311. <a href="https://doi.org/10.1038/s41591-018-0321-2" title="DOI URL">https://doi.org/10.1038/s41591-018-0321-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41591-018-0321-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41591-018-0321-2%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Medicine%26atitle%3DTranslation%252Bcontrol%252Bof%252Bthe%252Bimmune%252Bcheckpoint%252Bin%252Bcancer%252Band%252Bits%252Btherapeutic%252Btargeting%26aulast%3DXu%26aufirst%3DYichen%26date%3D2019%26date%3D2019%26volume%3D25%26issue%3D2%26spage%3D301%26epage%3D311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sonali  Uttam</span>, <span class="hlFld-ContribAuthor ">Calvin  Wong</span>, <span class="hlFld-ContribAuthor ">Theodore J.  Price</span>, <span class="hlFld-ContribAuthor ">Arkady  Khoutorsky</span>. </span><span class="cited-content_cbyCitation_article-title">eIF4E-Dependent Translational Control: A Central Mechanism for Regulation of Pain Plasticity. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Genetics</span><span> <strong>2018,</strong> <em>9 </em><a href="https://doi.org/10.3389/fgene.2018.00470" title="DOI URL">https://doi.org/10.3389/fgene.2018.00470</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fgene.2018.00470&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffgene.2018.00470%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Genetics%26atitle%3DeIF4E-Dependent%252BTranslational%252BControl%25253A%252BA%252BCentral%252BMechanism%252Bfor%252BRegulation%252Bof%252BPain%252BPlasticity%26aulast%3DUttam%26aufirst%3DSonali%26date%3D2018%26date%3D2018%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Supojjanee  Sansook</span>, <span class="hlFld-ContribAuthor ">Ella  Lineham</span>, <span class="hlFld-ContribAuthor ">Storm  Hassell-Hart</span>, <span class="hlFld-ContribAuthor ">Graham J.  Tizzard</span>, <span class="hlFld-ContribAuthor ">Simon J.  Coles</span>, <span class="hlFld-ContribAuthor ">John  Spencer</span>, <span class="hlFld-ContribAuthor ">Simon J.  Morley</span>. </span><span class="cited-content_cbyCitation_article-title">Probing the Anticancer Action of Novel Ferrocene Analogues of MNK Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (9)
                                     , 2126. <a href="https://doi.org/10.3390/molecules23092126" title="DOI URL">https://doi.org/10.3390/molecules23092126</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23092126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23092126%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DProbing%252Bthe%252BAnticancer%252BAction%252Bof%252BNovel%252BFerrocene%252BAnalogues%252Bof%252BMNK%252BInhibitors%26aulast%3DSansook%26aufirst%3DSupojjanee%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D9%26spage%3D2126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/medium/jm-2017-01795d_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01795&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/medium/jm-2017-01795d_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0001.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Translation is a tightly controlled process for a select set of mRNAs and dysregulation of this process drives aberrant proliferation, angiogenesis, survival, and alterations in immune function, all hallmarks of cancer. The key step of cap-dependent translation initiation by the eIF4F complex relies upon the availability of eukaryotic initiation factor eIF4E, which is in turn regulated by the mitogen-activated protein kinase interacting kinases MNK1/2. The MNKs are key regulators of mRNA translation integrating signals from oncogenic and immune signaling pathways (Ras, p38, TCR, and TLRs).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01795&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/medium/jm-2017-01795d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0002.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Crystal structures were obtained with MNK2 mutated to the canonical DFG from DFD to facilitate cocrystallization experiments.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> (A) Cocrystal structure showing the MNK2 active site with carboxamide <b>1</b> bound along with its binding data (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CJE">6CJE</a>). The surface representation of the electrostatic potential of Phe159 was calculated by DFT using the B3LYP method employing the 6-31G* basis set with Spartan (Wavefunction). (B) MNK2 crystal structure and binding data of compound <b>2</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CJW">6CJW</a>). (C) Compound <b>3</b> structure and data (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CJH">6CJH</a>). (D) One conformation of the compound <b>4</b> cocrystal structure along with its binding data (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CJ5">6CJ5</a>). (E,F) Two-dimensional structures and data for the compounds for which a cocrystal structure with MNK2 was not obtained, <b>5</b> and <b>6</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01795&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/medium/jm-2017-01795d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0003.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Trajectory of the series based on each of the starting molecules. Plot generated by only showing data for compounds that improve potency over the proceeding compounds, otherwise the previous molecules data was plotted (an exception was made for the Cmpd 1 Series where the first loss in potency from deconstruction is plotted).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01795&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/medium/jm-2017-01795d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0004.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Comparison of the binding modes from cocrystal structures of compounds <b>8</b> (green, PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CJY">6CJY</a>) and <b>9</b> (salmon, PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CK3">6CK3</a>) confirming the ring flip and orientation of the sp<sup>3</sup> substituent toward the p-loop of MNK (p-loop located above the plane and not shown for clarity). The distance to the hinge Met226 NH for compound <b>9</b> was 3 Å vs 3.5 Å for compound <b>8</b> suggesting improved binding. The figure was generated by overlapping the protein C-alphas for each cocrystal structure of compounds <b>8</b> and <b>9</b>; only the protein for compound <b>9</b> is displayed.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01795&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/medium/jm-2017-01795d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0005.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Depiction of the Dunitz interaction between a sulfur atom and the LUMO of an amide bond as found in compound <b>11</b>. (B) Crystal structure of compound <b>12</b> bound to MNK2 showing the interaction of the Cys225 sulfur with the carbonyl carbon of the pyridone (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CKI">6CKI</a>). (C) Visual depiction of the kinome selectivity difference between compounds <b>10</b> and <b>12</b> (see data in <a href="/doi/suppl/10.1021/acs.jmedchem.7b01795/suppl_file/jm7b01795_si_002.pdf" class="ext-link">Table S3</a>). The plot shows the MNK2% inhibition of the first 100 kinases in a 419 kinase panel screen of compounds <b>10</b> and <b>12</b> at 1 μM. For each compound, the kinases were sorted by percent inhibition, numbered from 1 to 419, and the % inhibition for each is plotted by kinase number. Green vertical lines indicate MNK1 and MNK2 for each profile. The plot shows the first 100 kinases and reveals that area under the curve described by compound <b>12</b> is 20% less than that of compound <b>10</b>. In addition, compound <b>12</b> at 1 μM inhibited MNK1 and MNK2 at 83 and 68%, respectively, while inhibiting only five other kinases >40% and one at 86%. Conversely, compound <b>10</b> in the same experiment inhibited MNK1 and 2 at 84 and 66%, respectively, but inhibited nine other kinases >40% and two at 100 and 91%, respectively. A similar trend was observed for other pyridone/benzene pairs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01795&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/medium/jm-2017-01795d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0006.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Facile formation of stable pyridone–aminal via acid-catalyzed ketone condensation. (B) Properties of the structure-guided focused pyridone library (80 compounds). Note that the compounds that are exceptionally potent fall in the area of higher logP and molecular weight noted in light blue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01795&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/medium/jm-2017-01795d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0007.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) Cocrystal structure of <b>23</b> bound to MNK2 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CK6">6CK6</a>). Compound <b>23</b> makes H-bond interactions with both hinge residues, Lys161 and Met162. The pyridone methyl interacts with the face of Phe159, and the Cys225 sulfur makes a similar Dunitz interaction as seen for compound <b>12</b> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B). In addition, the five-membered ring amide nitrogen interacts with Asp226. (B) Kinome plot depicting the selectivity of <b>23</b> across >400 kinases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01795&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/medium/jm-2017-01795d_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0023.jpeg" id="rightTab-gr101" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Plot showing the biochemical MNK IC<sub>50</sub> for compounds in the diarylamine series (including both pyridones and nonpyridones) leading up to <b>23</b>. The roadmap for the key molecules discussed in the text (circled in green) highlighting strategic potency loss (red vertical lines) and the key contenders for the candidate selection (circled in purple). Strategic potency losses: (A) Deconstruction of the hinge binder (increase in novelty); (B) incorporation of the pyridone (shift to lower logP); and (C) replacement of the 5-chloro on the pyridone ring with methyl (selectivity improvement). Note that for all of these key changes, the corresponding LE and LLE were largely maintained throughout the optimization.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01795&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/medium/jm-2017-01795d_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0008.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Compound <b>23</b> and some of its key properties.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01795&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/medium/jm-2017-01795d_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0009.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Compound <b>23</b> inhibits MNK signaling and the production of pro-inflammatory cytokines important for tumorigenesis. (A) TMD8 cells were treated with the indicated concentrations of <b>23</b> for 2 h. Cell lysates were analyzed by immunoblotting with the indicated antibodies. (B–D) TMD8 cells were treated with the indicated concentrations of <b>23</b> for 48 h. Cell supernatants were collected, and the indicated cytokines were quantitated by ELISA. (E) TMD8 cells were treated with 10 μM <b>23</b> for 24 h. Actinomycin D was added, and RNA was harvested from the cells at various time points (0–360 min). Quantitation of RNA was performed by TaqMan assay, and calculated mRNA half-lives are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01795&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/medium/jm-2017-01795d_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0010.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Compound <b>23</b> is efficacious in tumor xenografts. (A) TMD8 xenografts (10 mice/group) were treated with the indicated dose/schedule/route of <b>23</b> for 14 days. (B) HBL-1 xenografts (10 mice/group) were treated with indicated dose/schedule/route of <b>23</b> for 12 days. (C) MDA-MB-231 xenografts (10 mice/group) were treated with indicated dose/schedule/route of <b>23</b> for 23 days. Error bars are SEM. (D) TMD8 xenograft-bearing animals were treated with 1 mg/kg of <b>23</b>, and tumor and plasma samples were harvested at time points (0.5–24 h) postdose. Phosphorylation of eIF4E in the tumor was measured by immunoblot (% inhibition, left axis), and <b>23</b> levels were measured in plasma (nM, right axis). (E) Exposure–response plot of all time points and dosing groups of the TMD8 PK/PD study plotted as a function of the corresponding <b>23</b> exposure in plasma.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01795&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/medium/jm-2017-01795d_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0011.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Imidazopyridine <b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01795&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2-chloroacetaldehyde, ethanol, reflux, 86%; (b) NBS, DMF, 25 °C, 77%, (c) pyridine-3-ylboronic acid, Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane-H<sub>2</sub>O, 100 °C, 40%; (d) 30% H<sub>2</sub>O<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 0 to 25 °C, 28%.</p></p></figure><figure data-id="sch2" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/medium/jm-2017-01795d_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0012.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Pyrazole <b>5</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01795&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) di-<i>t</i>-butyl pyrocarbonate, 10% NaOH·H<sub>2</sub>O, 0 °C, 86%; (b) <i>t</i>-butyl-3,5-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole-1-carboxylate, tetrakis(triphenylphosphine)palladium(0), Na<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 100 °C, 24%. (c) HCl-1,4-dioxane, 0–25 °C, 42%.</p></p></figure><figure data-id="sch3" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/medium/jm-2017-01795d_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0013.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Benzamide <b>7</b> and Lactam <b>8</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01795&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 4,6-dichloropyrimidine, pTSA, toluene: 1,4-dioxane, 140 °C, 23%; (b) 10% Pd/C, H<sub>2</sub>, 1,4-dioxane/CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 15%; (c) camphorsulfonic acid, iPrOH, 100 °C, 58%.</p></p></figure><figure data-id="sch4" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/medium/jm-2017-01795d_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0014.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Lactams <b>9–11</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01795&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>p</i>-MeOBnNH<sub>2</sub>, DMF, Et<sub>3</sub>N, 65 °C, 75%; (b) NaH, MeI, THF, 25 °C, 57%; (c) 4-aminopyrimidine, NaO-<i>t</i>-Bu, XPhos, Pd<sub>2</sub>(dba)<sub>3</sub>, toluene, 110 °C, 58–65%; (d) TFA, 100 °C, 19–22%; (e) NaH, MeI, THF, 70 °C, 37%; (f) EtOH, H<sub>2</sub>SO<sub>4</sub>, 80 °C, 86%; (g) urea, H<sub>2</sub>O<sub>2</sub>, TFAA, CHCl<sub>3</sub>, 0–25 °C, 65%; (h) TFAA, DMF, 50 °C, 60%; (i) K<sub>2</sub>CO<sub>3</sub>, LiBr, Bu<sub>4</sub>NBr, BnBr, toluene–water, 80 °C, 65%; (j) 4-aminopyrimidine, Cs<sub>2</sub>CO<sub>3</sub>, xantphos, Pd<sub>2</sub>(dba)<sub>3</sub>, dioxane, 90 °C, 61%; (k) TfOH, toluene, 140 °C, MW, 61%; (i) NH<sub>4</sub>OH, 25 °C, 52%.</p></p></figure><figure data-id="sch5" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/medium/jm-2017-01795d_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0015.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. General Synthesis of Lactams <b>12–15</b>, <b>17</b>, <b>18</b>, <b>20–26</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01795&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 30% NH<sub>4</sub>OH, 0–25 °C, 75%; (b) R<sub>1</sub>R<sub>2</sub>CO, 1,4-dioxane, H<sub>2</sub>SO<sub>4</sub>, 100 °C, 83%; (c) 4-amino-6-R<sub>4</sub>-pyrimidine, Pd(OAc)<sub>2</sub>, xantphos, Cs<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 95 °C, 10–61%; (d) deprotection, KOH, EtOH, THF, H<sub>2</sub>O, 25 °C or 4 M HCl, 1,4-dioxane, CH<sub>2</sub>Cl<sub>2</sub>, MeOH, 25 °C, 80%.</p></p></figure><figure data-id="sch6" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/medium/jm-2017-01795d_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0016.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Lactam <b>16</b> and Compound <b>19</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01795/20180420/images/large/jm-2017-01795d_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01795&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (Boc)<sub>2</sub>O, DMAP, THF, 25 °C, 51%; (b) cyclopropanecarboxamide, Cs<sub>2</sub>CO<sub>3</sub>, xantphos, Pd<sub>2</sub>(dba)<sub>3</sub>, 1,4-dioxane, 25 °C, 96%; (c) 4 N HCl, 1,4-dioxane, 25 °C; (d) <b>38</b>, Cs<sub>2</sub>CO<sub>3</sub>, Xphos, Pd<sub>2</sub>(dba)<sub>3</sub>, 1,4-dioxane, 90 °C, 42%, two steps; (e) TFA, reflux, 46%; (f) K<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, monoglyme-H<sub>2</sub>O, 85 °C, 62%; (g) <i>t</i>-butyl-(3-hydroxycyclobutyl)carbamate, NaH, THF, °C, 29%; (h) 4 N HCl, MeOH, 25 °C, 58%.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i51">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64400" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64400" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 69 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sendoel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunn, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurwitz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levorse, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dill, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schramek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molina, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weissman, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, E.</span></span> <span> </span><span class="NLM_article-title">Translation from unconventional 5′ start sites drives tumour initiation</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>541</i></span>,  <span class="NLM_fpage">494</span>– <span class="NLM_lpage">499</span>, <span class="refDoi"> DOI: 10.1038/nature21036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1038%2Fnature21036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=28077873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC2sXos1CltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=541&publication_year=2017&pages=494-499&author=A.+Sendoelauthor=J.+G.+Dunnauthor=E.+H.+Rodriguezauthor=S.+Naikauthor=N.+C.+Gomezauthor=B.+Hurwitzauthor=J.+Levorseauthor=B.+D.+Dillauthor=D.+Schramekauthor=H.+Molinaauthor=J.+S.+Weissmanauthor=E.+Fuchs&title=Translation+from+unconventional+5%E2%80%B2+start+sites+drives+tumour+initiation&doi=10.1038%2Fnature21036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Translation from unconventional 5' start sites drives tumor initiation</span></div><div class="casAuthors">Sendoel, Ataman; Dunn, Joshua G.; Rodriguez, Edwin H.; Naik, Shruti; Gomez, Nicholas C.; Hurwitz, Brian; Levorse, John; Dill, Brian D.; Schramek, Daniel; Molina, Henrik; Weissman, Jonathan S.; Fuchs, Elaine</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">541</span>
        (<span class="NLM_cas:issue">7638</span>),
    <span class="NLM_cas:pages">494-499</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We are just beginning to understand how translational control affects tumor initiation and malignancy.  Here we use an epidermis-specific, in vivo ribosome profiling strategy to investigate the translational landscape during the transition from normal homeostasis to malignancy.  Using a mouse model of inducible SOX2, which is broadly expressed in oncogenic RAS-assocd. cancers, we show that despite widespread redns. in translation and protein synthesis, certain oncogenic mRNAs are spared.  During tumor initiation, the translational app. is redirected towards unconventional upstream initiation sites, enhancing the translational efficiency of oncogenic mRNAs.  An in vivo RNA interference screen of translational regulators revealed that depletion of conventional eIF2 complexes has adverse effects on normal but not oncogenic growth.  Conversely, the alternative initiation factor eIF2A is essential for cancer progression, during which it mediates initiation at these upstream sites, differentially skewing translation and protein expression.  Our findings unveil a role for the translation of 5' untranslated regions in cancer, and expose new targets for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9_HpXewJ0wLVg90H21EOLACvtfcHk0lh1SeLSDVj3SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXos1CltA%253D%253D&md5=58b04f0f20c9c6b80893bef52758e8c6</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnature21036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature21036%26sid%3Dliteratum%253Aachs%26aulast%3DSendoel%26aufirst%3DA.%26aulast%3DDunn%26aufirst%3DJ.%2BG.%26aulast%3DRodriguez%26aufirst%3DE.%2BH.%26aulast%3DNaik%26aufirst%3DS.%26aulast%3DGomez%26aufirst%3DN.%2BC.%26aulast%3DHurwitz%26aufirst%3DB.%26aulast%3DLevorse%26aufirst%3DJ.%26aulast%3DDill%26aufirst%3DB.%2BD.%26aulast%3DSchramek%26aufirst%3DD.%26aulast%3DMolina%26aufirst%3DH.%26aulast%3DWeissman%26aufirst%3DJ.%2BS.%26aulast%3DFuchs%26aufirst%3DE.%26atitle%3DTranslation%2520from%2520unconventional%25205%25E2%2580%25B2%2520start%2520sites%2520drives%2520tumour%2520initiation%26jtitle%3DNature%26date%3D2017%26volume%3D541%26spage%3D494%26epage%3D499%26doi%3D10.1038%2Fnature21036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graff, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruggero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonenberg, N.</span></span> <span> </span><span class="NLM_article-title">Targeting the eIF4F translation initiation complex: a critical nexus for cancer development</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">250</span>– <span class="NLM_lpage">263</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-14-2789</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1158%2F0008-5472.CAN-14-2789" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=250-263&author=J.+Pelletierauthor=J.+Graffauthor=D.+Ruggeroauthor=N.+Sonenberg&title=Targeting+the+eIF4F+translation+initiation+complex%3A+a+critical+nexus+for+cancer+development&doi=10.1158%2F0008-5472.CAN-14-2789"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-2789&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-2789%26sid%3Dliteratum%253Aachs%26aulast%3DPelletier%26aufirst%3DJ.%26aulast%3DGraff%26aufirst%3DJ.%26aulast%3DRuggero%26aufirst%3DD.%26aulast%3DSonenberg%26aufirst%3DN.%26atitle%3DTargeting%2520the%2520eIF4F%2520translation%2520initiation%2520complex%253A%2520a%2520critical%2520nexus%2520for%2520cancer%2520development%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26spage%3D250%26epage%3D263%26doi%3D10.1158%2F0008-5472.CAN-14-2789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robichaud, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulea, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonenberg, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Topisirovic, I.</span></span> <span> </span><span class="NLM_article-title">Targeting the translation machinery in cancer</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">261</span>– <span class="NLM_lpage">278</span>, <span class="refDoi"> DOI: 10.1038/nrd4505</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1038%2Fnrd4505" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=25743081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjvFOgs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=261-278&author=M.+Bhatauthor=N.+Robichaudauthor=L.+Huleaauthor=N.+Sonenbergauthor=J.+Pelletierauthor=I.+Topisirovic&title=Targeting+the+translation+machinery+in+cancer&doi=10.1038%2Fnrd4505"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the translation machinery in cancer</span></div><div class="casAuthors">Bhat, Mamatha; Robichaud, Nathaniel; Hulea, Laura; Sonenberg, Nahum; Pelletier, Jerry; Topisirovic, Ivan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">261-278</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Dysregulation of mRNA translation is a frequent feature of neoplasia.  Many oncogenes and tumor suppressors affect the translation machinery, making aberrant translation a widespread characteristic of tumor cells, independent of the genetic make-up of the cancer.  Therefore, therapeutic agents that target components of the protein synthesis app. hold promise as novel anticancer drugs that can overcome intra-tumor heterogeneity.  In this Review, we discuss the role of translation in cancer, with a particular focus on the eIF4F (eukaryotic translation initiation factor 4F) complex, and provide an overview of recent efforts aiming to 'translate' these results to the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7a57QrdxxsbVg90H21EOLACvtfcHk0lgsz9Zfk5wBPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjvFOgs70%253D&md5=51625a521b1d4f18887142383a8d28e8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrd4505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4505%26sid%3Dliteratum%253Aachs%26aulast%3DBhat%26aufirst%3DM.%26aulast%3DRobichaud%26aufirst%3DN.%26aulast%3DHulea%26aufirst%3DL.%26aulast%3DSonenberg%26aufirst%3DN.%26aulast%3DPelletier%26aufirst%3DJ.%26aulast%3DTopisirovic%26aufirst%3DI.%26atitle%3DTargeting%2520the%2520translation%2520machinery%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26spage%3D261%26epage%3D278%26doi%3D10.1038%2Fnrd4505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dreas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikulski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabritius, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brzozka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rzymski, T.</span></span> <span> </span><span class="NLM_article-title">Mitogen-activated protein kinase (MAPK) interacting kinases 1 and 2 (MNK1 and MNK2) as targets for cancer therapy: recent progress in the development of MNK inhibitors</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3025</span>– <span class="NLM_lpage">3053</span>, <span class="refDoi"> DOI: 10.2174/0929867324666170203123427</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.2174%2F0929867324666170203123427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=28164761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1SqsrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=3025-3053&author=A.+Dreasauthor=M.+Mikulskiauthor=M.+Milikauthor=C.+H.+Fabritiusauthor=K.+Brzozkaauthor=T.+Rzymski&title=Mitogen-activated+protein+kinase+%28MAPK%29+interacting+kinases+1+and+2+%28MNK1+and+MNK2%29+as+targets+for+cancer+therapy%3A+recent+progress+in+the+development+of+MNK+inhibitors&doi=10.2174%2F0929867324666170203123427"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Mitogen-activated Protein Kinase (MAPK) Interacting Kinases 1 and 2 (MNK1 and MNK2) as Targets for Cancer Therapy: Recent Progress in the Development of MNK Inhibitors</span></div><div class="casAuthors">Dreas, Agnieszka; Mikulski, Maciej; Milik, Mariusz; Fabritius, Charles-Henry; Brzozka, Krzysztof; Rzymski, Tomasz</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">3025-3053</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">MAP kinase-interacting kinases (MNK1 and MNK2) are often activated downstream of ERK and p38 MAPK in the MAP kinase family.  The role of MNKs in the development and progression of solid tumors and hematol. malignancies has been widely discussed, particularly in the context of cap dependent translation, regulated by phosphorylation of eIF4E.  MNK/eIF4E axis is involved in the expression of pro angiogenic, antiapoptotic, cell cycle, and motility proteins, such as MCL1, VEGF, MMP3, SNAIL, SMAD2, β-catenin or cyclin D1, and is essential during Ras and c Myc-induced transformation.  MNK1/2 emerged as eligible targets for drug discovery in oncol., based on the antitumor effects obsd. in genetic knockout and RNA interference expts. and at the same time lack of adverse effects in dual knockout animals. </P><P> There is a high interest in the development of pharmacol. inhibitors of MNK1/2 as not only tools for further basic research studies but also potential drugs in diseases characterized by deregulated translation.  Unfortunately, the role of MNK1/2 in cancer still remains elusive due to the absence of potent and selective probes.  Moreover, in many instances, hypotheses have been built reliant upon unspecific MNK1/2 inhibitors such as CGP57380 or cercosporamide.  Lately, the first two clin. programs targeting MNKs in oncol. have been revealed (eFT508 and BAY 1143269), although several other MNK programs are currently running at the preclin. stage.  This review aims to provide an overview of recent progress in the development of MNK inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjWDeCrlHD07Vg90H21EOLACvtfcHk0lgsz9Zfk5wBPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1SqsrnI&md5=c2a37d37d69521b11a38bb100e7964af</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2174%2F0929867324666170203123427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867324666170203123427%26sid%3Dliteratum%253Aachs%26aulast%3DDreas%26aufirst%3DA.%26aulast%3DMikulski%26aufirst%3DM.%26aulast%3DMilik%26aufirst%3DM.%26aulast%3DFabritius%26aufirst%3DC.%2BH.%26aulast%3DBrzozka%26aufirst%3DK.%26aulast%3DRzymski%26aufirst%3DT.%26atitle%3DMitogen-activated%2520protein%2520kinase%2520%2528MAPK%2529%2520interacting%2520kinases%25201%2520and%25202%2520%2528MNK1%2520and%2520MNK2%2529%2520as%2520targets%2520for%2520cancer%2520therapy%253A%2520recent%2520progress%2520in%2520the%2520development%2520of%2520MNK%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2017%26volume%3D24%26spage%3D3025%26epage%3D3053%26doi%3D10.2174%2F0929867324666170203123427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Truitt, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruggero, D.</span></span> <span> </span><span class="NLM_article-title">New frontiers in translational control of the cancer genome</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">288</span>– <span class="NLM_lpage">304</span>, <span class="refDoi"> DOI: 10.1038/nrc.2016.27</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1038%2Fnrc.2016.27" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=27112207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC28Xms1Omsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=288-304&author=M.+L.+Truittauthor=D.+Ruggero&title=New+frontiers+in+translational+control+of+the+cancer+genome&doi=10.1038%2Fnrc.2016.27"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">New frontiers in translational control of the cancer genome</span></div><div class="casAuthors">Truitt, Morgan L.; Ruggero, Davide</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">288-304</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The past several years have seen dramatic leaps in our understanding of how gene expression is rewired at the translation level during tumorigenesis to support the transformed phenotype.  This work has been driven by an explosion in technol. advances and is revealing previously unimagined regulatory mechanisms that dictate functional expression of the cancer genome.  In this Review we discuss emerging trends and exciting new discoveries that reveal how this translational circuitry contributes to specific aspects of tumorigenesis and cancer cell function, with a particular focus on recent insights into the role of translational control in the adaptive response to oncogenic stress conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWAtdm1QpVuLVg90H21EOLACvtfcHk0lgsz9Zfk5wBPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xms1Omsr0%253D&md5=ed2f746a30588ab8c00022d696861ceb</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrc.2016.27&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc.2016.27%26sid%3Dliteratum%253Aachs%26aulast%3DTruitt%26aufirst%3DM.%2BL.%26aulast%3DRuggero%26aufirst%3DD.%26atitle%3DNew%2520frontiers%2520in%2520translational%2520control%2520of%2520the%2520cancer%2520genome%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2016%26volume%3D16%26spage%3D288%26epage%3D304%26doi%3D10.1038%2Fnrc.2016.27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korneeva, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gram, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edens, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhoads, R. E.</span></span> <span> </span><span class="NLM_article-title">Inhibition of mitogen-activated protein kinase (MAPK)-interacting kinase (MNK) preferentially affects translation of mRNAs containing both a 5′-terminal cap and hairpin</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>291</i></span>,  <span class="NLM_fpage">3455</span>– <span class="NLM_lpage">3467</span>, <span class="refDoi"> DOI: 10.1074/jbc.M115.694190</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1074%2Fjbc.M115.694190" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=3455-3467&author=N.+L.+Korneevaauthor=A.+Songauthor=H.+Gramauthor=M.+A.+Edensauthor=R.+E.+Rhoads&title=Inhibition+of+mitogen-activated+protein+kinase+%28MAPK%29-interacting+kinase+%28MNK%29+preferentially+affects+translation+of+mRNAs+containing+both+a+5%E2%80%B2-terminal+cap+and+hairpin&doi=10.1074%2Fjbc.M115.694190"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.694190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.694190%26sid%3Dliteratum%253Aachs%26aulast%3DKorneeva%26aufirst%3DN.%2BL.%26aulast%3DSong%26aufirst%3DA.%26aulast%3DGram%26aufirst%3DH.%26aulast%3DEdens%26aufirst%3DM.%2BA.%26aulast%3DRhoads%26aufirst%3DR.%2BE.%26atitle%3DInhibition%2520of%2520mitogen-activated%2520protein%2520kinase%2520%2528MAPK%2529-interacting%2520kinase%2520%2528MNK%2529%2520preferentially%2520affects%2520translation%2520of%2520mRNAs%2520containing%2520both%2520a%25205%25E2%2580%25B2-terminal%2520cap%2520and%2520hairpin%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26spage%3D3455%26epage%3D3467%26doi%3D10.1074%2Fjbc.M115.694190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe-Fukunaga, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuyama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukunaga, R.</span></span> <span> </span><span class="NLM_article-title">MNK2 and MNK1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">6539</span>– <span class="NLM_lpage">6549</span>, <span class="refDoi"> DOI: 10.1128/MCB.24.15.6539-6549.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1128%2FMCB.24.15.6539-6549.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=15254222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtlKltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=6539-6549&author=T.+Uedaauthor=R.+Watanabe-Fukunagaauthor=H.+Fukuyamaauthor=S.+Nagataauthor=R.+Fukunaga&title=MNK2+and+MNK1+are+essential+for+constitutive+and+inducible+phosphorylation+of+eukaryotic+initiation+factor+4E+but+not+for+cell+growth+or+development&doi=10.1128%2FMCB.24.15.6539-6549.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development</span></div><div class="casAuthors">Ueda, Takeshi; Watanabe-Fukunaga, Rie; Fukuyama, Hidehiro; Nagata, Shigekazu; Fukunaga, Rikiro</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6539-6549</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Mnk1 and Mnk2 are protein kinases that are directly phosphorylated and activated by extracellular signal-regulated kinase (ERK) or p38 mitogen-activated protein (MAP) kinases and implicated in the regulation of protein synthesis through their phosphorylation of eukaryotic translation initiation factor 4E (eIF4E) at Ser209.  To investigate their physiol. functions, we generated mice lacking the Mnk1 or Mnk2 gene or both; the resulting KO mice were viable, fertile, and developed normally.  In embryonic fibroblasts prepd. from Mnk1-Mnk2 DKO mice, eIF4E was not detectably phosphorylated at Ser209, even when the ERK and/or p38 MAP kinases were activated.  Anal. of embryonic fibroblasts from single KO mice revealed that Mnk1 is responsible for the inducible phosphorylation of eIF4E in response to MAP kinase activation, whereas Mnk2 mainly contributes to eIF4E's basal, constitutive phosphorylation.  Lipopolysaccharide (LPS)- or insulin-induced upregulation of eIF4E phosphorylation in the spleen, liver, or skeletal muscle was abolished in Mnk1-/- mice, whereas the basal eIF4E phosphorylation levels were decreased in Mnk2-/- mice.  In Mnk1-Mnk2 DKO mice, no phosphorylated eIF4E was detected in any tissue studied, even after LPS or insulin injection.  However, neither general protein synthesis nor cap-dependent translation, as assayed by a bicistronic reporter assay system, was affected in Mnk-deficient embryonic fibroblasts, despite the absence of phosphorylated eIF4E.  Thus, Mnk1 and Mnk2 are exclusive eIF4E kinases both in cultured fibroblasts and adult tissues, and they regulate inducible and constitutive eIF4E phosphorylation, resp.  These results strongly suggest that eIF4E phosphorylation at Ser209 is not essential for cell growth during development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6LIGS-bIJs7Vg90H21EOLACvtfcHk0lh79XRCiEutvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtlKltLw%253D&md5=8ad9391afbf76148f4609f38d60b82aa</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1128%2FMCB.24.15.6539-6549.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.24.15.6539-6549.2004%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DT.%26aulast%3DWatanabe-Fukunaga%26aufirst%3DR.%26aulast%3DFukuyama%26aufirst%3DH.%26aulast%3DNagata%26aufirst%3DS.%26aulast%3DFukunaga%26aufirst%3DR.%26atitle%3DMNK2%2520and%2520MNK1%2520are%2520essential%2520for%2520constitutive%2520and%2520inducible%2520phosphorylation%2520of%2520eukaryotic%2520initiation%2520factor%25204E%2520but%2520not%2520for%2520cell%2520growth%2520or%2520development%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2004%26volume%3D24%26spage%3D6539%26epage%3D6549%26doi%3D10.1128%2FMCB.24.15.6539-6549.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wendel, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe-Fukunaga, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukunaga, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teruya-Feldstein, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, S. W.</span></span> <span> </span><span class="NLM_article-title">Dissecting eIF4E action in tumorigenesis</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">3232</span>– <span class="NLM_lpage">3237</span>, <span class="refDoi"> DOI: 10.1101/gad.1604407</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1101%2Fgad.1604407" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=3232-3237&author=H.+G.+Wendelauthor=R.+L.+Silvaauthor=A.+Malinaauthor=J.+R.+Millsauthor=H.+Zhuauthor=T.+Uedaauthor=R.+Watanabe-Fukunagaauthor=R.+Fukunagaauthor=J.+Teruya-Feldsteinauthor=J.+Pelletierauthor=S.+W.+Lowe&title=Dissecting+eIF4E+action+in+tumorigenesis&doi=10.1101%2Fgad.1604407"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1101%2Fgad.1604407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.1604407%26sid%3Dliteratum%253Aachs%26aulast%3DWendel%26aufirst%3DH.%2BG.%26aulast%3DSilva%26aufirst%3DR.%2BL.%26aulast%3DMalina%26aufirst%3DA.%26aulast%3DMills%26aufirst%3DJ.%2BR.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DUeda%26aufirst%3DT.%26aulast%3DWatanabe-Fukunaga%26aufirst%3DR.%26aulast%3DFukunaga%26aufirst%3DR.%26aulast%3DTeruya-Feldstein%26aufirst%3DJ.%26aulast%3DPelletier%26aufirst%3DJ.%26aulast%3DLowe%26aufirst%3DS.%2BW.%26atitle%3DDissecting%2520eIF4E%2520action%2520in%2520tumorigenesis%26jtitle%3DGenes%2520Dev.%26date%3D2007%26volume%3D21%26spage%3D3232%26epage%3D3237%26doi%3D10.1101%2Fgad.1604407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Furic, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koumakpayi, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brueschke, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petroulakis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robichaud, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaboury, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandolfi, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saad, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonenberg, N.</span></span> <span> </span><span class="NLM_article-title">eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">14134</span>– <span class="NLM_lpage">14139</span>, <span class="refDoi"> DOI: 10.1073/pnas.1005320107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1073%2Fpnas.1005320107" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=14134-14139&author=L.+Furicauthor=L.+Rongauthor=O.+Larssonauthor=I.+H.+Koumakpayiauthor=K.+Yoshidaauthor=A.+Brueschkeauthor=E.+Petroulakisauthor=N.+Robichaudauthor=M.+Pollakauthor=L.+A.+Gabouryauthor=P.+P.+Pandolfiauthor=F.+Saadauthor=N.+Sonenberg&title=eIF4E+phosphorylation+promotes+tumorigenesis+and+is+associated+with+prostate+cancer+progression&doi=10.1073%2Fpnas.1005320107"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1005320107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1005320107%26sid%3Dliteratum%253Aachs%26aulast%3DFuric%26aufirst%3DL.%26aulast%3DRong%26aufirst%3DL.%26aulast%3DLarsson%26aufirst%3DO.%26aulast%3DKoumakpayi%26aufirst%3DI.%2BH.%26aulast%3DYoshida%26aufirst%3DK.%26aulast%3DBrueschke%26aufirst%3DA.%26aulast%3DPetroulakis%26aufirst%3DE.%26aulast%3DRobichaud%26aufirst%3DN.%26aulast%3DPollak%26aufirst%3DM.%26aulast%3DGaboury%26aufirst%3DL.%2BA.%26aulast%3DPandolfi%26aufirst%3DP.%2BP.%26aulast%3DSaad%26aufirst%3DF.%26aulast%3DSonenberg%26aufirst%3DN.%26atitle%3DeIF4E%2520phosphorylation%2520promotes%2520tumorigenesis%2520and%2520is%2520associated%2520with%2520prostate%2520cancer%2520progression%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D14134%26epage%3D14139%26doi%3D10.1073%2Fpnas.1005320107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diab, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumarasiri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proud, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milne, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">MAP kinase-interacting kinases-emerging targets against cancer</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">441</span>– <span class="NLM_lpage">452</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2014.01.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1016%2Fj.chembiol.2014.01.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=24613018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjslyitb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=441-452&author=S.+Diabauthor=M.+Kumarasiriauthor=M.+Yuauthor=T.+Teoauthor=C.+Proudauthor=R.+Milneauthor=S.+Wang&title=MAP+kinase-interacting+kinases-emerging+targets+against+cancer&doi=10.1016%2Fj.chembiol.2014.01.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">MAP Kinase-Interacting Kinases-Emerging Targets against Cancer</span></div><div class="casAuthors">Diab, Sarah; Kumarasiri, Malika; Yu, Mingfeng; Teo, Theodosia; Proud, Christopher; Milne, Robert; Wang, Shudong</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">441-452</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Mitogen-activated protein kinase (MAPK)-interacting kinases (Mnks) regulate the initiation of translation through phosphorylation of eukaryotic initiation factor 4E (eIF4E).  Mnk-mediated eIF4E activation promotes cancer development and progression.  While the phosphorylation of eIF4E is necessary for oncogenic transformation, the kinase activity of Mnks seems dispensable for normal development.  For this reason, pharmacol. inhibition of Mnks could represent an ideal mechanism-based and nontoxic therapeutic strategy for cancer treatment.  In this review, we discuss the current understanding of Mnk biol. roles, structures, and functions, as well as clin. implications.  Importantly, we propose different strategies for identification of highly selective small mol. inhibitors of Mnks, including exploring a structural feature of their kinase domain, DFD motif, which is unique within the human kinome.  We also argue that a combined targeting of Mnks and other pathways should be considered given the complexity of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8J4FNfWRq27Vg90H21EOLACvtfcHk0lhbuxn-pE-GNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjslyitb0%253D&md5=472ef0f62dc9dc457139367b3a573c49</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2014.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2014.01.011%26sid%3Dliteratum%253Aachs%26aulast%3DDiab%26aufirst%3DS.%26aulast%3DKumarasiri%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DTeo%26aufirst%3DT.%26aulast%3DProud%26aufirst%3DC.%26aulast%3DMilne%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DMAP%2520kinase-interacting%2520kinases-emerging%2520targets%2520against%2520cancer%26jtitle%3DChem.%2520Biol.%26date%3D2014%26volume%3D21%26spage%3D441%26epage%3D452%26doi%3D10.1016%2Fj.chembiol.2014.01.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Piccirillo, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjur, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Topisirovic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonenberg, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, O.</span></span> <span> </span><span class="NLM_article-title">Translational control of immune responses: from transcripts to translatomes</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">503</span>– <span class="NLM_lpage">511</span>, <span class="refDoi"> DOI: 10.1038/ni.2891</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1038%2Fni.2891" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=24840981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC2cXot1yls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=503-511&author=C.+A.+Piccirilloauthor=E.+Bjurauthor=I.+Topisirovicauthor=N.+Sonenbergauthor=O.+Larsson&title=Translational+control+of+immune+responses%3A+from+transcripts+to+translatomes&doi=10.1038%2Fni.2891"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Translational control of immune responses: from transcripts to translatomes</span></div><div class="casAuthors">Piccirillo, Ciriaco A.; Bjur, Eva; Topisirovic, Ivan; Sonenberg, Nahum; Larsson, Ola</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">503-511</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Selective translational control of gene expression is emerging as a principal mechanism for the regulation of protein abundance that dets. a variety of functions in both the adaptive immune system and the innate immune system.  The translation-initiation factor eIF4E acts as a node for such regulation, but non-eIF4E mechanisms are also prevalent.  Studies of 'translatomes' (genome-wide pools of translated mRNA) have facilitated mechanistic discoveries by identifying key regulatory components, including transcription factors, that are under translational control.  Here we review the current knowledge on mechanisms that regulate translation and thereby modulate immunol. function.  We further describe approaches for measuring and analyzing translatomes and how such powerful tools can facilitate future insights on the role of translational control in the immune system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9UoBa7zbAT7Vg90H21EOLACvtfcHk0lhbuxn-pE-GNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXot1yls74%253D&md5=483f95cf6f868e2a6eff19c3d1bf2e0f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fni.2891&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.2891%26sid%3Dliteratum%253Aachs%26aulast%3DPiccirillo%26aufirst%3DC.%2BA.%26aulast%3DBjur%26aufirst%3DE.%26aulast%3DTopisirovic%26aufirst%3DI.%26aulast%3DSonenberg%26aufirst%3DN.%26aulast%3DLarsson%26aufirst%3DO.%26atitle%3DTranslational%2520control%2520of%2520immune%2520responses%253A%2520from%2520transcripts%2520to%2520translatomes%26jtitle%3DNat.%2520Immunol.%26date%3D2014%26volume%3D15%26spage%3D503%26epage%3D511%26doi%3D10.1038%2Fni.2891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buxade, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrice, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krebs, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proud, C. G.</span></span> <span> </span><span class="NLM_article-title">The PSF.p54nrb complex is a novel MNK substrate that binds the mRNA for tumor necrosis factor alpha</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">57</span>– <span class="NLM_lpage">65</span>, <span class="refDoi"> DOI: 10.1074/jbc.M705286200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1074%2Fjbc.M705286200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=57-65&author=M.+Buxadeauthor=N.+Morriceauthor=D.+L.+Krebsauthor=C.+G.+Proud&title=The+PSF.p54nrb+complex+is+a+novel+MNK+substrate+that+binds+the+mRNA+for+tumor+necrosis+factor+alpha&doi=10.1074%2Fjbc.M705286200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M705286200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M705286200%26sid%3Dliteratum%253Aachs%26aulast%3DBuxade%26aufirst%3DM.%26aulast%3DMorrice%26aufirst%3DN.%26aulast%3DKrebs%26aufirst%3DD.%2BL.%26aulast%3DProud%26aufirst%3DC.%2BG.%26atitle%3DThe%2520PSF.p54nrb%2520complex%2520is%2520a%2520novel%2520MNK%2520substrate%2520that%2520binds%2520the%2520mRNA%2520for%2520tumor%2520necrosis%2520factor%2520alpha%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D57%26epage%3D65%26doi%3D10.1074%2Fjbc.M705286200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buxade, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parra, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rousseau, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shpiro, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrice, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bain, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proud, C. G.</span></span> <span> </span><span class="NLM_article-title">The Mnks are novel components in the control of TNF alpha biosynthesis and phosphorylate and regulate hnRNP A1</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">177</span>– <span class="NLM_lpage">189</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2005.06.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1016%2Fj.immuni.2005.06.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=177-189&author=M.+Buxadeauthor=J.+L.+Parraauthor=S.+Rousseauauthor=N.+Shpiroauthor=R.+Marquezauthor=N.+Morriceauthor=J.+Bainauthor=E.+Espelauthor=C.+G.+Proud&title=The+Mnks+are+novel+components+in+the+control+of+TNF+alpha+biosynthesis+and+phosphorylate+and+regulate+hnRNP+A1&doi=10.1016%2Fj.immuni.2005.06.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2005.06.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2005.06.009%26sid%3Dliteratum%253Aachs%26aulast%3DBuxade%26aufirst%3DM.%26aulast%3DParra%26aufirst%3DJ.%2BL.%26aulast%3DRousseau%26aufirst%3DS.%26aulast%3DShpiro%26aufirst%3DN.%26aulast%3DMarquez%26aufirst%3DR.%26aulast%3DMorrice%26aufirst%3DN.%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DEspel%26aufirst%3DE.%26aulast%3DProud%26aufirst%3DC.%2BG.%26atitle%3DThe%2520Mnks%2520are%2520novel%2520components%2520in%2520the%2520control%2520of%2520TNF%2520alpha%2520biosynthesis%2520and%2520phosphorylate%2520and%2520regulate%2520hnRNP%2520A1%26jtitle%3DImmunity%26date%3D2005%26volume%3D23%26spage%3D177%26epage%3D189%26doi%3D10.1016%2Fj.immuni.2005.06.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Edwin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ying, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, T. B.</span></span> <span> </span><span class="NLM_article-title">Intermolecular interactions of sprouty proteins and their implications in development and disease</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">679</span>– <span class="NLM_lpage">691</span>, <span class="refDoi"> DOI: 10.1124/mol.109.055848</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1124%2Fmol.109.055848" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2009&pages=679-691&author=F.+Edwinauthor=K.+Andersonauthor=C.+Yingauthor=T.+B.+Patel&title=Intermolecular+interactions+of+sprouty+proteins+and+their+implications+in+development+and+disease&doi=10.1124%2Fmol.109.055848"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1124%2Fmol.109.055848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.109.055848%26sid%3Dliteratum%253Aachs%26aulast%3DEdwin%26aufirst%3DF.%26aulast%3DAnderson%26aufirst%3DK.%26aulast%3DYing%26aufirst%3DC.%26aulast%3DPatel%26aufirst%3DT.%2BB.%26atitle%3DIntermolecular%2520interactions%2520of%2520sprouty%2520proteins%2520and%2520their%2520implications%2520in%2520development%2520and%2520disease%26jtitle%3DMol.%2520Pharmacol.%26date%3D2009%26volume%3D76%26spage%3D679%26epage%3D691%26doi%3D10.1124%2Fmol.109.055848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Panel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boelle, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayala-Sanmartin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jouniaux, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamelin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masliah, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trugnan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flejou, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendum, D.</span></span> <span> </span><span class="NLM_article-title">Cytoplasmic phospholipase A2 expression in human colon adenocarcinoma is correlated with cyclooxygenase-2 expression and contributes to prostaglandin E2 production</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>243</i></span>,  <span class="NLM_fpage">255</span>– <span class="NLM_lpage">263</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2005.11.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1016%2Fj.canlet.2005.11.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=16458424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVGitr%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=243&publication_year=2006&pages=255-263&author=V.+Panelauthor=P.+Y.+Boelleauthor=J.+Ayala-Sanmartinauthor=A.+M.+Jouniauxauthor=R.+Hamelinauthor=J.+Masliahauthor=G.+Trugnanauthor=J.+F.+Flejouauthor=D.+Wendum&title=Cytoplasmic+phospholipase+A2+expression+in+human+colon+adenocarcinoma+is+correlated+with+cyclooxygenase-2+expression+and+contributes+to+prostaglandin+E2+production&doi=10.1016%2Fj.canlet.2005.11.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Cytoplasmic phospholipase A2 expression in human colon adenocarcinoma is correlated with cyclooxygenase-2 expression and contributes to prostaglandin E2 production</span></div><div class="casAuthors">Panel, Valentine; Boelle, Pierre-Yves; Ayala-Sanmartin, Jesus; Jouniaux, Anne-Marie; Hamelin, Richard; Masliah, Joelle; Trugnan, Germain; Flejou, Jean-Francois; Wendum, Dominique</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">243</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">255-263</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cytoplasmic phospholipase A2 (cPLA2) has a key role in prostaglandin prodn.  The role of cPLA2 in intestinal tumorigenesis has been suggested, however, contradictory data are found in the literature.  We evaluated cPLA2 and cyclooxygenase-2 (COX-2) protein expression in 65 colon carcinomas by immunohistochem., and in eight colorectal cancer cell lines by Western Blot.  PGE2 prodn. was evaluated by enzyme-immunoassay in the cell lines.  We demonstrate that cPLA2 is overexpressed in approx. 50% of colon cancers and cell lines. cPLA2 expression is correlated with COX-2 expression.  Both cPLA2 and COX-2 expressions are important in regard to PGE2 prodn.  Our data suggest that cPLA2 might be involved in colon tumor development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxgx_93uVh-rVg90H21EOLACvtfcHk0ljq40t2IQYEDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVGitr%252FF&md5=cf63d75a6214bb9a1d4b36c2c0a5ef9a</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2005.11.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2005.11.045%26sid%3Dliteratum%253Aachs%26aulast%3DPanel%26aufirst%3DV.%26aulast%3DBoelle%26aufirst%3DP.%2BY.%26aulast%3DAyala-Sanmartin%26aufirst%3DJ.%26aulast%3DJouniaux%26aufirst%3DA.%2BM.%26aulast%3DHamelin%26aufirst%3DR.%26aulast%3DMasliah%26aufirst%3DJ.%26aulast%3DTrugnan%26aufirst%3DG.%26aulast%3DFlejou%26aufirst%3DJ.%2BF.%26aulast%3DWendum%26aufirst%3DD.%26atitle%3DCytoplasmic%2520phospholipase%2520A2%2520expression%2520in%2520human%2520colon%2520adenocarcinoma%2520is%2520correlated%2520with%2520cyclooxygenase-2%2520expression%2520and%2520contributes%2520to%2520prostaglandin%2520E2%2520production%26jtitle%3DCancer%2520Lett.%26date%3D2006%26volume%3D243%26spage%3D255%26epage%3D263%26doi%3D10.1016%2Fj.canlet.2005.11.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jean-Philippe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caputi, M.</span></span> <span> </span><span class="NLM_article-title">hnRNP A1: the Swiss army knife of gene expression</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">18999</span>– <span class="NLM_lpage">19024</span>, <span class="refDoi"> DOI: 10.3390/ijms140918999</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.3390%2Fijms140918999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=24065100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlCgsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=18999-19024&author=J.+Jean-Philippeauthor=S.+Pazauthor=M.+Caputi&title=hnRNP+A1%3A+the+Swiss+army+knife+of+gene+expression&doi=10.3390%2Fijms140918999"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">hnRNP A1: the swiss army knife of gene expression</span></div><div class="casAuthors">Jean-Philippe, Jacques; Paz, Sean; Caputi, Massimo</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">18999-19024, 26 pp.</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Eukaryotic cells express a large variety of RNA binding proteins (RBPs), with diverse affinities and specificities towards target RNAs.  These proteins play a crucial role in almost every aspect of RNA biogenesis, expression and function.  The heterogeneous nuclear ribonucleoproteins (hnRNPs) are a complex and diverse family of RNA binding proteins.  HnRNPs display multiple functions in the processing of heterogeneous nuclear RNAs into mature mRNAs.  HnRNP A1 is one of the most abundant and ubiquitously expressed members of this protein family.  HnRNP A1 plays multiple roles in gene expression by regulating major steps in the processing of nascent RNA transcripts.  The transcription, splicing, stability, export through nuclear pores and translation of cellular and viral transcripts are all mechanisms modulated by this protein.  The diverse functions played by hnRNP A1 are not limited to mRNA biogenesis, but extend to the processing of microRNAs, telomere maintenance and the regulation of transcription factor activity.  Genomic approaches have recently uncovered the extent of hnRNP A1 roles in the development and differentiation of living organisms.  The aim of this review is to highlight recent developments in the study of this protein and to describe its functions in cellular and viral gene expression and its role in human pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCCTVp4ClGErVg90H21EOLACvtfcHk0ljq40t2IQYEDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlCgsro%253D&md5=ad3ddc1ad1a95151409f3723f9cb4d14</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.3390%2Fijms140918999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms140918999%26sid%3Dliteratum%253Aachs%26aulast%3DJean-Philippe%26aufirst%3DJ.%26aulast%3DPaz%26aufirst%3DS.%26aulast%3DCaputi%26aufirst%3DM.%26atitle%3DhnRNP%2520A1%253A%2520the%2520Swiss%2520army%2520knife%2520of%2520gene%2520expression%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2013%26volume%3D14%26spage%3D18999%26epage%3D19024%26doi%3D10.3390%2Fijms140918999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platanias, L. C.</span></span> <span> </span><span class="NLM_article-title">MNK kinase pathway: Cellular functions and biological outcomes</span>. <i>World J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">321</span>– <span class="NLM_lpage">333</span>, <span class="refDoi"> DOI: 10.4331/wjbc.v5.i3.321</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.4331%2Fwjbc.v5.i3.321" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=25225600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A280%3ADC%252BC2M7hvVCgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=321-333&author=S.+Joshiauthor=L.+C.+Platanias&title=MNK+kinase+pathway%3A+Cellular+functions+and+biological+outcomes&doi=10.4331%2Fwjbc.v5.i3.321"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Mnk kinase pathway: Cellular functions and biological outcomes</span></div><div class="casAuthors">Joshi Sonali; Platanias Leonidas C</div><div class="citationInfo"><span class="NLM_cas:title">World journal of biological chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">321-33</span>
        ISSN:<span class="NLM_cas:issn">1949-8454</span>.
    </div><div class="casAbstract">The mitogen-activated protein kinase (MAPK) interacting protein kinases 1 and 2 (Mnk1 and Mnk2) play important roles in controlling signals involved in mRNA translation.  In addition to the MAPKs (p38 or Erk), multiple studies suggest that the Mnk kinases can be regulated by other known kinases such as Pak2 and/or other unidentified kinases by phosphorylation of residues distinct from the sites phosphorylated by the MAPKs.  Several studies have established multiple Mnk protein targets, including PSF, heterogenous nuclear ribonucleoprotein A1, Sprouty 2 and have lead to the identification of distinct biological functions and substrate specificity for the Mnk kinases.  In this review we discuss the pathways regulating the Mnk kinases, their known substrates as well as the functional consequences of engagement of pathways controlled by Mnk kinases.  These kinases play an important role in mRNA translation via their regulation of eukaryotic initiation factor 4E (eIF4E) and their functions have important implications in tumor biology as well as the regulation of drug resistance to anti-oncogenic therapies.  Other studies have identified a role for the Mnk kinases in cap-independent mRNA translation, suggesting that the Mnk kinases can exert important functional effects independently of the phosphorylation of eIF4E.  The role of Mnk kinases in inflammation and inflammation-induced malignancies is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTQFICkwsHpykh5eUSa2oe_fW6udTcc2ebR0L3EEt7Yorntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7hvVCgtQ%253D%253D&md5=765d4facdd3bb2c0c393ef6f8d0b8fc8</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.4331%2Fwjbc.v5.i3.321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4331%252Fwjbc.v5.i3.321%26sid%3Dliteratum%253Aachs%26aulast%3DJoshi%26aufirst%3DS.%26aulast%3DPlatanias%26aufirst%3DL.%2BC.%26atitle%3DMNK%2520kinase%2520pathway%253A%2520Cellular%2520functions%2520and%2520biological%2520outcomes%26jtitle%3DWorld%2520J.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D5%26spage%3D321%26epage%3D333%26doi%3D10.4331%2Fwjbc.v5.i3.321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elia, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chio, I. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukunaga, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span> <span> </span><span class="NLM_article-title">Combined deficiency for MAP kinase-interacting kinase 1 and 2 (MNK1 and MNK2) delays tumor development</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">13984</span>– <span class="NLM_lpage">13990</span>, <span class="refDoi"> DOI: 10.1073/pnas.1008136107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1073%2Fpnas.1008136107" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=13984-13990&author=T.+Uedaauthor=M.+Sasakiauthor=A.+J.+Eliaauthor=I.+I.+Chioauthor=K.+Hamadaauthor=R.+Fukunagaauthor=T.+W.+Mak&title=Combined+deficiency+for+MAP+kinase-interacting+kinase+1+and+2+%28MNK1+and+MNK2%29+delays+tumor+development&doi=10.1073%2Fpnas.1008136107"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1008136107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1008136107%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DT.%26aulast%3DSasaki%26aufirst%3DM.%26aulast%3DElia%26aufirst%3DA.%2BJ.%26aulast%3DChio%26aufirst%3DI.%2BI.%26aulast%3DHamada%26aufirst%3DK.%26aulast%3DFukunaga%26aufirst%3DR.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DCombined%2520deficiency%2520for%2520MAP%2520kinase-interacting%2520kinase%25201%2520and%25202%2520%2528MNK1%2520and%2520MNK2%2529%2520delays%2520tumor%2520development%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D13984%26epage%3D13990%26doi%3D10.1073%2Fpnas.1008136107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lazaris-Karatzas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montine, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonenberg, N.</span></span> <span> </span><span class="NLM_article-title">Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>345</i></span>,  <span class="NLM_fpage">544</span>– <span class="NLM_lpage">547</span>, <span class="refDoi"> DOI: 10.1038/345544a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1038%2F345544a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=2348862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADyaK3cXktlygsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=345&publication_year=1990&pages=544-547&author=A.+Lazaris-Karatzasauthor=K.+S.+Montineauthor=N.+Sonenberg&title=Malignant+transformation+by+a+eukaryotic+initiation+factor+subunit+that+binds+to+mRNA+5%E2%80%B2+cap&doi=10.1038%2F345544a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap</span></div><div class="casAuthors">Lazaris-Karatzas, Anthoula; Montine, Kathleen S.; Sonenberg, Nahum</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">345</span>
        (<span class="NLM_cas:issue">6275</span>),
    <span class="NLM_cas:pages">544-7</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Overexpression of the translation factor eIF-4E from exogenous cDNA in rodent cell lines caused tumorigenic transformation, as detd. by 3 criteria: formation of transformed foci on a monolayer of cells, anchorage-independent growth, and tumor formation in nude mice.  An eIF-4E mutant whose serine 53 codon was mutated to alanine did not cause tumor formation in nude mice.  The mechanism by which eIF-4E transforms cells is not clear.  The expression of certain oncogenes or growth factors might be tightly controlled at the translational level by the availability of eIF-4E.  Increasing the level of eIF-4E might relieve translational repression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC3QZOSYEW5LVg90H21EOLACvtfcHk0lh48oGEtaL92g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXktlygsrg%253D&md5=b074e125f2b7c237ba1f646814493064</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2F345544a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F345544a0%26sid%3Dliteratum%253Aachs%26aulast%3DLazaris-Karatzas%26aufirst%3DA.%26aulast%3DMontine%26aufirst%3DK.%2BS.%26aulast%3DSonenberg%26aufirst%3DN.%26atitle%3DMalignant%2520transformation%2520by%2520a%2520eukaryotic%2520initiation%2520factor%2520subunit%2520that%2520binds%2520to%2520mRNA%25205%25E2%2580%25B2%2520cap%26jtitle%3DNature%26date%3D1990%26volume%3D345%26spage%3D544%26epage%3D547%26doi%3D10.1038%2F345544a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Konicek, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephens, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNulty, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robichaud, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peery, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumstorf, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowless, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iversen, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCann, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furic, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yingling, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stancato, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonenberg, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graff, J. R.</span></span> <span> </span><span class="NLM_article-title">Therapeutic inhibition of MAP kinase interacting kinase blocks eukaryotic initiation factor 4E phosphorylation and suppresses outgrowth of experimental lung metastases</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">1849</span>– <span class="NLM_lpage">1857</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-10-3298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1158%2F0008-5472.CAN-10-3298" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=1849-1857&author=B.+W.+Konicekauthor=J.+R.+Stephensauthor=A.+M.+McNultyauthor=N.+Robichaudauthor=R.+B.+Peeryauthor=C.+A.+Dumstorfauthor=M.+S.+Dowlessauthor=P.+W.+Iversenauthor=S.+Parsonsauthor=K.+E.+Ellisauthor=D.+J.+McCannauthor=J.+Pelletierauthor=L.+Furicauthor=J.+M.+Yinglingauthor=L.+F.+Stancatoauthor=N.+Sonenbergauthor=J.+R.+Graff&title=Therapeutic+inhibition+of+MAP+kinase+interacting+kinase+blocks+eukaryotic+initiation+factor+4E+phosphorylation+and+suppresses+outgrowth+of+experimental+lung+metastases&doi=10.1158%2F0008-5472.CAN-10-3298"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-3298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-3298%26sid%3Dliteratum%253Aachs%26aulast%3DKonicek%26aufirst%3DB.%2BW.%26aulast%3DStephens%26aufirst%3DJ.%2BR.%26aulast%3DMcNulty%26aufirst%3DA.%2BM.%26aulast%3DRobichaud%26aufirst%3DN.%26aulast%3DPeery%26aufirst%3DR.%2BB.%26aulast%3DDumstorf%26aufirst%3DC.%2BA.%26aulast%3DDowless%26aufirst%3DM.%2BS.%26aulast%3DIversen%26aufirst%3DP.%2BW.%26aulast%3DParsons%26aufirst%3DS.%26aulast%3DEllis%26aufirst%3DK.%2BE.%26aulast%3DMcCann%26aufirst%3DD.%2BJ.%26aulast%3DPelletier%26aufirst%3DJ.%26aulast%3DFuric%26aufirst%3DL.%26aulast%3DYingling%26aufirst%3DJ.%2BM.%26aulast%3DStancato%26aufirst%3DL.%2BF.%26aulast%3DSonenberg%26aufirst%3DN.%26aulast%3DGraff%26aufirst%3DJ.%2BR.%26atitle%3DTherapeutic%2520inhibition%2520of%2520MAP%2520kinase%2520interacting%2520kinase%2520blocks%2520eukaryotic%2520initiation%2520factor%25204E%2520phosphorylation%2520and%2520suppresses%2520outgrowth%2520of%2520experimental%2520lung%2520metastases%26jtitle%3DCancer%2520Res.%26date%3D2011%26volume%3D71%26spage%3D1849%26epage%3D1857%26doi%3D10.1158%2F0008-5472.CAN-10-3298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knauf, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschopp, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gram, H.</span></span> <span> </span><span class="NLM_article-title">Negative regulation of protein translation by mitogen-activated protein kinase-interacting kinases 1 and 2</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">5500</span>– <span class="NLM_lpage">5511</span>, <span class="refDoi"> DOI: 10.1128/MCB.21.16.5500-5511.2001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1128%2FMCB.21.16.5500-5511.2001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=11463832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlslOjtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=5500-5511&author=U.+Knaufauthor=C.+Tschoppauthor=H.+Gram&title=Negative+regulation+of+protein+translation+by+mitogen-activated+protein+kinase-interacting+kinases+1+and+2&doi=10.1128%2FMCB.21.16.5500-5511.2001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Negative regulation of protein translation by mitogen-activated protein kinase-interacting kinases 1 and 2</span></div><div class="casAuthors">Knauf, Ursula; Tschopp, Claude; Gram, Hermann</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5500-5511</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Eukaryotic initiation factor 4E (eIF4E) is a key component of the translational machinery and an important modulator of cell growth and proliferation.  The activity of eIF4E is thought to be regulated by interaction with inhibitory binding proteins (4E-BPs) and phosphorylation by mitogen-activated protein (MAP) kinase-interacting kinase (MNK) on Ser209 in response to mitogens and cellular stress.  Here we demonstrate that phosphorylation of eIF4E via MNK1 is mediated via the activation of either the Erk or p38 pathway.  We further show that expression of active mutants of MNK1 and MNK2 in 293 cells diminishes cap-dependent translation relative to cap-independent translation in a transient reporter assay.  The same effect on cap-dependent translation was obsd. when MNK1 was activated by the Erk or p38 pathway.  In line with these findings, addn. of recombinant active MNK1 to rabbit reticulocyte lysate resulted in a reduced protein synthesis in vitro, and overexpression of MNK2 caused a decreased rate of protein synthesis in 293 cells.  By using CGP 57380, a novel low-mol.-wt. kinase inhibitor of MNK1, we demonstrate that eIF4E phosphorylation is not crucial to the formation of the initiation complex, mitogen-stimulated increase in cap-dependent translation, and cell proliferation.  Our results imply that activation of MNK by MAP kinase pathways does not constitute a pos. regulatory mechanism to cap-dependent translation.  Instead, we propose that the kinase activity of MNKs, eventually through phosphorylation of eIF4E, may serve to limit cap-dependent translation under physiol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruNOjANWg6jLVg90H21EOLACvtfcHk0lh48oGEtaL92g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlslOjtb0%253D&md5=e50d12905c25505de246ca9a80e3da83</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1128%2FMCB.21.16.5500-5511.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.21.16.5500-5511.2001%26sid%3Dliteratum%253Aachs%26aulast%3DKnauf%26aufirst%3DU.%26aulast%3DTschopp%26aufirst%3DC.%26aulast%3DGram%26aufirst%3DH.%26atitle%3DNegative%2520regulation%2520of%2520protein%2520translation%2520by%2520mitogen-activated%2520protein%2520kinase-interacting%2520kinases%25201%2520and%25202%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2001%26volume%3D21%26spage%3D5500%26epage%3D5511%26doi%3D10.1128%2FMCB.21.16.5500-5511.2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basnet, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillam, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumarasiri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diab, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albrecht, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sykes, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">An integrated approach for discovery of highly potent and selective MNK inhibitors: screening, synthesis and SAR analysis</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">539</span>– <span class="NLM_lpage">550</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.09.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1016%2Fj.ejmech.2015.09.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2015&pages=539-550&author=T.+Teoauthor=Y.+Yangauthor=M.+Yuauthor=S.+K.+Basnetauthor=T.+Gillamauthor=J.+Houauthor=R.+M.+Schmidauthor=M.+Kumarasiriauthor=S.+Diabauthor=H.+Albrechtauthor=M.+J.+Sykesauthor=S.+Wang&title=An+integrated+approach+for+discovery+of+highly+potent+and+selective+MNK+inhibitors%3A+screening%2C+synthesis+and+SAR+analysis&doi=10.1016%2Fj.ejmech.2015.09.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DTeo%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DBasnet%26aufirst%3DS.%2BK.%26aulast%3DGillam%26aufirst%3DT.%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DSchmid%26aufirst%3DR.%2BM.%26aulast%3DKumarasiri%26aufirst%3DM.%26aulast%3DDiab%26aufirst%3DS.%26aulast%3DAlbrecht%26aufirst%3DH.%26aulast%3DSykes%26aufirst%3DM.%2BJ.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DAn%2520integrated%2520approach%2520for%2520discovery%2520of%2520highly%2520potent%2520and%2520selective%2520MNK%2520inhibitors%253A%2520screening%252C%2520synthesis%2520and%2520SAR%2520analysis%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D103%26spage%3D539%26epage%3D550%26doi%3D10.1016%2Fj.ejmech.2015.09.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kosciuczuk, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saleiro, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroczynska, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauchamp, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckerdt, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blyth, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abedin, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giles, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altman, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platanias, L. C.</span></span> <span> </span><span class="NLM_article-title">Merestinib blocks MNK kinase activity in acute myeloid leukemia progenitors and exhibits antileukemic effects in vitro and in vivo</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">410</span>– <span class="NLM_lpage">414</span>, <span class="refDoi"> DOI: 10.1182/blood-2016-02-698704</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1182%2Fblood-2016-02-698704" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=27307295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVymu7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2016&pages=410-414&author=E.+M.+Kosciuczukauthor=D.+Saleiroauthor=B.+Kroczynskaauthor=E.+M.+Beauchampauthor=F.+Eckerdtauthor=G.+T.+Blythauthor=S.+M.+Abedinauthor=F.+J.+Gilesauthor=J.+K.+Altmanauthor=L.+C.+Platanias&title=Merestinib+blocks+MNK+kinase+activity+in+acute+myeloid+leukemia+progenitors+and+exhibits+antileukemic+effects+in+vitro+and+in+vivo&doi=10.1182%2Fblood-2016-02-698704"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Merestinib blocks Mnk kinase activity in acute myeloid leukemia progenitors and exhibits antileukemic effects in vitro and in vivo</span></div><div class="casAuthors">Kosciuczuk, Ewa M.; Saleiro, Diana; Kroczynska, Barbara; Beauchamp, Elspeth M.; Eckerdt, Frank; Blyth, Gavin T.; Abedin, Sameem M.; Giles, Francis J.; Altman, Jessica K.; Platanias, Leonidas C.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">410-414</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">1528-0020</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Mitogen-activated protein kinase interacting protein kinases (Mnks) play important roles in the development and progression of acute myeloid leukemia (AML) by regulating eukaryotic translation initiation factor 4E (eIF4E) activation.  Inhibiting Mnk1/2-induced phosphorylation of eIF4E may represent a unique approach for the treatment of AML.  We provide evidence for antileukemic effects of merestinib, an orally bioavailable multikinase inhibitor with suppressive effects on Mnk activity.  Our studies show that merestinib effectively blocks eIF4E phosphorylation in AML cells and suppresses primitive leukemic progenitors from AML patients in vitro and in an AML xenograft model in vivo.  Our findings provide evidence for potent preclin. antileukemic properties of merestinib and support its clin. development for the treatment of patients with AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEFrhJ4BiK57Vg90H21EOLACvtfcHk0lgGULzfBwYO7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVymu7jE&md5=e1034d2ea79d51ffc297d86a6ae4b737</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1182%2Fblood-2016-02-698704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2016-02-698704%26sid%3Dliteratum%253Aachs%26aulast%3DKosciuczuk%26aufirst%3DE.%2BM.%26aulast%3DSaleiro%26aufirst%3DD.%26aulast%3DKroczynska%26aufirst%3DB.%26aulast%3DBeauchamp%26aufirst%3DE.%2BM.%26aulast%3DEckerdt%26aufirst%3DF.%26aulast%3DBlyth%26aufirst%3DG.%2BT.%26aulast%3DAbedin%26aufirst%3DS.%2BM.%26aulast%3DGiles%26aufirst%3DF.%2BJ.%26aulast%3DAltman%26aufirst%3DJ.%2BK.%26aulast%3DPlatanias%26aufirst%3DL.%2BC.%26atitle%3DMerestinib%2520blocks%2520MNK%2520kinase%2520activity%2520in%2520acute%2520myeloid%2520leukemia%2520progenitors%2520and%2520exhibits%2520antileukemic%2520effects%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DBlood%26date%3D2016%26volume%3D128%26spage%3D410%26epage%3D414%26doi%3D10.1182%2Fblood-2016-02-698704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Durante, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verrienti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filetti, S.</span></span> <span> </span><span class="NLM_article-title">XL184 (cabozantinib) for medullary thyroid carcinoma</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">407</span>– <span class="NLM_lpage">413</span>, <span class="refDoi"> DOI: 10.1517/13543784.2011.559163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1517%2F13543784.2011.559163" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=407-413&author=C.+Duranteauthor=D.+Russoauthor=A.+Verrientiauthor=S.+Filetti&title=XL184+%28cabozantinib%29+for+medullary+thyroid+carcinoma&doi=10.1517%2F13543784.2011.559163"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1517%2F13543784.2011.559163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2011.559163%26sid%3Dliteratum%253Aachs%26aulast%3DDurante%26aufirst%3DC.%26aulast%3DRusso%26aufirst%3DD.%26aulast%3DVerrienti%26aufirst%3DA.%26aulast%3DFiletti%26aufirst%3DS.%26atitle%3DXL184%2520%2528cabozantinib%2529%2520for%2520medullary%2520thyroid%2520carcinoma%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2011%26volume%3D20%26spage%3D407%26epage%3D413%26doi%3D10.1517%2F13543784.2011.559163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfister, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warne, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aikawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amiri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appleton, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuart, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanidi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shafer, C. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of a selective and potent Inhibitor of mitogen-activated protein kinase-interacting kinases 1 and 2 (MNK1/2) utilizing structure-based drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">3034</span>– <span class="NLM_lpage">3045</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01657</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01657" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC28Xks1eit7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3034-3045&author=W.+Hanauthor=Y.+Dingauthor=Y.+Xuauthor=K.+Pfisterauthor=S.+Zhuauthor=B.+Warneauthor=M.+Doyleauthor=M.+Aikawaauthor=P.+Amiriauthor=B.+Appletonauthor=D.+D.+Stuartauthor=A.+Fanidiauthor=C.+M.+Shafer&title=Discovery+of+a+selective+and+potent+Inhibitor+of+mitogen-activated+protein+kinase-interacting+kinases+1+and+2+%28MNK1%2F2%29+utilizing+structure-based+drug+design&doi=10.1021%2Facs.jmedchem.5b01657"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Selective and Potent Inhibitor of Mitogen-Activated Protein Kinase-Interacting Kinases 1 and 2 (MNK1/2) Utilizing Structure-Based Drug Design</span></div><div class="casAuthors">Han, Wooseok; Ding, Yu; Xu, Yongjin; Pfister, Keith; Zhu, Shejin; Warne, Bob; Doyle, Mike; Aikawa, Mina; Amiri, Payman; Appleton, Brent; Stuart, Darrin D.; Fanidi, Abdallah; Shafer, Cynthia M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3034-3045</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of a highly potent and selective small mol. inhibitor I for in vitro target validation of MNK1/2 kinases is described.  The aminopyrazine benzimidazole series was derived from an HTS hit and optimized by utilization of a docking model, conformation anal., and binding pocket comparison against antitargets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBT5jenqIBHLVg90H21EOLACvtfcHk0lgGULzfBwYO7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xks1eit7s%253D&md5=b4c3eb8122635da657fa52daddb6879a</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01657%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DW.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DPfister%26aufirst%3DK.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DWarne%26aufirst%3DB.%26aulast%3DDoyle%26aufirst%3DM.%26aulast%3DAikawa%26aufirst%3DM.%26aulast%3DAmiri%26aufirst%3DP.%26aulast%3DAppleton%26aufirst%3DB.%26aulast%3DStuart%26aufirst%3DD.%2BD.%26aulast%3DFanidi%26aufirst%3DA.%26aulast%3DShafer%26aufirst%3DC.%2BM.%26atitle%3DDiscovery%2520of%2520a%2520selective%2520and%2520potent%2520Inhibitor%2520of%2520mitogen-activated%2520protein%2520kinase-interacting%2520kinases%25201%2520and%25202%2520%2528MNK1%252F2%2529%2520utilizing%2520structure-based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3034%26epage%3D3045%26doi%3D10.1021%2Facs.jmedchem.5b01657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basnet, S. K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumarasiri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diab, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albrecht, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of 4-(dihydropyridinon-3-yl)amino-5-methylthieno[2,3-d]pyrimidine derivatives as potent MNK inhibitors: synthesis, structure-activity relationship analysis and biological evaluation</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">116</span>– <span class="NLM_lpage">126</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.03.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1016%2Fj.ejmech.2015.03.032" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2015&pages=116-126&author=M.+Yuauthor=P.+Liauthor=S.+K.+C.+Basnetauthor=M.+Kumarasiriauthor=S.+Diabauthor=T.+Teoauthor=H.+Albrechtauthor=S.+Wang&title=Discovery+of+4-%28dihydropyridinon-3-yl%29amino-5-methylthieno%5B2%2C3-d%5Dpyrimidine+derivatives+as+potent+MNK+inhibitors%3A+synthesis%2C+structure-activity+relationship+analysis+and+biological+evaluation&doi=10.1016%2Fj.ejmech.2015.03.032"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.03.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.03.032%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DBasnet%26aufirst%3DS.%2BK.%2BC.%26aulast%3DKumarasiri%26aufirst%3DM.%26aulast%3DDiab%26aufirst%3DS.%26aulast%3DTeo%26aufirst%3DT.%26aulast%3DAlbrecht%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDiscovery%2520of%25204-%2528dihydropyridinon-3-yl%2529amino-5-methylthieno%255B2%252C3-d%255Dpyrimidine%2520derivatives%2520as%2520potent%2520MNK%2520inhibitors%253A%2520synthesis%252C%2520structure-activity%2520relationship%2520analysis%2520and%2520biological%2520evaluation%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D95%26spage%3D116%26epage%3D126%26doi%3D10.1016%2Fj.ejmech.2015.03.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santag, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wengner, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lange, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bomer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puhler, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lienau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergemann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michels, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Nussbaum, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mumberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, K.</span></span> <span> </span><span class="NLM_article-title">BAY 1143269, a novel MNK1 inhibitor, targets oncogenic protein expression and shows potent anti-tumor activity</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>390</i></span>,  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">29</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2016.12.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1016%2Fj.canlet.2016.12.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=28043914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlt12ksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=390&publication_year=2017&pages=21-29&author=S.+Santagauthor=F.+Siegelauthor=A.+M.+Wengnerauthor=C.+Langeauthor=U.+Bomerauthor=K.+Eisauthor=F.+Puhlerauthor=P.+Lienauauthor=L.+Bergemannauthor=M.+Michelsauthor=F.+von+Nussbaumauthor=D.+Mumbergauthor=K.+Petersen&title=BAY+1143269%2C+a+novel+MNK1+inhibitor%2C+targets+oncogenic+protein+expression+and+shows+potent+anti-tumor+activity&doi=10.1016%2Fj.canlet.2016.12.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">BAY 1143269, a novel MNK1 inhibitor, targets oncogenic protein expression and shows potent anti-tumor activity</span></div><div class="casAuthors">Santag, Susann; Siegel, Franziska; Wengner, Antje M.; Lange, Claudia; Boemer, Ulf; Eis, Knut; Puehler, Florian; Lienau, Philip; Bergemann, Linda; Michels, Martin; von Nussbaum, Franz; Mumberg, Dominik; Petersen, Kirstin</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">390</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">21-29</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The initiation of mRNA translation has received increasing attention as an attractive target for cancer treatment in the recent years.  The oncogenic eukaryotic translation initiation factor 4E (eIF4E) is the major substrate of MAP kinase-interacting kinase 1 (MNK1), and it is located at the junction of the cancer-assocd. PI3K and MAPK pathways.  The fact that MNK1 is linked to cell transformation and tumorigenesis renders the kinase a promising target for cancer therapy.  We identified a novel small mol. MNK1 inhibitor, BAY 1143269, by high-throughput screening and lead optimization.  In kinase assays, BAY 1143269 showed potent and selective inhibition of MNK1.  By targeting MNK1 activity, BAY 1143269 strongly regulated downstream factors involved in cell cycle regulation, apoptosis, immune response and epithelial-mesenchymal transition in vitro or in vivo.  In addn., BAY 1143269 demonstrated strong efficacy in monotherapy in cell line and patient-derived non-small cell lung cancer xenograft models as well as delayed tumor regrowth in combination treatment with std. of care chemotherapeutics.  In summary, the inhibition of MNK1 activity with a highly potent and selective inhibitor BAY 1143269 may provide an innovative approach for anti-cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy6F-tMblwNrVg90H21EOLACvtfcHk0lg0iNET3CfdjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlt12ksg%253D%253D&md5=dadb4b5f5043263f22bc227950eef1cb</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2016.12.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2016.12.029%26sid%3Dliteratum%253Aachs%26aulast%3DSantag%26aufirst%3DS.%26aulast%3DSiegel%26aufirst%3DF.%26aulast%3DWengner%26aufirst%3DA.%2BM.%26aulast%3DLange%26aufirst%3DC.%26aulast%3DBomer%26aufirst%3DU.%26aulast%3DEis%26aufirst%3DK.%26aulast%3DPuhler%26aufirst%3DF.%26aulast%3DLienau%26aufirst%3DP.%26aulast%3DBergemann%26aufirst%3DL.%26aulast%3DMichels%26aufirst%3DM.%26aulast%3Dvon%2BNussbaum%26aufirst%3DF.%26aulast%3DMumberg%26aufirst%3DD.%26aulast%3DPetersen%26aufirst%3DK.%26atitle%3DBAY%25201143269%252C%2520a%2520novel%2520MNK1%2520inhibitor%252C%2520targets%2520oncogenic%2520protein%2520expression%2520and%2520shows%2520potent%2520anti-tumor%2520activity%26jtitle%3DCancer%2520Lett.%26date%3D2017%26volume%3D390%26spage%3D21%26epage%3D29%26doi%3D10.1016%2Fj.canlet.2016.12.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oyarzabal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarich, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albarran, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palacios, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbano-Cuadrado, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mateos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reymundo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabal, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salgado, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corrionero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fominaya, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bischoff, J. R.</span></span> <span> </span><span class="NLM_article-title">Discovery of mitogen-activated protein kinase-interacting kinase 1 inhibitors by a comprehensive fragment-oriented virtual screening approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">6618</span>– <span class="NLM_lpage">6628</span>, <span class="refDoi"> DOI: 10.1021/jm1005513</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1005513" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVCns7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6618-6628&author=J.+Oyarzabalauthor=N.+Zarichauthor=M.+I.+Albarranauthor=I.+Palaciosauthor=M.+Urbano-Cuadradoauthor=G.+Mateosauthor=I.+Reymundoauthor=O.+Rabalauthor=A.+Salgadoauthor=A.+Corrioneroauthor=J.+Fominayaauthor=J.+Pastorauthor=J.+R.+Bischoff&title=Discovery+of+mitogen-activated+protein+kinase-interacting+kinase+1+inhibitors+by+a+comprehensive+fragment-oriented+virtual+screening+approach&doi=10.1021%2Fjm1005513"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Mitogen-Activated Protein Kinase-Interacting Kinase 1 Inhibitors by a Comprehensive Fragment-Oriented Virtual Screening Approach</span></div><div class="casAuthors">Oyarzabal, Julen; Zarich, Natasha; Albarran, Maria Isabel; Palacios, Irene; Urbano-Cuadrado, Manuel; Mateos, Genoveva; Reymundo, Isabel; Rabal, Obdulia; Salgado, Antonio; Corrionero, Ana; Fominaya, Jesus; Pastor, Joaquin; Bischoff, James R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6618-6628</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mitogen-activated protein kinase-interacting kinases 1 and 2 (MNK1 and MNK2) phosphorylate the oncogene eIF4E on serine 209.  This phosphorylation has been reported to be required for its oncogenic activity.  To investigate if pharmacol. inhibition of MNK1 could be useful for the treatment of cancers, we pursued a comprehensive virtual screening approach to rapidly identify pharmacol. tools for target validation and to find optimal starting points for a plausible medicinal chem. project.  A collection of 1236 compds., selected from a library of 42 168 compds. and a database of 18.8 million structures, were assayed.  Of the identified hits, 26 were found to have IC50 values less than 10 μM (2.10% hit rate).  The most potent compd. had an IC50 value of 117 nM, and 73.1% of these hits were fragments.  The hits were characterized by a high ligand efficiency (0.32-0.52 kcal/mol per heavy atom).  Ten different chem. scaffolds were represented, giving a chemotype/hit ratio of 0.38.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWli1zSitx8LVg90H21EOLACvtfcHk0lg0iNET3CfdjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVCns7nM&md5=2ce8787b149c9175c52b01b2ea4adb3b</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm1005513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1005513%26sid%3Dliteratum%253Aachs%26aulast%3DOyarzabal%26aufirst%3DJ.%26aulast%3DZarich%26aufirst%3DN.%26aulast%3DAlbarran%26aufirst%3DM.%2BI.%26aulast%3DPalacios%26aufirst%3DI.%26aulast%3DUrbano-Cuadrado%26aufirst%3DM.%26aulast%3DMateos%26aufirst%3DG.%26aulast%3DReymundo%26aufirst%3DI.%26aulast%3DRabal%26aufirst%3DO.%26aulast%3DSalgado%26aufirst%3DA.%26aulast%3DCorrionero%26aufirst%3DA.%26aulast%3DFominaya%26aufirst%3DJ.%26aulast%3DPastor%26aufirst%3DJ.%26aulast%3DBischoff%26aufirst%3DJ.%2BR.%26atitle%3DDiscovery%2520of%2520mitogen-activated%2520protein%2520kinase-interacting%2520kinase%25201%2520inhibitors%2520by%2520a%2520comprehensive%2520fragment-oriented%2520virtual%2520screening%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6618%26epage%3D6628%26doi%3D10.1021%2Fjm1005513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Webster, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goel, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, I. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staunton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jessen, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wegerski, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appleman, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webber, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sprengeler, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reich, S. H.</span></span> <span> </span><span class="NLM_article-title">eFT508, a potent and selective mitogen-activated protein kinase interacting kinase (MNK) 1 and 2 inhibitor, is efficacious in preclinical models of diffuse large B-cell lymphoma (DLBCL)</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">1554</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2015&pages=1554&author=K.+R.+Websterauthor=V.+K.+Goelauthor=I.+N.+Hungauthor=G.+Parkerauthor=J.+Stauntonauthor=M.+Nealauthor=J.+Molterauthor=G.+G.+Chiangauthor=K.+A.+Jessenauthor=C.+J.+Wegerskiauthor=S.+Sperryauthor=V.+Huangauthor=J.+Chenauthor=P.+A.+Thompsonauthor=J.+R.+Applemanauthor=S.+E.+Webberauthor=P.+A.+Sprengelerauthor=S.+H.+Reich&title=eFT508%2C+a+potent+and+selective+mitogen-activated+protein+kinase+interacting+kinase+%28MNK%29+1+and+2+inhibitor%2C+is+efficacious+in+preclinical+models+of+diffuse+large+B-cell+lymphoma+%28DLBCL%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWebster%26aufirst%3DK.%2BR.%26aulast%3DGoel%26aufirst%3DV.%2BK.%26aulast%3DHung%26aufirst%3DI.%2BN.%26aulast%3DParker%26aufirst%3DG.%26aulast%3DStaunton%26aufirst%3DJ.%26aulast%3DNeal%26aufirst%3DM.%26aulast%3DMolter%26aufirst%3DJ.%26aulast%3DChiang%26aufirst%3DG.%2BG.%26aulast%3DJessen%26aufirst%3DK.%2BA.%26aulast%3DWegerski%26aufirst%3DC.%2BJ.%26aulast%3DSperry%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DThompson%26aufirst%3DP.%2BA.%26aulast%3DAppleman%26aufirst%3DJ.%2BR.%26aulast%3DWebber%26aufirst%3DS.%2BE.%26aulast%3DSprengeler%26aufirst%3DP.%2BA.%26aulast%3DReich%26aufirst%3DS.%2BH.%26atitle%3DeFT508%252C%2520a%2520potent%2520and%2520selective%2520mitogen-activated%2520protein%2520kinase%2520interacting%2520kinase%2520%2528MNK%2529%25201%2520and%25202%2520inhibitor%252C%2520is%2520efficacious%2520in%2520preclinical%2520models%2520of%2520diffuse%2520large%2520B-cell%2520lymphoma%2520%2528DLBCL%2529%26jtitle%3DBlood%26date%3D2015%26volume%3D126%26spage%3D1554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reich, S. H.</span>; <span class="NLM_string-name">Sprengeler, P. A.</span>; <span class="NLM_string-name">Webber, S. E.</span>; <span class="NLM_string-name">Xiang, A. X.</span>; <span class="NLM_string-name">Ernst, J.</span></span> <span> </span><span class="NLM_article-title">MNK Inhibitors and Methods Related Thereto</span>. U.S. Patent <span class="NLM_patent">9,382,248</span>, July 5, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=S.+H.+Reich&author=P.+A.+Sprengeler&author=S.+E.+Webber&author=A.+X.+Xiang&author=J.+Ernst&title=MNK+Inhibitors+and+Methods+Related+Thereto"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DReich%26aufirst%3DS.%2BH.%26atitle%3DMNK%2520Inhibitors%2520and%2520Methods%2520Related%2520Thereto%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raheem, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walji, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abeywickrema, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbe, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Childers, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clas, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubost, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Embrey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grobler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hafey, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartingh, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazuda, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuethe, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCabe Dunn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolting, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pajkovic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rada, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rearden, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreier, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sisko, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steele, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truchon, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, P. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of 2-pyridinone aminals: a prodrug strategy to advance a second generation of HIV-1 integrase strand transfer inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8154</span>– <span class="NLM_lpage">8165</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01037</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01037" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFersrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8154-8165&author=I.+T.+Raheemauthor=A.+M.+Waljiauthor=D.+Kleinauthor=J.+M.+Sandersauthor=D.+A.+Powellauthor=P.+Abeywickremaauthor=G.+Barbeauthor=A.+Bennetauthor=K.+Childersauthor=M.+Christensenauthor=S.+D.+Clasauthor=D.+Dubostauthor=M.+Embreyauthor=J.+Groblerauthor=M.+J.+Hafeyauthor=T.+J.+Hartinghauthor=D.+J.+Hazudaauthor=J.+T.+Kuetheauthor=J.+McCabe+Dunnauthor=M.+D.+Millerauthor=K.+P.+Mooreauthor=A.+Noltingauthor=N.+Pajkovicauthor=S.+Patelauthor=Z.+Pengauthor=V.+Radaauthor=P.+Reardenauthor=J.+D.+Schreierauthor=J.+Siskoauthor=T.+G.+Steeleauthor=J.+F.+Truchonauthor=J.+Waiauthor=M.+Xuauthor=P.+J.+Coleman&title=Discovery+of+2-pyridinone+aminals%3A+a+prodrug+strategy+to+advance+a+second+generation+of+HIV-1+integrase+strand+transfer+inhibitors&doi=10.1021%2Facs.jmedchem.5b01037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 2-Pyridinone Aminals: A Prodrug Strategy to Advance a Second Generation of HIV-1 Integrase Strand Transfer Inhibitors</span></div><div class="casAuthors">Raheem, Izzat T.; Walji, Abbas M.; Klein, Daniel; Sanders, John M.; Powell, David A.; Abeywickrema, Pravien; Barbe, Guillaume; Bennet, Amrith; Childers, Karla; Christensen, Melodie; Clas, Sophie-Dorothee; Dubost, David; Embrey, Mark; Grobler, Jay; Hafey, Michael J.; Hartingh, Timothy J.; Hazuda, Daria J.; Kuethe, Jeffrey T.; Dunn, Jamie McCabe; Miller, Michael D.; Moore, Keith P.; Nolting, Andrew; Pajkovic, Natasa; Patel, Sangita; Peng, Zuihui; Rada, Vanessa; Rearden, Paul; Schreier, John D.; Sisko, John; Steele, Thomas G.; Truchon, Jean-Francois; Wai, John; Xu, Min; Coleman, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8154-8165</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The search for new mol. constructs that resemble the crit. two-metal binding pharmacophore required for HIV integrase strand transfer inhibition represents a vibrant area of research within drug discovery.  Here the authors present the discovery of a new class of HIV integrase strand transfer inhibitors based on the 2-pyridinone core of MK-0536.  These efforts led to the identification of two lead compds. I and II with excellent antiviral activity and preclin. pharmacokinetic profiles to support a once-daily human dose prediction.  Dose escalating PK studies in dog revealed significant issues with limited oral absorption and required an innovative prodrug strategy to enhance the high-dose plasma exposures of the parent mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGEsuT4C8WELVg90H21EOLACvtfcHk0ljYndzoUL8M0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFersrvJ&md5=bec0c2f7710a1e4e8cc3a502067a2236</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01037%26sid%3Dliteratum%253Aachs%26aulast%3DRaheem%26aufirst%3DI.%2BT.%26aulast%3DWalji%26aufirst%3DA.%2BM.%26aulast%3DKlein%26aufirst%3DD.%26aulast%3DSanders%26aufirst%3DJ.%2BM.%26aulast%3DPowell%26aufirst%3DD.%2BA.%26aulast%3DAbeywickrema%26aufirst%3DP.%26aulast%3DBarbe%26aufirst%3DG.%26aulast%3DBennet%26aufirst%3DA.%26aulast%3DChilders%26aufirst%3DK.%26aulast%3DChristensen%26aufirst%3DM.%26aulast%3DClas%26aufirst%3DS.%2BD.%26aulast%3DDubost%26aufirst%3DD.%26aulast%3DEmbrey%26aufirst%3DM.%26aulast%3DGrobler%26aufirst%3DJ.%26aulast%3DHafey%26aufirst%3DM.%2BJ.%26aulast%3DHartingh%26aufirst%3DT.%2BJ.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DKuethe%26aufirst%3DJ.%2BT.%26aulast%3DMcCabe%2BDunn%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DM.%2BD.%26aulast%3DMoore%26aufirst%3DK.%2BP.%26aulast%3DNolting%26aufirst%3DA.%26aulast%3DPajkovic%26aufirst%3DN.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DPeng%26aufirst%3DZ.%26aulast%3DRada%26aufirst%3DV.%26aulast%3DRearden%26aufirst%3DP.%26aulast%3DSchreier%26aufirst%3DJ.%2BD.%26aulast%3DSisko%26aufirst%3DJ.%26aulast%3DSteele%26aufirst%3DT.%2BG.%26aulast%3DTruchon%26aufirst%3DJ.%2BF.%26aulast%3DWai%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520of%25202-pyridinone%2520aminals%253A%2520a%2520prodrug%2520strategy%2520to%2520advance%2520a%2520second%2520generation%2520of%2520HIV-1%2520integrase%2520strand%2520transfer%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8154%26epage%3D8165%26doi%3D10.1021%2Facs.jmedchem.5b01037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, R. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, R. P.</span></span> <span> </span><span class="NLM_article-title">Cytokines in cancer drug resistance: cues to new therapeutic strategies</span>. <i>Biochim. Biophys. Acta, Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>1865</i></span>,  <span class="NLM_fpage">255</span>– <span class="NLM_lpage">265</span>, <span class="refDoi"> DOI: 10.1016/j.bbcan.2016.03.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1016%2Fj.bbcan.2016.03.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=26993403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC28XksVWmsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1865&publication_year=2016&pages=255-265&author=V.+S.+Jonesauthor=R.+Y.+Huangauthor=L.+P.+Chenauthor=Z.+S.+Chenauthor=L.+Fuauthor=R.+P.+Huang&title=Cytokines+in+cancer+drug+resistance%3A+cues+to+new+therapeutic+strategies&doi=10.1016%2Fj.bbcan.2016.03.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Cytokines in cancer drug resistance: Cues to new therapeutic strategies</span></div><div class="casAuthors">Jones, Valerie Sloane; Huang, Ren-Yu; Chen, Li-Pai; Chen, Zhe-Sheng; Fu, Liwu; Huang, Ruo-Pan</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Reviews on Cancer</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1865</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">255-265</span>CODEN:
                <span class="NLM_cas:coden">BBACEU</span>;
        ISSN:<span class="NLM_cas:issn">0304-419X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The development of oncoprotein-targeted anticancer drugs is an invaluable weapon in the war against cancer.  However, cancers do not give up without a fight.  They may develop multiple mechanisms of drug resistance, including apoptosis inhibition, drug expulsion, and increased proliferation that reduce the effectiveness of the drug.  The collective work of researchers has highlighted the role of cytokines in the mechanisms of cancer drug resistance, as well as in cancer cell progression.  Furthermore, recent studies have described how specific cytokines secreted by cancer stromal cells confer resistance to chemotherapeutic treatments.  In order to gain a better understanding of mechanism of cancer drug resistance and a prediction of treatment outcome, it is imperative that correlations are established between global cytokine profiles and cancer drug resistance.  Here we discuss the recent discoveries in this field of research and discuss their implications for the future development of effective anti-cancer medicines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIYFeodi3D6LVg90H21EOLACvtfcHk0ljYndzoUL8M0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksVWmsbw%253D&md5=6457c45b3cb9d451c5082db397fd831a</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bbcan.2016.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbcan.2016.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DV.%2BS.%26aulast%3DHuang%26aufirst%3DR.%2BY.%26aulast%3DChen%26aufirst%3DL.%2BP.%26aulast%3DChen%26aufirst%3DZ.%2BS.%26aulast%3DFu%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DR.%2BP.%26atitle%3DCytokines%2520in%2520cancer%2520drug%2520resistance%253A%2520cues%2520to%2520new%2520therapeutic%2520strategies%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Rev.%2520Cancer%26date%3D2016%26volume%3D1865%26spage%3D255%26epage%3D265%26doi%3D10.1016%2Fj.bbcan.2016.03.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karin, M.</span></span> <span> </span><span class="NLM_article-title">A cytokine-mediated link between innate immunity, inflammation, and cancer</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">1175</span>– <span class="NLM_lpage">1183</span>, <span class="refDoi"> DOI: 10.1172/JCI31537</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1172%2FJCI31537" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2007&pages=1175-1183&author=W.+W.+Linauthor=M.+Karin&title=A+cytokine-mediated+link+between+innate+immunity%2C+inflammation%2C+and+cancer&doi=10.1172%2FJCI31537"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1172%2FJCI31537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI31537%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DW.%2BW.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DA%2520cytokine-mediated%2520link%2520between%2520innate%2520immunity%252C%2520inflammation%252C%2520and%2520cancer%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2007%26volume%3D117%26spage%3D1175%26epage%3D1183%26doi%3D10.1172%2FJCI31537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaikuad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span> <span> </span><span class="NLM_article-title">The ins and outs of selective kinase inhibitor development</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">818</span>– <span class="NLM_lpage">821</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1938</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1038%2Fnchembio.1938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=26485069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1ykt7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=818-821&author=S.+Mullerauthor=A.+Chaikuadauthor=N.+S.+Grayauthor=S.+Knapp&title=The+ins+and+outs+of+selective+kinase+inhibitor+development&doi=10.1038%2Fnchembio.1938"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The ins and outs of selective kinase inhibitor development</span></div><div class="casAuthors">Muller, Susanne; Chaikuad, Apirat; Gray, Nathanael S.; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">818-821</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protein kinases have emerged as one of the most successful families of drug targets.  To date, most selective kinase inhibitors have been discovered serendipitously either through broad selectivity screening or through the discovery of unique binding modes.  Here the authors discuss design strategies that could lead to a broader coverage of the kinome with selective inhibitors and to a more rational approach for developing them.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQzaMrxSYx_rVg90H21EOLACvtfcHk0ljBRBr_6T9_Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1ykt7fF&md5=f5adf0bbaa388c87b26bae23cfad0bae</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1938%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DS.%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DThe%2520ins%2520and%2520outs%2520of%2520selective%2520kinase%2520inhibitor%2520development%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3D818%26epage%3D821%26doi%3D10.1038%2Fnchembio.1938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bissantz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M.</span></span> <span> </span><span class="NLM_article-title">A medicinal chemist’s guide to molecular interactions</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">5061</span>– <span class="NLM_lpage">5084</span>, <span class="refDoi"> DOI: 10.1021/jm100112j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100112j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvFKjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5061-5084&author=C.+Bissantzauthor=B.+Kuhnauthor=M.+Stahl&title=A+medicinal+chemist%E2%80%99s+guide+to+molecular+interactions&doi=10.1021%2Fjm100112j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">A Medicinal Chemist's Guide to Molecular Interactions</span></div><div class="casAuthors">Bissantz, Caterina; Kuhn, Bernd; Stahl, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5061-5084</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraV8HPbwsihbVg90H21EOLACvtfcHk0ljBRBr_6T9_Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvFKjtbs%253D&md5=f39cf8700267cdc311c73de4d433bab0</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm100112j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100112j%26sid%3Dliteratum%253Aachs%26aulast%3DBissantz%26aufirst%3DC.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DA%2520medicinal%2520chemist%25E2%2580%2599s%2520guide%2520to%2520molecular%2520interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5061%26epage%3D5084%26doi%3D10.1021%2Fjm100112j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fufezan, C.</span></span> <span> </span><span class="NLM_article-title">The role of Buergi-Dunitz interactions in the structural stability of proteins</span>. <i>Proteins: Struct., Funct., Genet.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">2831</span>– <span class="NLM_lpage">2838</span>, <span class="refDoi"> DOI: 10.1002/prot.22800</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1002%2Fprot.22800" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=20635415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGqs73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2010&pages=2831-2838&author=C.+Fufezan&title=The+role+of+Buergi-Dunitz+interactions+in+the+structural+stability+of+proteins&doi=10.1002%2Fprot.22800"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">The role of Buergi-Dunitz interactions in the structural stability of proteins</span></div><div class="casAuthors">Fufezan, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Bioinformatics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2831-2838</span>CODEN:
                <span class="NLM_cas:coden">PSFBAF</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Non-bonding interactions are essential for protein stability and maintenance of secondary structure.  Their strength, however, is not always exptl. accessible.  One example is the stability of collagen, which is in part due to Buergi-Dunitz or n → π* interactions between the peptide backbone atoms.  Here, the overall frequency of n → π* interactions in proteins has been investigated.  The anal. of a non-redundant set of protein structures showed that 45.1% of all residues have a backbone conformation favoring a n → π* nucleophilic attack between the carbonyl oxygen of residue i - 1 and the carbonyl carbon of residue i.  These residues form a substantial fraction of right- and left-handed α helixes, 310 helixes, π helixes, and hydrogen bonded turns.  Simulations showed that there are only four regions in Ramachandran space that favor backbone ni-1 → πi* interactions and these Φ, Ψ combinations are obsd. with high frequencies in the non-redundant protein structure set.  Anal. of carbonyl carbon displacements out of the peptide plane in ultra-high resoln. protein structures indeed reveals the presence of the Buergi-Dunitz trajectory.  The Buergi-Dunitz interaction thus appears to play an important and general role in protein structure stability that has not hitherto been fully explored.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroccrxMw9b1rVg90H21EOLACvtfcHk0ljBRBr_6T9_Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGqs73N&md5=58b891d088dcd9828da546d4b1a1e97a</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2Fprot.22800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.22800%26sid%3Dliteratum%253Aachs%26aulast%3DFufezan%26aufirst%3DC.%26atitle%3DThe%2520role%2520of%2520Buergi-Dunitz%2520interactions%2520in%2520the%2520structural%2520stability%2520of%2520proteins%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2010%26volume%3D78%26spage%3D2831%26epage%3D2838%26doi%3D10.1002%2Fprot.22800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paulini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, F.</span></span> <span> </span><span class="NLM_article-title">Orthogonal multipolar interactions in structural chemistry and biology</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">1788</span>– <span class="NLM_lpage">1805</span>, <span class="refDoi"> DOI: 10.1002/anie.200462213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1002%2Fanie.200462213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BD2MXislWkt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=1788-1805&author=R.+Pauliniauthor=K.+Mullerauthor=F.+Diederich&title=Orthogonal+multipolar+interactions+in+structural+chemistry+and+biology&doi=10.1002%2Fanie.200462213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Orthogonal multipolar interactions in structural chemistry and biology</span></div><div class="casAuthors">Paulini, Ralph; Mueller, Klaus; Diederich, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1788-1805</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The past few decades of mol. recognition studies have greatly enhanced our knowledge on apolar, ion-dipole, and hydrogen-bonding interactions.  However, much less attention has been given to the role that multipolar interactions, in particular those with orthogonal dipolar alignment, play in organizing a crystal lattice or stabilizing complexes involving biol. receptors.  By using results from database mining, this review attempts to give an overview of types and structural features of these previously rather overlooked interactions.  A no. of illustrative examples of these interactions found in X-ray crystal structures of small mols. and protein-ligand complexes demonstrate their propensity and thus potential importance for both, chem. and biol. mol. recognition processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTGHoutIq12LVg90H21EOLACvtfcHk0lgi7cd-XpXqiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXislWkt7s%253D&md5=6ad842547313b27fc1676e9c3a001909</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2Fanie.200462213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200462213%26sid%3Dliteratum%253Aachs%26aulast%3DPaulini%26aufirst%3DR.%26aulast%3DMuller%26aufirst%3DK.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DOrthogonal%2520multipolar%2520interactions%2520in%2520structural%2520chemistry%2520and%2520biology%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2005%26volume%3D44%26spage%3D1788%26epage%3D1805%26doi%3D10.1002%2Fanie.200462213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jauch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Netter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aicher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackle, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahl, M. C.</span></span> <span> </span><span class="NLM_article-title">Crystal structures of the MNK2 kinase domain reveal an inhibitory conformation and a zinc binding site</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1559</span>– <span class="NLM_lpage">1568</span>, <span class="refDoi"> DOI: 10.1016/j.str.2005.07.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1016%2Fj.str.2005.07.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=1559-1568&author=R.+Jauchauthor=S.+Jakelauthor=C.+Netterauthor=K.+Schreiterauthor=B.+Aicherauthor=H.+Jackleauthor=M.+C.+Wahl&title=Crystal+structures+of+the+MNK2+kinase+domain+reveal+an+inhibitory+conformation+and+a+zinc+binding+site&doi=10.1016%2Fj.str.2005.07.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2005.07.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2005.07.013%26sid%3Dliteratum%253Aachs%26aulast%3DJauch%26aufirst%3DR.%26aulast%3DJakel%26aufirst%3DS.%26aulast%3DNetter%26aufirst%3DC.%26aulast%3DSchreiter%26aufirst%3DK.%26aulast%3DAicher%26aufirst%3DB.%26aulast%3DJackle%26aufirst%3DH.%26aulast%3DWahl%26aufirst%3DM.%2BC.%26atitle%3DCrystal%2520structures%2520of%2520the%2520MNK2%2520kinase%2520domain%2520reveal%2520an%2520inhibitory%2520conformation%2520and%2520a%2520zinc%2520binding%2520site%26jtitle%3DStructure%26date%3D2005%26volume%3D13%26spage%3D1559%26epage%3D1568%26doi%3D10.1016%2Fj.str.2005.07.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeqiraj, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jha, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlicky, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thevakumaran, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talukdar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pillon, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceccarelli, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juang, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaughan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinton, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perelygin, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kourinov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guarne, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sicheri, F.</span></span> <span> </span><span class="NLM_article-title">Dimeric structure of pseudokinase RNase L bound to 2–5A reveals a basis for interferon-induced antiviral activity</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">221</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2013.12.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1016%2Fj.molcel.2013.12.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=24462203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1GrtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=221-234&author=H.+Huangauthor=E.+Zeqirajauthor=B.+Dongauthor=B.+K.+Jhaauthor=N.+M.+Duffyauthor=S.+Orlickyauthor=N.+Thevakumaranauthor=M.+Talukdarauthor=M.+C.+Pillonauthor=D.+F.+Ceccarelliauthor=L.+C.+Wanauthor=Y.+C.+Juangauthor=D.+Y.+Maoauthor=C.+Gaughanauthor=M.+A.+Brintonauthor=A.+A.+Perelyginauthor=I.+Kourinovauthor=A.+Guarneauthor=R.+H.+Silvermanauthor=F.+Sicheri&title=Dimeric+structure+of+pseudokinase+RNase+L+bound+to+2%E2%80%935A+reveals+a+basis+for+interferon-induced+antiviral+activity&doi=10.1016%2Fj.molcel.2013.12.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Dimeric Structure of Pseudokinase RNase L Bound to 2-5A Reveals a Basis for Interferon-Induced Antiviral Activity</span></div><div class="casAuthors">Huang, Hao; Zeqiraj, Elton; Dong, Beihua; Jha, Babal Kant; Duffy, Nicole M.; Orlicky, Stephen; Thevakumaran, Neroshan; Talukdar, Manisha; Pillon, Monica C.; Ceccarelli, Derek F.; Wan, Leo C. K.; Juang, Yu-Chi; Mao, Daniel Y. L.; Gaughan, Christina; Brinton, Margo A.; Perelygin, Andrey A.; Kourinov, Igor; Guarne, Alba; Silverman, Robert H.; Sicheri, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">221-234</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">RNase L is an ankyrin repeat domain-contg. dual endoribonuclease-pseudokinase that is activated by unusual 2,'5'-oligoadenylate (2-5A) second messengers and which impedes viral infections in higher vertebrates.  Despite its importance in interferon-regulated antiviral innate immunity, relatively little is known about its precise mechanism of action.  Here we present a functional characterization of 2.5 Å and 3.25 Å X-ray crystal and small-angle X-ray scattering structures of RNase L bound to a natural 2-5A activator with and without ADP or the nonhydrolysable ATP mimetic AMP-PNP.  These studies reveal how recognition of 2-5A through interactions with the ankyrin repeat domain and the pseudokinase domain, together with nucleotide binding, imposes a rigid intertwined dimer configuration that is essential for RNase catalytic and antiviral functions.  The involvement of the pseudokinase domain of RNase L in 2-5A sensing, nucleotide binding, dimerization, and RNase functions highlights the evolutionary adaptability of the eukaryotic protein kinase fold.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxh3n6FswZu7Vg90H21EOLACvtfcHk0lgi7cd-XpXqiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1GrtL8%253D&md5=14c2856a405ae2308c2d37592241a593</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2013.12.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2013.12.025%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DZeqiraj%26aufirst%3DE.%26aulast%3DDong%26aufirst%3DB.%26aulast%3DJha%26aufirst%3DB.%2BK.%26aulast%3DDuffy%26aufirst%3DN.%2BM.%26aulast%3DOrlicky%26aufirst%3DS.%26aulast%3DThevakumaran%26aufirst%3DN.%26aulast%3DTalukdar%26aufirst%3DM.%26aulast%3DPillon%26aufirst%3DM.%2BC.%26aulast%3DCeccarelli%26aufirst%3DD.%2BF.%26aulast%3DWan%26aufirst%3DL.%2BC.%26aulast%3DJuang%26aufirst%3DY.%2BC.%26aulast%3DMao%26aufirst%3DD.%2BY.%26aulast%3DGaughan%26aufirst%3DC.%26aulast%3DBrinton%26aufirst%3DM.%2BA.%26aulast%3DPerelygin%26aufirst%3DA.%2BA.%26aulast%3DKourinov%26aufirst%3DI.%26aulast%3DGuarne%26aufirst%3DA.%26aulast%3DSilverman%26aufirst%3DR.%2BH.%26aulast%3DSicheri%26aufirst%3DF.%26atitle%3DDimeric%2520structure%2520of%2520pseudokinase%2520RNase%2520L%2520bound%2520to%25202%25E2%2580%25935A%2520reveals%2520a%2520basis%2520for%2520interferon-induced%2520antiviral%2520activity%26jtitle%3DMol.%2520Cell%26date%3D2014%26volume%3D53%26spage%3D221%26epage%3D234%26doi%3D10.1016%2Fj.molcel.2013.12.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berman, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westbrook, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilliland, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weissig, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shindyalov, I. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourne, P. E.</span></span> <span> </span><span class="NLM_article-title">The Protein Data Bank</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">242</span>, <span class="refDoi"> DOI: 10.1093/nar/28.1.235</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1093%2Fnar%2F28.1.235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10592235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvVKjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=235-242&author=H.+M.+Bermanauthor=J.+Westbrookauthor=Z.+Fengauthor=G.+Gillilandauthor=T.+N.+Bhatauthor=H.+Weissigauthor=I.+N.+Shindyalovauthor=P.+E.+Bourne&title=The+Protein+Data+Bank&doi=10.1093%2Fnar%2F28.1.235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Data Bank</span></div><div class="casAuthors">Berman, Helen M.; Westbrook, John; Feng, Zukang; Gilliland, Gary; Bhat, T. N.; Weissig, Helge; Shindyalov, Ilya N.; Bourne, Philip E.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The Protein Data Bank (PDB; http://www.rcsb.org/pdb/)is the single worldwide archive of structural data of biol. macromols.  This paper describes the goals of the PDB, the systems in place for data deposition and access, how to obtain further information, and near-term plans for the future development of the resource.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpStGCxT8QzirVg90H21EOLACvtfcHk0lgLY0qL79AIaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvVKjt7w%253D&md5=227fb393f754be2be375ab727bfd05dc</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1093%2Fnar%2F28.1.235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252F28.1.235%26sid%3Dliteratum%253Aachs%26aulast%3DBerman%26aufirst%3DH.%2BM.%26aulast%3DWestbrook%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DGilliland%26aufirst%3DG.%26aulast%3DBhat%26aufirst%3DT.%2BN.%26aulast%3DWeissig%26aufirst%3DH.%26aulast%3DShindyalov%26aufirst%3DI.%2BN.%26aulast%3DBourne%26aufirst%3DP.%2BE.%26atitle%3DThe%2520Protein%2520Data%2520Bank%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2000%26volume%3D28%26spage%3D235%26epage%3D242%26doi%3D10.1093%2Fnar%2F28.1.235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Groom, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruno, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lightfoot, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, S. C.</span></span> <span> </span><span class="NLM_article-title">The Cambridge Structural Database</span>. <i>Acta Crystallogr., Sect. B: Struct. Sci., Cryst. Eng. Mater.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">171</span>– <span class="NLM_lpage">179</span>, <span class="refDoi"> DOI: 10.1107/S2052520616003954</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1107%2FS2052520616003954" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=27048719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC28Xls1Kntro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2016&pages=171-179&author=C.+R.+Groomauthor=I.+J.+Brunoauthor=M.+P.+Lightfootauthor=S.+C.+Ward&title=The+Cambridge+Structural+Database&doi=10.1107%2FS2052520616003954"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The Cambridge Structural Database</span></div><div class="casAuthors">Groom, Colin R.; Bruno, Ian J.; Lightfoot, Matthew P.; Ward, Suzanna C.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section B: Structural Science, Crystal Engineering and Materials</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">171-179</span>CODEN:
                <span class="NLM_cas:coden">ACSBDA</span>;
        ISSN:<span class="NLM_cas:issn">2052-5206</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The Cambridge Structural Database (CSD) contains a complete record of all published org. and metal-org. small-mol. crystal structures.  The database has been in operation for over 50 years and continues to be the primary means of sharing structural chem. data and knowledge across disciplines.  As well as structures that are made public to support scientific articles, it includes many structures published directly as CSD Communications.  All structures are processed both computationally and by expert structural chem. editors prior to entering the database.  A key component of this processing is the reliable assocn. of the chem. identity of the structure studied with the exptl. data.  This important step helps ensure that data is widely discoverable and readily reusable.  Content is further enriched through selective inclusion of addnl. exptl. data.  Entries are available to anyone through free CSD community web services.  Linking services developed and maintained by the CCDC, combined with the use of std. identifiers, facilitate discovery from other resources.  Data can also be accessed through CCDC and third party software applications and through an application programming interface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvlnx06ebv_bVg90H21EOLACvtfcHk0lgLY0qL79AIaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xls1Kntro%253D&md5=f9c65ab86fc9db429588c95b0da3f9b2</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1107%2FS2052520616003954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2052520616003954%26sid%3Dliteratum%253Aachs%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DBruno%26aufirst%3DI.%2BJ.%26aulast%3DLightfoot%26aufirst%3DM.%2BP.%26aulast%3DWard%26aufirst%3DS.%2BC.%26atitle%3DThe%2520Cambridge%2520Structural%2520Database%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520B%253A%2520Struct.%2520Sci.%252C%2520Cryst.%2520Eng.%2520Mater.%26date%3D2016%26volume%3D72%26spage%3D171%26epage%3D179%26doi%3D10.1107%2FS2052520616003954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, L.</span></span> <span> </span><span class="NLM_article-title">Calculating partition coefficient by atom-additive method</span>. <i>Perspect. Drug Discovery Des.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">47</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1023/A:1008763405023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1023%2FA%3A1008763405023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=47-66&author=R.+Wangauthor=Y.+Gaoauthor=L.+Lai&title=Calculating+partition+coefficient+by+atom-additive+method&doi=10.1023%2FA%3A1008763405023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1023%2FA%3A1008763405023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1008763405023%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DR.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DLai%26aufirst%3DL.%26atitle%3DCalculating%2520partition%2520coefficient%2520by%2520atom-additive%2520method%26jtitle%3DPerspect.%2520Drug%2520Discovery%2520Des.%26date%3D2000%26volume%3D19%26spage%3D47%26epage%3D66%26doi%3D10.1023%2FA%3A1008763405023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platanias, L. C.</span></span> <span> </span><span class="NLM_article-title">MNK kinases in cytokine signaling and regulation of cytokine responses</span>. <i>Biomol. Concepts</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">139</span>, <span class="refDoi"> DOI: 10.1515/bmc-2011-1057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1515%2Fbmc-2011-1057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=23710261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsFejsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=127-139&author=S.+Joshiauthor=L.+C.+Platanias&title=MNK+kinases+in+cytokine+signaling+and+regulation+of+cytokine+responses&doi=10.1515%2Fbmc-2011-1057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Mnk kinases in cytokine signaling and regulation of cytokine responses</span></div><div class="casAuthors">Joshi, Sonali; Platanias, Leonidas C.</div><div class="citationInfo"><span class="NLM_cas:title">Biomolecular Concepts</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">127-139</span>CODEN:
                <span class="NLM_cas:coden">BCIOB8</span>;
        ISSN:<span class="NLM_cas:issn">1868-5021</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH</span>)
        </div><div class="casAbstract">A review.  The kinases Mnk1 and Mnk2 are activated downstream of the p38 MAPK and MEK/ERK signaling pathways.  Extensive work over the years has shown that these kinases control phosphorylation of the eukaryotic initiation factor 4E (eIF4E) and regulate engagement of other effector elements, including hnRNPA1 and PSF.  Mnk kinases are ubiquitously expressed and play crit. roles in signaling for various cytokine receptors, while there is emerging evidence that they have important functions as mediators of pro-inflammatory cytokine prodn.  In this review the mechanisms of activation of MNK pathways by cytokine receptors are addressed and their roles in diverse cytokine-dependent biol. processes are reviewed.  The clin.-translational implications of such work and the relevance of future development of specific MNK inhibitors for the treatment of malignancies and auto-immune disorders are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxR8pAs-R4DrVg90H21EOLACvtfcHk0lgLY0qL79AIaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsFejsbY%253D&md5=dbc78d19a43b77cccb3499c7863ad3bc</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1515%2Fbmc-2011-1057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fbmc-2011-1057%26sid%3Dliteratum%253Aachs%26aulast%3DJoshi%26aufirst%3DS.%26aulast%3DPlatanias%26aufirst%3DL.%2BC.%26atitle%3DMNK%2520kinases%2520in%2520cytokine%2520signaling%2520and%2520regulation%2520of%2520cytokine%2520responses%26jtitle%3DBiomol.%2520Concepts%26date%3D2012%26volume%3D3%26spage%3D127%26epage%3D139%26doi%3D10.1515%2Fbmc-2011-1057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rowlett, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chrestensen, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyce, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harp, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelo, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cominelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizarro, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturgill, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Worthington, M. T.</span></span> <span> </span><span class="NLM_article-title">MNK kinases regulate multiple TLR pathways and innate proinflammatory cytokines in macrophages</span>. <i>Am. J. Physiol. Gastrointest. Liver Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>294</i></span>,  <span class="NLM_fpage">G452</span>– <span class="NLM_lpage">459</span>, <span class="refDoi"> DOI: 10.1152/ajpgi.00077.2007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1152%2Fajpgi.00077.2007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2008&pages=G452-459&author=R.+M.+Rowlettauthor=C.+A.+Chrestensenauthor=M.+Nyceauthor=M.+G.+Harpauthor=J.+W.+Peloauthor=F.+Cominelliauthor=P.+B.+Ernstauthor=T.+T.+Pizarroauthor=T.+W.+Sturgillauthor=M.+T.+Worthington&title=MNK+kinases+regulate+multiple+TLR+pathways+and+innate+proinflammatory+cytokines+in+macrophages&doi=10.1152%2Fajpgi.00077.2007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1152%2Fajpgi.00077.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpgi.00077.2007%26sid%3Dliteratum%253Aachs%26aulast%3DRowlett%26aufirst%3DR.%2BM.%26aulast%3DChrestensen%26aufirst%3DC.%2BA.%26aulast%3DNyce%26aufirst%3DM.%26aulast%3DHarp%26aufirst%3DM.%2BG.%26aulast%3DPelo%26aufirst%3DJ.%2BW.%26aulast%3DCominelli%26aufirst%3DF.%26aulast%3DErnst%26aufirst%3DP.%2BB.%26aulast%3DPizarro%26aufirst%3DT.%2BT.%26aulast%3DSturgill%26aufirst%3DT.%2BW.%26aulast%3DWorthington%26aufirst%3DM.%2BT.%26atitle%3DMNK%2520kinases%2520regulate%2520multiple%2520TLR%2520pathways%2520and%2520innate%2520proinflammatory%2520cytokines%2520in%2520macrophages%26jtitle%3DAm.%2520J.%2520Physiol.%2520Gastrointest.%2520Liver%2520Physiol.%26date%3D2008%26volume%3D294%26spage%3DG452%26epage%3D459%26doi%3D10.1152%2Fajpgi.00077.2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Landon, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muniandy, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shetty, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehrmann, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volpon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peroutka, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazan-Mamczarz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinhardt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahurkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borden, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gartenhaus, R. B.</span></span> <span> </span><span class="NLM_article-title">MNKs act as a regulatory switch for eIF4E1 and eIF4E3 driven mRNA translation in DLBCL</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">5413</span>, <span class="refDoi"> DOI: 10.1038/ncomms6413</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1038%2Fncomms6413" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=25403230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A280%3ADC%252BC2M3ptVOnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=5413&author=A.+L.+Landonauthor=P.+A.+Muniandyauthor=A.+C.+Shettyauthor=E.+Lehrmannauthor=L.+Volponauthor=S.+Houngauthor=Y.+Zhangauthor=B.+Daiauthor=R.+Peroutkaauthor=K.+Mazan-Mamczarzauthor=J.+Steinhardtauthor=A.+Mahurkarauthor=K.+G.+Beckerauthor=K.+L.+Bordenauthor=R.+B.+Gartenhaus&title=MNKs+act+as+a+regulatory+switch+for+eIF4E1+and+eIF4E3+driven+mRNA+translation+in+DLBCL&doi=10.1038%2Fncomms6413"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">MNKs act as a regulatory switch for eIF4E1 and eIF4E3 driven mRNA translation in DLBCL</span></div><div class="casAuthors">Landon Ari L; Peroutka Raymond; Mazan-Mamczarz Krystyna; Steinhardt James; Muniandy Parameswary A; Houng Simone; Dai Bojie; Gartenhaus Ronald B; Shetty Amol C; Mahurkar Anup; Lehrmann Elin; Zhang Yongqing; Becker Kevin G; Volpon Laurent; Borden Katherine L</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5413</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The phosphorylation of eIF4E1 at serine 209 by MNK1 or MNK2 has been shown to initiate oncogenic mRNA translation, a process that favours cancer development and maintenance.  Here, we interrogate the MNK-eIF4E axis in diffuse large B-cell lymphoma (DLBCL) and show a distinct distribution of MNK1 and MNK2 in germinal centre B-cell (GCB) and activated B-cell (ABC) DLBCL.  Despite displaying a differential distribution in GCB and ABC, both MNKs functionally complement each other to sustain cell survival.  MNK inhibition ablates eIF4E1 phosphorylation and concurrently enhances eIF4E3 expression.  Loss of MNK protein itself downregulates total eIF4E1 protein level by reducing eIF4E1 mRNA polysomal loading without affecting total mRNA level or stability.  Enhanced eIF4E3 expression marginally suppresses eIF4E1-driven translation but exhibits a unique translatome that unveils a novel role for eIF4E3 in translation initiation.  We propose that MNKs can modulate oncogenic translation by regulating eIF4E1-eIF4E3 levels and activity in DLBCL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRRAX0_1tXXk2gRQsDqrjW_fW6udTcc2eYv6vqQAGWLlLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M3ptVOnuw%253D%253D&md5=c74031f79715242324239fc9022c5cc6</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fncomms6413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms6413%26sid%3Dliteratum%253Aachs%26aulast%3DLandon%26aufirst%3DA.%2BL.%26aulast%3DMuniandy%26aufirst%3DP.%2BA.%26aulast%3DShetty%26aufirst%3DA.%2BC.%26aulast%3DLehrmann%26aufirst%3DE.%26aulast%3DVolpon%26aufirst%3DL.%26aulast%3DHoung%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DDai%26aufirst%3DB.%26aulast%3DPeroutka%26aufirst%3DR.%26aulast%3DMazan-Mamczarz%26aufirst%3DK.%26aulast%3DSteinhardt%26aufirst%3DJ.%26aulast%3DMahurkar%26aufirst%3DA.%26aulast%3DBecker%26aufirst%3DK.%2BG.%26aulast%3DBorden%26aufirst%3DK.%2BL.%26aulast%3DGartenhaus%26aufirst%3DR.%2BB.%26atitle%3DMNKs%2520act%2520as%2520a%2520regulatory%2520switch%2520for%2520eIF4E1%2520and%2520eIF4E3%2520driven%2520mRNA%2520translation%2520in%2520DLBCL%26jtitle%3DNat.%2520Commun.%26date%3D2014%26volume%3D5%26spage%3D5413%26doi%3D10.1038%2Fncomms6413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wheater, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaydes, J. P.</span></span> <span> </span><span class="NLM_article-title">The role of MNK proteins and eIF4E phosphorylation in breast cancer cell proliferation and survival</span>. <i>Cancer Biol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">728</span>– <span class="NLM_lpage">735</span>, <span class="refDoi"> DOI: 10.4161/cbt.10.7.12965</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.4161%2Fcbt.10.7.12965" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=20686366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVKrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=728-735&author=M.+J.+Wheaterauthor=P.+W.+Johnsonauthor=J.+P.+Blaydes&title=The+role+of+MNK+proteins+and+eIF4E+phosphorylation+in+breast+cancer+cell+proliferation+and+survival&doi=10.4161%2Fcbt.10.7.12965"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The role of MNK proteins and eIF4E phosphorylation in breast cancer cell proliferation and survival</span></div><div class="casAuthors">Wheater, Matthew J.; Johnson, Peter W. M.; Blaydes, Jeremy P.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">728-735</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">EIF4E is overexpressed in many tumors, including a high proportion of breast cancers.  EIF4E is an oncogene, and signaling pathways which promote eIF4E activity represent potential targets for therapeutic intervention in cancer.  MNKs phosphorylate eIF4E on serine 209, a modification that can be required for eIF4E-dependent cell transformation.  There is therefore a clear requirement to det. the role of MNKs in the proliferation and survival of cells from the major human tumors, such as breast cancer.  Phosphorylated eIF4E protein was readily detectable in some breast tumor samples, but was below the limits of detection in others.  Of six breast cancer cell lines representing the major subtypes of breast cancer, phosphorylated eIF4E was readily detectable in five of them, with MCF-7 cells displaying markedly lower levels.  Long term colony forming assays demonstrated that all the five lines with high levels of phosphorylated eIF4E were highly sensitive to a MNK inhibitor.  In short term assays, a range of responses was revealed.  MCF-7 cells were insensitive in both assays.  The anti-proliferative effects of the MNK inhibitor in breast cancer cells are primarily cytostatic, rather than cytotoxic, and are potentially due to the inhibition of cyclin D1 synthesis.  Our data provide evidence that the sensitivity of breast cancer cells to MNK inhibition may correlate with baseline levels of eIF4E phosphorylation, and suggest that a proportion of breast cancers could be sensitive to inhibiting MNK kinase activity, and that the presence of phosphorylated eIF4E could provide a biomarker for the identification of responsive tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV-LNAQtLdjbVg90H21EOLACvtfcHk0li2oPqTQCoKnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVKrtQ%253D%253D&md5=b2ad022bde5142aa92b6e46d32c36c01</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.4161%2Fcbt.10.7.12965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.10.7.12965%26sid%3Dliteratum%253Aachs%26aulast%3DWheater%26aufirst%3DM.%2BJ.%26aulast%3DJohnson%26aufirst%3DP.%2BW.%26aulast%3DBlaydes%26aufirst%3DJ.%2BP.%26atitle%3DThe%2520role%2520of%2520MNK%2520proteins%2520and%2520eIF4E%2520phosphorylation%2520in%2520breast%2520cancer%2520cell%2520proliferation%2520and%2520survival%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2010%26volume%3D10%26spage%3D728%26epage%3D735%26doi%3D10.4161%2Fcbt.10.7.12965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makarova-Rusher, O. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulahannan, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahma, O. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fioravanti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdullah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raffeld, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abi-Jaoudeh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trepel, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinberg, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Revenko, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacLeod, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peer, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figg, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greten, T. F.</span></span> <span> </span><span class="NLM_article-title">Modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750-an antisense oligonucleotide against eIF4E-in combination with irinotecan in solid tumors and irinotecan-refractory colorectal cancer</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">1648</span>– <span class="NLM_lpage">1657</span>, <span class="refDoi"> DOI: 10.1002/ijc.30199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1002%2Fijc.30199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=27194579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVCktrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2016&pages=1648-1657&author=A.+G.+Duffyauthor=O.+V.+Makarova-Rusherauthor=S.+V.+Ulahannanauthor=O.+E.+Rahmaauthor=S.+Fioravantiauthor=M.+Walkerauthor=S.+Abdullahauthor=M.+Raffeldauthor=V.+Andersonauthor=N.+Abi-Jaoudehauthor=E.+Levyauthor=B.+J.+Woodauthor=S.+Leeauthor=Y.+Tomitaauthor=J.+B.+Trepelauthor=S.+M.+Steinbergauthor=A.+S.+Revenkoauthor=A.+R.+MacLeodauthor=C.+J.+Peerauthor=W.+D.+Figgauthor=T.+F.+Greten&title=Modulation+of+tumor+eIF4E+by+antisense+inhibition%3A+A+phase+I%2FII+translational+clinical+trial+of+ISIS+183750-an+antisense+oligonucleotide+against+eIF4E-in+combination+with+irinotecan+in+solid+tumors+and+irinotecan-refractory+colorectal+cancer&doi=10.1002%2Fijc.30199"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750-an antisense oligonucleotide against eIF4E-in combination with irinotecan in solid tumors and irinotecan-refractory colorectal cancer</span></div><div class="casAuthors">Duffy, A. G.; Makarova-Rusher, O. V.; Ulahannan, S. V.; Rahma, O. E.; Fioravanti, S.; Walker, M.; Abdullah, S.; Raffeld, M.; Anderson, V.; Abi-Jaoudeh, N.; Levy, E.; Wood, B. J.; Lee, S.; Tomita, Y.; Trepel, J. B.; Steinberg, S. M.; Revenko, A. S.; MacLeod, A. R.; Peer, C. J.; Figg, W. D.; Greten, T. F.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1648-1657</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The eukaryotic translation initiation factor 4E (eIF4E) is a potent oncogene that is found to be dysregulated in 30% of human cancer, including colorectal carcinogenesis (CRC).  ISIS 183750 is a second-generation antisense oligonucleotide (ASO) designed to inhibit the prodn. of the eIF4E protein.  In preclin. studies we found that EIF4e ASOs reduced expression of EIF4e mRNA and inhibited proliferation of colorectal carcinoma cells.  An additive antiproliferative effect was obsd. in combination with irinotecan.  We then performed a clin. trial evaluating this combination in patients with refractory cancer.  No dose-limiting toxicities were seen but based on pharmacokinetic data and tolerability the dose of irinotecan was reduced to 160 mg/m2 biweekly.  Efficacy was evaluated in 15 patients with irinotecan-refractory colorectal cancer.  The median time of disease control was 22.1 wk.  After ISIS 183750 treatment, peripheral blood levels of eIF4E mRNA were decreased in 13 of 19 patients.  Matched pre- and posttreatment tumor biopsies showed decreased eIF4E mRNA levels in five of nine patients.  In tumor tissue, the intracellular and stromal presence of ISIS 183750 was detected by IHC in all biopsied patients.  Although there were no objective responses stable disease was seen in seven of 15 (47%) patients who were progressing before study entry, six of whom were stable at the time of the week 16 CT scan.  We were also able to confirm through mandatory pre- and posttherapy tumor biopsies penetration of the ASO into the site of metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJBZIx5IBc87Vg90H21EOLACvtfcHk0lgq1aAqQoYVZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVCktrjM&md5=3e81c31e018e29f8a4233b9edfcd0372</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2Fijc.30199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.30199%26sid%3Dliteratum%253Aachs%26aulast%3DDuffy%26aufirst%3DA.%2BG.%26aulast%3DMakarova-Rusher%26aufirst%3DO.%2BV.%26aulast%3DUlahannan%26aufirst%3DS.%2BV.%26aulast%3DRahma%26aufirst%3DO.%2BE.%26aulast%3DFioravanti%26aufirst%3DS.%26aulast%3DWalker%26aufirst%3DM.%26aulast%3DAbdullah%26aufirst%3DS.%26aulast%3DRaffeld%26aufirst%3DM.%26aulast%3DAnderson%26aufirst%3DV.%26aulast%3DAbi-Jaoudeh%26aufirst%3DN.%26aulast%3DLevy%26aufirst%3DE.%26aulast%3DWood%26aufirst%3DB.%2BJ.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DTomita%26aufirst%3DY.%26aulast%3DTrepel%26aufirst%3DJ.%2BB.%26aulast%3DSteinberg%26aufirst%3DS.%2BM.%26aulast%3DRevenko%26aufirst%3DA.%2BS.%26aulast%3DMacLeod%26aufirst%3DA.%2BR.%26aulast%3DPeer%26aufirst%3DC.%2BJ.%26aulast%3DFigg%26aufirst%3DW.%2BD.%26aulast%3DGreten%26aufirst%3DT.%2BF.%26atitle%3DModulation%2520of%2520tumor%2520eIF4E%2520by%2520antisense%2520inhibition%253A%2520A%2520phase%2520I%252FII%2520translational%2520clinical%2520trial%2520of%2520ISIS%2520183750-an%2520antisense%2520oligonucleotide%2520against%2520eIF4E-in%2520combination%2520with%2520irinotecan%2520in%2520solid%2520tumors%2520and%2520irinotecan-refractory%2520colorectal%2520cancer%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2016%26volume%3D139%26spage%3D1648%26epage%3D1657%26doi%3D10.1002%2Fijc.30199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aktas, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahoo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denoyelle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kabha, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freedman, R. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supko, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chorev, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halperin, J. A.</span></span> <span> </span><span class="NLM_article-title">Tumor suppression by small molecule inhibitors of translation initiation</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">869</span>– <span class="NLM_lpage">881</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.598</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.18632%2Foncotarget.598" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=869-881&author=L.+Chenauthor=B.+H.+Aktasauthor=Y.+Wangauthor=X.+Heauthor=R.+Sahooauthor=N.+Zhangauthor=S.+Denoyelleauthor=E.+Kabhaauthor=H.+Yangauthor=R.+Y.+Freedmanauthor=J.+G.+Supkoauthor=M.+Chorevauthor=G.+Wagnerauthor=J.+A.+Halperin&title=Tumor+suppression+by+small+molecule+inhibitors+of+translation+initiation&doi=10.18632%2Foncotarget.598"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.598%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DAktas%26aufirst%3DB.%2BH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DSahoo%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DDenoyelle%26aufirst%3DS.%26aulast%3DKabha%26aufirst%3DE.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DFreedman%26aufirst%3DR.%2BY.%26aulast%3DSupko%26aufirst%3DJ.%2BG.%26aulast%3DChorev%26aufirst%3DM.%26aulast%3DWagner%26aufirst%3DG.%26aulast%3DHalperin%26aufirst%3DJ.%2BA.%26atitle%3DTumor%2520suppression%2520by%2520small%2520molecule%2520inhibitors%2520of%2520translation%2520initiation%26jtitle%3DOncotarget%26date%3D2012%26volume%3D3%26spage%3D869%26epage%3D881%26doi%3D10.18632%2Foncotarget.598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cencic, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robert, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurtkaya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dingledine, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozakov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vajda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, J.</span></span> <span> </span><span class="NLM_article-title">Reversing chemoresistance by small molecule inhibition of the translation initiation complex eIF4F</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">1046</span>– <span class="NLM_lpage">1051</span>, <span class="refDoi"> DOI: 10.1073/pnas.1011477108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1073%2Fpnas.1011477108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=21191102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlWrsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=1046-1051&author=R.+Cencicauthor=D.+R.+Hallauthor=F.+Robertauthor=Y.+Duauthor=J.+Minauthor=L.+Liauthor=M.+Quiauthor=I.+Lewisauthor=S.+Kurtkayaauthor=R.+Dingledineauthor=H.+Fuauthor=D.+Kozakovauthor=S.+Vajdaauthor=J.+Pelletier&title=Reversing+chemoresistance+by+small+molecule+inhibition+of+the+translation+initiation+complex+eIF4F&doi=10.1073%2Fpnas.1011477108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Reversing chemoresistance by small molecule inhibition of the translation initiation complex eIF4F</span></div><div class="casAuthors">Cencic, Regina; Hall, David R.; Robert, Francis; Du, Yuhong; Min, Jaeki; Li, Lian; Qui, Min; Lewis, Iestyn; Kurtkaya, Serdar; Dingledine, Ray; Fu, Haian; Kozakov, Dima; Vajda, Sandor; Pelletier, Jerry</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1046-1051, S1046/1-S1046/7</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Deregulation of cap-dependent translation is assocd. with cancer initiation and progression.  The rate-limiting step of protein synthesis is the loading of ribosomes onto mRNA templates stimulated by the heterotrimeric complex, eukaryotic initiation factor (elF)4F.  This step represents an attractive target for anticancer drug discovery because it resides at the nexus of the TOR signaling pathway.  We have undertaken an ultra-high-throughput screen to identify inhibitors that prevent assembly of the eIF4F complex.  One of the identified compds. blocks interaction between two subunits of elF4F.  As a consequence, cap-dependent translation is inhibited.  This compd. can reverse tumor chemoresistance in a genetically engineered lymphoma mouse model by sensitizing cells to the proapoptotic action of DNA damage.  Mol. modeling expts. provide insight into the mechanism of action of this small mol. inhibitor.  Our expts. validate targeting the eIF4F complex as a strategy for cancer therapy to modulate chemo-sensitivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp523wPn1DaGbVg90H21EOLACvtfcHk0lgq1aAqQoYVZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlWrsrs%253D&md5=8b9fa0bf7dc5638b9a85e1a8e1556088</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1011477108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1011477108%26sid%3Dliteratum%253Aachs%26aulast%3DCencic%26aufirst%3DR.%26aulast%3DHall%26aufirst%3DD.%2BR.%26aulast%3DRobert%26aufirst%3DF.%26aulast%3DDu%26aufirst%3DY.%26aulast%3DMin%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DQui%26aufirst%3DM.%26aulast%3DLewis%26aufirst%3DI.%26aulast%3DKurtkaya%26aufirst%3DS.%26aulast%3DDingledine%26aufirst%3DR.%26aulast%3DFu%26aufirst%3DH.%26aulast%3DKozakov%26aufirst%3DD.%26aulast%3DVajda%26aufirst%3DS.%26aulast%3DPelletier%26aufirst%3DJ.%26atitle%3DReversing%2520chemoresistance%2520by%2520small%2520molecule%2520inhibition%2520of%2520the%2520translation%2520initiation%2520complex%2520eIF4F%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D1046%26epage%3D1051%26doi%3D10.1073%2Fpnas.1011477108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallireddigari, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosenza, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallela, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robell, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, E. P.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of (E)-styrylbenzylsulfones as novel anticancer agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">86</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1021/jm701077b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701077b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=86-100&author=M.+V.+Reddyauthor=M.+R.+Mallireddigariauthor=S.+C.+Cosenzaauthor=V.+R.+Pallelaauthor=N.+M.+Iqbalauthor=K.+A.+Robellauthor=A.+D.+Kangauthor=E.+P.+Reddy&title=Design%2C+synthesis%2C+and+biological+evaluation+of+%28E%29-styrylbenzylsulfones+as+novel+anticancer+agents&doi=10.1021%2Fjm701077b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm701077b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701077b%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DM.%2BV.%26aulast%3DMallireddigari%26aufirst%3DM.%2BR.%26aulast%3DCosenza%26aufirst%3DS.%2BC.%26aulast%3DPallela%26aufirst%3DV.%2BR.%26aulast%3DIqbal%26aufirst%3DN.%2BM.%26aulast%3DRobell%26aufirst%3DK.%2BA.%26aulast%3DKang%26aufirst%3DA.%2BD.%26aulast%3DReddy%26aufirst%3DE.%2BP.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520%2528E%2529-styrylbenzylsulfones%2520as%2520novel%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D86%26epage%3D100%26doi%3D10.1021%2Fjm701077b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sekiyama, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arthanari, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Mias, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leger-Abraham, M.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanism of the dual activity of 4EGI-1: Dissociating eIF4G from eIF4E but stabilizing the binding of unphosphorylated 4E-BP1</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">E4036</span>– <span class="NLM_lpage">4045</span>, <span class="refDoi"> DOI: 10.1073/pnas.1512118112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1073%2Fpnas.1512118112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=26170285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFGktr3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=E4036-4045&author=N.+Sekiyamaauthor=H.+Arthanariauthor=E.+Papadopoulosauthor=R.+A.+Rodriguez-Miasauthor=G.+Wagnerauthor=M.+Leger-Abraham&title=Molecular+mechanism+of+the+dual+activity+of+4EGI-1%3A+Dissociating+eIF4G+from+eIF4E+but+stabilizing+the+binding+of+unphosphorylated+4E-BP1&doi=10.1073%2Fpnas.1512118112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanism of the dual activity of 4EGI-1: Dissociating eIF4G from eIF4E but stabilizing the binding of unphosphorylated 4E-BP1</span></div><div class="casAuthors">Sekiyama, Naotaka; Arthanari, Haribabu; Papadopoulos, Evangelos; Rodriguez-Mias, Ricard A.; Wagner, Gerhard; Leger-Abraham, Melissa</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">E4036-E4045</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The eIF4E-binding protein (4E-BP) is a phosphorylation-dependent regulator of protein synthesis.  The nonphosphorylated or minimally phosphorylated form binds translation initiation factor 4E (eIF4E), preventing binding of eIF4G and the recruitment of the small ribosomal subunit.  Signaling events stimulate serial phosphorylation of 4E-BP, primarily by mammalian target of rapamycin complex 1 (mTORC1) at residues T37/T46, followed by T70 and S65.  Hyperphosphorylated 4E-BP dissocs. from eIF4E, allowing eIF4E to interact with eIF4G and translation initiation to resume.  Because overexpression of eIF4E is linked to cellular transformation, 4E-BP is a tumor suppressor, and up-regulation of its activity is a goal of interest for cancer therapy.  A recently discovered small mol., eIF4E/eIF4G interaction inhibitor 1 (4EGI-1), disrupts the eIF4E/eIF4G interaction and promotes binding of 4E-BP1 to eIF4E.  Structures of 14- to 16-residue 4E-BP fragments bound to eIF4E contain the eIF4E consensus binding motif, 54YXXXXLΦ60 (motif 1) but lack known phosphorylation sites.  We report here a 2.1-Å crystal structure of mouse eIF4E in complex with m7GTP and with a fragment of human 4E-BP1, extended C-terminally from the consensus-binding motif (4E-BP150-84).  The extension, which includes a proline-turn-helix segment (motif 2) followed by a loop of irregular structure, reveals the location of two phosphorylation sites (S65 and T70).  Our major finding is that the C-terminal extension (motif 3) is crit. to 4E-BP1-mediated cell cycle arrest and that it partially overlaps with the binding site of 4EGI-1.  The binding of 4E-BP1 and 4EGI-1 to eIF4E is therefore not mutually exclusive, and both ligands contribute to shift the equil. toward the inhibition of translation initiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5UX9gpOLePrVg90H21EOLACvtfcHk0lhGSO9dv6_9OQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFGktr3K&md5=4b08a4764b5c8b6557f9266402c00dd2</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1512118112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1512118112%26sid%3Dliteratum%253Aachs%26aulast%3DSekiyama%26aufirst%3DN.%26aulast%3DArthanari%26aufirst%3DH.%26aulast%3DPapadopoulos%26aufirst%3DE.%26aulast%3DRodriguez-Mias%26aufirst%3DR.%2BA.%26aulast%3DWagner%26aufirst%3DG.%26aulast%3DLeger-Abraham%26aufirst%3DM.%26atitle%3DMolecular%2520mechanism%2520of%2520the%2520dual%2520activity%2520of%25204EGI-1%253A%2520Dissociating%2520eIF4G%2520from%2520eIF4E%2520but%2520stabilizing%2520the%2520binding%2520of%2520unphosphorylated%25204E-BP1%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3DE4036%26epage%3D4045%26doi%3D10.1073%2Fpnas.1512118112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lock, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingraham, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maertens, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weledji, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Legius, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konicek, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graff, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cichowski, K.</span></span> <span> </span><span class="NLM_article-title">Cotargeting MNK and MEK kinases induces the regression of NF1-mutant cancers</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">2181</span>– <span class="NLM_lpage">2190</span>, <span class="refDoi"> DOI: 10.1172/JCI85183</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1172%2FJCI85183" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2016&pages=2181-2190&author=R.+Lockauthor=R.+Ingrahamauthor=O.+Maertensauthor=A.+L.+Millerauthor=N.+Weledjiauthor=E.+Legiusauthor=B.+M.+Konicekauthor=S.+C.+Yanauthor=J.+R.+Graffauthor=K.+Cichowski&title=Cotargeting+MNK+and+MEK+kinases+induces+the+regression+of+NF1-mutant+cancers&doi=10.1172%2FJCI85183"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1172%2FJCI85183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI85183%26sid%3Dliteratum%253Aachs%26aulast%3DLock%26aufirst%3DR.%26aulast%3DIngraham%26aufirst%3DR.%26aulast%3DMaertens%26aufirst%3DO.%26aulast%3DMiller%26aufirst%3DA.%2BL.%26aulast%3DWeledji%26aufirst%3DN.%26aulast%3DLegius%26aufirst%3DE.%26aulast%3DKonicek%26aufirst%3DB.%2BM.%26aulast%3DYan%26aufirst%3DS.%2BC.%26aulast%3DGraff%26aufirst%3DJ.%2BR.%26aulast%3DCichowski%26aufirst%3DK.%26atitle%3DCotargeting%2520MNK%2520and%2520MEK%2520kinases%2520induces%2520the%2520regression%2520of%2520NF1-mutant%2520cancers%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2016%26volume%3D126%26spage%3D2181%26epage%3D2190%26doi%3D10.1172%2FJCI85183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cherian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nacro, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poh, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeyaraj, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joy, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwek, Z. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wee, J. L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ong, E. H. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choong, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pendharkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manoharan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chew, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangthongpitag, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ong, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, T. H.</span></span> <span> </span><span class="NLM_article-title">Structure–activity relationship studies of mitogen activated protein kinase interacting kinase (MNK) 1 and 2 and BCR-ABL1 inhibitors targeting chronic myeloid leukemic cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">3063</span>– <span class="NLM_lpage">3078</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01712</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01712" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3063-3078&author=J.+Cherianauthor=K.+Nacroauthor=Z.+Y.+Pohauthor=S.+Guoauthor=D.+A.+Jeyarajauthor=Y.+X.+Wongauthor=M.+Hoauthor=H.+Y.+Yangauthor=J.+K.+Joyauthor=Z.+P.+Kwekauthor=B.+Liuauthor=J.+L.+K.+Weeauthor=E.+H.+Q.+Ongauthor=M.+L.+Choongauthor=A.+Poulsenauthor=M.+A.+Leeauthor=V.+Pendharkarauthor=L.+J.+Dingauthor=V.+Manoharanauthor=Y.+S.+Chewauthor=K.+Sangthongpitagauthor=S.+Limauthor=S.+T.+Ongauthor=J.+Hillauthor=T.+H.+Keller&title=Structure%E2%80%93activity+relationship+studies+of+mitogen+activated+protein+kinase+interacting+kinase+%28MNK%29+1+and+2+and+BCR-ABL1+inhibitors+targeting+chronic+myeloid+leukemic+cells&doi=10.1021%2Facs.jmedchem.5b01712"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01712%26sid%3Dliteratum%253Aachs%26aulast%3DCherian%26aufirst%3DJ.%26aulast%3DNacro%26aufirst%3DK.%26aulast%3DPoh%26aufirst%3DZ.%2BY.%26aulast%3DGuo%26aufirst%3DS.%26aulast%3DJeyaraj%26aufirst%3DD.%2BA.%26aulast%3DWong%26aufirst%3DY.%2BX.%26aulast%3DHo%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DH.%2BY.%26aulast%3DJoy%26aufirst%3DJ.%2BK.%26aulast%3DKwek%26aufirst%3DZ.%2BP.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DWee%26aufirst%3DJ.%2BL.%2BK.%26aulast%3DOng%26aufirst%3DE.%2BH.%2BQ.%26aulast%3DChoong%26aufirst%3DM.%2BL.%26aulast%3DPoulsen%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DM.%2BA.%26aulast%3DPendharkar%26aufirst%3DV.%26aulast%3DDing%26aufirst%3DL.%2BJ.%26aulast%3DManoharan%26aufirst%3DV.%26aulast%3DChew%26aufirst%3DY.%2BS.%26aulast%3DSangthongpitag%26aufirst%3DK.%26aulast%3DLim%26aufirst%3DS.%26aulast%3DOng%26aufirst%3DS.%2BT.%26aulast%3DHill%26aufirst%3DJ.%26aulast%3DKeller%26aufirst%3DT.%2BH.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520studies%2520of%2520mitogen%2520activated%2520protein%2520kinase%2520interacting%2520kinase%2520%2528MNK%2529%25201%2520and%25202%2520and%2520BCR-ABL1%2520inhibitors%2520targeting%2520chronic%2520myeloid%2520leukemic%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3063%26epage%3D3078%26doi%3D10.1021%2Facs.jmedchem.5b01712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanjo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akira, S.</span></span> <span> </span><span class="NLM_article-title">DRAKs, novel serine/threonine kinases related to death-associated protein kinase that trigger apoptosis</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>273</i></span>,  <span class="NLM_fpage">29066</span>– <span class="NLM_lpage">29071</span>, <span class="refDoi"> DOI: 10.1074/jbc.273.44.29066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1074%2Fjbc.273.44.29066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=9786912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADyaK1cXntlaht7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=29066-29071&author=H.+Sanjoauthor=T.+Kawaiauthor=S.+Akira&title=DRAKs%2C+novel+serine%2Fthreonine+kinases+related+to+death-associated+protein+kinase+that+trigger+apoptosis&doi=10.1074%2Fjbc.273.44.29066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">DRAKs, novel serine/threonine kinases related to death-associated protein kinase that trigger apoptosis</span></div><div class="casAuthors">Sanjo, Hideki; Kawai, Taro; Akira, Shizuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">29066-29071</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The present study describes the cloning of two novel serine/threonine kinases termed DRAK1 and DRAK2, whose catalytic domains are related to that of death-assocd. protein kinase, a serine/threonine kinase involved in apoptosis.  Both DRAKs are composed of the N-terminal catalytic domain and the C-terminal domain that is responsible for regulation of kinase activity.  DRAK1 and DRAK2 show 59.7% identity and display ubiquitous expression.  An in vitro kinase assay revealed that both DRAKs are autophosphorylated and phosphorylate myosin light chain as an exogenous substrate, although the kinase activity of DRAK2 is significantly lower than that of DRAK1.  Both DRAKs are exclusively localized to the nucleus.  Furthermore, overexpression of both DRAKs induces the morphol. changes of apoptosis in NIH 3T3 cells, suggesting the role of DRAKs in apoptotic signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmFXOHrs4s2bVg90H21EOLACvtfcHk0lhGSO9dv6_9OQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXntlaht7s%253D&md5=6b17b0e7dd8e61ec3b435b245cbcb627</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1074%2Fjbc.273.44.29066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.273.44.29066%26sid%3Dliteratum%253Aachs%26aulast%3DSanjo%26aufirst%3DH.%26aulast%3DKawai%26aufirst%3DT.%26aulast%3DAkira%26aufirst%3DS.%26atitle%3DDRAKs%252C%2520novel%2520serine%252Fthreonine%2520kinases%2520related%2520to%2520death-associated%2520protein%2520kinase%2520that%2520trigger%2520apoptosis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D29066%26epage%3D29071%26doi%3D10.1074%2Fjbc.273.44.29066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hever, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niemaszyk, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haghkerdar, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yanco, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyrouthy, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerley-Hamilton, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freemantle, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spinella, M. J.</span></span> <span> </span><span class="NLM_article-title">Serine/threonine kinase 17A is a novel p53 target gene and modulator of cisplatin toxicity and reactive oxygen species in testicular cancer cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">19381</span>– <span class="NLM_lpage">19391</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.218040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1074%2Fjbc.M111.218040" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=19381-19391&author=P.+Maoauthor=M.+P.+Heverauthor=L.+M.+Niemaszykauthor=J.+M.+Haghkerdarauthor=E.+G.+Yancoauthor=D.+Desaiauthor=M.+J.+Beyrouthyauthor=J.+S.+Kerley-Hamiltonauthor=S.+J.+Freemantleauthor=M.+J.+Spinella&title=Serine%2Fthreonine+kinase+17A+is+a+novel+p53+target+gene+and+modulator+of+cisplatin+toxicity+and+reactive+oxygen+species+in+testicular+cancer+cells&doi=10.1074%2Fjbc.M111.218040"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.218040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.218040%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DP.%26aulast%3DHever%26aufirst%3DM.%2BP.%26aulast%3DNiemaszyk%26aufirst%3DL.%2BM.%26aulast%3DHaghkerdar%26aufirst%3DJ.%2BM.%26aulast%3DYanco%26aufirst%3DE.%2BG.%26aulast%3DDesai%26aufirst%3DD.%26aulast%3DBeyrouthy%26aufirst%3DM.%2BJ.%26aulast%3DKerley-Hamilton%26aufirst%3DJ.%2BS.%26aulast%3DFreemantle%26aufirst%3DS.%2BJ.%26aulast%3DSpinella%26aufirst%3DM.%2BJ.%26atitle%3DSerine%252Fthreonine%2520kinase%252017A%2520is%2520a%2520novel%2520p53%2520target%2520gene%2520and%2520modulator%2520of%2520cisplatin%2520toxicity%2520and%2520reactive%2520oxygen%2520species%2520in%2520testicular%2520cancer%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D19381%26epage%3D19391%26doi%3D10.1074%2Fjbc.M111.218040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hever-Jardine, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahme, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biswal, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fadul, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaur, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Israel, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spinella, M. J.</span></span> <span> </span><span class="NLM_article-title">Serine/threonine kinase 17A is a novel candidate for therapeutic targeting in glioblastoma</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e81803</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0081803</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1371%2Fjournal.pone.0081803" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e81803&author=P.+Maoauthor=M.+P.+Hever-Jardineauthor=G.+J.+Rahmeauthor=E.+Yangauthor=J.+Tamauthor=A.+Kodaliauthor=B.+Biswalauthor=C.+E.+Fadulauthor=A.+Gaurauthor=M.+A.+Israelauthor=M.+J.+Spinella&title=Serine%2Fthreonine+kinase+17A+is+a+novel+candidate+for+therapeutic+targeting+in+glioblastoma&doi=10.1371%2Fjournal.pone.0081803"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0081803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0081803%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DP.%26aulast%3DHever-Jardine%26aufirst%3DM.%2BP.%26aulast%3DRahme%26aufirst%3DG.%2BJ.%26aulast%3DYang%26aufirst%3DE.%26aulast%3DTam%26aufirst%3DJ.%26aulast%3DKodali%26aufirst%3DA.%26aulast%3DBiswal%26aufirst%3DB.%26aulast%3DFadul%26aufirst%3DC.%2BE.%26aulast%3DGaur%26aufirst%3DA.%26aulast%3DIsrael%26aufirst%3DM.%2BA.%26aulast%3DSpinella%26aufirst%3DM.%2BJ.%26atitle%3DSerine%252Fthreonine%2520kinase%252017A%2520is%2520a%2520novel%2520candidate%2520for%2520therapeutic%2520targeting%2520in%2520glioblastoma%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De81803%26doi%3D10.1371%2Fjournal.pone.0081803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. J.</span></span> <span> </span><span class="NLM_article-title">Cytoplasmic DRAK1 overexpressed in head and neck cancers inhibits TGF-beta1 tumor suppressor activity by binding to SMAD3 to interrupt its complex formation with SMAD4</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">5037</span>– <span class="NLM_lpage">5045</span>, <span class="refDoi"> DOI: 10.1038/onc.2014.423</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1038%2Fonc.2014.423" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=5037-5045&author=Y.+Parkauthor=W.+Kimauthor=J.+M.+Leeauthor=J.+Parkauthor=J.+K.+Choauthor=K.+Pangauthor=J.+Leeauthor=D.+Kimauthor=S.+W.+Parkauthor=K.+M.+Yangauthor=S.+J.+Kim&title=Cytoplasmic+DRAK1+overexpressed+in+head+and+neck+cancers+inhibits+TGF-beta1+tumor+suppressor+activity+by+binding+to+SMAD3+to+interrupt+its+complex+formation+with+SMAD4&doi=10.1038%2Fonc.2014.423"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1038%2Fonc.2014.423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2014.423%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DW.%26aulast%3DLee%26aufirst%3DJ.%2BM.%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DCho%26aufirst%3DJ.%2BK.%26aulast%3DPang%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DPark%26aufirst%3DS.%2BW.%26aulast%3DYang%26aufirst%3DK.%2BM.%26aulast%3DKim%26aufirst%3DS.%2BJ.%26atitle%3DCytoplasmic%2520DRAK1%2520overexpressed%2520in%2520head%2520and%2520neck%2520cancers%2520inhibits%2520TGF-beta1%2520tumor%2520suppressor%2520activity%2520by%2520binding%2520to%2520SMAD3%2520to%2520interrupt%2520its%2520complex%2520formation%2520with%2520SMAD4%26jtitle%3DOncogene%26date%3D2015%26volume%3D34%26spage%3D5037%26epage%3D5045%26doi%3D10.1038%2Fonc.2014.423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hagiwara, M.</span></span> <span> </span><span class="NLM_article-title">Alternative splicing: a new drug target of the post-genome era</span>. <i>Biochim. Biophys. Acta, Proteins Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>1754</i></span>,  <span class="NLM_fpage">324</span>– <span class="NLM_lpage">331</span>, <span class="refDoi"> DOI: 10.1016/j.bbapap.2005.09.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1016%2Fj.bbapap.2005.09.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=16260193" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlags7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1754&publication_year=2005&pages=324-331&author=M.+Hagiwara&title=Alternative+splicing%3A+a+new+drug+target+of+the+post-genome+era&doi=10.1016%2Fj.bbapap.2005.09.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Alternative splicing: A new drug target of the post-genome era</span></div><div class="casAuthors">Hagiwara, Masatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1754</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">324-331</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Alternative splicing allows for the creation of multiple distinct mRNA transcripts from a given gene in a multicellular organism.  Pre-mRNA splicing is catalyzed by a multi-mol. complex, including serine/arginine-rich (SR) proteins, which are highly phosphorylated in living cells, and thought to play crucial roles in spliceosomal formation and in the regulation of alternative splicing.  Recently, reports of low mol. compds., which alter splicing pattern of genes, have been accumulated.  A benzothiazole compd. TG003, a kinase inhibitor that targets Clk1 and Clk4, suppressed dissocn. of nuclear speckles, altered the splicing patterns, and rescued the embryonic defects induced by excessive Clk activity.  The emerging inhibitors of the signal transduction pathways regulating pre-mRNA alternative splicing may open the way to therapies against diseases caused by missplicing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqz8eRhyUntS7Vg90H21EOLACvtfcHk0lizc06Ll132RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlags7fL&md5=d2f7ac7d230d7145395f7a76907e1593</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2005.09.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2005.09.010%26sid%3Dliteratum%253Aachs%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DAlternative%2520splicing%253A%2520a%2520new%2520drug%2520target%2520of%2520the%2520post-genome%2520era%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2005%26volume%3D1754%26spage%3D324%26epage%3D331%26doi%3D10.1016%2Fj.bbapap.2005.09.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petsalaki, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zachos, G.</span></span> <span> </span><span class="NLM_article-title">Clks 1, 2 and 4 prevent chromatin breakage by regulating the aurora b-dependent abscission checkpoint</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">11451</span>, <span class="refDoi"> DOI: 10.1038/ncomms11451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1038%2Fncomms11451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=27126587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC28XntVChs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=11451&author=E.+Petsalakiauthor=G.+Zachos&title=Clks+1%2C+2+and+4+prevent+chromatin+breakage+by+regulating+the+aurora+b-dependent+abscission+checkpoint&doi=10.1038%2Fncomms11451"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Clks 1, 2 and 4 prevent chromatin breakage by regulating the Aurora B-dependent abscission checkpoint</span></div><div class="casAuthors">Petsalaki, Eleni; Zachos, George</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11451</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">When chromatin is trapped at the intercellular bridge, cells delay completion of cytokinesis (abscission) to prevent chromosome breakage.  Here we show that inhibition of Cdc-like kinases (Clks) 1, 2 or 4 accelerates midbody resoln. in normally segregating cells and correlates with premature abscission, chromatin breakage and generation of DNA damage in cytokinesis with trapped chromatin.  Clk1, Clk2 and Clk4 localize to the midbody in an interdependent manner, assoc. with Aurora B kinase and are required for Aurora B-serine 331 (S331) phosphorylation and complete Aurora B activation in late cytokinesis.  Phosphorylated Aurora B-S331 localizes to the midbody center and is required for phosphorylation and optimal localization of the abscission protein Chmp4c.  In addn., expression of phosphomimetic mutants Aurora B-S331E or Chmp4c-S210D delays midbody disassembly and prevents chromatin breakage in Clk-deficient cells.  We propose that Clks 1, 2 and 4 impose the abscission checkpoint by phosphorylating Aurora B-S331 at the midbody.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFOFFAoNsM2rVg90H21EOLACvtfcHk0lgI88sERrALQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntVChs7c%253D&md5=5894acf24c2720cf4c020fceaf1e34e3</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1038%2Fncomms11451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms11451%26sid%3Dliteratum%253Aachs%26aulast%3DPetsalaki%26aufirst%3DE.%26aulast%3DZachos%26aufirst%3DG.%26atitle%3DClks%25201%252C%25202%2520and%25204%2520prevent%2520chromatin%2520breakage%2520by%2520regulating%2520the%2520aurora%2520b-dependent%2520abscission%2520checkpoint%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D11451%26doi%3D10.1038%2Fncomms11451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lenz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emre, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohlhammer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dave, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carty, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaffer, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenwald, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ott, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller-Hermelink, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gascoyne, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connors, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaffe, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delabie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smeland, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rimsza, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weisenburger, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staudt, L. M.</span></span> <span> </span><span class="NLM_article-title">Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">13520</span>– <span class="NLM_lpage">13525</span>, <span class="refDoi"> DOI: 10.1073/pnas.0804295105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1073%2Fpnas.0804295105" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=13520-13525&author=G.+Lenzauthor=G.+W.+Wrightauthor=N.+C.+Emreauthor=H.+Kohlhammerauthor=S.+S.+Daveauthor=R.+E.+Davisauthor=S.+Cartyauthor=L.+T.+Lamauthor=A.+L.+Shafferauthor=W.+Xiaoauthor=J.+Powellauthor=A.+Rosenwaldauthor=G.+Ottauthor=H.+K.+Muller-Hermelinkauthor=R.+D.+Gascoyneauthor=J.+M.+Connorsauthor=E.+Campoauthor=E.+S.+Jaffeauthor=J.+Delabieauthor=E.+B.+Smelandauthor=L.+M.+Rimszaauthor=R.+I.+Fisherauthor=D.+D.+Weisenburgerauthor=W.+C.+Chanauthor=L.+M.+Staudt&title=Molecular+subtypes+of+diffuse+large+B-cell+lymphoma+arise+by+distinct+genetic+pathways&doi=10.1073%2Fpnas.0804295105"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0804295105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0804295105%26sid%3Dliteratum%253Aachs%26aulast%3DLenz%26aufirst%3DG.%26aulast%3DWright%26aufirst%3DG.%2BW.%26aulast%3DEmre%26aufirst%3DN.%2BC.%26aulast%3DKohlhammer%26aufirst%3DH.%26aulast%3DDave%26aufirst%3DS.%2BS.%26aulast%3DDavis%26aufirst%3DR.%2BE.%26aulast%3DCarty%26aufirst%3DS.%26aulast%3DLam%26aufirst%3DL.%2BT.%26aulast%3DShaffer%26aufirst%3DA.%2BL.%26aulast%3DXiao%26aufirst%3DW.%26aulast%3DPowell%26aufirst%3DJ.%26aulast%3DRosenwald%26aufirst%3DA.%26aulast%3DOtt%26aufirst%3DG.%26aulast%3DMuller-Hermelink%26aufirst%3DH.%2BK.%26aulast%3DGascoyne%26aufirst%3DR.%2BD.%26aulast%3DConnors%26aufirst%3DJ.%2BM.%26aulast%3DCampo%26aufirst%3DE.%26aulast%3DJaffe%26aufirst%3DE.%2BS.%26aulast%3DDelabie%26aufirst%3DJ.%26aulast%3DSmeland%26aufirst%3DE.%2BB.%26aulast%3DRimsza%26aufirst%3DL.%2BM.%26aulast%3DFisher%26aufirst%3DR.%2BI.%26aulast%3DWeisenburger%26aufirst%3DD.%2BD.%26aulast%3DChan%26aufirst%3DW.%2BC.%26aulast%3DStaudt%26aufirst%3DL.%2BM.%26atitle%3DMolecular%2520subtypes%2520of%2520diffuse%2520large%2520B-cell%2520lymphoma%2520arise%2520by%2520distinct%2520genetic%2520pathways%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D13520%26epage%3D13525%26doi%3D10.1073%2Fpnas.0804295105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staudt, L. M.</span></span> <span> </span><span class="NLM_article-title">Targeting pathological B cell receptor signalling in lymphoid malignancies</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">229</span>– <span class="NLM_lpage">243</span>, <span class="refDoi"> DOI: 10.1038/nrd3937</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1038%2Fnrd3937" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=229-243&author=R.+M.+Youngauthor=L.+M.+Staudt&title=Targeting+pathological+B+cell+receptor+signalling+in+lymphoid+malignancies&doi=10.1038%2Fnrd3937"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1038%2Fnrd3937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3937%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%2BM.%26aulast%3DStaudt%26aufirst%3DL.%2BM.%26atitle%3DTargeting%2520pathological%2520B%2520cell%2520receptor%2520signalling%2520in%2520lymphoid%2520malignancies%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26spage%3D229%26epage%3D243%26doi%3D10.1038%2Fnrd3937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, P.</span></span> <span> </span><span class="NLM_article-title">Post-transcriptional regulons coordinate the initiation and resolution of inflammation</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">24</span>– <span class="NLM_lpage">35</span>, <span class="refDoi"> DOI: 10.1038/nri2685</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1038%2Fnri2685" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=20029446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsF2hsL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=24-35&author=P.+Anderson&title=Post-transcriptional+regulons+coordinate+the+initiation+and+resolution+of+inflammation&doi=10.1038%2Fnri2685"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Post-transcriptional regulons coordinate the initiation and resolution of inflammation</span></div><div class="casAuthors">Anderson, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">24-35</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Transcriptional control mechanisms chart the course of the inflammatory response by synthesizing mRNAs encoding proteins that promote or inhibit inflammation.  Because these mRNAs can be long-lived, turning off their synthesis does not rapidly stop or change the direction of inflammation.  Post-transcriptional mechanisms that modify mRNA stability and/or translation provide more rapid and flexible control of this process and are particularly important in coordinating the initiation and resoln. of inflammation.  Here, the author reviews the surprising variety of post-transcriptional control mechanisms that regulate the initiation and resoln. of inflammation and discuss how these mechanisms are integrated to coordinate this essential process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDDA-upgugSbVg90H21EOLACvtfcHk0lgI88sERrALQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsF2hsL7E&md5=57f2eee1e6b9d8049d8fccdbfef81faa</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fnri2685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2685%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DP.%26atitle%3DPost-transcriptional%2520regulons%2520coordinate%2520the%2520initiation%2520and%2520resolution%2520of%2520inflammation%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2010%26volume%3D10%26spage%3D24%26epage%3D35%26doi%3D10.1038%2Fnri2685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palucka, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coussens, L. M.</span></span> <span> </span><span class="NLM_article-title">The basis of oncoimmunology</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>164</i></span>,  <span class="NLM_fpage">1233</span>– <span class="NLM_lpage">1247</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2016.01.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1016%2Fj.cell.2016.01.049" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2016&pages=1233-1247&author=A.+K.+Paluckaauthor=L.+M.+Coussens&title=The+basis+of+oncoimmunology&doi=10.1016%2Fj.cell.2016.01.049"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2016.01.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2016.01.049%26sid%3Dliteratum%253Aachs%26aulast%3DPalucka%26aufirst%3DA.%2BK.%26aulast%3DCoussens%26aufirst%3DL.%2BM.%26atitle%3DThe%2520basis%2520of%2520oncoimmunology%26jtitle%3DCell%26date%3D2016%26volume%3D164%26spage%3D1233%26epage%3D1247%26doi%3D10.1016%2Fj.cell.2016.01.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robichaud, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Rincon, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huor, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alain, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petruccelli, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hearnden, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goncalves, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grotegut, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spruck, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furic, L.</span></span> <span> </span><span class="NLM_article-title">Phosphorylation of eIF4E promotes EMT and metastasis via translational control of SNAIL and MMP-3</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">2032</span>– <span class="NLM_lpage">2042</span>, <span class="refDoi"> DOI: 10.1038/onc.2014.146</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1038%2Fonc.2014.146" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=2032-2042&author=N.+Robichaudauthor=S.+V.+Del+Rinconauthor=B.+Huorauthor=T.+Alainauthor=L.+A.+Petruccelliauthor=J.+Hearndenauthor=C.+Goncalvesauthor=S.+Grotegutauthor=C.+H.+Spruckauthor=L.+Furic&title=Phosphorylation+of+eIF4E+promotes+EMT+and+metastasis+via+translational+control+of+SNAIL+and+MMP-3&doi=10.1038%2Fonc.2014.146"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1038%2Fonc.2014.146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2014.146%26sid%3Dliteratum%253Aachs%26aulast%3DRobichaud%26aufirst%3DN.%26aulast%3DDel%2BRincon%26aufirst%3DS.%2BV.%26aulast%3DHuor%26aufirst%3DB.%26aulast%3DAlain%26aufirst%3DT.%26aulast%3DPetruccelli%26aufirst%3DL.%2BA.%26aulast%3DHearnden%26aufirst%3DJ.%26aulast%3DGoncalves%26aufirst%3DC.%26aulast%3DGrotegut%26aufirst%3DS.%26aulast%3DSpruck%26aufirst%3DC.%2BH.%26aulast%3DFuric%26aufirst%3DL.%26atitle%3DPhosphorylation%2520of%2520eIF4E%2520promotes%2520EMT%2520and%2520metastasis%2520via%2520translational%2520control%2520of%2520SNAIL%2520and%2520MMP-3%26jtitle%3DOncogene%26date%3D2015%26volume%3D34%26spage%3D2032%26epage%3D2042%26doi%3D10.1038%2Fonc.2014.146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Topisirovic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz-Gutierrez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borden, K. L.</span></span> <span> </span><span class="NLM_article-title">Phosphorylation of the eukaryotic translation initiation factor eIF4E contributes to its transformation and mRNA transport activities</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">8639</span>– <span class="NLM_lpage">8642</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-04-2677</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=10.1158%2F0008-5472.CAN-04-2677" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=8639-8642&author=I.+Topisirovicauthor=M.+Ruiz-Gutierrezauthor=K.+L.+Borden&title=Phosphorylation+of+the+eukaryotic+translation+initiation+factor+eIF4E+contributes+to+its+transformation+and+mRNA+transport+activities&doi=10.1158%2F0008-5472.CAN-04-2677"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-2677&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-2677%26sid%3Dliteratum%253Aachs%26aulast%3DTopisirovic%26aufirst%3DI.%26aulast%3DRuiz-Gutierrez%26aufirst%3DM.%26aulast%3DBorden%26aufirst%3DK.%2BL.%26atitle%3DPhosphorylation%2520of%2520the%2520eukaryotic%2520translation%2520initiation%2520factor%2520eIF4E%2520contributes%2520to%2520its%2520transformation%2520and%2520mRNA%2520transport%2520activities%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D8639%26epage%3D8642%26doi%3D10.1158%2F0008-5472.CAN-04-2677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reich, S. H.</span>; <span class="NLM_string-name">Bleckman, T. M.</span>; <span class="NLM_string-name">Kephart, S. E.</span>; <span class="NLM_string-name">Romines, W. H.</span>; <span class="NLM_string-name">Wallace, M. B.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Disubstituted Indazole Compounds as Cyclin Dependent Kinase Inhibitors and Methods of Inhibiting Cell Proliferation</span>. <span class="NLM_patent">WO2001053268</span>, <span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=S.+H.+Reich&author=T.+M.+Bleckman&author=S.+E.+Kephart&author=W.+H.+Romines&author=M.+B.+Wallace&title=Synthesis+of+Disubstituted+Indazole+Compounds+as+Cyclin+Dependent+Kinase+Inhibitors+and+Methods+of+Inhibiting+Cell+Proliferation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DReich%26aufirst%3DS.%2BH.%26atitle%3DSynthesis%2520of%2520Disubstituted%2520Indazole%2520Compounds%2520as%2520Cyclin%2520Dependent%2520Kinase%2520Inhibitors%2520and%2520Methods%2520of%2520Inhibiting%2520Cell%2520Proliferation%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konze, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meslamani, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrowsmith, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaniskan, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vedadi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship studies for enhancer of zeste homologue 2 (EZH2) and enhancer of zeste homologue 1 (EZH1) inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">7617</span>– <span class="NLM_lpage">7633</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00855</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00855" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Gmtr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7617-7633&author=X.+Yangauthor=F.+Liauthor=K.+D.+Konzeauthor=J.+Meslamaniauthor=A.+Maauthor=P.+J.+Brownauthor=M.+M.+Zhouauthor=C.+H.+Arrowsmithauthor=H.+U.+Kaniskanauthor=M.+Vedadiauthor=J.+Jin&title=Structure-activity+relationship+studies+for+enhancer+of+zeste+homologue+2+%28EZH2%29+and+enhancer+of+zeste+homologue+1+%28EZH1%29+inhibitors&doi=10.1021%2Facs.jmedchem.6b00855"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationship Studies for Enhancer of Zeste Homologue 2 (EZH2) and Enhancer of Zeste Homologue 1 (EZH1) Inhibitors</span></div><div class="casAuthors">Yang, Xiaobao; Li, Fengling; Konze, Kyle D.; Meslamani, Jamel; Ma, Anqi; Brown, Peter J.; Zhou, Ming-Ming; Arrowsmith, Cheryl H.; Kaniskan, H. Umit; Vedadi, Masoud; Jin, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7617-7633</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">EZH2 or EZH1 (enhancer of zeste homolog 2 or 1) is the catalytic subunit of polycomb repressive complex 2 (PRC2) that catalyzes methylation of histone H3 lysine 27 (H3K27).  PRC2 hyperactivity and/or hypertrimethylation of H3K27 are assocd. with numerous human cancers, therefore inhibition of PRC2 complex has emerged as a promising therapeutic approach.  Recent studies have shown that EZH2 and EZH1 are not functionally redundant and inhibition of both EZH2 and EZH1 is necessary to block the progression of certain cancers such as MLL (mixed-lineage leukemia)-rearranged leukemias.  Despite the significant advances in discovery of EZH2 inhibitors, there has not been a systematic structure-activity relation (SAR) study to investigate the selectivity between EZH2 and EZH1 inhibition.  Here, the authors report the authors SAR studies that focus on modifications to various regions of the EZH2/1 inhibitor UNC1999 (5) to investigate the impact of the structural changes on EZH2 and EZH1 inhibition and selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7AOr5A2kOH7Vg90H21EOLACvtfcHk0lgjeo8oMApnLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Gmtr3P&md5=14d5dba978adc28baaf2b781ae9a1541</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00855&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00855%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DKonze%26aufirst%3DK.%2BD.%26aulast%3DMeslamani%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DA.%26aulast%3DBrown%26aufirst%3DP.%2BJ.%26aulast%3DZhou%26aufirst%3DM.%2BM.%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DKaniskan%26aufirst%3DH.%2BU.%26aulast%3DVedadi%26aufirst%3DM.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DStructure-activity%2520relationship%2520studies%2520for%2520enhancer%2520of%2520zeste%2520homologue%25202%2520%2528EZH2%2529%2520and%2520enhancer%2520of%2520zeste%2520homologue%25201%2520%2528EZH1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7617%26epage%3D7633%26doi%3D10.1021%2Facs.jmedchem.6b00855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bilodeau, M. T.</span>; <span class="NLM_string-name">Duggan, M. E.</span>; <span class="NLM_string-name">Hartnett, J. C.</span>; <span class="NLM_string-name">Lindsley, C. W.</span>; <span class="NLM_string-name">Wu, Z.</span>; <span class="NLM_string-name">Zhao, Z.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of Akt Activity</span>. U.S. Patent <span class="NLM_patent">7,579,355</span>, August 5, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=M.+T.+Bilodeau&author=M.+E.+Duggan&author=J.+C.+Hartnett&author=C.+W.+Lindsley&author=Z.+Wu&author=Z.+Zhao&title=Inhibitors+of+Akt+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26atitle%3DInhibitors%2520of%2520Akt%2520Activity%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sprengeler, P. A.</span>; <span class="NLM_string-name">Reich, S. H.</span>; <span class="NLM_string-name">Ernst, J. T.</span>; <span class="NLM_string-name">Webber, S. E.</span>; <span class="NLM_string-name">Shaghafi, M.</span>; <span class="NLM_string-name">Murphy, D.</span>; <span class="NLM_string-name">Tran, C.</span></span> <span> </span><span class="NLM_article-title">Preparation of Isoindoline, Azaisoindoline, Dihydroindenone and Dihydroazaindenone Inhibitors of MNK1 and MNK2</span>. <span class="NLM_patent">WO 2017075394</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=P.+A.+Sprengeler&author=S.+H.+Reich&author=J.+T.+Ernst&author=S.+E.+Webber&author=M.+Shaghafi&author=D.+Murphy&author=C.+Tran&title=Preparation+of+Isoindoline%2C+Azaisoindoline%2C+Dihydroindenone+and+Dihydroazaindenone+Inhibitors+of+MNK1+and+MNK2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSprengeler%26aufirst%3DP.%2BA.%26atitle%3DPreparation%2520of%2520Isoindoline%252C%2520Azaisoindoline%252C%2520Dihydroindenone%2520and%2520Dihydroazaindenone%2520Inhibitors%2520of%2520MNK1%2520and%2520MNK2%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CJE" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CJE','PDB','6CJE'); return false;">PDB: 6CJE</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CJW" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CJW','PDB','6CJW'); return false;">PDB: 6CJW</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CJH" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CJH','PDB','6CJH'); return false;">PDB: 6CJH</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CJ5" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CJ5','PDB','6CJ5'); return false;">PDB: 6CJ5</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CJY" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CJY','PDB','6CJY'); return false;">PDB: 6CJY</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CK3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CK3','PDB','6CK3'); return false;">PDB: 6CK3</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CKI" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CKI','PDB','6CKI'); return false;">PDB: 6CKI</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CK6" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CK6','PDB','6CK6'); return false;">PDB: 6CK6</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-4"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i47"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01795">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_54037"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01795">10.1021/acs.jmedchem.7b01795</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01795/suppl_file/jm7b01795_si_001.csv">CSV</a>)</p></li><li><p class="inline">Additional data regarding <i>in vitro</i> assays, <i>in vivo</i> efficacy, pharmacokinetic data, MNK2 protein expression, purification, crystallization, data collection, structure solution and refinement, characterization data, <sup>13</sup>C NMR, and HPLC for compounds <b>2</b>–<b>26</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01795/suppl_file/jm7b01795_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01795/suppl_file/jm7b01795_si_001.csv">jm7b01795_si_001.csv (1.19 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01795/suppl_file/jm7b01795_si_002.pdf">jm7b01795_si_002.pdf (8.27 MB)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">New protein–ligand coordinates have been deposited in the PDB with codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CJ5">6CJ5</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CJE">6CJE</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CJH">6CJH</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CJW">6CJW</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CJY">6CJY</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CK3">6CK3</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CK6">6CK6</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CKI">6CKI</a>.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01795&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-8%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01795%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01795" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                14MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799b9a88bad32b5","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
